Characterisation of two calmodulin-related calcium sensors, CaBP7 and CaBP8 by McCue, Hannah
    
Characterisation  of  Two  Calmodulin-­‐
Related  Calcium  Sensors,    
CaBP7  and  CaBP8  
  
  




Thesis  submitted  in  accordance  with  the  
requirements  of  the  University  of  Liverpool  for  




   i  
Abstract  
The  CaBPs   are   a   family  of   small   EF-­‐hand-­‐containing   calcium  binding  proteins  with  
limited   homology   to   calmodulin   (CaM).   The   family   comprises   seven   genes   with  
alternative  splicing  giving  rise  to  a  greater  number  of  protein  variants.  Two  distinct  
groups   exist   within   the   CaBP   family   based   on   differences   in   their   cation   binding  
properties  and  domain  organization:  CaBPs  1-­‐5  and  CaBP7  &  8.  CaBPs  1-­‐5   interact  
with  a  number  of  known  CaM  target  proteins  but  generally  exert  unique  regulatory  
roles   and   have   been   implicated   in   the   regulation   of   numerous   Ca2+-­‐channels.   A  
number   of   interacting   binding   partners   have   also   been   identified   which   do   not  
overlap  with  those  of  CaM  and  knockout  studies  have  revealed  non-­‐redundant  roles  
for  CaBP4  and  CaBP5.  Much  less  is  known  about  the  functions  of  CaBP7  and  CaBP8  
with   only   a   direct   interaction   with   phosphatidylinositol   4-­‐kinase   III   ?? ?????III??  
having  been  characterized   in  detail.   The   research  presented   in   this   thesis   focused  
on  the  less  well  characterised  members  of  this  protein  family,  CaBP7  and  CaBP8.  
  
Bioinformatic   analyses   revealed   that   CaBP7   and   CaBP8   form   a   distinct   group   of  
calcium   sensors   from   the   rest   of   the   CaBP   family   and   are   highly   conserved  
throughout   evolution.   Examination   of   CaBP   sequences   present   in   species  
representing   important   evolutionary   nodes   indicated   that   the   CaBP   family   first  
arose   with   the   appearance   of   early   vertebrates.   The   primordial   CaBP   family  
members,  CaBP1S  and  CaBP8,  were  identified  in  lamprey,  the  closest  living  relative  
to  the  common  vertebrate  ancestor.  The  expansion  in  the  number  of  CaBP  proteins  
from  lamprey  to  mammals  largely  coincides  with  a  whole  genome  duplication  event  
occurring  before   the  divergence  of  cartilaginous   fish.  A  transient  expansion  of  the  
group  encompassing  CaBPs1-­‐5  between  the  divergence  of  cartilaginous  fish  and  the  
emergence  of  bony  fish  is  also  apparent.  
  
Examination  of   the  targeting  mechanisms  of  CaBP7  and  CaBP8  demonstrated  that  
these  proteins  form  a  unique  class  of  calcium  sensors  which  associate  with  cellular  
membranes   via   a   C-­‐terminal   tail   anchor.   The   membrane   topology   of   CaBP7   and  
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CaBP8   was   found   to   be   characteristic   of   the   tail   anchored   class   of   integral  
membrane   proteins   and   was   consistent   with   the   previously   reported   interaction  
????? ???? ?????????? ??????? ?????????? ???????? ???????????? ??? ?????? ????????????
distributions  revealed  that  CaBP7  and  CaBP8  localise  to  the  trans-­‐Golgi  network  and  
to   vesicles  which  were  positive   for  markers   of   the   late   endosomal   and   lysosomal  
pathway.   This   is   the   first   reported   instance   of   a   CaM-­‐related   calcium   sensor  
localising  to  membranes  of  acidic  compartments.    
  
CaBP7  also  co-­‐localised  with  markers  of   late  endosomes  and  lysosomes  in  dividing  
cells.   These   CaBP7   positive   vesicles   redistributed   to   the   vicinity   of   the   interzonal  
microtubules   and   opposite   poles   of   the   spindle   during   cytokinesis.   In   accordance  
with  previous  reports,  knockdown  of  CaBP7  in  HeLa  cells  resulted  in  an  increase  in  
the  number  of  binucleate  cells,   inferring  that  CaBP7  plays  an  important  role  in  the  
regulation   of   cytokinesis.   CaBP7  was   shown   to   co-­‐localise  with   VAMP7,   a   protein  
known   to   be   important   for   Ca2+-­‐regulated   lysosomal   exocytosis   and   also   for   the  
completion   of   cytokinesis.   In   addition   CaBP7   localised   to   VSVG   positive   vesicles  
which   have   been   previously   shown   to   directly   dock   and   fuse   with   the   plasma  
membrane   at   the   midzone.   Lysosomes   are   emerging   as   important   platforms   for  
Ca2+-­‐signalling,  and  proteins  important  for  the  release  of  lysosomal  Ca2+  stores  have  
also  been  implicated  in  mitosis.  This  may  suggest  a  role  for  CaBP7  in  the  regulation  
of  Ca2+  signalling  processes  at  the  lysosomal  membrane  during  both  interphase  and  
in  dividing  cells.    
  
Finally  the  use  of  nuclear  magnetic  resonance  (NMR)  spectroscopy  led  to  the  partial  
backbone   and   side   chain   assignment   of   a   100   amino   acid  N-­‐terminal   fragment  of  
CaBP7.  Using  this  data  the  secondary  structure  of  this  fragment  was  calculated  and  
closely   resembled  that  of  Ca2+-­‐bound  CaM  and  CaBP1S  N-­‐termini.   Spectra   for  apo  
CaBP7  were   distinct   from   that   of   Ca2+-­‐saturated   CaBP7   implying   that   the   protein  
undergoes  a  significant  conformational  change  upon  Ca2+  binding.   In  addition,   the  
use  of  native  PAGE  demonstrated  a  shift  in  mobility  of  CaBP7  1-­‐100  upon  addition  
of   Ca2+   but   not  Mg2+.   Continued   NMR   analysis   of   CaBP7   will   be   required   for   the  
determination  of  a  high-­‐resolution  structure  for  this  protein.  
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CCPN   Collaborative  computing  project  for  NMR  
CDF   Calcium  dependent  facilitation  
CDI   Calcium  dependent  inactivation  
CHMP   Charged  MVB  protein  
CHO   Chinese  hamster  ovary  
CICR   Calcium-­‐induced  calcium-­‐release  
Cl-­‐   Chloride  ion  
CSI   Chemical  shift  index  
CSNB   Congenital  Stationary  night  blindness  
CSV   Constitutive  secretory  vesicle  
Cv   Voltage  dependent  calcium  channel  
D2R   Dopamine  D2  receptor  
DAG   Diacylglycerol  
DANGLE   Dihedral  angles  from  global  likelihood  estimate  
DAPI   4',  6-­‐diamidino-­‐2-­‐phenylindole  
DMEM   Dulbecco's  Modified  Eagle  Medium  
   x  
DMSO   Dimethyl  Sulphoxide  
DNA   Deoxyribonucleic  acid  
dNTP   Deoxyribonucleotide  triphosphate  
DREAM   Downstream  regulatory  element  antagonist  modulator  
EBI   European  bioinformatics  institute  
ECFP   Enhanced  cyan  fluorescent  protein  
ECL   Enhanced  chemiluminescence  
EDTA   Ethylenediamine  tetraacetic  acid  
EF1,  EF2,  EF3,  EF4   EF-­‐hand  1,  EF-­‐hand  2,  EF-­‐hand  3,  EF-­‐hand  4  
EGFP   Enhanced  green  fluorescent  protein  
EGTA   Ethylene  glycol  tetraacetic  acid  
EMBL   European  molecular  biology  laboratory  
ER   Endoplasmic  reticulum  
ERG   Electroretinography  
ESCRT   Endosomal  sorting  complexes  required  for  transport  
EYFP   Enhanced  yellow  fluorescent  protein  
FBS   Foetal  bovine  serum  
FITC   Fluorescein  isothiocyanate  
FRET   Fluorescence  resonance  energy  transfer  
GABA   ?-­‐amino-­‐butyric  acid  
GAPDH   Glyceraldehyde  3-­‐phosphate  dehydrogenase  
GC   Guanylyl  cyclase  
GCAP   Guanylyl  cyclase  activating  protein  
GPCR   G-­‐protein  coupled  receptor  
GST   Glutathione  S-­‐transferase  
GTP   Guanosine  triphosphate  
His6   Hexa-­‐histidine  
HRS   Hepatocyte  growth  factor-­‐regulated  tyrosine  kinase  substrate  
HSQC   Heteronuclear  single-­‐quantum  correlation    
IL1RAPL   Interleukin-­‐1  receptor  accessory  protein-­‐like  
IP3   Inositol  1,4,5-­‐trisphosphate  
IP3R   Inositol  1,4,5-­‐trisphosphate  receptor  
IPTG   ???????????-­‐D-­‐1-­‐thiogalactopyranoside  
ITC   Isothermic  titration  calorimetry  
K+   Potassium  ion  
KChIP   Potassium  channel  interacting  protein  
KHM   Potassium,  HEPES,  Magnesium    
KPSI   Kilopound  per  square  inch  
Kv   Voltage  dependent  potassium  channel  
LAMP1   Lysosomal-­‐associated  membrane  protein  1  
LAP   Lysosomal  acid  phosphatase  
LB   Lysogeny  Broth  
LC3   Light  chain  3  of  MAP1A/B  
LCA   Leber's  congenital  amaurosis  
LGCC   Ligand  gated  Ca2+  channel  
LIMP2   Lysosomal  integral  membrane  protein  2  
   xi  
LKU   Lipid  kinase  unique  
LTD   Long  term  depression  
LTP   Long  term  potentiation  
M6PR   Mannose  6-­‐phosphate  receptor  
MAP1A/B   Microtubule  associated  protein  1A/B  
MAPK   Microtubule  associated  protein  kinase  
mCherry   Monomeric  cherry  fluorescent  protein  
MDCK   Madin-­‐Darby  Canine  Kidney  
Mg2+   Magnesium  ion  
mGluR   Metabotropic  glutamate  receptor  
MLCK   Myosin  light  chain  kinase  
mOrange   Monomeric  orange  fluorescent  protein  
mRNA   Messenger  ribonucleic  acid  
MVB   Multivesicular  body  
Myo1c   Myosin  1c  
N2A   Neuroblastoma  2A  
Na+   Sodium  ion  
NAADP   Nicotinic  acid  adenine  diphosphate  
NCBI   National  centre  for  biotechnology  information  
NCS   Neuronal  calcium  sensor  
NCX   Na+/Ca2+  exchanger  
NEAA   Non-­‐essential  amino  acids  
NMDA   N-­‐methyl-­‐D-­‐aspartic  acid  
NMR   Nuclear  magnetic  resonance  
PAGE   Polyacrylamide  gel  electrophoresis  
PBS   Phosphate  buffered  saline  
PBSB   Phosphate  buffered  saline  with  BSA  
PBST   Phosphate  buffered  saline  with  Tween  20  
PCR   Polymerase  chain  reaction  
PDB  ID   Protein  database  identification  
PH   Pleckstrin  homology  
pI   Isoelectric  point  
PI(3,4,5)P3   Phosphatidylinositol  3,  4,  5-­‐trisphosphate  
PI(4,5)P2   Phosphatidylinositol  4,  5-­‐bisphosphate  
PI3K   Phosphatidylinositol  3-­‐kinase  
PI4K   Phosphatidylinositol  4-­‐kinase  
PI4P   Phosphatidylinositol  4-­‐phosphate  
PKC   Protein  kinase  C  
PLC   Phospholipase  C  
PM   Plasma  membrane  
PMCA   Plasma  membrane  Ca2+-­‐ATPase  
PtdIns   Phosphatidylinositol    
PTM   Pichia  trace  metal  
PTV   Piccollo  bassoon  vesicle  
RFP   Red  fluorescent  protein  
RNAi   Ribonucleic  acid  interference  
   xii  
rpm   Revolutions  per  minute  
RyR   Ryanodine  receptor  
SCP   Sarcoplasmic  Ca2+  binding  protein  
SDS   Sodium  dodecyl  sulphate  
SERCA   Sarcoplasmic/endoplasmic  reticulum  Ca2+-­‐ATPase  
siRNA   Short  interfering  ribonucleic  acid  
SNAP29   Synaptosomal-­‐associated  protein  29  
SNARE   Soluble  NSF  attachment  protein  receptor  
SOC   Super  optimal  broth  with  catabolite  suppression  
SOCC   Store  operated  Ca2+  channel  
SP2   Spectrophotometer  detection  system  2  
SRP   Signal  recognition  particle  
SUMO   Small  Ubiquitin-­‐like  Modifier  
TA   Tail  anchor  
TAE   Tris  base,  acetic  acid,  EDTA  
TEV   Tobacco  etch  virus  
TGN   Trans-­‐Golgi  network  
TIRF   Total  internal  reflection  fluorescence  
Tm   Melting  temperature  
TMD   Transmembrane  domain  
TOM20   Translocase  of  outer  mitochondrial  membranes  20  kDa  
TPC   Two  pore  channel  
TRP   Transient  receptor  potential  
U   Unit  of  enzyme  activity  
UTR   Untranslated  region  
UV   Ultraviolet  
VAMP7   Vesicle  associated  membrane  protein  7  
VGCC   Voltage-­‐gated  Ca2+  channel  
VILIP   Visinin-­‐like  protein  
VSVG   Vesicular  stomatitis  virus  G  
WGD   Whole  genome  duplication  














1.1.  An  Overview  of  Calcium  Signalling  
The  calcium   ion   (Ca2+)   is   involved   in   the  regulation  of  almost  all   cellular  processes  
making   it   the  most  versatile   intracellular  messenger  known  to  date   (Berridge  et  al.,  
2000,  Clapham,  2007).   It  modulates  a  plethora  of  cellular   functions  over  time  scales  
ranging  from  microseconds  to  years  (Petersen  et  al.,  2005).  It  is  this  promiscuity  that  
makes  calcium  signalling  integral  to  all  living  processes.  
In  most   cells,   calcium   signalling  events   are   initiated  by  an   increase   in   cytoplasmic  
Ca2+.   At   resting   levels   the   concentration   of   intracellular   (cytoplasmic)   free   Ca2+  
([Ca2+]i)  in  cells  is  estimated  at  ?100  nM,  but,  when  opened,  channels  on  the  plasma  
membrane   (PM)  and  endoplasmic   reticulum   (ER)   can  elevate   [Ca2+]i   to  over  1  ?M  
(Bootman  et  al.,   2001).  Due   to  unique   combinations   of   channels,   ATPases   and  Ca2+  
sensors,   each   cell   type   possesses   different   calcium   signalling   properties.   Resting  
[Ca2+]i   is  maintained  by  membrane  pumps  and   ion  exchangers  which  remove  Ca
2+  
from  the  cytosol  and  transport   it  either  out  of  the  cell,  or   into   intracellular   stores  
(Clapham,   2007)   (Figure   1.1).   Some   Ca2+-­‐binding   proteins,   restricted   to   specific  
cellular   locations,   are   also   important   in   buffering   [Ca2+   ]i.For   instance,   in   the   ER  
where  [Ca2+]  is  high,  the  Ca2+  buffer,  calreticulin,  can  bind  20  mol  of  Ca2+  per  mol  of  
protein  which  greatly  increases  the  capacity  of  the  ER  as  an  intracellular  Ca2+  store  
(Michalak  et  al.,  2009).  [Ca2+]i  is  therefore  strictly  regulated  using  numerous  different  
mechanisms.This   tight   regulation   prevents   persistent   and   potentially   cytotoxic  
elevations  in  [Ca2+  ]i,  whilst  increasing  the  dynamic  range  of  Ca
2+  signals.    
Elevations   of   [Ca2+]i   result   from   both   influx   of   extracellular   Ca
2+   at   the   PM   and  
release   of   Ca2+   from   intracellular   stores   (Figure   1.1).   Cells   possess   a   variety   of  
families   of   PM   Ca2+   influx   channels,   each   with   unique   mechanisms   of   activation.  
Voltage-­‐gated  Ca2+  channels  (VGCCs)  are  activated  by  depolarisation  of  the  PM  and  
are   usually   found   in   excitable   cells   (Lukyanetz,   1997).   Ligand-­‐gated   Ca2+   channels  
(LGCCs)  are  activated  by  binding  of  a  specific   ligand  to  the  extracellular  domain  of  
the  channel   (Barritt,  1999).  These  are  usually   found   in  secretory  cells  and  on  nerve  





Figure  1.1.  An  Overview  of  calcium  Signalling.  Ca2+  influx  into  the  cell  is  mediated  by  voltage-­‐gated  
Ca2+   channels   (VGCC),   Ligand-­‐gated  Ca2+   channels   (LGCC),   or   store  operated  Ca2+   channels   (SOCC).  
Binding  of  extracellular  agonists  to  G-­‐protein  coupled  receptors  (GPCRs)  stimulates  the  production  of  
second  messengers  such  as  IP3  and  cyclic  ADP  ribose  which  bind  to  and  activate  IP3Rs  and  RyRs  on  
the  ER.  Both  IP3Rs  and  RyRs  are  sensitive  to  increases  in  [Ca
2+]i,  allowing  the  signal  to  be  propagated  
through  the  process  of  calcium-­‐induced  calcium-­‐release  (CICR).  SOCCs  on  the  PM  are  opened  upon  
activation   of   ER   IP3Rs.   Ca
2+   signals   are   attenuated   by   several   mechanisms   including:   transport   of  
cytoplasmic   Ca2+  into   the   ER   by   the   sarco/endoplasmic   reticulum  Ca2+-­‐ATPase   (SERCA)   or   efflux   of  
Ca2+   from   the   cell   by   either   the   PM   Ca2+-­‐ATPase   (PMCA)   or   the   Na+/Ca2+   exchanger   (NCX).   Other  
organelles   such   as   the   mitochondria,   lysosomes   and   endosomes   also   sequester   Ca2+.   Ca2+   from  
endosomes  and  lysosomes  is  released  via  the  NAADP-­‐sensitive  two  pore  channels,  TPC1  and  TPC2,  
respectively.  
  
channels   (SOCCs)   are   activated   in   response   to   the   depletion   of   intracellular   Ca2+  
stores  (Smyth  et  al.,  2006).  These  are  thought  to  be  one  of  the  most  ubiquitous  types  
of  Ca2+  channels  (Bootman  et  al.,  2001).  
Ca2+   release   from   intracellular   stores   is   triggered   by   messenger   activation   of  
channels   on   the   ER   or   by   activation   of   the  mitochondrial   permeability   transition.  
The   mitochondrial   permeability   transition   pore   opens   under   conditions   of  
mitochondrial  Ca2+  overload  coupled  with  oxidative  stress,  elevated  phosphate,  or  
adenine   nucleotide   depletion.   This   results   in   extensive   mitochondrial   swelling,  




stored  Ca2+.  This  results  in  the  induction  of  apoptosis  pathways  and,  ultimately,  cell  
death  (Halestrap,  2009).  
Release   of   Ca2+   from   the   ER  occurs   through   two   families   of   ion   channels,   inositol  
trisphosphate   receptors   (IP3Rs)   and   ryanodine   receptors   (RyRs).   IP3Rs   are   found  
ubiquitously   whereas   RyRs   are   predominantly   restricted   to   excitable   cell   types.  
These   receptors   are   large   tetrameric   complexes   and   contain   cytosolic   domains  
which  possess  a  number  of  modulatory  sites.  Binding  of  extracellular  agonists  to  G-­‐
protein  coupled  receptors  (GPCRs)  stimulates  the  production  of  second  messengers  
such  as  inositol  trisphosphate  (IP3)  and  cyclic  ADP  ribose  which  bind  to  and  activate  
IP3Rs   and   RyRs,   respectively.The   binding   of   ligand   increases   the   sensitivity   of   the  
channels   to   [Ca2+]i.   Both   types   of   receptor   are   also   sensitive   to   local   increases   in  
[Ca2+]i,  resulting  in  calcium-­‐induced  calcium-­‐release  (CICR)  where  increases  in  [Ca
2+]i  
induce  further   release   from   intracellular   stores.  At  higher   [Ca2+]i,   the  sensitivity  of  
both  IP3Rs  and  RyRs  decreases  and  the  channels  begin  to  close  once  again  (Clapham,  
2007),   accounting   for   the   classic   bell-­‐shaped   Ca2+   dose   response   curve   for   both  
classes  of  channel.  
A   less   well-­‐understood   mechanism   of   intracellular   Ca2+   release   is   modulated   by  
NAADP   via   two   pore   channels   (TPCs)   on   the   membranes   of   acidic   subcellular  
compartments.  TPCs  are  relatively  novel  members  of  the  voltage  gated  ion  channel  
superfamily.  Three  TPC  genes  have  been  reported  although  TPC3  is  absent  in  most  
primates  and  some  rodent  species.  TPC2  mRNA  is  detectable  in  most  human  tissues  
with   higher   levels   observed   in   the   liver   and   kidneys.   TPC2   has   been   shown   to  
underpin   NAADP-­‐induced   Ca2+   release   from   lysosomal   stores,   whereas   TPC1   and  
TPC3  are  localised  to  endosomal  membranes  and  may  permit  NAADP-­‐mediated  Ca2+  
release  from  these  classes  of  acidic  Ca2+  stores.  Stimulation  of  TPC2  with  NAADP  in  
the   range   of   10   nM   -­‐   10   ?M   induces   Ca2+   release   whereas   higher   NAADP  
concentrations  do  not  elicit  a   response  suggesting   that  high   ligand  concentrations  
desensitize  the  channels  (Calcraft  et  al.,  2009).  
Specific  changes  occur  in  the  cell  based  on  the  type  of  Ca2+-­‐signal  that  is  generated.  




modulation   of   the   signal.   Unique   Ca2+   signals   can   therefore   be   generated   within  
distinct  locations  and  organelles  in  the  cell.  Regulation  of  the  amplitude,  frequency  
and  duration  of  Ca2+  spikes   is  also   important  with  some  Ca2+-­‐dependent  processes  
responding  only  at  optimal  frequencies  of  Ca2+  oscillations  (Thomas  et  al.,  1996).  It  is  
these  parameters  which  allow  this  simple  metal  ion  to  carry  out  such  a  wide  range  
of  essential  physiological  functions.  
Ca2+   microdomains   are   formed   from   elementary   Ca2+   release   events   which   have  
been  named  according  to  the  particular  release  channel   involved.  Events   involving  
IP3??????????????????????????????????????????????????????????????????? ?????????????
?????? ?????? ??????? ???? ??????? ????????? ???? ?????????? ?? ??2+   ??????? ??? ???????? ???????
due   to   the   opening   of   single   IP3Rs   or   RyRs,   respectively,   and   gives   rise   to   a   Ca
2+  
signal   lasting  ?200  ms  with  an  amplitude  of   less  than  30  nM.  These  signals  usually  
spread  no  further  than  1  -­‐  2  ??.  The  coordinated  release  of  Ca2+  from  a  cluster  of  
IP3Rs  (or  RyRs)  is  termed  a  Ca
2+  ?????????????????????????????sists  for  ?500  ms,  has  a  
peak  amplitude  of  ?200  nM  and  extends  less  than  6  ??.  Finally,  if  the  Ca2+  released  
????????????????????????????????????????????????????????????????????????3Rs  this  can  give  
rise  to  a  Ca2+  ?????????????????????????????????????????????????????????????????????
of  these  different  types  of  Ca2+  signal  depends  upon  their  ability  to  overcome  Ca2+  
buffering   and   uptake   mechanisms.   These   mechanisms   act   to   restrict   Ca2+   signals  
and   therefore  modulate   the   activity   of   the   channels   involved   in   signal   generation  
(Berridge   et   al.,   2000,   Laude   and   Simpson,   2009).   Removal   of   Ca2+   from   the   cytosol  
prevents   both   CICR   of   IP3Rs   and   RyRs,   and   the   stimulation   of   SOCCs,   thereby  
terminating  the  Ca2+  signal.  
Ca2+   acts   as   a   second   messenger   regulating   many   different   processes   including  
secretion,  muscle  contraction,  fertilisation,  gene  transcription  and  cell  proliferation  
(Bootman   et   al.,   2001).   In   order   for   this   ion   to   carry   out   such   a   wide   range   of  
functions  it  must  be  able  to  activate  downstream  signalling  pathways.  To  do  this  a  
variety   of   specific   Ca2+-­‐binding   proteins   have   evolved.   As   introduced   previously,  
certain  Ca2+-­‐binding  proteins  have  a  very  high  affinity  for  Ca2+  and  will  be  saturated  
even  under  resting  conditions.  These  proteins  are  involved  in  the  buffering  of  [Ca2+]i  




signal   transduction,   binding   Ca2+   and   becoming   activated   in   response   to   local   or  
global   elevations   in   [Ca2+]iat   specific   cellular   locations   (Schwaller,   2009).   In   general  
Ca2+-­‐buffering   proteins   exhibit   little   conformational   change   on   Ca2+   binding.   In  
contrast,  Ca2+-­‐sensors  undergo  significant  conformational  shifts  and  thereby  expose  
unique  binding  sites  for  specific  target  proteins  and  nucleic  acids.  
1.2.  Ca2+  Binding  Motifs  
The   effects   of   increased   [Ca2+]i   are   mediated   indirectly   through   the   actions   of  
various   Ca2+-­‐binding   proteins.   Each   Ca2+-­‐binding   protein   possesses   unique  
properties   which   allow   it   to   decipher   different   types   of   Ca2+   signal   and   elicit   the  
relevant   biochemical   response.   As   such,   Ca2+-­‐binding   proteins   must   be   able   to  
respond  to  short-­‐lived  or  local  [Ca2+]i  fluxes  and  have  therefore  evolved  to  bind  and  
respond   very   rapidly   to   changes   in   [Ca2+]i   (Schwaller,   2009).   The   majority   of   Ca
2+-­‐
binding   proteins   belong   to   a   family   of   homologous   proteins   containing   Ca2+  
chelating   EF-­‐hand  motifs,   however,   other   Ca2+   binding  domains   also   exist   such   as  
the   C2   domain   (Rizo   and   Sudhof,   1998)   and   the   endonexin   fold   (Kourie   and  Wood,  
2000).  
C2   domains,   also   known   as   Ca2+   and   lipid   binding   domains,   are   named   for   their  
?????????????? ???? ????????????????? ???????????????????????????????????????????
consist   of   130   amino   acids   in   an   eight-­‐????????? ????????????? ?? ?????????? ??2+   is  
bound   along   one   edge   of   the   structure   by   three   Ca2+   chelating   loops   containing  
aspartate   residues.   Ca2+-­‐bound   C2   domains   bind   to   negatively   charged  
phospholipids   and   therefore   Ca2+   binding   can   act   as   an   electrostatic   switch   that  
allows   soluble   C2   domain   containing   proteins   to   associate   with   membranes.   C2  
domain   containing   proteins   are   common   in   signal   transduction   and   membrane  
trafficking,   and   include   phosphatidylinositol   3-­‐kinases   (PI3Ks),   protein   kinase   C  
(PKC),   synaptotagmins,  RIM  proteins   and   rabphillin  3A   (Rizo  and  Sudhof,  1998).   The  
affinities  of  C2  domains  vary,  as  do  the  number  of  Ca2+-­‐binding  sites  with  some  C2  
domain   proteins   having   evolved   divergent   functions   which   do   not   require   Ca2+  




The  endonexin  fold  domain  is  a  34  kDa  conserved  domain  found  in  the  C-­‐termini  of  
proteins   of   the   annexin   family   of   Ca2+/phospholipid   binding   proteins   (Kourie   and  
Wood,  2000).  This  domain  consists  of  four  Ca2+-­‐binding  repeats  (eight  in  annexin  VI)  
of  an  ~70  amino  acid  sequence.  The  annexins  form  a  diverse  family  of  Ca2+-­‐binding  
proteins  which  form  voltage-­‐dependent  Ca2+  channels  in  lipid  bilayers  and  are  found  
throughout   all   eukaryotic   kingdoms   (Kourie   and   Wood,   2000).   The   N-­‐termini   of  
annexins   are   significantly   more   variable   than   the   endonexin   fold-­‐containing   C-­‐
termini   and   it   is   this   region   which   permits   this   class   of   proteins   to   function   in   a  
diverse   range   of   cellular   processes.   Annexins   have   reported   roles   in   endo-­‐   and  
exocytosis,   regulation   of   the   cytoskeleton,   and   membrane   conductance   and  
organisation  (Fatimathas  and  Moss,  2010).  
  
Figure   1.2.  The   EF-­‐hand  motif   has   a   typical   helix-­‐loop-­‐helix   structure.  A)   The   structure   of   an   EF-­‐
hand  is  said  to  resemble  the  forefinger  and  thumb  of  a  hand  with  Ca2+  held  at  the  base  of  the  two  
digits.  B)  Ribbon  representation  of  the  structure  of  the  first  EF-­‐Hand  from  calmodulin  with  a  bound  
Ca2+  ion  (adapted  from  (Burgoyne,  2007)).  
  
1.3.  EF-­‐hand  motifs  
This   thesis  will   focus   on   the   EF-­‐hand   family   of   Ca2+   binding   proteins   -­‐   one   of   the  
largest   protein   families   containing   a   single   type   of   motif.   Analysis   of   the   human  




have  been  identified  in  total  from  various  different  species  (Schwaller,  2009).  The  EF-­‐
hand  motif  derives  its  name  from  the  E  and  F  helices  of  parvalbumin,  the  protein  in  
which  the  motif  was  first  discovered.  A  twelve  amino  acid  linking  loop  between  the  
two  helices   forms   the   Ca2+   binding   site   and   gives   the  motif   a   characteristic   helix-­‐
loop-­‐helix  structure  (Figure  1.2).  In  the  canonical  EF-­‐hand,  residues  1,  3,  5,  7,  9,  and  
12  of  the  binding   loop  chelate  Ca2+.  This  forms  a  pentagonal  bi-­‐pyramidal  array  of  
seven  oxygen  ligands.  Residues  1,  3  and  5  have  side-­‐chain  oxygens  and  are  usually  
aspartate   residues.   Residue   12   is   nearly   always   a   glutamate   which   provides   a  
bidentate   oxygen   ligand   from   its   two   side-­‐chain   caboxylate   oxygens.   Residue   7  
coordinates   Ca2+  with   a  main   chain   oxygen   and   residue   9   hydrogen-­‐bonds  with   a  
water   molecule   to   provide   the   final   oxygen   ligand   (Nelson   and   Chazin,   1998).   This  
canonical  motif  is  found  in  most  EF-­‐hand  proteins,  however,  some  atypical  binding  
loops  have  been  described,  although  the  relevance  to  their  structure  and  function  is  
not  yet  known  (Gifford  et  al.,  2007).    
The  EF-­‐hand  superfamily  can  be  divided  into  two  subsets:  the  Ca2+-­‐buffers  and  the  
Ca2+-­‐sensors.  The  key  differences  between   the   two  classes  are   their  Ca2+  affinities  
and   their   ability   to   undergo   shifts   in   conformation   (Nelson  and  Chazin,   1998).   Ca2+-­‐
buffers   usually   have   high   Ca2+   binding   affinities   and   do   not   undergo   a   significant  
conformational   change   upon   Ca2+   binding.   They   constitute   a   smaller   subset   of  
proteins   and   help   to   modulate   Ca2+   signals   spatially   and   temporally,   helping   the  
transmission   of   the   signal   through   the   cell,   or   sequestering   the   ion   from   the  
cytoplasm.  Calbindin  D9k  is  a  high  affinity  Ca2+-­‐buffer  that  has  roles   in  Ca2+  uptake  
and   transport.   Upon   Ca2+   binding,   calbindin   D9k   undergoes   only   minor  
conformational   changes   which   are   key   for   maintaining   its   function.   Larger  
conformational  changes  would  result  in  the  exposure  of  hydrophobic  regions  which  
would  reduce  its  Ca2+  affinity  and  hence  alter  its  binding  capacity  (Kordel  et  al.,  1993).  
Similarly,   parvalbumin,   which   has   roles   in   the   quenching   of   Ca2+   signals   in  
contracting   muscle   cells,   does   not   undergo   a   change   in   conformation   upon   Ca2+  
binding.  Parvalbumin  may  also  protect  against  Ca2+  toxicity  in  non-­‐muscle  cells  and  
act  to  sequester  Ca2+  ions  away  from  the  cytosol  preventing  the  activation  of  signal  




Ca2+  binding  characteristics  but  a  Ca2+-­‐induced  conformational  change  in  the  protein  
would  likely  adversely  influence  these  properties  (Pauls  et  al.,  1996).    
Although   Ca2+   buffers   play   important   regulatory   roles   in   intracellular   calcium  
signalling,   the  majority  of   EF-­‐hand   containing   proteins   are   Ca2+-­‐sensors  which   are  
responsible   for   the   activation   of   downstream   signalling   pathways   in   response   to  
changes   in  [Ca2+]i  (Gifford  et  al.,  2007).  Ca
2+-­‐sensors  generally  exhibit  a   large  shift   in  
conformation,   often   exposing   hydrophobic   surfaces   which   provide   a   means   to  
interact   with   binding   partners   (Nelson   and   Chazin,   1998).   EF-­‐hand   containing   Ca2+-­‐
sensors  will  be  the  focus  of  this  thesis  and  will  therefore  be  discussed  in  more  detail  
in  the  following  sections.  
1.4.  Factors  Affecting  Ca2+-­‐binding  to  EF-­‐hand  motifs  
The  core  structure  of  EF-­‐hand  motifs   is  generally  well   conserved  with   the  flanking  
regions  containing  more  variation.  This  variation  gives  rise  to  dissociation  constants  
ranging  from  10-­‐7  to  10-­‐5molL-­‐1(Gifford  et  al.,  2007).  The  relative  stability  of  the  Ca2+-­‐
?????? ????? ?????? ????????????????2+  ???????? ????? ??????? ?????????????2+-­‐sensor  
determines  its  overall  affinity  for  Ca2+.  The  stability  of  the  protein  is  defined  by  the  
energy  change  upon  the  transition  from  a  Ca2+-­‐bound  state  to  an  unbound  state  ?  
???? ????? ??????? ??? ????????? ????????? ??????? ???? ??2+-­‐bound   form,   the   greater   the  
energy  difference  between  the   two  forms.   If  a  protein   is  unstable   in   the  Ca2+-­‐free  
form,  the  protein  will  have  a  greater  Ca2+  binding  affinity   (Gifford  et  al.,  2007).  CaM  
can  be  used  as  an  example  of  this:  the  C-­‐terminal  EF-­‐hands  have  a  higher  affinity  for  
Ca2+   than   the   N-­‐terminal   domain   which   is   thought   to   be   due   to   the   greater  
instability  of  the  C-­‐terminal  domain  in  its  Ca2+-­‐free  form.  The  residues  of  the  flexible  
linker   between   the   two   domains   have   been   suggested   to   be   the   cause   of   this  
instability:   the   linker   increases   the   stability   of   the   Ca2+-­‐free   state   therefore  
decreasing   the  Ca2+-­‐affinity.  Domain   linking   regions  and  other   regions  flanking  the  
EF-­‐hands  can  therefore  influence  the  stability  of  the  Ca2+-­‐unbound  state  of  a  protein  
and  may  help  to  fine  tune  the  Ca2+-­‐affinity  of  EF-­‐hand  motifs  (Gifford  et  al.,  2007).  In  
addition   to   this,   dissociation   kinetics   are   important   for   the   control   of  Ca2+   sensor  
function   in   order   to   transduce   a   signal   at   the   correct   time   and   for   the   desired  




sarcoplasmic  reticulum  initially  binds  to  troponin  C  which  triggers  contraction  by  the  
tropomyosin   complex.   After   a   brief   lag   period,   the   Ca2+   then   starts   to   bind   to  
parvalbumin  which  sequesters  it  away  from  troponin  C  and  inactivates  contraction.  
The  kinetics  of  Ca2+  dissociation  are  therefore  important  for  the  proper  execution  of  
this   process   (Renner   et   al.,   1993,   Pechere   et   al.,   1977).   The   9th   position   in   the   Ca2+-­‐
binding   loop  of   the   EF-­‐hand  motif   is   thought   to   be   important   in  determining   this  
dissociation   rate.   Substitutions   at   this   position,   to   test   different   amino   acid   side  
chains  of  varying  size  and  charge,  have  been  shown  to  affect  the  dissociation  rate  
but  not  the  Ca2+-­‐affinity.  Long  or  acidic  side  chains  at  position  9  of  the  binding  loop  
were   found   to   cause   slower   dissociation   rates   due   to   steric   hindrance   or  
electrostatic   barriers,   respectively   (Renner   et   al.,   1993).   Ca2+   buffers   have   slower  
dissociation  rates  and  therefore  remain  bound  to  Ca2+  for  longer.    
In  addition  to  Ca2+,EF-­‐hands  can  also  bind  other  similar  sized  divalent  and  trivalent  
ions.  As  most  of  these  ions  exist  at  only  very  low  concentrations  in  the  cell,  this  does  
not  usually  pose  a  problem.  Free  magnesium  ions  (Mg2+),  however,  are  present  at  
estimated   cellular   concentrations   of   0.5   -­‐   5.0   mM   (Romani   and   Scarpa,   1992)   and  
binding   of   this   ion   can   decrease   the   Ca2+   affinity   of   many   EF-­‐hand   containing  
proteins   (Gifford  et  al.,  2007).  Each   individual  EF-­‐hand  can  be  categorised  based  on  
their  specificity  for  Ca2+  or  Mg2+.  Sites  which  bind  to  either  Ca2+  or  Mg2+  are  known  
as  structural  sites  whereas  sites  which  have  a  higher  affinity  for  Ca2+  are  known  as  
regulatory  sites.   In  order   to  discriminate  over  the  102  -­‐  104   -­‐fold  excess  of  Mg2+   in  
the  cell,  the  structure  of  regulatory  EF-­‐hands  prevents  formation  of  the  required  six-­‐
fold   co-­‐ordination   in   the   preferred   smaller   binding   site.   Despite   this   specificity,  
many   regulatory   sites   still  bind   to  Mg2+  under   resting  conditions,  although  usually  
form   only   a   four-­‐fold   co-­‐ordination.   This   therefore   has   no   effect   on   the   overall  
conformation  of  the  protein.  This  can  be  observed  in  CaM  where  the  conformation  
of  the  ion  free  form  is  almost  identical  to  that  of  the  Mg2+-­‐bound  form  (Gifford  et  al.,  
2007,  Ohki  et  al.,  1997).    
Conversely,  structural  sites  have  a  much  higher  affinity  for  Mg2+  and,  in  many  cases,  
Mg2+   ???????? ???? ????????? ???? ?????????? ??2+-­‐binding   affinities.   In   contrast   to   the  




induce  conformational  changes  and  in  some  cases  can  bring  about  functions  distinct  
from   those   carried   out   upon   Ca2+-­‐binding   (Gifford   et   al.,   2007,   Aravind   et   al.,   2008).  
DREAM   (or   KChIP3)   represents   a   key   example   of   this.  Mg2+-­‐binding   stabilises   the  
?????????? ????? ??? ?????? ???? ??? ????????? ???? ???? ????????????????? ????????? ??????
DNA  target  elements  which  results  in  the  transcriptional  repression  of  prodynorphin  
and   c-­‐fos   genes.   Binding   of   Ca2+   causes   a   conformational   change   and   subsequent  
dimerization   of   DREAM,   which   disrupts   DNA   binding   and   releases   transcriptional  
repression   (Osawa  et  al.,   2005).  Mg2+   is   therefore   physiologically   important   for   the  
regulation   of   EF-­‐hand   proteins.   This   cation   can   serve   a   structural   purpose   to  
stabilise  the  Ca2+-­‐free  form  allowing  Ca2+-­‐independent  interactions  to  occur  and  can  
also  modulate  the  Ca2+-­‐binding  affinity  of  individual  EF-­‐hands.  
EF-­‐hand  motifs  nearly  always  occur  in  pairs  and  this  is  presumed  to  be  important  for  
protein   stabilization,   increasing   Ca2+-­‐affinity   and   allowing   cooperativity   of   Ca2+-­‐
binding.  In  support  of  this,  no  proteins  containing  a  single  EF-­‐hand  motif  have  been  
identified   to   date   and  even   if   one   of   the   EF-­‐hands   in   a   pair   is   non-­‐functional   the  
symmetry   of   their   structure   is   often   maintained.   For   example,   EF2   in   the  
invertebrate   protein,   sarcoplasmic   Ca2+-­‐binding   protein   (SCP),   has   an   insertion  
which  inactivates  this  EF-­‐hand  yet  it  is  still  paired  with  the  functional  EF1  motif  and  
the   two-­‐fold   symmetry   is   approximately   preserved   (Vijay-­‐Kumar   and   Cook,   1992).  
There   is   huge   diversity   in   the   packing   of   EF-­‐hands   in   Ca2+   binding   proteins   with  
proteins   containing   anything   from   2   to   12   motifs   (Grabarek,   2006).   This  
diversification  is  further  increased  by  the  ability  of  some  EF  hands  to  dimerise.  For  
example   the   S100   proteins   can   dimerise   to   generate   a   unit   comprising   four   EF-­‐
hands   or   in   calpain   the   unpaired   5th   EF-­‐hand   can   dimerise   with   other   calpain  
monomers   to   give   a   unit   containing   ten   EF-­‐hands   (Nelson   and   Chazin,   1998).   The  
majority  of  the  EF-­‐hand  family  of  proteins,  however,  contain  two  pairs  of  EF-­‐hands  
as  in  CaM  and  troponin  C  (Grabarek,  2006).  Phylogenetic  studies  have  suggested  that  
the   EF   hand  protein   family  may  have  derived   from  a   four   EF-­‐hand   ancestor   gene  
through   tandem   gene   duplication.   In   support   of   this   theory,   CaM,   a   ubiquitous  




et  al.,  1996)  and  many  other  EF-­‐hand  containing  Ca2+  sensors  have  been  discovered  
with  a  high  degree  of  homology  to  this  protein.  
1.5.  Calmodulin  
CaM  was  discovered  in  1970  and  is  a  small  (148  amino  acids)  acidic  protein  (pI  ~3.9)  
containing   four   EF-­‐hand  motifs.   CaM   is   the  most   ubiquitous   Ca2+   binding   protein  
and  is  involved  in  the  regulation  of  many  essential  physiological  processes  including  
cell  motility,  exocytosis,  cytoskeletal  assembly  and  modulation  of   intracellular  Ca2+  
and   cAMP   concentrations.   This   protein   has   been   highly   conserved   throughout  
evolution  as  it  is  found  in  all  eukaryotes  and  is  100%  identical  across  all  vertebrates  
at  the  amino  acid  level  (Toutenhoofd  and  Strehler,  2000).  Although  CaM  appears  first  
in   eukaryotic   organisms,   CaM-­‐like   proteins   have   also   been   identified   in   bacteria  
(Friedberg  and  Rhoads,   2001).   Its   ubiquitous   nature   and   ability   to   interact  with   and  
regulate   multiple   protein   targets   has   meant   that   CaM   is   the   most   extensively  
studied   Ca2+   sensor   and   can   often   serve   as   a   useful   prototype   for   understanding  
other  members  of  the  EF-­‐hand  protein  family.  
Signal  transduction  through  EF-­‐hand  containing  proteins  typically  occurs  following  a  
Ca2+-­‐induced   conformational   change.   This   is   exemplified   by   CaM,   in   which   Ca2+  
binding  brings   about   a   conformational   change   that   exposes   hydrophobic   residues  
and  mediates  binding  to  target  proteins.    The  first  two  EF-­‐hands  of  CaM  form  an  N-­‐
terminal  globular  domain  which  is  joined  by  a  flexible  linker  to  a  highly  homologous  
C-­‐terminal   region   encompassing   the   third   and   fourth   EF-­‐hands   (Figure   1.3A).   The  
highly   flexible   linker  between  the   two  domains  can  be  drastically   reoriented  upon  
binding   to   target  proteins   and   is   an  essential  property  of  CaM  which  permits   this  
protein   to   interact  with  a  diverse   array  of   interacting  partners   (Figure  1.3B)   (Ikura  
and  Ames,  2006).  The  C-­‐terminal  pair  of  EF-­‐hands  has  a  much  higher  affinity  for  Ca2+  
than   the   N-­‐terminal   pair,   allowing   the   two   domains   to   behave   independently   at  
varying  Ca2+  concentrations.  In  the  absence  of  Ca2+  the  N-­‐terminal  domain  adopts  a  
closed   conformation,   whereas   the   C-­‐terminal   domain   exhibits   a   semi-­‐open  
conformation.   Under   these   conditions   a   hydrophobic   patch   is   revealed   in   the   C-­‐
terminal  domain  which  is  accessible  to  solvent  and  may  allow  CaM  to  interact  with  





Figure  1.3.The  structure  of  Ca2+-­‐bound  CaM.  A)The  crystal  structure  of  CaM  in  its  Ca2+-­‐loaded  form  
(PDB   ID  code  1CLL   (Chattopadhyaya  et  al.,  1992))  with   four  Ca2+   ions   (black  spheres)  bound  to  the  
four  EF-­‐hands.  The  central   linker  alpha  helix  between   the   two  EF-­‐hand  pairs   is   shown   in  green.  B)  
The   solution   nuclear   magnetic   resonance   (NMR)   structure   of   Ca2+-­‐bound   CaM   complexed   with   a  
peptide   representing   the   calmdoulin   binding   domain   of   calmodulin   kinase   I   (CaMKI;   PDB   ID   code  
2L7L  (Gifford  et  al.,  2011)).  CaM  binding  to  the  alpha-­‐helical  CaMKI  peptide  (Red)  induces  changes  in  
the   CaM   linker   domain   (green)   which   allow   its   N-­‐   and   C-­‐   terminal   domains   to   wrap   around   the  
peptide  helix.  
  
Upon  elevation  of  [Ca2+]i,  Ca
2+  is  co-­‐ordinated  by  the  Ca2+-­‐binding  loops  leading  to  a  
large  shift  in  conformation  of  the  E  and  F  helices  to  a  much  more  open  arrangement  
thus  exposing  hydrophobic  residues  to  solvent  (Figure  1.3A)  (Chin  and  Means,  2000).  
This  unfolding  of  CaM  upon  Ca2+-­‐binding  releases  considerable  free  energy  (???????
(Hopkins  Jr  and  Gayden,  1989))  and  it   is  this  ability  to  convert  the  Ca2+-­‐binding  event  
into   biochemical   energy   which   permits   Ca2+   sensors   to   transduce   cellular   signals  
(Chin  and  Means,  2000).  Exposure  of  hydrophobic  residues  permits  binding  of  CaM  to  
target  binding  partners  and  this   in  turn  raises  the  affinity  of  CaM  for  Ca2+  ten-­‐fold  
and   sensitizes   the  complex   to   further   changes   in   [Ca2+]i.  CaM   interacts  with  many  
effectors  which  are  involved  in  phosphorylation  and  also  regulates  Ca2+  pumps,  ion  
channels,   ryanodine   receptors  and   some   IP3R   isoforms.  Each  of   these   interactions  
??????? ?????? ?????????? ??????????? ???? ?????   binding   partners   can   be   categorised  
into  different   classes  depending  on   their  mode  of   interaction  under   conditions  of  




effectors  depending  on  the  presence  of  Ca2+  suggests  that  it  must  possess  multiple  
interaction  surfaces  to  accomplish  this  (Chin  and  Means,  2000).  
CaM   is   the  archetypal  Ca2+-­‐sensor  due   to   its  ubiquitous  nature  and  abundant  and  
often   paradoxical   protein   interactions.   Ca2+   activation   of   CaM  has   been   found   to  
have   a   heterogeneous   distribution   within   the   cell   implying   that   discrete   pools   of  
CaM   must   exist   and   emphasizing   the   importance   of   spatial   and   temporal  
parameters  in  calcium  signalling  (Torok  et  al.,  2002).  How  this  single  protein  is  able  to  
participate   in   such   a   diverse   array   of   cellular   processes   still   remains   a   central  
question  in  cell  biology.  The  interaction  of  CaM  with  adenylyl  cyclase  illustrates  this  
complexity:   CaM   activates   both   adenylyl   cyclase   and   cyclic   nucleotide  
phosphodiesterase   thereby   modulating   both   the   synthesis   and   degradation   of  
cAMP.   In  order   for  productive   cAMP   signalling   to  occur,   CaM  must  be  modulated  
both  spatially  and  temporally  (Toutenhoofd  and  Strehler,  2000).    
Part  of  this  regulation  may  occur  at  the  transcript  level  in  higher  vertebrates  where  
three   non-­‐allelic   genes   encode   the   CaM   protein.   The   CaM   multigene   family   is  
unique   in   that   its   three  allelic  genes  do  not  encode  different   isoforms  but  encode  
the   same   identical   protein.   Although   it   may   be   expected   that   three   completely  
identical   gene   products   would   give   rise   to   redundancy,   their   high   conservation  
would   seem   to   argue   against   this   and   suggest   that   there   are   selective   pressures  
acting   to   conserve   these   sequences   in   vertebrates.   Therefore,   it   stands   to   reason  
that   the   three   CaM   proteins   must   target   and   modulate   different   populations   of  
interacting   partners,   possibly   at   different   sites   within   the   cell   (Toutenhoofd   and  
Strehler,  2000).    
??????????????????????????? ???????????????????????????????????????????????-­‐  ??????-­‐  
untranslated   regions   (UTRs)   but   have   identical   intron-­‐exon  boundaries   implying   a  
common  ancestor.  During  evolution  the  number  of  functions  for  CaM  has  increased  
significantly   and   the   advent   of   three   separate   genes   encoding   CaM   may   have  
permitted  tighter  regulation  of  protein  expression  through  differential  expression  of  
the  genes  and  regulation  of  the  various  mRNA  transcripts  at  distinct  subcellular  loci  




It  has  been  established  that  there  are  differences  in  CaM  concentration  in  different  
cellular  compartments  generating  distinct  pools  of  CaM  which  may  go  some  way  to  
explaining   how   CaM   carries   out   such   a   diverse   array   of   processes   (Persechini   and  
Stemmer,  2002).   It  has  not  been  established,  however,  whether   the  different   gene  
transcripts   derive   different   cellular   pools   of   CaM.   CaM   could   be   regulated   at   a  
number  of  different  levels.  Two  distinct  pools  of  CaM  have  been  detected  in  cells:  a  
???????? ???2+   ??????????? ????????? ???? ??? ?????????? ???2+   ????????????? ?????????
(Toutenhoofd  and  Strehler,  2000).  It  is  thought  that  CaM  may  be  stored  in  an  inactive  
form  either  by  binding  to  molecules  which  prevent  its  activity  or  by  phosphorylation  
to  reduce  its  potency  as  an  activator  of  target  proteins.  An  appropriate  signal  such  
as  an  elevation  in  Ca2+,  may  then  release  CaM  from  this  inactive  pool   (Toutenhoofd  
and  Strehler,  2000).  Regulation  at  the  spatial  level  may  be  inferred  by  the  trafficking  
of   pre-­‐synthesised   CaM  along   cytoskeletal   elements   to  particular   subcellular   sites  
(Toutenhoofd  and  Strehler,  2000).  CaM  can  also  be  post-­‐translationally  modified  by  a  
variety   of   mechanisms   including   acetylation,   trimethylation,   carboxylmethylation,  
proteolytic  cleavage  and  phosphorylation.  These  modifications  may  also  modulate  
CaM's   activity   and   target   proteins   (Ikura   and   Ames,   2006).   Similarly,   CaM   target  
proteins   can   be   regulated   at   the   protein   level   both   spatially   and   temporally   and  
through   protein   modifications.   For   instance,   phosphorylation   of   CaM   kinase  
modulates   its   sensitivity   to   CaM   (Hook   and   Means,   2001).   Regulation   of   the  
concentration  of  both  CaM  and   its   relevant   target  proteins   at  particular   locations  
??????? ???? ????? ??? ????? ???????????? ??? ???????????? ?????? ???????????? ?? ???-­‐affinity  
binding  partner  that  is  expressed  at  a  low  concentration  in  a  particular  locale  is  less  
likely  to  interact  with  CaM  than  a  more  highly  expressed  or  higher-­‐affinity  binding  
partner.  Illustrating  this  theory,  Schaad  et  al.(Schaad  et  al.,  1996)  reported  that  NCS-­‐1  
is   able   to   replace   CaM   in   interactions   with   calcineurin   (Schaad   et   al.,   1996).  
Subsequent   studies,   however,   could   not   confirm   this   as   a   significant   interaction  
physiologically,  and  previously  reported  dissociation  constants  show  that  NCS-­‐1  has  
a   three-­‐fold   lower   binding   affinity   for   calcineurin   than   CaM   (Schaad   et   al.,   1996,  
Hubbard  and  Klee,  1987).  This,  together  with  the  fact  that  CaM  is  expressed  at  5  -­‐  200  




relevant   interaction   is   between   calcineurin   and   CaM,   not   NCS-­‐1   (Fitzgerald   et   al.,  
2008).    
At  the  transcript  level,  CaM  expression  may  be  regulated  through  the  trafficking  of  
different   CaM  mRNAs   to   specific   cellular   compartments   for   localised   translation.  
Finally,   transcriptional   control   within   the   nucleus   could   control   which   of   the  
multiple  CaM  genes  are  expressed  thereby   fulfilling   individual   cell   and  tissue   type  
requirements  for  CaM  (Toutenhoofd  and  Strehler,  2000).  
Various  transcripts  arise  from  each  of  the  three  CaM  genes  with  varying  expression  
levels  depending  on  the  tissue  type.  This  is  also  apparent  in  the  brain  where  CaM  I  
and  CaM  II  are  highly  expressed  in  the  granular  cell  layer  of  the  cerebellum  whereas  
CaM   III   is   expressed   at   a  much   lower   level.   In   the  Purkinje   cells,   however,   strong  
expression  of  CaM  II  is  observed  with  lower  level  expression  for  CaM  I  and  CaM  III.  
Characteristic  subcellular  distributions  for  each  mRNA  species  are  also  observed  in  
neurons  with  CaM  II  mRNA  mostly  appearing   in  perikaryal  regions,  and  CaM  I  and  
??????????????????????????????????????????????????????????????????????????????????????
be   important   in   determining   these   distinct   tissue   and   subcellular   expression  
patterns  (Friedberg  and  Rhoads,  2001).  This  regulation  may  be  particularly  important  
in  specialised  cells  such  as  neurons  and  complex  mechanisms  that  have  evolved  to  
regulate  CaM  may  be  related  to  the  enhancement  of  synaptic  plasticity  in  mammals  
(Friedberg   and   Rhoads,   2001).   A   number   of   Ca2+-­‐sensing   proteins,   evolutionarily  
related  to  CaM,  have  been  discovered  which  are  enriched  or  expressed  exclusively  
in  the  brain.  Further  duplication  and  diversification  of  the  CaM  gene  has  given  rise  
to  these  neuronal  Ca2+-­‐sensing  proteins  which  carry  out  specific  neuronal  functions  
in  higher  organisms  (Burgoyne,  2007,  McCue  et  al.,  2010b,  Mikhaylova  et  al.,  2011).  
1.6.  Neuronal  Calcium  Signalling  
Calcium  signalling  in  neurons,  like  in  other  cell  types,  can  mediate  gene  expression,  
cell  growth,  development,  cell  survival,  and  cell  death.  In  addition,  neuronal  calcium  
signalling  processes  have  adapted  to  modulate  the  function  of  important  pathways  
in   the  brain,   including  neuronal   survival,  axon  outgrowth,  and  changes   in  synaptic  




transduction   of   Ca2+   signals   leading   both   to   short   term   responses,   such   as   the  
modification   of   synaptic   proteins,   and   long   term   responses   requiring   changes   in  
gene  expression  (Ghosh  and  Greenberg,  1995).    
It   is   well   established   that   Ca2+   plays   a   key   role   in   synaptic   transmission   between  
neurons,   acting   as   a   trigger   for   neurotransmitter   release   upon   its   entry   into   the  
presynaptic   terminal.   Many   other   specialised   roles   for   Ca2+   have   also   now   been  
identified   which   are   essential   for   the   development   and   plasticity   of   the   nervous  
system  (Ghosh  and  Greenberg,  1995).  The  mechanisms  by  which  changes  in  [Ca2+]i   in  
neurons   can   bring   about   such   diverse   and   long-­‐lasting   responses   has   become   a  
topic  of  widespread  interest.  
Many   of   these   processes   have   been   shown   to   be   largely   dependent   upon   the  
particular  route  of  Ca2+  entry  into  the  cell  (Ghosh  and  Greenberg,  1995).  For  instance,  
Ca2+   influx   through   VGCCs   can   lead   to   increased   survival   of   embryonic   neurons,  
whereas   influx   of   Ca2+   through   NMDA   receptors   in   postnatal   neurons   mediates  
excitotoxic  cell  death  (Choi,  1988,  Franklin  and  Johnson  Jr,  1992).  Changes  in  [Ca2+]i  are  
mediated,  as  in  other  cell  types,  by  influx  from  either  the  extracellular  space  or  from  
intracellular   stores   such   as   the   ER.   The   major   PM   Ca2+   channels   in   neurons   are  
VGCCs   and   NMDA   receptors,   however,   specific   subsets   of   neurons   also   express  
other   specialised   channels   such   as   the   neuronal   acetylcholine   receptor,   type   3  
serotonin   receptors,   AMPA   receptors   and   kainate   receptors   (Ghosh  and  Greenberg,  
1995,  Berridge,  1998).  The  contributions  of  the  various  VGCCs  in  neurons  have  been  
well   characterised   and   the  majority  of   Ca2+   currents   generated   by   these   channels  
appear  to  be  mediated  by  L-­‐,  N-­‐,  and  P-­‐type  channels   (Ghosh  and  Greenberg,  1995).  
Each  of  these  channels  seems  to  have  distinct  functions  and  they  are  expressed  in  
distinct  PM  domains.  N-­‐type  channels  tend  to  be  quite  broadly  distributed  and  have  
been  implicated,  along  with  P-­‐type  channels,  in  the  regulation  of  neurotransmitter  
release.   L-­‐type   channels   on   the   other   hand,   are   concentrated   at   the   base   of   the  
apical  dendrite  in  hippocampal  pyramidal  neurons  and  can  regulate  Ca2+-­‐dependent  




NMDA   receptors   are   particularly   important   neuronal   Ca2+   influx   channels   due   to  
their  critical   involvement   in  processes  such  as  synaptic  plasticity  and  cell  death.   In  
contrast  to  the  VGCCs,  NMDA  receptor  activation  requires  both  ligand  binding  and  
membrane   depolarisation   (Ghosh   and   Greenberg,   1995).   Postsynaptic   Ca2+   signals  
arising  from  activation  of  NMDA  receptors  give  rise  to  two   important  processes   in  
synaptic  plasticity,  long  term  potentiation  (LTP)  and  long  term  depression  (LTD).  LTP  
and  LTD  are  examples  of  the  way  synaptic  transmission  can  change  synaptic  efficacy  
and  are  thought  to  be  important  in  modulating  learning  and  memory.  Importantly,  
the   Ca2+   signals   that  bring   about  either   LTP   or   LTD  differ   only   in   their   timing   and  
duration.  LTP  is  triggered  by  Ca2+  signals  on  the  ?M  scale  for  a  few  seconds  whereas  
LTD  is  triggered  by  Ca2+  signals  on  the  scale  of  hundreds  of  nM  for  longer  durations  
(Burgoyne,  2007,  Bear  and  Malenka,  1994).  
Ca2+  release  from  internal  stores  also  contributes  significantly  to  changes  in  [Ca2+]i.    
The  main   Ca2+   store   in   neurons,   as   in   other   cell   types,   is   the   ER  which   forms   an  
elaborate   network   extending   throughout   the   whole   cell,   from   the   nuclear  
membrane   into   the  dendrites   and  along   the  axon   (Berridge,  1998).  As   in  other   cell  
types  Ca2+   is  released  from  ER  stores  by  two  main  mechanisms  involving  IP3Rs  and  
RyRs  (Berridge,  1998).The  extensive  ER  network  is  thought  to  be  very  important  for  
?????????????????????????????????????? ??????????????????????????????-­‐within-­‐a-­‐
????????(Berridge,  1998).  The  ER  can  act  as  a  sink  for  localised  Ca2+  pulses  generated  
by  brief  neuronal  activity  and  the  Ca2+  will  gradually  dissipate.      In  this  way  the  ER  
can  buffer  a  large  number  of  Ca2+  spikes.  As  the  load  of  the  ER  increases,  however,  
IP3Rs   and   RyRs   become   increasingly   sensitized   due   to   the   increase   in   [Ca
2+]i   and  
eventually   Ca2+  may   be   released   back   into   the   cytosol   as   a   consequence   of   CICR.  
Therefore,  by  acting  as  a  sink   for  brief  elevations  of  Ca2+   release,   the  ER  can  keep  
track   of   the   cumulative   Ca2+   spikes   eventually   leading   to   opening   of   intracellular  
channels.   This   can   then   lead   to   the   generation  of   a   global   signal   that   reaches   the  
nucleus,  causing  changes  in  gene  transcription  (Berridge,  1998).  
The  highly  polarised  nature  of  neurons  means  that  calcium  signalling  in  this  cell  type  
is  usually  highly  localised.  For  this  reason  the  spatial  proximity  of  molecular  targets  




instance  the  influx  of  Ca2+  through  a  single  Ca2+  channel  can  only  be  translated  into  
a   signal   if   the   relevant   Ca2+-­‐sensor   is   within   50   nm   of   the   channel.   At   the  
presynaptic   terminal,   neurotransmitter   release   is   triggered   by   the   influx   of   Ca2+  
through  clusters  of  channels  which  creates  a  Ca2+-­‐microdomain.  This  influx  activates  
Ca2+-­‐sensors  which  are  situated  within  a  fraction  of  a  ??  of  the  channels  (Augustine  
et  al.,  2003).  Another  example  of  highly  localised  neuronal  calcium  signalling  occurs  
in  dendritic  spines  where  ligand-­‐gated  channels  are  targeted  to  the  tip  of  the  spine.  
Ca2+   influx   through   these   channels   creates   nanodomains   or  microdomains   within  
the  spine  head  which  decay  over   the  approximately  1?m  length  of  the  spine.  The  
specific   localisation   of   the   ligand-­‐gated   channels   together   with   the   restricted  
movement  of  Ca2+  within  the  thin  neck  of  the  spine  results  in  a  highly  localised  Ca2+  
signal   (Augustine   et   al.,   2003).   Differences   in   diffusion   rates   can   give   rise   to   large  
differences   in   the  magnitude  and   speed  of   a  Ca2+   signal.   It   is   therefore   important  
that   the   Ca2+-­‐sensors   involved   in   a   given   process   have   properties   that   are  
appropriate  for  the  local  Ca2+  signal  being  detected.  In  accordance  with  this,  families  
of   Ca2+-­‐sensors   that   are   expressed   specifically   in   neurons   have   been   reported.  
These  neuronal  Ca2+  sensors  each  possess  unique  properties  which  determine  their  
site   of   action   within   the   neuron   and   which   allow   them   to   carry   out   highly  
specialised  functions  in  the  nervous  system.  
1.7.  The  Neuronal  Calcium  Sensor  Family  
Whereas   CaM   is   ubiquitously   expressed,   the   expression   of   other   Ca2+-­‐sensing  
proteins  is  restricted  to  particular  cell  types.  A  key  example  of  this  is  the  neuronal  
calcium  sensor  (NCS)  family  of  proteins  which  are  primarily  expressed  in  neurons  or  
retinal   photoreceptors.   The   NCS   family   of   proteins   are   related   to   CaM   but   have  
distinct  properties  that  allow  them  to  carry  out  non-­‐redundant  functions.  Members  
of   the   NCS   protein   family   have   been   implicated   in   the   regulation   of  
neurotransmitter  release,  regulation  of  receptors  and  ion  channels,  control  of  gene  
transcription,   cell   growth   and   cell   survival   (Burgoyne,   2007).   The   NCS   proteins   are  
encoded  by  a  family  of  fourteen  genes  in  mammals  with  a  further  level  of  diversity  
being   generated   by   alternative   splicing.   The   gene   products   each   contain   four   EF-­‐




NCS-­‐1,  the  mammalian  homologue  of  yeast  frequenin,  is  the  most  widely  expressed  
member  of  this  family  and  is  thought  to  be  the  primordial  NCS  protein.  The  protein  
was   first   discovered   in   Drosophila   melanogaster   and   although   initially   it   was  
originally  described  as  neuronal  specific  it  has  since  been  demonstrated  to  exhibit  a  
wider  expression  profile.  An  NCS-­‐1  orthologue  has  been  identified  in  yeast  which  is  
essential   for   survival   (Hilfiker,   2003)   and   there   appears   to   have   been   a   steady  
increase   in   the   complexity   of   this   protein   family   throughout   evolutionary   history.  
Five  distinct   classes  of  NCS  protein  have  now  been   identified   in  higher  organisms  
termed   classes   A-­‐E.   Class   A   comprises   NCS-­‐1,   which   first   arose   in   yeast.   Class   B  
consists  of  the  visinin-­‐like  proteins  (VILIPs),  which  appeared  first   in  Caenorhabditis  
elegans.   Classes   C   and   D   first   appeared   in   fish   and   comprise   recoverin   and   the  
guanylyl-­‐cyclase-­‐activating  proteins  (GCAPs),  respectively.  Finally  class  E  encode  the  
K+   channel-­‐interacting   proteins   (KChIPs)   which   are   present   in   insects   and  
evolutionary   subsequent   species   (Burgoyne,  2004).     Mammals  have  a   single  NCS-­‐1,  
five  VILIP  proteins,  a  single  recoverin,  three  GCAPs  and  four  KCHIPs.  The  recoverins  
and   GCAPs   are   restricted   to   the   retina   whereas   the   rest   of   the   NCS   family   are  
expressed   in   neurons   with   varying   expression   profiles   (Burgoyne,   2007).   Although  
localisation  and  expression   studies  have  proven  difficult  due   to   cross-­‐reactivity  of  
antibodies,  it  has  been  established  that  certain  neurons  express  several  or  all  of  the  
NCS   proteins.   The   expression   pattern   for   each   of   the   NCS   proteins   is   unique,  
however,   suggesting   that   despite   the   high   sequence   homology  within   this   family,  
each  one   is   likely   to  perform  distinct   functions   in   specific   cell   types   (Burgoyne  and  
Weiss,  2001).  
In  contrast  with  CaM,  not  all  EF-­‐hand  motifs  in  the  NCS  proteins  are  functional  and  
the   first   EF-­‐hand   is   unable   to   bind   Ca2+   in   all   family  members   (Figure   1.4).   In   the  
case  of  recoverin  and  KChIP1  only  two  of  their  four  EF-­‐hand  motifs  are  functional  in  
Ca2+   binding   (Burgoyne,   2007,   Burgoyne  et   al.,   2004).   Unlike   the   extended   dumbbell  
structure  of  CaM,  NCS  proteins  are  compact  and  globular  when  bound  to  Ca2+.  The  
NCS  proteins  also  differ   from  CaM   in  that   they  have  covalent  modifications  which  
can  allow  direct   association  with   cellular  membranes.   KChIP1  and  all  members  of  




(Figure  1.4).   In  some  cases  the  membrane  association  conferred  by  these  moieties  
only   occurs   upon   Ca2+   binding   when   a   sequestered   N-­‐myristoyl   acyl   chain   is  
extruded   from   the   protein   core   after   a   shift   in   conformation.   For   instance   VILIP  
proteins  and  recoverin  are  cytosolic  at  resting  Ca2+  concentration  but  localise  to  the  
PM   or   Golgi   upon   Ca2+   elevation.   Each   of   the   NCS   proteins   displays   distinct  
subcellular   localisations   which   in   some   cases   are   additionally   influenced   by   the  
specific  phosphoinositides  with  which  their  N-­‐termini  interact  (Burgoyne,  2007).  
  
  
Figure  1.4.  Schematic  diagram  showing  the  typical  domain  organisation  of  the  NCS  proteins.With  
the  exception  of  recoverin  and  KChIP1,  the  NCS  proteins  have  three  functional  EF-­‐hands  (yellow)  (i).  
EF-­‐1  is  non-­‐functional  in  all  NCS  proteins  (orange).  All  NCS  proteins  with  the  exception  of  KChIP2  and  
KChIP3  are  N-­‐myristoylated  (i)  (de??????????????????????????????????????????????-­‐terminal  extension  
????? ????????? ????? ?????? -­‐   the   source   of   multiple   splice   isoforms   and   different   mechanisms   of  
membrane   association   (either   N-­‐myristoylation   or   palmitoylation).   (Adapted   from   (Burgoyne   and  
Weiss,  2001)).  
  
NCS   proteins   are   multifunctional   regulators   of   various   proteins   involved   in  
processes   ranging   from   vesicular   trafficking   and   ion   channel   modulation   to   gene  
transcription   (Burgoyne   et   al.,   2004).   NCS-­‐1   has   been   shown   to   enhance  
neurotransmitter   release   and   constitutive   exocytosis   when   overexpressed.  
Consistent   with   this   function,   an   interaction   with   phosphatidylinositol-­‐4   kinase  
(PI4K)   has   been   reported   in  both   yeast   and  mammals   suggesting   that  NCS-­‐1  may  
regulate   neuronal   secretion   through   the   modulation   of   phosphatidylinositol-­‐
dependent   trafficking   steps   (Hilfiker,  2003).   The  VILIP   or   class   B   proteins  modulate  
various   signal   transduction   pathways   including   cyclic   nucleotide   and   MAPK  




involved   in  membrane  trafficking   (Braunewell  and  Klein-­‐Szanto,  2009).  Recoverin  and  
the  GCAPs  are  expressed  exclusively  in  the  retina  and  have  important  roles  in  light  
adaptation.   Recoverin   interacts  with   and   inhibits   the   activity   of   rhodopsin   kinase  
and   can   prolong   phototransduction   and   enhance   visual   sensitivity   (Sampath   et   al.,  
2005).  GCAPs   are   the   only   known   activators  of   retinal   guanylyl   cyclases   (GCs)   and  
are  unusual   in  that  they  activate  GCs  when   in  their  Ca2+-­‐free  form  but  GCAP2  and  
GCAP3  become  inhibitors  of  GCs  at  higher  Ca2+  concentrations.  GCAP3  is  expressed  
in   cone   cells   whereas   GCAP1   and   GCAP2   are   expressed   in   rod   cells   and   despite  
GCAP1  and  GCAP2  sharing  the  same  function  in  the  same  cell  type  each  protein  has  
different  Ca2+  binding  affinities  for  GC  activation.  This  means  that  both  proteins  are  
required  for  GC  activation  over  the  full  physiological  range  of  [Ca2+]i  thus  increasing  
dynamic  range  and   light  sensitivity   in  the  mammalian  retina.  The  GCAPs  therefore  
represent   an   example   of   how  Ca2+   sensors  have   become   adapted   to   increase   the  
sensitivity  of   important   regulatory  mechanisms   in   specialised   cell   types   (Burgoyne,  
2007,  Burgoyne  and  Weiss,  2001,  Palczewski  et  al.,  2004).  
KChIPs   have   been   found   to   associate   with   transient   voltage-­‐gated   potassium  
channels  of  the  Kv4  family,  but  the  specific  functions  of  these  proteins  in  the  brain  
remains  unclear   (Wang,  2008).   They   are   expressed   predominantly   in   the   brain   but  
KChIP2   is   also   expressed   in   the   heart   and  depletion   of   KChIP2   causes   a   complete  
loss   of   Ca2+-­‐dependent   transient   outward   potassium   currents   and   a   susceptibility  
towards  ventricular  tachycardia  (Kuo  et  al.,  2001).  Knockouts  of  KChIP1  have  revealed  
a   potential   role   in   the  GABAergic   inhibitory   system   (Xiong  et  al.,  2009)   and   KChIP3  
knockout  mice  exhibit   reduced   responses   in  acute  pain  models   (Reisch  et  al.,  2006)  
???????????????-­‐amyloid  production   (Lilliehook  et  al.,  2003).  KChIP3,  also  known  as  
DREAM  or  calsenilin,  is  the  most  comprehensively  understood  of  the  KChIPs  and  has  
roles   identified   in   transcriptional   regulation   (Burgoyne   et   al.,   2004,   Yakovleva   et   al.,  
2006)   and   in   the   processing   of   presenilins   which   are   important   proteins   in  
?????? ?????????????????????????????(Buxbaum  et  al.,  1998).  
In  support  of  the  NCS  proteins  having  essential  roles  in  higher  organisms,  a  number  
of  recent  discoveries  have  implicated  these  proteins  in  the  pathological  processes  of  




KChIP3   with   presenilins   (Jo   et   al.,   2004),   the   NCS   proteins   have   been   linked   with  
?????? ????????? ??? ???? ???????? ???????? ??????? ???? ????? ? ????????? ??? ?????? ?????
disease  due   to  an  association  with  amyloid  plaques   in  diseased  brains   (Schnurra  et  
al.,  2001).  NCS-­‐1  has  been   found  to  be  up-­‐regulated   in  neural   tissue  from  patients  
with   schizophrenia   and   bipolar   disorders   (Koh   et   al.,   2003)   and   also   interacts  with  
interleukin-­‐1   receptor   accessory   protein-­‐like   (IL1RAPL),   a   protein   which,   when  
mutated,  results  in  X-­‐linked  mental  retardation  (Bahi  et  al.,  2003).  Apart  from  links  to  
neurological   disorders,   NCS   protein   function   has   also   been   implicated   in   cancer.  
Recoverin   is   detected   in   68%   of   small   cell   and   85%   of   non-­‐small-­‐cell   cancer-­‐
associated  retinopathy-­‐producing  lung  carcinomas  and  was  also  expressed  in  ~50%  
of   other   tested   tumour   types   including   breast   and   ovarian   cancers   (Bazhin   et   al.,  
2004).  Recoverin  is  hypothesized  to  regulate  cancer  cell  growth  in  a  Ca2+-­‐dependent  
manner  through  modulation  of  receptor  kinases  and  may  offer  a  therapeutic  target  
for   the   treatment   of   recoverin   expressing   tumours   (Braunewell,   2005).   High  
expression  of  VILIP1  has  been  detected  in  less  aggressive  skin  tumours  in  mice  but  
expression   was   significantly   reduced   or   absent   in   invasive   squamous   carcinoma.  
However,   when   aggressive   tumour   cell   lines   were   transfected   with   VILIP-­‐1   the  
cancer  cells  became  less  invasive  hinting  at  a  role  for  VILIP-­‐1  as  a  tumour  suppressor  
(Mahloogi  et  al.,  2003).  The  effects  that  NCS  proteins  confer  in  these  diseases  appear  
to   be   dependent   on   the   up-­‐   or   down-­‐regulation   of   their   expression.   As   yet,   few  
genetic   links   have   been   found   between   the   NCS   proteins   and   these   diseases  
suggesting  epigenetic  effects  may  be  responsible.  Epigenetic  effects  also  have  a  role  
in   synaptic   plasticity   and   memory   formation   which   are   affected   in   many  
?????????????????? ?????????? ????? ??? ?????? ????? ????????? ?-­‐linked   mental  
retardation   and   schizophrenia   and   have   also   been   linked   to   the   regulatory  
mechanisms   carried   out   by   the   NCS   proteins.   A   current   hypothesis   is   that   the  
epigenetic   deregulation   of   NCS   proteins   may   contribute   to   the   cognitive  
impairments   seen   in   many   neurodegenerative   diseases   making   the   epigenetic  





This   family   of   proteins   have   evolved   to   carry   out   specialized   neuronal   functions  
which   are   separate   to   the   functions   of   CaM.  When   trying   to   decipher  why   these  
proteins   are   particularly   well   adapted   for   carrying   out   functions   in   neuronal  
populations  it  is  therefore  useful  to  compare  their  properties  to  those  of  CaM.    Of  
particular  note   is   their   approximately  10-­‐fold  higher   affinity   for  Ca2+   compared   to  
CaM.   This   higher   affinity   allows   the   NCS   proteins   to   be   activated   at   low   Ca2+  
concentrations   which   would   ordinarily   activate   only   a   fraction   of   cellular   CaM.  
Expression  of  Ca2+  binding  proteins  with  a  range  of  Ca2+  binding  affinities  increases  
the  dynamic  range  over  which  Ca2+  can  regulate  neuronal  processes.  In  this  way  the  
cell   can   respond   to   very   slight   or  more   dramatic   changes   in   [Ca2+]i   depending   on  
which  populations  of  Ca2+   sensors   are   activated  under   those  particular   conditions  
(Burgoyne   and   Weiss,   2001).   As   mentioned   previously,   the   individual   expression  
patterns  and  the  subcellular  localisation  of  each  of  the  NCS  proteins  is  also  likely  to  
play   an   important   role   in   their   suitability   for   neuronal   cell   signalling.   The  
characteristic  N-­‐myristoylation   or   palmitoylation  modifications,  which   allow   these  
proteins   to  associate  with  membranes,  may  position   them  at   relevant   sites   in   the  
cell  leading  to  a  faster  and  more  efficient  response  to  Ca2+  signals.  
The  NCS  proteins  represent  a   family  of  neuronal  Ca2+  binding  proteins  which  have  
evolved  to  carry  out  discrete  functions  separate  to  those  of  CaM.  Various  members  
of  this  protein  family  arose  at  different  points  in  evolutionary  history  and  carry  out  
a   diverse   array   of   functions.   The   NCS   proteins   are   a   prime   example   of   how   the  
properties  of  Ca2+  binding  proteins  have  been  fine-­‐tuned  to  allow  them  to  regulate  
specific  targets  in  neuronal  signalling  pathways.    
As   an   example   of   how   the   NCS   proteins   are   adapted   to   carry   out   specialised  
functions,  two  members  of  this  protein  family  will  be  discussed  in  more  detail.  NCS-­‐
1   represents   an   important   member   of   the   NCS   family   and   has   been   well  
characterised  functionally.  The  function  of  recoverin  is  less  well  characterised  than  
for   NCS-­‐1,   however,   the   structure   of   recoverin   has   been   extensively   studied.  
???????????????????????????????????????????????????????????????????????????????????





NCS-­‐1   the   primordial   NCS   protein   has   been   highly   evolutionarily   conserved,  
retaining  59%  homology  with  its  yeast  orthologue,  frequenin.  It  displays  a  high  Ca2+  
affinity  (??440  nM)  compared  to  CaM  (??4  -­‐  20  ?M)  (Schaad  et  al.,  1996)  and  is  able  
to   respond   to   marginal   changes   in   [Ca2+]i.   Like   many   of   the   other   NCS   family  
members   NCS-­‐1   has   an  N-­‐myristoyl   group   which   enables   membrane   association.  
Endogenous  NCS-­‐1  is  therefore  predominantly  associated  with  Golgi  and  trans-­‐Golgi  
membranes  and  in  some  cell  lines,  has  been  detected  in  vesicular  structures  and  at  
the   PM   (Hilfiker,   2003).   NCS-­‐1   carries   out   important   neuronal   functions   and,   for  
example,  has  been   found  to   regulate  phosphorylation,   trafficking  and  signalling  of  
D2   dopamine   receptors   (D2Rs).   D2Rs   represent   an   important   target   for   the  
development   of   novel   therapeutic   drugs   for   the   treatment   of   schizophrenia   and,  
interestingly,  NCS-­‐1  can  also  contribute  to  the  pathology  of  schizophrenia  and  has  
been  suggested  as  an  alternative  molecular  target  for  antipsychotic  drugs   (Kabbani  
et  al.,  2011).  Unlike  the  rest  of  NCS  family,  however,  NCS-­‐1  is  not  neuron  specific  and  
is   expressed   in   neuroendocrine   cells   and   several   non-­‐neuronal   cell   types   at   low  
levels.   For  example,  a   study  using  NCS-­‐1   (-­‐/-­‐)   knockout  mice   identified  NCS-­‐1  as  a  
novel  regulator  of  calcium  signalling  in  immature  and  hypertrophic  hearts.  This  was  
mediated   in  part  by   regulation  of   IP3R   function   (Nakamura  et  al.,  2011).   In   addition  
NCS-­‐1   is   essential   for   survival   in   yeast   and   taken   together   these   facts   suggest   a  
more  generalized  role  for  NCS-­‐1  (Hilfiker,  2003).  
NCS-­‐1  has  three  functional  EF-­‐hand  motifs  which  have  differing  cation  specificities.  
It   is   hypothesised   that   under   resting   conditions   EF2   and   EF3   are   Mg2+   bound,  
whereas   EF4   is   a   Ca2+   specific   binding   site   and   remains   unoccupied.   In   resting  
conditions,   when   in   its   Mg2+   bound   form,   NCS-­‐1   adopts   a   conformation   which  
drastically   reduces   exposed   hydrophobic   regions.   This   may   be   important   in   the  
prevention  of  non-­‐specific  interactions  in  the  absence  of  an  appropriate  Ca2+-­‐signal.  
In  the  presence  of  Ca2+,  EF2  and  EF3  are  bound  simultaneously  followed  by  binding  
to  EF4  (Aravind  et  al.,  2008).  The  Mg2+  bound  form  of  NCS-­‐1  has  a  5-­‐fold  lower  affinity  
for  Ca2+  than  the  apo-­‐form  (440  nM  versus  90  nM)   (Aravind  et  al.,  2008).  As  resting  
[Ca2+]i   is   ?? 100   nM   a   Ca




revert   to   its   Ca2+-­‐free   form.   Binding   to  Mg2+   therefore   lowers   the   Ca2+   affinity   of  
NCS-­‐1   thereby   allowing   a  more   efficient   reversal   to   the   Ca2+-­‐unbound   state.   This  
implies  that  Mg2+  binding  provides  significant  modulation  of  NCS-­‐1  and  is  important  
in  fine-­‐tuning  its  Ca2+  sensing  ability  (Aravind  et  al.,  2008).  
Much   of   the   current   understanding   regarding   the   function   of   NCS-­‐1   stems   from  
overexpression   or   knockout   studies.   Overexpression   in   Drosophila   caused   a  
frequency-­‐dependent  facilitation  of  neurotransmitter  release  (Pongs  et  al.,  1993)  and  
in   Xenopus   caused   enhanced   spontaneous   and   evoked   transmission   at  
neuromuscular   junctions   (Olafsson   et   al.,   1995).   Overexpression   was   also   found   to  
increase  Ca2+-­‐dependent  exocytosis  of  dense  core  granules   in  PC12  cells   (McFerran  
et  al.,  1998)  and  to  enhance  associative  learning  and  memory  in  C.  elegans  (Gomez  et  
al.,  2001,  Hilfiker,  2003).  
Knockout  of  NCS-­‐1  in  Sacchormyces  cerevisiae  is  lethal  due  to  its  involvement  in  the  
activation  of  Pik1,  one  of  the  two  yeast  PI4Ks.  NCS-­‐1  can  interact  with  PI4K  in  both  
yeast   and   in  mammals   and  enhances   its   activity   3   -­‐   10   fold   (Hendricks  et  al.,   1999,  
Taverna   et   al.,   2002).   The   high   conservation   of   both   its   sequence   and   function  
between  yeast  and  mammalian  orthologs   suggests  an   important   role   for  NCS-­‐1   in  
the   regulation  of  phosphoinositides  and  hence  membrane   trafficking.  Knockout   in  
other   organisms,   however,   is   not   lethal   but   does   lead   to   developmental  
phenotypes.   Knockout   in   Dictyostelium   discoideum   changes   the   rate   of  
development  (Coukell  et  al.,  2004)  and  in  C.  elegans  results  in  impaired  learning  and  
memory   (Gomez   et   al.,   2001).   NCS-­‐1   therefore   appears   to   be   important   in  
developmental  processes   in  various  different  organisms  and  knockdown  of  one  of  
the  NCS-­‐1  genes  in  Danio  Rerio,  ncs-­‐1,  prevents  formation  of  the  semicircular  canals  
of   the   inner   ear   (Burgoyne,  2007,  Hilfiker,  2003).   Further   investigation   identified   the  
involvement   of   a   previously   described   (Haynes   et   al.,   2005,   Haynes   et   al.,   2007)  
signalling  pathway  involving  NCS-­‐1,  ARF1  and  PI4KIII?  which  was  found  to  modulate  
the   secretion   of   components   important   for   the   development   of   the   vestibular  




Many   different   binding   partners   have   been   identified   for   NCS-­‐1   and   often   these  
interactions  and  the  effects   they  confer  are  very   similar   to   those  of  CaM.  Despite  
this   overlap   in   roles,   these   Ca2+-­‐sensors   have   not   become   redundant   due   to  
differences  in  their  Ca2+  binding  properties  (Schaad  et  al.,  1996,  Fitzgerald  et  al.,  2008).  
NCS-­‐1   has   a   higher   affinity   for   Ca2+   than   CaM   and   therefore   may   preferentially  
interact  with  some  binding  partners  when  the  Ca2+  elevation  is  too  small  to  activate  
CaM  activity.  For  example,  both  CaM  and  NCS-­‐1  have  been  shown  to  interact  with  
and   desensitize   dopamine   D2   receptors   but   are   likely   to  mediate   their   effects   at  
different  Ca2+   levels  due  to  the  10-­‐fold  difference   in  Ca2+  affinity  between  the  two  
proteins  (Kabbani  et  al.,  2002,  Woods  et  al.,  2008).  NCS-­‐1  does  not  merely  represent  an  
alternative   regulator   of   classical   CaM   targets,   however,   and   numerous   NCS-­‐1  
specific   binding   partners   have   been   identified   which   have   no   documented  
interactions  with  CaM.  These  proteins   include  ILRAPL1,  Kv4.2  channels,  PI4K,  ARF1  
and  TGF???(Haynes  et  al.,  2006).  
The  example  of  NCS-­‐1   illustrates  how  evolutionary  pressures  have   fine  tuned  Ca2+  
sensors  to  carry  out  specialized  functions.  The  individual  properties  of  NCS-­‐1  allow  
this  protein  to  localise  to  discrete  domains  within  the  cell  and  interact  with  distinct  
target  proteins   under   conditions   of   Ca2+  stimulation  which  would  not   activate   the  
archetypal  Ca2+   sensor,  CaM.     NCS-­‐1   is  not  neuronal   specific  and  appears   to   carry  
out   more   generalized   functions   which   have   been   conserved   through   evolution.  
Further   adaptive  mutations,   however,   have   given   rise   to  many  more  members   of  
the  NCS  protein  family  which  can  carry  out  more  dedicated  functions.  
1.7.2.  Recoverin  
Insights   into  how  calcium  signalling  has  been   fine-­‐tuned  to  allow   the  evolution  of  
the  complex  vertebrate  nervous  system  can  be  gained  by  studying  more  accessible  
regions  of   the  nervous  system  such  as  the  retina   (Polans  et  al.,  1996).   In  particular,  
photoreceptor   cells   can   be   maintained   in   isolation   for   biochemical   and  
electrophysiological   investigations   and   the   response  of  photoreceptors   to   a   single  
photon   can   be   quantified.   Therefore,   the   biochemical   steps   involved   in  
phototransduction  have  been  extensively  studied  and  comprise  a  useful  model  for  




Ca2+   modulates   several   stages   in   phototransduction   through   the   activation   of  
various   Ca2+   binding   proteins   and   is   the   key   regulator   during   light   adaptation.    
Retinal   NCS   proteins   that   are   important   in   phototransduction,   include   GCAPs,  
visinin  and  recoverin  (Polans  et  al.,  1996).  
Recoverin  is  found  primarily  in  rod  and  cone  cells  of  the  retina  (Braunewell  and  Klein-­‐
Szanto,   2009,   Yamagata   et   al.,   1990,   Dizhoor   et   al.,   1991)   and   is   thought   to   act   to  
prolong   the   lifetime   of   photolyzed   rhodopsin   by   inhibiting   its   rhodopsin   kinase  
mediated  phosphorylation  and  prolonging   the   light   response.  Recoverin   activity   is  
therefore   important   for   the   modulation   of   light   adaptation   (Klenchin   et   al.,   1995).  
This  function  remains  controversial,  however,  with  several  observations  suggesting  
that   this   hypothesis   may   be   oversimplified.   The   interaction   of   recoverin   with  
rhodopsin   kinase   was   found   to   occur   in   a   Ca2+-­‐dependent   manner,   however   the  
binding   of   Ca2+   to   recoverin   also   increases   its   hydrophobicity   and   results   in   its  
binding   to  various  photoreceptor  proteins,  not   just   rhodopsin  kinase   (Polans  et  al.,  
1991,  Chen  et  al.,  1995a).  Discrepancies  have  also  arisen  regarding  the  [Ca2+]  required  
for  interaction  with  rhodopsin  kinase  which  may  be  out  of  the  normal  physiological  
range   (Baylor,   1996).   In   addition,   the   expected   phenotype   was   not   observed   in  
knockout  mice  which  only  displayed  changes   in  the   response  to   flashes  of   light  at  
the   end   of   background   illumination   but   showed   no   change   in   the   response   to  
general  flashes  of   light  as  would  be  expected   (Chen  et  al.,  1995b).   It   is  possible  that  
other  components  of  the  phototransduction  pathway  could  compensate  for  the  loss  
of  recoverin  in  these  mice.  Further  work  is  therefore  required  to  deduce  the  exact  
role  of  recoverin  in  light  adaptation  (Polans  et  al.,  1996).  
Despite  the  ambiguity  surrounding  the  possible  function  of  recoverin,  the  structure  
of  this  protein  is  the  most  extensively  studied  of  all  the  NCS  proteins.  Unlike  the  rest  
of   the  NCS   proteins,   recoverin   has   only   two   functional   EF-­‐hand  motifs   due   to   an  
internal   salt   bridge   in   EF4   (Ames   et   al.,   1996).   X-­‐ray   crystallography   and   nuclear  
magnetic   resonance   (NMR)   studies   have   been   used   to   deduce   the   structure   of  
recoverin   in   its   Ca2+-­‐bound   and   unbound   forms   and   have   revealed   unusual  
properties  which   are   unique   to   this  member   of   the  NCS   family   (Ames  et   al.,   1997,  




bent  linker  and  forms  a  compact  structure  in  the  absence  of  Ca2+.  Upon  binding  of  
Ca2+,  the  N-­‐terminal  domain  comprising  EF1  and  EF2  rotates  through  45o  relative  to  
the   C-­‐terminal   domain   and   a   usually   buried   N-­‐myristoyl   group   is   extruded.   This  
allows  the  protein   to  associate  with  membranes  whilst   simultaneously   revealing  a  
hydrophobic   surface   which   forms   the   binding   pocket   for   its   interaction   with  
rhodopsin  kinase  (Ames  et  al.,  1996).  The  residues  involved  in  the  interaction  of  the  
myristoyl  group  with  the  hydrophobic  pocket  are  also  conserved  in  other  members  
?????????????????????????????????????????????????? ?????????????????????-­‐1  and  KChIP1  
are   constitutively   membrane   bound   via   their   permanently   extruded   N-­‐myristoyl  
groups,  but,   similar   to   recoverin,  expose  a  hydrophobic  surface  upon  Ca2+  binding  
which   could   also   be   important   for   their   target   interactions   (Ames   et   al.,   1996).  
Information   about   the   structure   of   recoverin   may   go   some   way   to   aid  
understanding  of   the   generally   conserved   structural   features  of   the  NCS  proteins.  
There   are   subtle   differences   in   the   surface   residues   of   the   individual   proteins,  
however,  that  may  confer  structural  variation,  giving  rise  to  their  ability  to  interact  
with  a  wide  range  of  non-­‐overlapping  target  proteins.  
1.8.  The  CaBP  Family  of  CaM-­‐related  Ca2+  Sensors  
The  Calcium  Binding  Proteins  (CaBPs)  are  a  relatively  recently  discovered  family  of  
Ca2+   sensors  which   first  arose   in  vertebrates   (Chapter  3,   (McCue  et  al.,  2010a))  and  
are  likely  to  represent  another  example  of  how  Ca2+  sensors  have  evolved  to  carry  
out  discrete  processes  important  for  the  divergence  of  higher  organisms.  The  CaBPs  
share   sequence   homology   with   CaM   and   also   display   a   similar   structural  
arrangement  of  EF-­‐hand  motifs.  Each  of  the  CaBPs  has  four  EF  hand  motifs  and,  like  
the  NCS  proteins,  display  different  patterns  of  EF-­‐hand  inactivation  when  compared  
to  CaM  (Figure  1.5).  Another  key  difference  between  the  CaBPs  and  CaM  is  a  four  
amino   acid   extension   within   their   central   linking   alpha   helix,   between   the   C-­‐
terminal   and   N-­‐terminal   EF-­‐hand   pairs.   This   has   been   suggested   to   allow   these  
proteins  to   interact  with   larger  targets   (Haeseleer  et  al.,  2000).  The  CaBP  family  can  
be  divided  into  two  subgroups  depending  on  their  pattern  of  EF-­‐hand  inactivation:  










Figure  1.5.  Schematic  diagram  showing  the  domain  structure  of  CaM  and  the  CaBPs.  Functional  EF-­‐
hand  motifs  are  shown  in  yellow  and  non-­‐functional  EF-­‐hands  are  shown  in  orange.  The  CaBPs  have  
an  extended  linker  region  between  their  first  and  second  EF-­‐hand  pairs  (red).  CaBP1  and  CaBP2  each  
have  an  N-­‐??????????????? ??????????????????????????????????????????????????????????????????????-­‐termini  
give  rise  to  long  and  short  splice  variants  (green).  Caldendrin  is  a  longer  splice  isoform  of  CaBP1  that  
does  not  contain  an  N-­‐myristoylation  motif.  CaBP7  and  CaBP8  possess  a  38  amino  acid  hydrophobic  
domain  at  their  C-­‐?????????????????????????????  
  
1.8.1.  CaBPs  1-­‐5  
Five  genes  encode  CaBP1,  CaBP2,  CaBP3,  CaBP4  and  CaBP5.  CaBP3  differs  from  the  
remaining  members  of  this  family  as  it  is  predicted  to  have  only  two  active  EF-­‐hand  
motifs:   EF-­‐hands   3   and   4.   CaBP3   is   thought   to   be   a   pseudogene,   however,   as  
although  the  mRNA  has  been  detected  in  cells,  no  protein  product  has  been  found  
(Haeseleer  et  al.,  2000).  Three   isoforms  of  CaBP1   (Caldendrin,  CaBP1  Long   (CaBP1L)  
and  CaBP1  Short  (CaBP1S)),  and  two  splice  isoforms  of  CaBP2  (CaBP2  Long  (CaBP2L)  
and  CaBP2  Short  (CaBP2S)),  are  also  generated  through  alternative  spicing  of  their  
respective   mRNAs.   Caldendrin   is   the   longest   isoform   of   CaBP1   and   lacks   the   N-­‐
myristoylation   motif   which   is   found   in   other   splice   isoforms   of   both   CaBP1   and  




association  with  both  the  PM  and  Golgi  apparatus  (Haeseleer  et  al.,  2000).  CaBP4  and  
CaBP5   lack   this   N-­‐myristoylation   motif   and   are   predominantly   cytosolic.   The  
greatest  region  of  divergence  between  CaBPs  1-­‐5  resides  in  their  N-­‐termini  and  it  is  
thought  that  this  region  may  be  important  for  the  correct  localisation  of  CaBP1  and  
CaBP2.  As   such,   the   long   and   short   isoforms  of   CaBP1   show   subtle   differences   in  
their  subcellular   localisation.  CaBP1L   localises  predominantly  to  the  Golgi  and  also  
displays  some  cytosolic   localisation  whereas  CaBP1S   localises  most  prominently  to  
the  PM  and  to  Golgi  structures  (Haeseleer  et  al.,  2000,  McCue  et  al.,  2009).    
Various  proteins  have  been  identified  as  targets  of  the  CaBP  family,  some  of  which  
are  also  targets   for  CaM.  The  outcomes  of  such   interactions  are  generally  not  the  
same,   however.   Differences   in   expression   patterns,   subcellular   targeting  
mechanisms   and   Ca2+   binding   properties   of   the   various   members   of   the   CaBP  
protein   family   have   likely   allowed   them   to   carry   out   highly   specialised,   non-­‐
redundant,  regulatory  roles.    
  
Much  of  the  work  examining  the  function  of  CaBP1  has  been  derived  from  studies  
of  caldendrin.  It  is  not  yet  clear  whether  the  different  splice  isoforms  of  CaBP1  can  
carry   out   the   same   functions   although   some   differences   have   been   observed  
(Tippens  and  Lee,  2007).  CaBP1  and  caldendrin  have  roles  in  the  regulation  of  various  
different  types  of  Ca2+  channels  including  P/Q-­‐type  channels  (Lee  et  al.,  2002),  L-­‐type  
channels  (Zhou  et  al.,  2005,  Cui  et  al.,  2007),  IP3Rs  (Haynes  et  al.,  2004),  and  the  TRPC5  
channel  (Kinoshita-­‐Kawada  et  al.,  2005).  Interactions  of  CaM  with  these  Ca2+-­‐channels  
have  also  been  reported,  but  the  regulatory  outcome  is  quite  different.  In  addition,  
CaBP1  has  also  been  shown  to  compete  with  CaM  for  a  number  of  other  interacting  
binding  partners.  CaBP1  is  able  to  compete  with  CaM  for  binding  to  the  IQ  domain  
of  myo1C,  a  member  of  the  myosin-­‐1  family  of  motor  proteins  (Tang  et  al.,  2007)  and  
also  to  presynaptic  group  III  metabotropic  glutamate  receptors  (mGluRs)   (Nakajima,  
2011).   Numerous   molecules   including,   Ca2+,   cAMP,   PKC,   and   Munc   18-­‐1,   are  
involved   in   the   fine   tuning   of   presynaptic   mGluR   function,   hence   allowing   the  




level   of   regulation   which   is   Ca2+   dependent   and   is   blocked   by   PKC   dependent  
phosphorylation  of  the  receptor  (Nakajima,  2011).  
  
Unique   interactions   of   Caldendrin   with   other   types   of   proteins,   which   are   not  
shared  with  CaM,  have  also  been  reported.  Caldendrin,  but  not  CaM,  interacts  with  
light  chain  3   (LC3)  of  MAP1A/B,  a  cytoskeletal  protein  which   is   involved  in  cellular  
transport  processes   and   in   the  biogenesis   of   autophagosomes   (Seidenbecher  et  al.,  
2004,   Weidberg   et   al.,   2010).   In   addition,   a   unique   role   for   Caldendrin   in   NMDA  
receptor   signalling   has   been   reported   via   an   interaction   with   a   novel   neuronal  
protein,   Jacob   (Dieterich   et   al.,   2008).   Upon   NMDA   receptor   activation   Jacob   is  
normally  recruited  to  the  nucleus  through  the  importin  pathway,  and  results  in  the  
stripping   of   synaptic   contacts   and   drastic   alterations   in   the   morphology   of   the  
dendritic   tree.   When   there   is   a   sustained   synaptodendritic   elevation   in   [Ca2+],  
caldendrin   binds   to   Jacob   to   prevent   its   nuclear   trafficking   (Dieterich   et   al.,   2008).  
Finally,   a   Ca2+-­‐dependent   interaction   between   caldendrin   and   recoverin   has   been  
reported  and  the  two  proteins  were  observed  to  co-­‐localise  in  the  retina  (Fries  et  al.,  
2010).  
Limited   information   has   been   published   on   the   functions   of   CaBP2   and   CaBP5.  
CaBP2  was  found  to  stimulate  CaM  Kinase   II  activity  more  strongly  than  the  other  
CaBPs   in   in  vitro  studies,  however  the  physiological  relevance  of  this  has  not  been  
investigated   further   (Haeseleer  et  al.,  2000).  CaBP2  and  CaBP5  expression  has  been  
detected   in   the   retina  and   in  hair   cells  of   the   inner  ear  where   it   is  proposed  they  
may  regulate  the  activity  of  VGCCs   (Rieke  et  al.,  2008,  Yang  et  al.,  2006a).  CaBP5  was  
found  to  directly   interact  with  the  CaM  binding  domain  of  Cav1.2  and  co-­‐localised  
with  Cav1.2  in  rod  bipolar  cells   (Rieke  et  al.,  2008).  CaBP5  was  also  shown  to  have  a  
modest   inhibitory   effect   on   the   inactivation   of   Cav1.3   channels   in   transfected  
HEK293T  cells  whereas  CaBP2  was  unable  to  exert  similar  effects  (Yang  et  al.,  2006a).  
A   crucial   role   for  CaBP5   in   the   retina   is   supported  by   the  observation   that  CaBP5  
knockout  mice  have   reduced  sensitivity  of   retinal   ganglion  cells   to   light   responses  





CaBP4  is  expressed  in  the  retina,  localising  to  synaptic  terminals,  and  has  also  been  
detected  specifically  in  hair  cells  of  the  inner  ear   (Yang  et  al.,  2006a,  Cui  et  al.,  2007).  
CaBP4,   like   CaBP1   and   CaBP5,   appears   to   modulate   VGCCs,   including   Cav1.3   and  
Cav1.4  channels  (Cui  et  al.,  2007,  Yang  et  al.,  2006a,  Haeseleer  et  al.,  2004).  The  function  
??? ?????? ????????????? ??? ???????? ??????? ??? ??? ???? ?????a,  which   increases   CaBP4  
phosphorylation  in  light-­‐adapted  retinas  (Lee  et  al.,  2007b).  This  phosphorylation  was  
shown   to   prolong   Ca2+   currents   through   Cav1.3   channels   and   suggests   that   light-­‐
stimulated  phosphorylation  of  CaBP4  might  help  to  regulate  presynaptic  Ca2+  signals  
in   photoreceptors   (Lee   et   al.,   2007b).   CaBP4   has   also   been   implicated   in  
neurotransmitter  release  at  synaptic  terminals  due  to  its  interaction  with  unc119,  a  
synaptic   photoreceptor   protein   important   for   neurotransmitter   release   and  
maintenance   of   the   nervous   system   (Haeseleer,   2008).      CaBP4   (-­‐/-­‐)   homozygous  
knockout  mice  exhibit  abnormal  synaptic  morphology  and  function.  These  knockout  
mice  have  impaired  rod  and  cone  function  and  resemble  animals  that  are  deficient  
in  subunits  of  the  Cav1.4  channel  (Haeseleer,  2008).  
  
As  in  the  NCS  family  of  Ca2+  sensors,  the  importance  of  the  CaBPs  can  be  illustrated  
by  their   involvement   in  multiple  neuronal  diseases.  Post-­‐mortem  brains  of  chronic  
schizophrenics   have   been   shown   to   exhibit   reduced   numbers   of   caldendrin  
immunoreactive  neurons  which  express  the  protein  at  elevated   levels.  This   loss  of  
caldendrin   in   some   neurons   and   upregulation   in   others   is   likely   to   profoundly  
change  synapto-­‐dendritic  signalling  in  schizophrenic  patients   (Bernstein  et  al.,  2007).  
Changes   in   the   distribution   of   caldendrin   have   also   been   observed   in   kainate-­‐
induced   epileptic   seizures   in   rats.   Caldendrin   translocated   to   the   post   synaptic  
density   only   in   rats   which   suffered   epileptic   seizures   and   this   may   implicate   the  
protein  in  the  pathophysiology  of  the  disease  (Smalla  et  al.,  2003).    
  
CaBP4  has  the  most  well  characterised  role  in  disease  within  this  family  of  proteins.  
Genetic   mutations   in   this   gene   have   been   shown   to   cause   defects   in   retinal  
function.   Knockout   of   CaBP4  was   shown   to   cause   a   phenotype   similar   to   that   of  
incomplete   congenital   stationary   night   blindness   (CSNB)   patients   (Haeseleer   et   al.,  




et  al.,  2006).   Patients  with  mutations   in   the  CaBP4  gene  have  been   identified   that  
display  CSNB,  however,  some  patients  with  mutations  display  different  phenotypes  
(Zeitz  et   al.,   2006).   In   particular   a   novel   homozygous   nonsense  mutation   has   been  
reported  in  two  siblings,  which  resulted  in  severely  reduced  cone  function  but  only  
negligible   effects   on   rod   function   (Littink   et   al.,   2009).   In   addition,   a   homozygous  
single  base  pair  mutation  in  CaBP4  has  been  found  in  four  family  members  suffering  
?? ???????????????????????????????????? ?????-­‐like  disease.  The  phenotype  of  LCA   is  
more   severe   than   CSNB   and   patients   symptoms   include:   involuntary   eye  
movements,   severe   visual   impairment,   and   severely   diminished   or   absent  
electroretinography   (ERG)   measurements   (Aldahmesh   et   al.,   2010).   It   appears,  
therefore,   that   genetic   mutations   in   CaBP4   cause   multiple   cone-­‐rod   synaptic  
disorders  of  varying  physiological  severity  (Littink  et  al.,  2009,  Littink  et  al.,  2010).  
1.8.2.  CaBP7  and  CaBP8  
CaBP8   was   first   discovered   in   2001   and   originally   named   Calneuron   I   (Wu   et   al.,  
2001).  It  was  identified  as  a  CaM-­‐related  protein  with  homology  to  the  CaBPs.  Initial  
sequence   analysis   identified   some   differences   between   the   CaBPs   and   CaBP8.  
Whereas   the   CaBPs   share   similar   sized   mRNAs   and   genomic   structure   to   CaM,  
CaBP8  mRNA  is  much  larger  and  displays  a  different  intron-­‐exon  organisation  (Wu  et  
al.,  2001).  A  second  protein  with  a  high  degree  of  homology  to  CaBP8  (or  calneuron  
I)   was   later   discovered   and   named   Calneuron   II   (referred   to   here   as   CaBP7)  
(Mikhaylova  et  al.,  2006).  These  proteins  have  been  consistently  grouped  with  CaBPs  
1-­‐5  due  to  the  homology  shared  among  these  proteins  and  were  first  referred  to  as  
CaBP7   and  CaBP8   in   2002  by  Haeseleer  et   al.(Haeseleer  et  al.,  2002).   For   simplicity  
these   proteins  will   be   referred   to   as   CaBP7   and   CaBP8   for   the   remainder   of   this  
thesis.      
CaBP7  and  CaBP8  have  a  different  pattern  of  EF-­‐hand   inactivation  compared  with  
the  rest  of  the  CaBPs,  with  active  EF-­‐hands  1  and  2  and   inactive  EF-­‐hands  3  and  4  
(Mikhaylova  et  al.,  2006).  Another  key  difference   is  that  CaBP7  and  CaBP8  possess  a  
highly  hydrophobic,  38  amino  acid  extension  at  their  C-­‐terminus,  when  compared  to  






Figure  1.6  Proposed  model   for  the  Ca2+-­‐dependent  molecular  switch  between  CaBP7/8  mediated  
inhibition   and   NCS-­‐1   mediated   activation   of   PI4KIII?   at   the   TGN.   At   low   [Ca2+]i  (Left)   PI4KIII?? is  
predominantly   in   the   CaBP7/8-­‐bound   form   which   inhibits   kinase   activity   and   slows   TGN   to   PM  
trafficking.   When   [Ca2+]i  becomes   elevated   (Right)   NCS-­‐1   binds   Ca
2+   and   is   able   to   compete   with  
CaBP7/8   for   binding   to   PI4KIII??? ???-­‐1   stimulates   the   activity   of   PI4KIII?? ???? ??????? ?? ?? ??? ?-­‐fold  
increase   in  PI4P  and  PI(4,5)P2  production  which   in  turn  enhances  TGN  to  PM  trafficking.  CaBP7  and  
CaBP8   are   therefore   thought   to   set   the   threshold   Ca2+   concentration   at   which   PI4KIII?? ????????
activated  (Adapted  from(Mikhaylova  et  al.,  2009)).  
  
inhibit   its   activity   at   low   or   resting   Ca2+   levels   (Mikhaylova   et   al.,   2009).  
Overexpression   of   the   proteins   caused   a   reduction   in   phosphatidylinositol   4-­‐
phosphate   (PI4P)   levels   in   COS-­‐7   cells   and   inhibited   Golgi-­‐to-­‐PM   trafficking   in  
cortical  neuron   cultures,   implicating   them  as   regulators  of   cargo   release   from   the  
Golgi.   Overexpression   of   CaBP7   or   CaBP8   also   caused   enlargement   of   the   trans-­‐
Golgi   network   (TGN)   and   reduced   trafficking   of   synaptophysin-­‐containing   vesicles  
and  piccolo-­‐basson  vesicles  (PTVs).  In  accordance  with  this,  knockdown  of  CaBP8  in  
cortical  neurons  caused  a  reduction  in  the  size  of  the  TGN  and  a  significant  increase  
in   the  number  of   axonal   PTVs   (Mikhaylova  et  al.,  2009).  NCS-­‐1  had  been  previously  
shown   to   activate   PI4K   in   a   Ca2+-­‐dependent   manner   (Zhao   et   al.,   2001)   and  
Mikhaylova   et   al.   proposed   that   a   molecular   switch   for   the   production   of  
phosphoinositides  at  the  TGN  is  created  by  the  opposing  roles  of  NCS-­‐1  and  CaBP7  
or   CaBP8   (Figure   1.6)   (Mikhaylova   et   al.,   2009).   At   resting   Ca2+   levels,   CaBP7   and  
CaBP7/8:  Ca2+-­‐????? ???2+-­‐
bound  
NCS-­‐1:  Mg2+-­‐bound  and  Ca2+-­‐








?????? ????? ??? ????????? ???? ???????? ????? ???????????? ??? ????????? ??2+   levels   NCS-­‐1  
preferentially   ?????? ??? ?????????? ?????????? ????? ?????? ??? ?????? ????????? ????
enzyme  is  hence  activated,  generating  PI4P  at  the  TGN  and  allowing  increased  TGN-­‐
to-­‐PM  trafficking  (Mikhaylova  et  al.,  2009).  As  part  of  this  study,  the  ability  of  CaBP7  
and   CaBP8   to   bind   to   Ca2+   and   Mg2+   was   also   assessed.   Isothermal   Titration  
Calorimetry   (ITC)  experiments   revealed   that  CaBP7  and  CaBP8,  as  predicted,  have  
two  high   affinity   Ca2+   binding   sites,  with   global   affinities   of   230   nM  and   180   nM,  
respectively   (Mikhaylova   et   al.,   2009).   No   binding   to   Mg2+   was   observed   in   these  
experiments,   consistent   with   related   fluorimetry   analyses   where   no   change   in  
fluorescence  intensity  was  detected  upon  addition  of  Mg2+  to  apo-­‐CaBP8  whereas  a  
significant  change  was  observed  upon  addition  of  Ca2+  (Mikhaylova  et  al.,  2009).  
Whole  cell  patch-­‐clamping  experiments  in  bovine  adrenal  chromaffin  cells,  cells  of  a  
neural  lineage,  have  shown  that  overexpression  of  CaBP8  can  inhibit  Ca2+  influx  (Shih  
et   al.,   2009).   A   similar   effect   was   observed   in   cells   overexpressing   a   Ca2+-­‐binding  
deficient  mutant  but  not  with  a  mutant   lacking  the  hydrophobic  38  amino  acid  C-­‐
terminal   region.   The  major   VGCCs   in   bovine   chromaffin   cells   are   L-­‐,  N-­‐,   and   P/Q-­‐
type   channels   and   through   the   use   of   specific   VGCC   blocking   toxins,   Shih   et   al.  
found  that  the  dominant  VGCC  in  these  cells  were  N-­‐type  channels  (Shih  et  al.,  2009).  
Measurement  of  Ca2+  influx  in  HEK293T  cells  co-­‐transfected  with  the  N-­‐type  channel  
and   CaBP8   showed   an   inhibition   of   Ca2+influx   which   was   not   seen   in   cells  
transfected  with  GFP  alone.  Again,  a  truncated  mutant   lacking  the  hydrophobic  C-­‐
terminus  of  CaBP8  was  unable  to  inhibit  Ca2+influx  through  N-­‐type  channels  (Shih  et  
al.,  2009).  As  will  be  discussed  in  Chapter  4,  the  hydrophobic  C-­‐termini  of  CaBP7  and  
CaBP8   are   important   for   their   normal   subcellular   localisation   (McCue   et   al.,   2009,  
McCue  et  al.,  2011,  Hradsky  et  al.,  2011).  The  data   from  Shih  et  al.   therefore  suggest  
that  subcellular  localisation  but  not  Ca2+-­‐binding  is  important  for  CaBP8  inhibition  of  
Ca2+  influx  (Shih  et  al.,  2009).  As  previously  discussed,  CaBPs  1-­‐5  have  numerous  roles  
in  regulating  VGCCs.  Shih  et  al.  demonstrated  that  CaBP8  also  has  an  effect  on  the  
activity  of  VGCCs,  however,  as  CaBP8  has  been  shown  to  be  important  in  TGN  to  PM  




with  VGCCs.  It  is  possible  that  the  observed  inhibition  results  from  the  inhibition  of  
VGCC  transport  to  the  PM  thus  indirectly  preventing  Ca2+  influx  (Shih  et  al.,  2009).  
More  recently,  CaBP7  was  identified  in  a  high  throughput  siRNA  screen  identifying  
genes   that   function   during  mitosis   (Neumann  et  al.,   2010).   Knockdown  of   CaBP7   in  
HeLa  cells  resulted  in  a  binucleate  phenotype  suggestive  of  a  role  for  CaBP7  during  
cytokinesis.  This  phenotype  was  not  observed  in  HeLa  cells  stably  transfected  with  
an  RNAi  resistant  mouse  orthologue  of  CaBP7  when  treated  with  the  same  siRNAs,  
implying   that   it  was  not  an  off-­‐target  effect.  No  other  proteins  of   the  CaBP   family  
were  identified  in  this  screen  (Neumann  et  al.,  2010).    
1.9.  Important  Interacting  Binding  Partners  of  the  CaBP  Family  
1.9.1.  Voltage-­‐gated  Ca2+  channels  (VGCCs)  
VGCCs  mediate   cellular   Ca2+   influx   in   response   to  membrane   depolarisation.   Ca2+  
entering   through   these   channels   acts   as   a   second   messenger   and   initiates  
intracellular  events  such  as  contraction,   secretion,   synaptic  transmission  and  gene  
expression.   There   are  multiple   types   of   Ca2+   current  which   are   designated   L-­‐,   N-­‐,  
P/Q-­‐,   R-­‐   or   T-­‐type   depending   upon   physiological   and   pharmacological   criteria  
(Catterall,   2000).   L-­‐type   currents   are   categorised   as   high   voltage   activation   (HVA)  
channels,   which   exhibit   slow   voltage-­‐dependent   inactivation,   are   regulated   by  
cAMP   dependent   phosphorylation,   and   are   inhibited   by   dihydropyridines.   L-­‐type  
?????????????????????????????????? ?????? ?????-­‐??????????????????? ????????????????-­‐  
type   currents   are   generated   through   low   voltage   activated   (LVA)   channels,  which  
inactivate   rapidly,   and  are   insensitive   to  pharmacological   channel  blockers.  T-­‐type  
????????????????????????????? ???????????????????????-­‐,  P/Q-­‐  and  R-­‐type  channels  are  
all   HVA   channels   and   are   distinguished   from   L-­‐type   channels   through   their  
sensitivity   to   various   peptide   toxins:  N-­‐????? ????????? ???? ???????? ????-­‐conotoxin  
GVIA;   and   P/Q-­‐type   channels   are   sensitive   to   ?-­‐agatoxin   IVA.   Finally   R-­‐type  
channels  are  resistant  to  all  known  Ca2+  channel  blockers  (Catterall,  2000).  
VGCCs  are  made  up  four  principal  components:  a  transmembrane,  pore-­‐forming  ?1  
subunit,   which   dictates   the   functional   and   pharmacological   properties   of   the  





subunit.   These   subunits  exist   in  different   combinations  depending  on   the   channel  
type  (Catterall,  2000,  Minor  and  Findeisen,  2010)  and  various  isoforms  exist  for  each  of  
the  subunits.  The  most  important  subunit  for  channel  function  and  characterisation,  
????????? ??? ???? ?1   ????????? ??????????? ??? ???? ?1   subunit   alone   is   sufficient   to  
produce  functional  Ca2+  channels,  however,  the  additional  subunits  are  required  to  
regulate   the   kinetics,   voltage  dependence  and   trafficking  of   the   channel   (Catterall,  
2000,  Bichet  et  al.,  2000)?? ?????1   subunit   shares   structural   homology   to  Na
+   and  K+  
channels   and   each   is   composed   of   six   transmembrane   segments   (S1-­‐S6)   and   a  
membrane  associated  loop  between  S5  and  S6.  The  S4  segment  acts  as  the  voltage  
sensor   for   the   channel,   and   S5   and   S6,   with   the   associated   loop,   form   the   pore  
lining.  Glutamate   residues   in   the  pore   loop  are   required   to   confer  Ca2+   selectivity  
(Catterall,  2000).  
Different   types   of   Ca2+   ????????? ???? ???????? ??? ???? ????????? ?1   subunits   that   the  
channel   is   assembled   from.   Ten  disti???? ?1   subunits   have  been   identified   and   are  
divided   into   structurally   and   functionally   related   families:   L-­‐type   currents   are  
mediated  by  the  Cav1  family;  P/Q-­‐,  N-­‐  and  R-­‐type  channels  are  mediated  by  the  Cav2  
family;   and   T-­‐type   channels   are  mediated   by   the   Cav3   family.   There   are  multiple  
subunits  mediating   L-­‐type   currents   (Cav1.1   -­‐   Cav1.4)   and   T-­‐type   currents   (Cav3.1   -­‐  
Cav3.3),  whereas  single  subunits  have  been  identified  which  generate  P/Q-­‐,  N-­‐  and  
R-­‐type  currents  (Cav2.1,  Cav2.2  and  Cav2.3  subunits,  respectively).  Further  diversity  
??????????????????????????????????????????????????????????2???????????(Catterall,  2000,  
Minor  and  Findeisen,  2010).  
Ca2+   entering   through   VGCCs   influences   many   intracellular   signalling   pathways  
through   the   activation   of   various   Ca2+   sensors.   Some   Ca2+   sensors   are   highly  
localised  to  the  regions  surrounding  the  channels  and  act  as  feedback  regulators  of  
channel   function.   For   example   the   L-­‐type,   Cav1.2   channel   is   regulated   by   direct  
binding  of  CaM.  CaM  binds  to  the  IQ  domain  in  the  C-­‐terminus  of  Cav1.2,  eliminates  
Ca2+   dependent   inactivation   (CDI)   and   causes   Ca2+   dependent   facilitation   (CDF)   of  




As  discussed  earlier,  CaBPs  1-­‐5  have  emerged  as  important  regulators  of  L-­‐  and  P/Q-­‐
type  VGCCs   (Lee  et  al.,  2002,  Zhou  et  al.,  2004,  Zhou  et  al.,  2005,  Haeseleer  et  al.,  2004,  
Few  et  al.,  2005,  Tippens  and  Lee,  2007,  Findeisen  and  Minor,  2010,  Oz  et  al.,  2011).  The  
first   interaction   of   L-­‐type   channels   with   the   CaBPs   was   reported   between   CaBP4  
and  Cav1.4  channels  in  2004  (Zhou  et  al.,  2004).    CaBP4  shifted  the  activation  range  of  
Cav1.4  to  more  hyperpolarised  voltages  which  led  to  enhanced  Ca
2+  influx  (Haeseleer  
et  al.,  2004).   Since   this   initial   observation,   numerous   interactions   of   CaBP1,   CaBP4  
and   CaBP5  with   the   L-­‐type   channels,   Cav1.2   and   Cav1.3,   have   also   been   reported  
(Zhou  et  al.,  2005,  Tippens  and  Lee,  2007,  Zhou  et  al.,  2004,  Findeisen  and  Minor,  2010,  Oz  
et  al.,  2011).   Like   CaM,   CaBP1   and  CaBP5  were   shown   to   inhibit   CDI   and   promote  
CDF   (Rieke  et  al.,  2008,  Zhou  et  al.,  2004,  Zhou  et  al.,  2005,  Findeisen  and  Minor,  2010).  
CaBP1   and   CaBP4   were   also   shown   to   suppress   CDI   of   Cav1.3   in   inner   hair   cells  
where  CDI  is  weak  or  absent  and  CaBP5  had  similar  effects  in  transfected  HEK293T  
cells  (Cui  et  al.,  2007).  This  property  of  inner  hair  cells  is  thought  to  allow  the  audition  
of   sustained   sounds   (Yang   et   al.,   2006a).   A   stronger   inhibitory   effect   has   been  
described   for  CaBP1  than  CaBP4,  however,   suggesting  that   CaBP1  may  be   the  key  
Ca2+  sensor  involved  in  this  process  (Cui  et  al.,  2007).  In  contrast,  CaBP1  modulation  
of  the  P/Q-­‐type,  Cav2.1  channel,  enhances  CDI  and  does  not  support  CDF  (Lee  et  al.,  
2002,  Few  et  al.,  2005).  Interestingly,  the  interactions  of  CaBP1  with  both  Cav1.2  and  
Cav2.1   channels   do   not   require   functional   EF-­‐hand   motifs   suggesting   that   these  
interactions  are  Ca2+-­‐independent  (Few  et  al.,  2005,  Findeisen  and  Minor,  2010).  
The   interaction  of  Cav2.1  with  CaBP1  appears  to  be  fine  tuned  by  the  presence  or  
absence   of   an  N-­‐myristoylation   signal.  Wild   type   CaBP1L,   which   possesses   an   N-­‐
myristoyl   group,   enhances   inactivation   and   shifts   the   activation   range   of   the  
channel   to   more   depolarising   voltages   (Lee   et   al.,   2002).   An   N-­‐myristoylation   site  
mutant,  however,  was  unable  to  support  these  effects,  but   instead  modulated  the  
channels  with  similar  effects  to  CaM  which  promotes  facilitation  of  the  channel  (Few  
et   al.,   2005).   Differential   modulation   of   L-­‐type   channels   depending   on   the   splice  
isoform   of   CaBP1   has   also   been   observed.   CaBP1   has   been   shown   to   completely  
inhibit   inactivation   of   Cav1.2   channels   (Zhou   et   al.,   2005),   but   caldendrin   causes   a  




determinants  (Tippens  and  Lee,  2007).  This  suggests  that  the  sub  cellular  localisation  
of  CaBP1  is  important  for  its  function  and  there  are  likely  to  be  individual  roles  for  
the  various  splice  isoforms.  
In   depth   analysis   of   the   interactions   between   CaBP1   and   Cav1.2   channels   have  
revealed   that   CaBP1   binds   to   the  N-­‐terminus,   the   S3-­‐S4   linker   region   and   the   IQ  
domain  at  the  C-­‐terminus  of  Cav1.2  (Findeisen  and  Minor,  2010).  CaBP1  can  compete  
with  CaM  for  binding  to  the   IQ  domain,  however,   interaction  with  the  N-­‐terminus  
and  the  S3-­‐S4  linker  region  appear  to  be  the  crucial  determinants  for  the  regulatory  
function   of   CaBP1   on   CDI.   Interestingly   Caldendrin,   which   causes   a  more  modest  
suppression   of   CDI,   does   not   bind   to   the   N-­‐terminus   of   Cav1.2   (Tippens   and   Lee,  
2007).    
1.9.2.  Transient  Receptor  Potential  Channels  
Transient  receptor  potential   (TRP)  channels  mediate  the   influx  of  extracellular  Na+  
and  Ca2+  into  the  cytoplasm.  In  excitable  cells  this  influx  depolarizes  the  PM  and  is  
important  for  the  generation  of  action  potentials.  In  non-­‐excitable  cells,  membrane  
depolarisation  by  TRP  channels  stimulates  voltage  dependant  channels  (Ca2+,  K+  and  
Cl-­‐   channels).   TRP   channels   have   important   functions   mediating   vision,   taste,  
olfaction,  hearing,   touch,   thermo-­‐sensation,  and  osmo-­‐sensation,  and  mutation  or  
deregulation  of  TRP  channels  has  been  associated  with  various  diseases   (Song  and  
Yuan,  2010).    
TRP  genes  are  found  in  organisms  ranging  from  archaea  to  plants  and  animals,  and  
in  mammals  are  expressed  in  brain,  heart,  lung  and  other  tissues.  TRP  proteins  are  
transmembrane   proteins   which   form   cation   channels   with   varying   cation  
selectivities.  Their  topology  is  composed  of  six  transmembrane  domains  (TMD)  with  
a   pore   forming   domain   between   TMD   5   and   6.   The   functional   TRP   channel   is  
composed  of  a  homo-­‐  or  hetero-­‐tetramer  of  TRP  proteins,  each   subunit  of  which,  
contributes   to   the   ion   selectivity  of   the  pore.   The  TRP   superfamily   is   divided   into  
two  groups  based  on  sequence  and  topological  homology  and  these  two  groups  are  




TRPM,   TRPA   and   TRPN,   and   group   2   comprises,   TRPP   and   TRPML   (Song   and   Yuan,  
2010).    
CaBP1  was  found  to  interact  with  TRPC5  (Kinoshita-­‐Kawada  et  al.,  2005),  a  member  of  
the   TRPC   family   of   channels   which   have   been   implicated   in   neurite   extension,  
growth   cone  morphology   and   synaptogenesis   in   hippocampal   neurons.   The   TRPC  
subfamily  contains  7  genes  which  can  be  grouped  depending  on  their  sequence  and  
functional   characteristics.   Group   1   contains   TRPC1,   4   and   5.   TRPC1   is   widely  
expressed  in  many  tissues  and  forms  heteromeric  channels  with  TRPC4  and  TRPC5,  
whereas  TRPC4  and  TRPC5  can  form  homomeric  channels.  Together,  TRPC1,  4  and  5  
form   non-­‐selective   cation   channels   which   are   activated   by   signalling   through  
trimeric  Gq/11  proteins  which  activate  a  phosolipase  C  (PLC)  mediated  pathway.  The  
exact   signalling  mechanism   is  not   fully  understood,  however   (Song  and  Yuan,  2010,  
Beech,  2007).    
Kinoshita-­‐Kawada   et   al.   demonstrated   that   the   activity   of   TRPC5   channels   in  
Xenopus  ooctyes  is  dependent  on  the  presence  of  Ca2+  (Kinoshita-­‐Kawada  et  al.,  2005).  
They  also   reported  a  direct   interaction  of  CaBP1  with  TRPC5  and  showed  that   co-­‐
expression   resulted   in   inhibition  of   TRPC5  activity.   CaM  also   interacts  with   TRPC5  
but  does  not  have  an  inhibitory  role  and  binds  to  TRPC5  at  sites  in  close  proximity,  
but   not   identical,   to   those   bound   by   CaBP1   (Kinoshita-­‐Kawada   et   al.,   2005,   Beech,  
2007).    
Biological   functions   for  TRPC5  have  been   identified   including   roles  mediating  Ca2+  
entry  and  excitation  in  smooth  muscle,  and  as  a  regulator  of  neuronal  growth  cone  
extension.  In  addition,  the  TRPC5  gene  is  located  on  a  region  of  the  X  chromosome  
which  has  been  linked  to  X-­‐linked  mental  retardation  (Beech,  2007).    
1.9.3.  Inositol  1,4,5-­‐trisphosphate  Receptors  
IP3  and  diacylglycerol  (DAG)  are  second  messengers  which  are  produced  as  a  result  
of  hydrolysis  of  phosphatidylinositol  4,5-­‐bisphosphate  (PI(4,5)P2)  by  PLC.  IP3  induces  
Ca2+  release  from  intracellular  Ca2+  stores  such  as  the  ER.  This  is  mediated  by  IP3Rs,  
which  are  an  IP3-­‐gated  Ca
2+  release  channel.  The  conversion  of  IP3  signals  into  Ca
2+  




differentiation,   fertilisation,   secretion,   light   transduction   and   brain   function  
(Mikoshiba,  2007,  Yang  et  al.,  2002a).    
There  are  three  types  of  IP3Rs  in  human,  IP3R1-­‐3.  Each  type  of  IP3R  has  different  IP3  
binding   and   modulation   properties.   All   three   share   a   similar   structure   with   five  
major  domains:  1)  an  N-­‐terminal  IP3-­‐binding  suppressor  domain,  2)  the  IP3  domain,  
3)   the   central  modulatory   domain,   4)   the   channel   forming   domain,   and   5)   the   C-­‐
terminal  gate-­‐keeper  domain.  IP3R  subunits  assemble  into  either  homo-­‐  or  hetero-­‐
tetramers  to  form  functional  Ca2+-­‐release  channels  (Mikoshiba,  2007).  
IP3Rs   are   regulated   by   various   endogenous   ligands   such   as   ATP   and,   importantly  
Ca2+   itself.   Ca2+   release   from   IP3Rs   is   enhanced  at   low   levels   of  Ca
2+   through  CICR  
whereas,   at   higher   [Ca2+]i,   IP3R   activity   is   inhibited.   CICR   allows   amplification   and  
regenerative  propagation  of  Ca2+   signals  and   is  a  property  which   is  also  shared  by  
RyRs   suggesting   that   it   is   a   key   feature   for   the   regulation   of   intracellular   calcium  
signalling  (Mikoshiba,  2007).    
An  interaction  of  proteins  of  the  CaBP  family  with  IP3Rs  was  first  described  by  Yang  
et  al.  in  2002  (Yang  et  al.,  2002a).  This  study  reported  a  Ca2+-­‐dependent  interaction  of  
CaBP1S  and  a  C-­‐terminal  CaBP1  fragment,  encompassing  the  four  EF-­‐hand  domains,  
with   all   three   IP3R   isoforms   (Yang   et   al.,   2002a).   Patch-­‐clamping   experiments   in  
Xenopus   ooctyes   with   different   combinations   of   agonist   in   the   pipette   solutions  
revealed  that  CaBP1S,  the  C-­‐terminal   fragment  of  CaBP1,  CaBP2S  and  CaBP5  were  
all  able  to  enhance  IP3R  mediated  Ca
2+  release  independently  of  IP3.  CaBP4  was  not  
tested   in  these  experiments  and  CaM  had  no  effect  on   IP3R  activity.  These  results  
indicated  that   there  could  be  an  alternative  activation  mechanism  for   IP3Rs  which  
does   not   require   IP3.   This   mechanism   may   be   important   for   inducing   CICR   from  
IP3Rs  when  the  phosphoinositide  signalling  pathway  has  not  been  engaged  (Yang  et  
al.,  2002a).  Haynes  et  al.(Haynes  et  al.,  2004)  later  reported  a  direct,  Ca2+-­‐dependent,  
interaction   between   CaBP1L   and   IP3R1.   Conversely,   this   study   found   that  
overexpression   of   CaBP1L   in   PC12   cells   inhibited   IP3R   mediated   Ca
2+   release   in  
response   to   agonists   selective   for   purinergic   receptors   (Haynes   et   al.,   2004).   The  




activities   of   the   CaBP1   splice   isoforms  used   or   could   be   due   to  differences   in   the  
experimental   systems.   Interestingly   an   earlier   study   also   reported   an   inhibitory  
effect  of  CaBP1  on  CICR  release  through  an  IP3  independent  mechanism  (Kasri  et  al.,  
2003)  and  Kasri  et  al.(Kasri  et  al.,  2004)  reported  an  inhibitory  effect  of  both  CaBP1S  
and  CaBP1L   in  COS  cells.  CaM  also  binds  to  and   inhibits   IP3R,  however,   it  has  100-­‐
fold  lower  binding  affinity  and  elicits  a  weaker  inhibitory  effect  than  CaBP1  (Kasri  et  
al.,   2004).   It   was   suggested   that   CaBP1   function   may   be   important   for   the   tight  
regulation  of  IP3Rs  in  neurons  where  CaM  may  predominantly  regulate  RyRs  (Kasri  et  
al.,  2004).    
1.9.4.  Phosphatidylinositol  4-­‐kinases  
PI4Ks   are   essential   for   the   production   of   most   phosphoinositide   derivatives   of  
phosphatidylinositol   (PtdIns)   (Balla  and  Balla,  2006).  They  catalyse  the  production  of  
PI4P   from   PtdIns   which   is   the   first   step   in   the   synthesis   of   PI(4,5)P2   and   PtdIns  
(3,4,5)-­‐trisphosphate   (PI(3,4,5)P3).   PI(4,5)P2   is   the   main   substrate   of   PLC   which  
generates   the   important   second   messengers,   IP3   and   DAG.   PI(4,5)P2   also   has  
important   roles   in   the   regulation   of   several   ion   channels   and   enzymes   such   as  
phospholipase  D.  PI(3,4,5)P3  is  generated  from  PI(4,5)P2  through  the  action  of  PI3Ks  
and  regulates  a  range  of  pathways  including  cell  metabolism  and  an  anti-­‐apoptotic  
pathway.   The   production   of   important   signalling   phosphoinositides   is   therefore  
acutely  dependent  on  the  function  of  PI4Ks  (Balla  and  Balla,  2006).  
There   are   four   identified   PI4Ks   in   mammalian   cells   which   are   divided   into   two  
classes  depending  on  their  sensitivity  to  wortmanin,  which  is  a  potent  PI3K  inhibitor  
(Graham   and   Burd,   2011).   Type   III   PI4Ks   are   sensitive   to   wortmanin   and   include  
??????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????  a  high  degree  of  
homology  between  their  catalytic  domains  and  explaining  their  shared  sensitivity  to  
wortmanin.   A   number   of   other   domains   are   conserved   between   yeast   and  
??????????????????????????????? ???????????? ???????????????????? ??????????????????
frequenin/NCS-­‐1  binding  domain,  and  the  rab  GTPase  binding  site  (Hom2  domain).  
????????????????????????????????????????????????????????????????????????????????-­‐




Type   II   PI4Ks   are   smaller   proteins  with   little   sequence  homology   to   Type   III   PI4Ks  
and  contain  two  catalytic  domains,  one  of  which  harbours  a  cysteine-­‐rich  insert  that  
is  palmitoylated  allowing  these  proteins  to  localise  to  membranes  and  orientate  the  
kinase  domains  close  to  the  PtdIns  substrate  (Balla  and  Balla,  2006).    
Each   type   of   PI4K   therefore   resides   at   a   distinct   subcellular   compartment   due   to  
different   targeting   mechanisms   which   allow   them   to   conduct   specific   non-­‐
redundant  roles  in  vesicle  trafficking  and  Golgi  function  (Balla  and  Balla,  2006).  These  
kinases  control  signalling  events  through  the  production  of  PI(4,5)P2  at  the  PM  and  
nucleus,   regulate   endocytosis   and   determine   the   fate   of   endocytosed   cargo   by  
directing  membrane  proteins  for  degradation,  and  regulate  the  lipid  composition  of  
cellular  membranes.  PI4Ks  are  therefore  important  not  simply  for  the  production  of  
PI4P,  as  the  precursor  of  PI(4,5)P2,  but  also  for  the  correct  functioning  of  numerous  
downstream  signalling  pathways  (Balla  and  Balla,  2006).  
As   discussed   above,   CaBP7   and   CaBP8  have   been   shown   to   interact   directly  with  
??????????????????????????????????????????????????????????????????????????????????????
PI(4,5)P2  production   (Mikhaylova  et  al.,  2009)????????????????????? ?????????????????
Golgi   localised   and   is   recruited   to   this   organelle   via   an   interaction  with   the   small  
GTP-­‐binding  protein  Arf1  (Graham  and  Burd,  2011)??????????????????????????????????????
regulated   by   NCS-­‐1   but   it   is   unknown   if   this   contributes   to   the   recruitment   of  
????????? ??? ???? ?????? (Zhao   et   al.,   2001,   Balla   and   Balla,   2006).   The   details   of   how  
????????? ???????? ?????? ????????? ???? ???? ?????? ???????????? ????????? ????????? ???
????????? ?????????? ?????? ????? ????? ???? ?????? ???????? ????? ??? ?????? ???? ??????? ???
recruit   several   effectors  which   promote   the  budding   and   release   of  Golgi-­‐derived  
transport   vesicles.   PI4Ks   have  also  been   found   in   secretory   granules   and   synaptic  
???????????????????????????????? ???????????????? ???????????????????????????????????
It   has   been   proposed,   therefore   that   PI4KI???? ???? ????? ? ???????? ?????? ??? ????
transport  and  exocytosis  of  synaptic  vesicles  (Balla  and  Balla,  2006).  
1.10.  Differential  Tissue  expression  of  the  CaBPs  
The  CaBPs  have  typically  been  described  as  neuronal  Ca2+  sensors.  CaBP1  is  widely  




specific  proteins  (Haeseleer  et  al.,  2000).  CaBP7  and  CaBP8  are  also  highly  expressed  
in  the  brain  and   in  situ  hybridization  in  rat  brain  highlighted  differential  expression  
when  the  two  proteins  were  compared.  CaBP7  is  restricted  to  the  CA3  region  of  the  
hippocampus,  entorhinal  cortex,  the  antero-­‐dorsal  and  entero-­‐ventral  thalamus  and  
the  inferior  and  superior  colliculus  (Mikhaylova  et  al.,  2006).  In  contrast,  CaBP8  has  a  
more   widespread   distribution   in   the   brain   with   intense   hybridization   signals  
detected   throughout   the   cerebellum,   cortex   and   hippocampus   (Mikhaylova   et   al.,  
2009).   These   expression   patterns   along   with   the   reported   interactions   with  
important  neuronal  effectors  such  as  the  VGCCs  suggest  an   important  role  for  the  
CaBP   family   in   the   regulation   of   neuronal   function.   More   recently,   however,  
evidence   has   begun   to   emerge   that   suggests   a   more   widespread   expression   for  
many  of  the  CaBP  proteins.    
A  study  examining  the  expression  of  CaBP  mRNAs  in  gastrointestinal  smooth  muscle  
identified  significant   levels  of  CaBP1L  but  not  caldendrin,  CaBP2,  CaBP4,  CaBP5  or  
CaBP7  (Ohya  and  Horowitz,  2002).  CaBP1  has  also  been  detected  in  type  II  taste  cells  
isolated   from   taste   buds   in  mice   (Rebello  et   al.,   2011).   In   addition,   a   5-­‐fold   down-­‐
regulation  of  CaBP5  expression  was  detected  in  a  microarray  examining  the  platelet  
expression   profile   of   a   patient   with   a   mutation   in   the   transcription   factor,   core  
binding   factor   A2   (CBFA2)  which   causes   abnormal   platelet   aggregation   (Sun  et   al.,  
2007).  This  study  suggests  that  CaBP5   is  normally  expressed   in  platelets  and   is  not  
restricted   to   the   retina.   The   discovery   that   CaBP7   expression   in   HeLa   cells   is  
essential   for   efficient   cytokinesis   is   also   suggestive   of   a   more   widespread  
distribution  of  this  protein  in  dividing  cells  (Neumann  et  al.,  2010).    
The   Human   Protein   Atlas   project   (http://www.proteinatlas.org/)   is   a   publicly  
accessible   database   containing   data   about   the   normal   expression   and   cellular  
distribution  of  proteins   in  46  different  human  tissues.   Immunohistochemistry  data  
was   available   for   CaBP5   and   CaBP8   in   this   database.   Moderate   to   strong   CaBP5  
immunostaining   was   detected   in   most   normal   tissues   with   the   exception   of  
pneumocytes,  renal  glomeruli,  ovarian  stromal  cells  and  smooth  muscle  cells.  CaBP8  
showed  moderate  staining  in  neuronal  cells  and  strong  positive  staining  in  a  subset  




membranous   staining   in   basal   layers   of   squamous   epithelium,   gall   bladder,   renal  
glomeruli,   Leydig   cells,   myocytes   and   a   subset   of   bone   marrow   poietic   cells.   A  
second   online   database,   Genenote   (http://bioinfo2.weizmann.ac.il/cgi-­‐
bin/genenote/home_page.pl),  which  uses  microarrays  to  examine  gene  expression  
in  normal  human   tissues,  also   contains  data   for  CaBP1,  CaBP4,  CaBP7  and  CaBP8.  
This   data   suggested   that   CaBPs   are   expressed   in   non-­‐neuronal   tissues   (thymus,  
bone   marrow,   spleen,   heart,   skeletal   muscle,   kidney,   lung,   liver,   pancreas,   and  
prostate),  and  in  the  cases  of  CaBP4  and  CaBP8,  at  similar  expression  levels  to  that  
found  in  the  brain  or  spinal  cord.  
1.11.  Summary  of  CaBP  Expression  and  Function  
The  CaBPs  are  emerging  as  important  regulators  of  various  neuronal  functions.  The  
numerous   reported   interactions   of   CaBPs   1-­‐5   with   VGCCs   suggest   that   these  
proteins   may   perform   important   roles   regulating   synaptic   function   and   plasticity  
through  the  regulation  of  Ca2+  influx  into  neurons.  Interactions  with  other  important  
Ca2+  channels  such  as  IP3Rs  and  TRPC5  channels  also  support  an  important  role  for  
these   proteins   in   the   fine-­‐tuning   of   calcium   signalling   in   higher   organisms.   In  
contrast   to   the   numerous   roles   of   the   CaBPs   in   the   regulation   of   ion   channels,  
interactions  with  proteins  important  for  cellular  transport  have  also  been  detected  
and  an  interaction  with  presynaptic  mGluRs  is  suggestive  of  an  important  regulatory  
role   in   neurotransmission.   CaBP7   and   CaBP8   are   the  most   divergent  members   of  
the  CaBP  family  and  may  constitute  a  separate  family  of  Ca2+  sensors   in  their  own  
right.  The  only  well-­‐characterised  function  of  these  proteins  is  the  regulation  of  TGN  
to   PM   trafficking   through   an   interaction  with  PI4KIII?.   Roles   in   the  modulation   of  
VGCCs  and  during  cytokinesis  have  also  been  postulated,  but   it   is  not  known  how  
CaBP7  and  CaBP8  exert  their  effects  in  these  processes.    
Characterisation  of  the  CaBP  family  to  date  has  largely  focused  on  their  functions  in  
neuronal  cell  types,  however  emerging  data  suggests  that  CaBP  protein  expression  
may  not  be  restricted  to  the  central  nervous  system.  In  particular,  a  requirement  for  
CaBP7   for   efficient   cytokinesis   in  HeLa   cells   is   suggestive  of   an   important   role   for  
this  protein  in  dividing  cells.  It  therefore  seems  that  the  current  knowledge  of  CaBP  




required   to   elucidate   the   full   impact   of   the   CaBPs   upon   calcium   signalling   in  
vertebrates  and  higher  organisms.  
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1.  12.  Aims  and  objectives  
  
The   aim   of   this   study   was   to   characterise   CaBP7   and   CaBP8   using   a   variety   of  
different  techniques.  Four  main  research  issues  were  addressed:  
  
? The   evolutionary   origin   of   the   CaBP   family   was   examined   and   used   to  
deduce  whether  CaBP7  and  CaBP8  constitute  a  unique  family  of  Ca2+  sensors  
separate  from  the  rest  of  the  CaBP  family.  
  
? The   subcellular   localisation   and   targeting  mechanism   of   CaBP7   and   CaBP8  
was  examined  in  neuronal  and  non-­‐neuronal  cell  types.  
  
? An   investigation   was   carried   out   into   a   potential   role   for   CaBP7   in  
cytokinesis.  
  
? NMR   spectroscopy   was   employed   to   investigate   the   structural   differences  
between  the  two  classes  of  CaBP  proteins:  CaBPs  1-­‐5  and  CaBP7  &  8.  CaBP4  









Materials  and  Methods  
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2.1.  Bioinformatics  
The   GenBank   database   accession   numbers   for   human   CaBP   proteins  
(http://www.ncbi.nlm.nih.gov/sites/entrez)   used   for  bioinformatics   analyses  were:  
Caldendrin  (NM_001033677)  CaBP1L  (NM_031205),  CaBP1S  (NM_004276),  CaBP2S  
(NM_031204),   CaBP2L   (NM_016366),   CaBP4   (NM_145200),   CaBP5   (NM_019855),  
CaBP7   (NM_182527),   CaBP8   (AY007302),   CaM   (AAA35635).   BLAST   2.2.22   at   NCBI  
(http://blast.ncbi.nih.gov/blast.cgi)  was  used  to  perform  BLASTP  searches  of  these  
sequences  restricted  to  particular  organisms:  Danio  rerio,  Xenopus  tropicalis,  Anolis  
carolinenesis,   Gallus   gallus,   Monodelphis   domestica,   Mus   musculus,   Pan  
troglodytes,   and  Homo   sapiens.   Further   searches   using   TBLASTN  were   performed  
against  the  reference  genomic  sequence  and  reference  mRNA  sequence  databases  
to  identify  missing  CaBP  sequences  not  found  in  BLASTP  searches.  The  genomes  of  
the   deuterostomes,   strongylocentrotus   purpuratus,   ciona   intestinalis   and  
branchiostoma   floridae   and   the   jawless   fish,   Lamprey   (Petromyzon  marinus),were  
searched   using   the   BLAT   facility   at   http://genome.ucsc.edu/cgi-­‐
bin/hgBlat?command=start.  A  TBLASTN  search  of  the  elephant  shark  (Callorhinchus  
milli)   genomic   sequences   was   carried   out   at   http://esharkgenome.imcb.a-­‐
star.edu.sg/.  Exon  sequences   from  the  human  CaBPs  were   found  by   searching   for  
each   gene   in   the   CCDS   database   at  
http://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi.   Sequence   identity   between  
elephant   shark   and   human   exon   sequences   was   calculated   using   ClustalW  
(http://www.ebi.ac.uk/Tools/msa/clustalw2/).   The   accession   numbers   of   zebrafish  
(Danio  Rerio)  protein  sequences  used  for  analysis  were:  CaM:  (NP_955864),  CaBP1  
(NP_001002414),   CaBP2   (NP_001025439),   CaBP4   (XP_001338361),   CaBP5  
(NP_956992),   CaBP7   (XP_683885),   CaBP8   (XP_690899).   There   were   additional  
duplicated   protein   sequences   identified   in   zebrafish   which   were:   CaBP1  
(NP_001005962),   CaBP2   (XP_688066),   CaBP5   (NP_00108568),   CaBP7  
(XP_001920190)  and  CaBP8  (XP_001343041).  
  
Multiple  sequence  alignments  were  compiled  using   the  ClustalX   function   (Conway  
Institute,   UCD,   Dublin)   within   the   BioEdit   Sequence   Alignment   Editor   6.0.5   (Tom  
Hall,   Ibis   Therapeutics,   Carlsbad,   California;  
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http://www.mbio.ncsu.edu/BioEdit.bioedit.html),   using   the  BLOSUM62  matrix   and  
default  settings.  The  positions  of  the  EF-­‐hand  motifs  were  identified  by  comparison  
to   the   EF-­‐hand   consensus   sequence   (Moncrief   et   al.,   1990)   and   alignment   with  
CaM.   Identity   values   between   different   protein   sequences   were   generated   using  
the  Sequence  Identity  Matrix  option  in  BioEdit.    
  
The   open   reading   frames   of   human   CaBP7   and   CaBP8  were   identified   from   their  
mRNA  transcripts  (NM_001017440.2  and  NM_031468.3  respectively)  using  BioEdit  
and  the  sequences  surrounding  their  multiple  start  sites  were  examined  to  identify  
the  presence  of  a  Kozak  consensus  sequence.  
  
A  phylogenetic   tree  was  constructed  using   the  human  and  zebrafish  CaBP  protein  
sequences  based  on  alignments  created  using  ClustalW  (EMBL-­‐EBI).  The  variable  N-­‐
termini   of   the   proteins   were   removed   to   aid   construction   of   the   tree   and   the  
alignment   of   the   C-­‐termini   of   CaBP7   and   CaBP8   with   the   rest   of   the   CaBPs   was  
adjusted   to   give   a   more   realistic   representation   of   homology   in   this   region.   The  
maximum   likelihood  method  was  used  to  create   the   tree  using  the  Phylip  suite  of  
programs   (www.phylip.com).   Seqboot.exe   was   used   to   make   2000   bootstrapped  
data  sets   from  the  alignment  and  proml.exe  was   then  used  to   find  the  phylogeny  
estimate   for   each   of   these   data   sets   using   the   maximum   likelihood   method   for  
protein  amino  acid  sequences.  CaM  was  used  as  the  out-­‐group  to  root  the  tree.  The  
outtree  file  from  proml.exe  was  input   into  consensus.exe  to  generate  a  consensus  
tree.   The   final   Consensus   tree   was   drawn   using   TreeView  
(http://darwin.zoology.gla.ac.uk/~rpage/treeviewx/download.html).    
  
Percentage  sequence  conservation  within  defining  regions  of  the  CaBPs  (CaBP1L  16-­‐
75,   CaBP2L   1-­‐56,   CaBP4   1-­‐120,   CaBP7   189-­‐215   and   CaBP8   193-­‐219)   in   various  
species   compared   to   human   was   assessed   by   creating   pairwise   sequence  
alignments  using   ClustalW  and   viewing   the   result   summary   to   obtain   the   identity  
values.  
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2.2.  Molecular  Biology  
2.2.1.  PCR  
DNA   sequences   for   insertion   into   plasmids   were   prepared   using   PCR   subcloning  
from  existing  plasmids.  100  µl  PCR  reaction  mixes  contained  20  µl  5x  PCR  reaction  
buffer,  5%  v/v  DMSO,  0.2  mM  dNTPs,  0.5  µM  forward  and  reverse  primers,  0.5  µg  
template  DNA  and  1  U  Phusion  ®  polymerase  (New  England  Biolabs,  Hertfordshire,  
UK)  and  distilled  water  to  100  µl.  The  following  PCR  conditions  were  used:  
1  cycle:     98oC      1  minute  
35  cycles:   98oC      30  seconds  
         *Tm-­‐5
oC   30  seconds  
         72oC      15  seconds  per  kilobase  
1  cycle:   72oC      5  minutes  
         30oC      1  minute  
  
*  The  annealing  temperature  used  was  5oC  below  the  lowest  melting  temperature  
(Tm)  of  the  primer  pair.  
2.2.2.  Restriction  Endonuclease  Digestion  
Complimentary  overhangs  on  plasmids  and   inserts   for   subcloning  were  generated  
by  digestion  with  the  appropriate  restriction  endonucleases  as  detailed  in  table  2.1,  
section  2.2.4.  Digestion  reactions  containing  4  µl  of  the  appropriate  10x  buffer  (New  
England  Biolabs),  1  U  of  each  required  enzyme  (New  England  Biolabs)  and  1  µg  of  
DNA   in   a   total   of   40   µl   distilled   water,   were   incubated   at   37oC   for   60   minutes.  
Digested  products  were   separated   by   agarose   gel   electrophoresis   and   purified  by  
gel  extraction  where  necessary.  
2.2.3.  Agarose  gel  electrophoresis  and  gel  extraction  
For  visualization  and  purification  of  PCR  products  or  digested  DNA  products,  DNA  
was   separated   by   agarose   gel   electrophoresis   using   a   gel   composed   of   1%   w/v  
agarose  dissolved  in  TAE  buffer  (40  mM  Tris  base  pH  8.0,  20  mM  acetic  acid,  1  mM  
EDTA).  0.5  µl/ml  Sybr  Safe  (Invitrogen,  Paisley,  UK)  was  included  in  the  gels  to  stain  
the  DNA.  10%  sucrose  was  added  to  the  samples  ?????????????????????????????????
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DNA   molecular   weight   markers   (Bioline,   Sheffield,   UK)   at   60-­‐80   V.   After  
electrophoresis,   DNA   fragments   were   purified   from   agarose   gels   by   visualisation  
using  a  UV  transilluminator  and  excision  of  the  required  bands.  DNA  was  extracted  
from   the   excised   bands   using   a   gel   extraction   kit   (NBS   biologicals   Ltd,  
Cambridgeshire,  UK).  Briefly,  excised  bands  were  dissolved  into  the  supplied  binding  
buffer  and  released  DNA  then  bound  to  an   ion  exchange  column.  The  bound  DNA  
was  then  washed  and  eluted  in  30-­‐50  µl  elution  buffer.  
2.2.4.  Ligation  
For   subcloning   of   prepared   DNA   inserts   into   linearised   acceptor   vectors,   ligation  
reactions   were   used   to   generate   circular   plasmid   constructs.   50   ng   of   acceptor  
vector  was  used  with  a  1:3  molar  ratio  of  vector:insert  and  mixed  with  2  µl  10x  T4  
DNA   ligase   reaction   buffer   (New  England  Biolabs)   and   400  U   T4  DNA   ligase   (New  
England   Biolabs)   in   a   final   volume   of   20   µl   made   up   with   deionised   water.   The  
reaction  was  incubated  at  room  temperature  for  15  -­‐  30  minutes  then  5  µl  removed  
and  used  to  transform  chemically  competent  XL-­‐1  E.  coli  cells.  
  
Table  2.1   lists  the  plasmids  which  were  made  by  subcloning,  with  the  PCR  primers  
and  plasmid   template  used   in  PCR   reactions,  and   the   restriction  enzymes  used  to  
generate  complementary  overhangs  for  ligation  reactions.  
  
Table  2.1.  Plasmids  made  by  subcloning  
  
  
A  number  of  protein  expression  plasmids  were  generated  during  the  course  of  this  
project   which  were   not   used   to   generate   any   of   the   final   data.   Details   for   these  
plasmids  are  therefore  not  described  here  with  the  exception  of  TrcHisA-­‐optimised  
CaBP7   1-­‐188   as   this   was   used   as   a   template   to   subclone   SUMOPRO-­‐optimised  
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CaBP7   1-­‐188.   The   names   of   the   remaining   plasmids   can   be   found   in   table   6.1,  
chapter  6,  section  6.2.1.  
2.2.5.  Transformation  of  chemically  competent  E.  coli  
To  amplify  DNA  constructs  by  plasmid  miniprep  or  maxiprep  methods,  competent  E.  
coli,  prepared  in-­‐house,  were  transformed  with  5  µl  of  ligation  reaction  or  0.5  µl  of  
the   relevant   plasmid   for   amplification.   The   DNA   was   incubated   with   50   µl  
chemically  competent  cells  on  ice  for  30  minutes  before  being  subjected  to  a  heat  
shock   of   45   seconds   at   42oC.   The   cells  were   then   returned   to   ice   for   a   further   2  
minutes   followed  by   addition  of  450  µl   SOC  medium   (2%  w/v   tryptone,   0.5%  w/v  
yeast   extract,   8.56   mM   NaCl,   2.5   mM   KCl,   10mM   MgCl2,   20mM   glucose)   and  
incubation  at  37oC  for  1  hour  with  continuous  shaking  at  250  rpm.  The  transformed  
E.   coli  were   spread  onto   sterile   LB   agar   plates   (1.5%  w/v   agar,   1%  w/v   tryptone,  
0.5%  w/v  yeast  extract,  8.56  mM  NaCl)  containing  the  appropriate  antibiotic  for  the  
selection  of  positive  transformants  of  the  plasmid   in  question.  The  transformation  
plates  were   incubated  at  37oC  overnight  and  colonies  selected  for   further  analysis  
or  proliferation.    
2.2.6.  Purification  of  Plasmid  DNA  
To   analyse   E.   coli   transfomants   of   newly   ligated   plasmids,   single   colonies   were  
selected   and   grown   overnight   at   37oC,   with   shaking,   in   5   ml   LB   media   (1%   w/v  
tryptone,   0.5%   w/v   yeast   extract,   8.56   mM   NaCl)   containing   the   appropriate  
antibiotic.   The   cultures   were   then   pelleted   by   centrifugation   (12   000   x   g,   10  
minutes)   and   plasmid   DNA   extracted   using   a   spin   column   miniprep   kit   (NBS  
???????????? ????? ?????????? ??? ??????????????????? ??????????????????? ???????ere   lysed  
with  an  alkaline  solution  containing  sodium  dodecyl  sulphate  (SDS)  and  immediately  
neutralized   by   addition   of   acetate   which   precipitates   both   the   SDS   and   genomic  
DNA.  After  centrifugation  (12  000  x  g,  5  minutes)  to  pellet  precipitated  material,  the  
supernatant   was   transferred   to   a   silica   gel   based   spin   column   to   bind   the   DNA.  
Bound  DNA  was  washed   to   remove   impurities   and   then   eluted   in   30   -­‐   50   µl   Tris  
based   elution   buffer.   Purified   plasmid   DNA   could   then   be   analysed   by   restriction  
endonuclease  digestion  and  agarose  gel  electrophoresis  (see  section  2.2.2).  
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For   large   scale   plasmid  preparations   150  ml   LB  media   containing   the   appropriate  
antibiotic   was   inoculated  with   a   single   colony   from   the   transformation   plate   and  
incubated  overnight  at  37oC  with  shaking  at  250   rpm.  Plasmid  DNA  was  extracted  
from  the  cultures  using  a  QIAfilter  HiSpeed  Plasmid  Maxi  Kit  (Qiagen,  West  Sussex,  
???? ?????????? ??? ???? ??????????????? ?????????????? ???? ?????????????? ??? ?????????
plasmid  DNA  was  determined  from  the  absorbance  of  the  DNA  sample  at  260  nm.  
2.2.7.  Generation  of  plasmids  by  mutagenesis  
A  number  of  plasmids  were  generated  using   site  directed  mutagenesis  of  existing  
expression  vectors.  These  plasmids  are   listed   in  Table  2.2,  along  with  the   relevant  
mutagenesis  primers  and  the  original  plasmid  which  was  used  as  a  template.  
  
Reactions  for  site  directed  mutagenesis  contained  5  µl  10x  PCR  reaction  buffer,  50  
ng  template  DNA,  125  ng  forward  and  reverse  mutagenesis  primers,  0.2  mM  dNTPs  
and  1  U  PfuTurbo  (Invitrogen).  The  following  PCR  conditions  were  used:  
      Step  1:     95oC      30  seconds  
      Step  2:     95oC      30  seconds  
            55oC      1  minutes  
            68oC      6  minutes   (1  minute  per  kilobase)  
  
Step   2   was   repeated   for   a   different   number   of   cycles   depending   on   the   type   of  
mutation:  
      x12  for  a  single  base  change  
      x16  for  a  single  amino  acid  change  
      x18  for  multiple  amino  acid  changes  
  
The   reactions   were   subsequently   cooled   on   ice   for   2   minutes   then   treated   with  
Dpn1   (New   England   Biolabs),   to   digest   the   parental   template   DNA,   for   1   hour   at  
37oC.   1   µl   of   the   Dpn1   digested   material   was   transformed   into   chemically  
competent   E.   coli   as   described   in   section   2.2.5.   Plasmids   were   checked   and  
amplified  as  for  subcloned  plasmids  (sections  2.2.5-­‐2.2.6).  
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Table  2.2.  Plasmids  made  by  mutagenesis.  
  
  
2.2.8.  Commercially  synthesized  genes  and  insertion  into  expression  vectors  
A   number   of   customized   genes   were   ordered   from   either   Integrated   DNA  
Technologies   (IDT,   Glasgow,   UK)   or   GeneArt   (Invitrogen).   The   required   protein  
sequences   were   sent   to   either   IDT   or   GeneArt   and   the   corresponding   gene  
synthesized  with  optimized  codon  usage  for  expression  in  the  relevant  organism.  A  
codon  optimized  variant  of  CaBP7  1-­‐188  was  obtained  from  IDT  in  order  to  improve  
the  DNA  sequence  for  translation  in  E.  coli.  This  was  used  to  produce  recombinant  
CaBP7   1-­‐188   and  CaBP7   1-­‐100  proteins.   A   codon  optimized   variant   of   CaBP4  was  
ordered  from  GeneArt  for  the  same  reasons.    
  
?????????????????????????????????????????????????????????????????????????????????????
cloning   into   the   relevant   expression   plasmid.   For   instance,   CaBP7   1-­‐188   was  
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???????????? ????? ?? ??   ????? ????? ???? ?? ??? ?????? ????? ??? ?????? ??????? ????????? ?????
pTrcHisA.    The  restriction  sites  used  are  listed  in  table  2.3.  Synthesised  genes  were  
cloned  into  their  relevant  expression  vector  by  digestion  of  the  acceptor  and  donor  
vectors   with   the   relevant   restriction   enzymes,   gel   purification   and   subsequent  
ligation  of  the  vector  and  insert  as  described  in  sections  2.2.2  ?  2.2.4.  
  
Table  2.3  Plasmids  made  from  custom  synthesized  genes  
  
  
2.2.9.  CaBP7  shRNA  and  other  plasmids  
CaBP7   shRNA   and   scrambled   shRNA  were   ordered   from   origene   (Cambridge,   UK)  
from  the  HuSH-­‐29  range  of  pre-­‐designed  human  shRNA  plasmids.  The  sequence  for  
the   scrambled   shRNA   was:   ??-­‐GCACTACCAGAGCTAACTCAGATAGTACT-­‐??.   The  
sequence   for   the   CaBP7   specific   shRNA   was:   ??-­‐
GACATGGATGGTGATGGTCAAGTGGACTT-­‐??.   The   plasmid   encodes   a   29-­‐mer   shRNA  
under   control   of   a   human   U6   promoter.   The   plasmid   also   encodes   GFP   under  
control  of  a  cMV  promoter  to  verify  transfection  efficiency.  
  
Table  2.4  lists  any  other  plasmids  that  were  used  in  this  thesis.    
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Table  2.4.  Other  plasmids.  
Plamid  name   Obtained  from  
Caldendrin-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP1L-­‐EYFP   Dr  L.  Haynes,  University  of  Liverpool  
CaBP1L-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP1S-­‐mOrange   Dr  L.  Haynes,  University  of  Liverpool  
CaBP1S-­‐EYFP   Dr  L.  Haynes,  University  of  Liverpool  
CaBP2-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP4-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP5-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP7-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP8-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
mCherry-­‐CaBP7   Dr  L.  Haynes,  University  of  Liverpool  
mCherry-­‐CaBP8   Dr  L.  Haynes,  University  of  Liverpool  
EYFP-­‐CaBP7   Dr  L.  Haynes,  University  of  Liverpool  
EYFP-­‐CaBP8   Dr  L.  Haynes,  University  of  Liverpool  
mCherry-­‐CaBP7  1-­‐188   Dr  L.  Haynes,  University  of  Liverpool  
mCherry-­‐CaBP8  1-­‐192   Dr  L.  Haynes,  University  of  Liverpool  
CaBP5CaBP7TMD-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
CaBP5CaBP8TMD-­‐mCherry   Dr  L.  Haynes,  University  of  Liverpool  
LAMP1-­‐EYFP   Dr  L.  Haynes,  University  of  Liverpool  
Rab5A-­‐EYFP   Dr  L.  Haynes,  University  of  Liverpool  
LC3-­‐EYFP   Dr  L.  Haynes,  University  of  Liverpool  
EGFP-­‐  VAMP7   A  gift  from  Prof  T.  Galli  
VSVG-­‐GFP  ts045   A  gift  from  Dr  J.  Presley  
Optimised  CaBP7  1-­‐188   Customised  synthesis  from  IDT  
Optimised  CaBP4   Customised  synthesis  from  GeneArt  
ECFP-­‐C1   Clontech,  Saint-­‐Germain-­‐en-­‐Laye,  France  
CaBP7  shRNA   Origene,  Cambridge,  UK  
Scrambled  shRNA   Origene,  Cambridge,  UK  
  
2.2.10.  DNA  sequencing  
???? ???????????? ?????????????????????? ??????????? ??????????????? ????? ???????????
????????????????????????????  
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2.3.  Cell  culture  and  transfection  
All  cell  culture  reagents  used  to  maintain  cell  lines  were  purchased  from  Invitrogen.  
Cells   were   cultured   in   75   cm2   flasks   at   37oC   in   a   humidified   atmosphere   of   5%  
CO2/95%  air.    
  
Cells   for   transfection   were   seeded   onto   24-­‐well   or   6-­‐well   trays   at   a   density   of  
~4x105.   Cells   for   imaging   were   grown   on   coverslips   in   24   well   trays   or   on   glass  
bottomed  dishes  (MatTek  corporation,  Massachusetts,  USA).  Transfection  mixtures  
contained   the   DNA   plasmids   to   be   transfected  with   3   µl   GeneJuice®   transfection  
reagent  per  1  µg  DNA,  made  up  to  either,  100  µl  for  each  well  of  a  24  well  plate,  or  
300   µl   for   each   well   of   a   6   well   plate,   with   Opti-­‐MEM®   serum   free   media.   The  
reaction  mixtures  were  incubated  for  15  -­‐  20  minutes  at  room  temperature  to  allow  
the   lipid  and  DNA  complexes   to  associate   then  added  drop-­‐wise   to  the  cells.  Cells  
were   maintained   for   24   hours   post   transfection   before   use   unless   otherwise  
indicated.  Cells  for  fixation  without  further  processing  were  washed  three  times  in  
phosphate  buffered  saline  (PBS;  137  mM  NaCl,  2.7mM  KCl,  10  mM  Na2PO4,  2  mM  
NaH2PO4,  pH  7.4)  then  fixed  in  4%  formaldehyde  in  PBS  at  room  temperature  for  10  
minutes.  Cells  were  then  washed  a  further  three  times  in  PBS,  the  coverslips  rinsed  
gently  with  deionized  H2O  and  dried,  then  the  coverslips  mounted  onto  glass  slides  
using  ProLong®  Gold  antifade  mounting  reagent  (Invitrogen)  and  left  to  dry  at  room  
temperature  overnight  before  imaging.  
2.3.1.  HeLa  cell  culture  
????? ?????? ????? ??????????? ??? ??????????? ????????? ???????? ??????? ???????
supplemented   with   5%   foetal   bovine   serum   (FBS),   1%   non-­‐essential   amino   acids  
(NEAA)  and  1%  penicillin-­‐streptomycin.  
2.3.2.  N2A  cell  culture  
Neuroblastoma  2A  (N2A)  cells  were  cultured  in  DMEM  supplemented  with  10%  FBS  
and   1%   penicillin-­‐streptomycin.   To   stimulate   differentiation   prior   to   transient  
transfection,  N2A  cell  media  was  exchanged  for  DMEM  supplemented  with  2%  FBS,  
1%  penicillin-­‐streptomycin,  and  20  µM  retinoic  acid.  
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2.4.  Immunofluorescence  
Table  2.5.  List  of  antibodies  used  for  immunofluorescence  and  their  dilutions.  
Antibody   Description   Supplier   Dilution  
?  -­‐Tubulin  (DM1A)   Mouse  monoclonal  
Abcam  
(Cambridge,  UK)   1  in  500  
c-­‐myc   Rabbit  polyclonal  
Sigma    
(Missouri,  USA)   1  in  100  
CaBP7   Rabbit  polyclonal  
Santa  Cruz  
(California,  USA)   1in  200  
Calnexin   Rabbit  polyclonal  
Sigma  
(Missouri  USA)   1  in  200  
CD63  
FITC  conjugated  Mouse  
monoclonal  
Abcam  
(Cambridge,  UK)   1  in  00  
CD63   Mouse  monoclonal  
  Biodesign  
International  
(Maine,  USA)   1  in  200  
HRS     Rabbit  polyclonal  
Dr  Sylvie  Urbé  
(University  of  
Liverpool,  UK)     1  in  1000  
LAMP1   Mouse  monoclonal  
Abcam  
(Cambridge,  UK)   1  in  400  
M6PR   Rabbit  polyclonal  
Prof  Paul  Luzio  
(University  of  
Cambridge,  UK)   1  in  500  
p230   Mouse  polyclonal  
BD  Biosciences  
(Oxford,  UK)   1  in  200  
Rab11   Rabbit  polyclonal  
Zymed  (California,  
USA)   1  in  500  
RFP   Rabbit  polyclonal  
Dr  Ian  prior  
(University  of  
Liverpool,  UK)   1  in  100  
SNAP29   Rabbit  polyclonal  
Sigma    
(Cambridge,  UK)   1  in  50  
Syntaxin6   Mouse  monoclonal  
Abcam  
(Cambridge,  UK)   1  in  200  
TOM20   Mouse  monoclonal  
  BD  Biosciences  
(Oxford,  UK)   1  in  1000  
VAMP7   Mouse  monoclonal  
Abcam  
(Cambridge,  UK)   1  in  500  
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Cells  were  washed  three  times  in  PBS  then  fixed  in  4%  formaldehyde  in  PBS  at  room  
temperature   for  10  minutes.  Cells  were  washed  a   further   three   times   in  PBS   then  
permeabilised  using  0.2%  triton  X-­‐100   in  PBS   for  6  minutes  at   room  temperature.  
Cells   were   washed   three   times   in   PBS   to   remove   detergent   then   twice   in   PBS  
containing  5%  BSA  (PBSB).  Cells  were  then  incubated  with  primary  antibody  at  the  
dilutions  indicated  in  table  2.5,  for  1  hour  at  room  temperature  in  PBSB.  Cells  were  
washed  three  times  in  PBS  and  twice  in  PBSB  prior  to  incubation  with  the  relevant  
fluorophore  conjugated  secondary  antibody  (1  in  75  dilution  for  FITC  conjugates,  1  
in  400  dilution  for  Alexa  Fluor  conjugates)  for  1  hour  at  room  temperature  except  in  
the  case  of  directly  FITC  conjugated  anti-­‐CD63  primary  antibody.  Cells  were  washed  
again  three  times  in  PBS,  rinsed  with  deionized  H2O,  dried  and  mounted  onto  glass  
slides   using   ProLong®   Gold   antifade   reagent   (Invitrogen).   Where   nuclei   were  
visualized,   ProLong®   Gold   antifade   reagent   supplemented   with   DAPI   (Invitrogen)  
was  used.  
2.5.  Confocal  Microscopy  
Table   2.6.   Fluorophores   used   in   confocal   microscopy   and   the   excitation   and  






ECFP   405   450-­‐500  
EYFP   488     520-­‐570  
EGFP   488     505-­‐615  
mCherry   594     610-­‐710  
FITC   488     500-­‐540  
Alexa  594   594     590-­‐710  
Alexa  405/DAPI   405     450-­‐500  








2.5.1.  Fixed  cell  imaging  
Imaging   of   transfected   and/or   immunostained   cells  was   carried   out   using   a   Leica  
AOBS   SP2  microscope   (Leica  microsystems,   Heidelberg,   Germany)   using   a   63x   oil  
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immersion  objective  with  a  1.4  numerical  aperture.  In  most  cases  the  pinhole  was  
set  to  Airy1  to  give  the  optimum  signal  to  noise  ratio  and  hence  minimum  thickness  
confocal  section  for  the  excitation  laser  used.  The  wavelengths  used  for  excitation  
of  fluorophores  and  the  emission  ranges  collected  are  listed  in  table  2.6.  
2.5.2.  Live  cell  imaging  
All   live   cell   imaging   experiments   with   the   exception   of   the   experiment   using  
??????????????????????????????????????????????????????????? ??????????????????????
oil   immersion   objective   with   a   1.4   numerical   aperture.   Cells   were   maintained   at  
room  temperature  throughout  each  experiment  as  indicated  in  section  2.6.2.  
  
Imaging  of   Ly???????????????????-­‐22   (Invitrogen)  uptake  was   carried  out  using  a  
Zeiss   LSM510   confocal   system.   Cells   were   incubated   for   30   minutes   in   media  
??????????? ??? ??? ????????????? ????? ???-­‐22   at   37oC.   Loading   media   was   then  
exchanged   for   fresh  media  and  the   fluore?????????????? ? ????????????????????????
fluorescence  was  measured  by  excitation  with  a  UV  laser  line  at  351  nm.    
2.5.3.  Image  analysis  
All   Images   were   processed   using   the   CorelDraw   software   package   (Corel  
Corporation,  Ottawa,  Canada)  or  ImageJ  Java-­‐based  imaging  software  (NIH,  USA).    
2.6.  Cell  assays  
2.6.1.  VSVG  assay  
For   colocalisation   of   ts045   VSVG-­‐GFP   at   the   TGN   cells   were   co-­‐transfected   with  
various   wild   type   and  mutant,   colour   tagged,   CaBP7   and   CaBP8   constructs   along  
with   ts045   VSVG-­‐GFP.   Cells  were   incubated   at   37oC   for   4   hours   post-­‐transfection  
then  transferred  to  40oC  overnight.  Cells  were  subsequently  transferred  to  20oC  for  
2  hours  to  trap  ts045  VSVG-­‐GFP  at  the  TGN  before  fixation.  
2.6.2.  Fluorescence  Protease  Protection  Assay  
HeLa  cells  were  plated  onto  glass  bottomed  dishes  and  triply  transfected  with  1  ?g  
of  each  of  three  constructs:  ECFP-­‐C1,  either  EYFP-­‐CaBP7  or  EYFP-­‐CaBP8,  and  either  
CaBP7-­‐mCherry   or   CaBP8-­‐mCherry.   Protease   protection   of   the   fluorescent   colour  
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tag   was   examined   using   a   previously   described  method   (Lorenz   et   al.,   2006).   24  
hours   post-­‐transfection   cells   were   washed   three   times   in   KHM   buffer   (20   mM  
HEPES   pH7.2,   110   mM   potassium   acetate,   2   mM   magnesium   chloride)   at   room  
temperature.   The   cell   chamber  was   set  up   for  perfusion  on   the  microscope   stage  
and   the  microscope   focused  on  one  or   two  transfected  cells.   Imaging  was   started  
during   this   pre-­‐permeabilisation   stage  with   one   frame   collected   every   8   seconds.  
Each  of  the  three  colour  channels  was  recorded  in  series  to  avoid  potential  bleed-­‐
through.  Cells  were  perfused  with  KHM  buffer  containing  40  ?M  digitonin  until  the  
cytosolic   ECFP   fluorescence   started   to   dissipate.   Perfusion   was   then   switched   to  
KHM  buffer  alone  until  the  ECFP  fluorescence  had  disappeared  (approximately  10  -­‐  
60  sec)  then  switched  to  KHM  buffer  containing  4  mM  trypsin  (Sigma).  Images  were  
recorded  until  the  EYFP  signal  was  lost.  
2.6.3.  Biochemical  Protease  Protection  Assay  
HeLa   cells  were   plated  at   a  density   of   ~4x105   on   6-­‐well   trays   and  duplicate  wells  
transfected  with  3  ?g  of  either:  mCherry-­‐C1,  mCherry-­‐CaBP7  or  CaBP7-­‐mCherry.  24  
hours  post-­‐transfection  cells  were  washed  twice  in  KHM  buffer.  One  well  from  each  
condition   was   then   treated   with   40   ?M   digitonin   in   KHM   buffer   for   1  minute   at  
room  temperature  to  selectively  permeabilise  the  PM.  After  permeabilisation  cells  
were  treated  with  4  mM  trypsin  in  KHM  buffer  for  5  min  at  room  temperature.  The  
cells   were   then   washed   and   solubilised   into   300   ?l   Laemmli   buffer,   then   the  
samples  boiled  for  5  minutes.  The  remaining  wells  were  not  treated  with  digitonin  
or  trypsin  but  were  also  lysed  into  300  ?l  Laemmli  buffer  and  boiled.  25  ?l  volumes  
of   each   sample   were   analysed   by   SDS-­‐PAGE   and   western   blotting   using   a   rabbit  
polyclonal  RFP  antibody  (Table  2.7).  
2.6.4.  Antibody  accessibility  experiments  
Cells   plated   onto   glass   coverslips   were   transfected   with   1   ?g   of   either   mCherry-­‐
CaBP7-­‐myc   or  mCherry-­‐CaBP8-­‐myc.   24   hours  post-­‐transfection   cells  were  washed  
and  permeabilised  in  one  of  two  ways:  Control  cells  were  fixed  in  4%  formaldehyde  
in  PBS  then  all  cellular  membranes  non-­‐selectively  permeabilised  by  incubation  with  
0.2%  Triton-­‐X-­‐100   in  PBS   for  6  minutes.   For   selective  permeabilisation  of   the  PM,  
cells  were  first  treated  with  40  ?M  digitonin  in  KHM  buffer  for  one  minute  before  
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fixation  using  4%  formaldehyde  in  PBS.  Cells  from  both  conditions  were  processed  
for  immunofluorescence  using  either  a  monoclonal  anti-­‐c-­‐myc  antibody  or  a  rabbit  
polyclonal  anti-­‐RFP  antibody  (Table  2.5).  
2.7.  SDS  PAGE  and  Western  blotting  
Cells  transfected  on  a  6  well  tray  were  solubilised  into  300  ?lLaemmli  buffer,  boiled  
for  5  minutes  and  proteins  resolved  by  SDS  PAGE.  Typically  either  fixed  12%  or  15%  
acrylamide  gels  or  pre-­‐cast  Novex  8-­‐16%  Tris-­‐glycine  gradient  gels  (Invitrogen)  were  
used.  5  µl   SeeBlue®  plus  2  prestained   standard  molecular  weight  protein  markers  
(Invitrogen)  were  loaded  alongside  protein  samples.  SDS  PAGE  gels  were  run  at  140  
?? ???? ??????? ?????? ??? ????????? ????? ????? ???????? ????? ?? ????????? ??????????
(Invitrogen)   or   transferred   to   nitrocellulose   membranes   by   transverse  
electrophoresis   for   1   hour   at   80   V.   Nitrocellulose   membranes   were   stained   with  
Ponceau-­‐S  solution  (Sigma)  to  confirm  successful  protein  transfer.  Membranes  were  
washed  with  PBS   to   remove   the   stain   then  blocked   in  blocking  buffer   (5%  milk   in  
PBS)  for  1  hour.  This  was  followed  by  incubation  for  1  hour  with  primary  antibody  in  
blocking  buffer  at  the  concentration  indicated  in  table  2.7.  The  membrane  was  then  
washed   three   times   in   PBS   plus   0.1%   Tween   20   (PBST)   and   once   in   PBS   before  
incubation   with   the   appropriate   horseradish   peroxidase-­‐conjugated   secondary  
antibody   (Sigma)   (1   in   400)   in   blocking   buffer.   Membranes   were   subsequently  
washed  once  in  PBST  followed  by  two  washes  in  PBS.  A  high  salt  wash  using  0.5  M  
NaCl  in  PBS  was  then  performed  for  30  minutes  at  room  temperature  followed  by  a  
15  minute  wash  in  dH2O  before  blots  were  developed  by  incubation  for  ~2  minutes  
with   ECL   Plus   Western   Blotting   Detection   Reagents   (GE   Healthcare,  
Buckinghamshire,   UK).   Blots   were   imaged   on   a   ChemiDoc   XRS   system   (BioRad,  
California,  USA).  
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Table  2.7.  List  of  antibodies  and  their  dilutions  used  for  western  blotting.    





(Cambridge,  UK)   1  in  500  
CaBP7   Rabbit  polyclonal  
Santa  Cruz  





(Missouri,  USA)   1  in  1000  
RFP   Rabbit  polyclonal  
Dr  Ian  prior  
(University  of  
Liverpool,  UK)   1  in  200  
2.8.  Protein  expression  and  purification  
Recombinant  proteins  made  for  any  purpose  other  than  NMR  were  expressed  from  
BL21  cells  grown  in  superbroth  media  (0.5%  w/v  NaCl,  1.5%  w/v  tryptone,  2.5%  w/v  
yeast   extract)   supplemented   with   the   appropriate   antibiotics   for   the   expression  
plasmid   (appendix,   table   A1)   and   BL21   strain   used   (Table   6.1,   chapter   6).  
Isotopically   labelled   proteins   for   NMR   were   made   by   growing   the   expression  
bacteria  in  M9  minimal  media  (50  mM  sodium  phosphate  buffer,  22  mM  potassium  
phosphate  buffer,  8.5  mM  NaCl,  pH  7.2)  supplemented  with  1  mM  MgSO4,  50  µM  
CaCl2,  23  mM  NH4Cl,  22  mM  glucose  and  100  µl  PTM1   salts   (24  mM  CuSO4.5H2O,  
0.534  mM  NaI,  17.8  mM  MnSO4.5H2O,  0.827  mM  NaMoO4.2H2O,  0.323  mM  H3BO3,  
2.1  mM  CoCl2.6H2O,  147  mM  ZnCl2,  234  mM  FeSO4.7H2O,  1.64  mM  biotin,  188  mM  
H2SO4)  per  litre.  Media  was  also  supplemented  with  appropriate  antibiotics  for  the  
expression  plasmid  and  specific  BL21  strains  used.  Unlabelled  ammonium  chloride  
was   substituted   with   15N   labelled   ammonium   chloride   (ISOTEC®,   Sigma)   in   single  
and  double  labelled  protein  preparations.  Unlabelled  glucose  was  substituted  with  
13C  labelled  glucose  (ISOTEC®,  Sigma)  in  double  labelled  protein  preparations.  Single  
labelled  but  not  double  labelled  protein  preparations  were  supplemented  with  0.5  g  
15N   labelled   ISOGRO  ®   (ISOTEC®,  Sigma)  per  1   litre  minimal  media.   ISOGRO®   is  an  
algal   lysate-­‐derived  complex   labelled  growth  medium  which  supports  acceleration  
of  host  cell  metabolism.  
  
     66  
Expression  bacteria  were   grown   at   37oC   until   an  OD600   of   0.8   -­‐   1.0  was   achieved.  
Protein   expression   of   various   glutathione   S-­‐transferase   (GST)   and   His6-­‐tag   fusion  
proteins  was   induced  using   IPTG   according   to   the   parameters   listed   in   chapter   6,  
section   6.2.1,   table   6.1.   Standard   BL21   (DE3)   cells   were   taken   from   lab   stocks.   A  
range  of  BL21  variants  were  tested  as   in  Chapter  6,  section  6.2.1,   table  6.1.  These  
????????? ????????? ?????? ?????????? ?????? ???????Darmstadt,   Germany),   BL21-­‐
CodonPlus®  (DE3)-­‐RIL  cells  (Agilent  Technologies,  California,  USA),  BL21-­‐CodonPlus®  
(DE3)-­‐RP   cells   (Agilent   Technologies),   and   ArcticExpress   (DE3)-­‐RIL   competent   cells  
(Agilent  Technologies).  After  induction  bacteria  were  harvested  by  centrifugation  at  
2400  x  g  for  10  mins.  Pellets  were  resuspended  in  binding  buffer,  either:  50  mM  Tris  
pH  7.0  for  GST  fusion  proteins;  or  50  mM  sodium  phosphate  buffer  pH  7.0,  300  mM  
NaCl   (Talon  buffer)   for  His   fusion  proteins.  Both  buffers  were   supplemented  with  
protease  inhibitors  (Complete  mini  protease  inhibitor  cocktail  tablets,  Roche,  Basel,  
Switzerland).   Cells   were   lysed   using   a   cell   disrupter   (Constant   Systems   Ltd,  
Daventry,  UK)   set   at   27   KPSI   then   centrifuged   at   100   000   x   g   in   a   Beckman   L80K  
ultracentrifuge  for  1  hour  at  4oC  to  separate  soluble  and  insoluble  fractions.  
  
Glutathione  cellulose  resin  (Bioline)  was  used  to  affinity  purify  GST  fusion  proteins.  
??????? ?????? ????????? ?????? ????????? ?????-­‐Germain-­‐en-­‐?????? ???????? ??? ????????
IMAC  FF  columns  (GE  Healthcare)  charged  with  NiSO4,  were  used  to  affinity  purify  
His  tagged  proteins.  For  purification  with  unpacked  resin,  the  resin  was  prewashed  
in  the  appropriate  binding  buffer  then  incubated  with  clarified  bacterial  lysate  for  1  
hour  at  4oC.  The  resin  was  then  washed  extensively  (>  30  resin  volumes)  in  binding  
buffer.   To  elute  bound  protein   from   the   resin   the   appropriate  binding  buffer  was  
supplemented  with  10  mM  reduced  glutathione  for  GST  fusion  proteins  or  500  mM  
imidazole   for   His6-­‐??????? ?????????? ???? ????????????? ?????? ???????? ???????? ????
Healthcare),   the   clarified   lysate  was   loaded  onto   the   column  using  a   syringe.   The  
column   was   then   washed   extensively   with   binding   buffer   (>   5   column   volumes)  
followed   by   binding   buffer   supplemented   with   25   mM   imidazole   (>   5   column  
volumes)   to   remove   non-­‐specifically   bound   protein.   Protein   remaining   on   the  
column  was  eluted   in   3  ml   fractions  using  binding   buffer   supplemented  with  500  
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mM   imidazole.   Protein   expression   and   yield   was   checked   by   SDS   PAGE   and   gels  
???????? ?????? ????????????????????????????????  
  
Affinity  tags  were  cleaved  using  commercially  available  proteases  according  to  the  
??????????????? ???tructions.   PreScission   Protease   (GE   Healthcare)   was   used   to  
cleave  GST  tags,  Tobacco  etch  virus  (TEV)  protease  (Invitrogen)  was  used  to  cleave  
the  His6-­‐tag   from  proteins   expressed   from   the  TrcHisTEV  plasmid,   and   the   SUMO  
Protease,   ULP1,   was   used   to   cleave   His6-­‐SUMO   tags   (made   in-­‐house   by   Dr   Andy  
Herbert).   ULP1   is   compatible   for   use   in   a   range   of   different   buffers   and   was  
generally   used   in   the  buffer   subsequently   used   for  NMR  experiments.   The   SUMO  
Protease  protocol  was  adjusted  to  perform  the  cleavage  with  recombinant  protein  
immobilized  on  affinity  resin  as  described  in  chapter  6,  section  6.2.  
  
????????????????????????????????????????????????????? ? ???????????????????????
dialysis   into  an  appropriate   compatible  NMR  buffer.  After  dialysis   the  His6-­‐SUMO-­‐
tag  was  cleaved  by  incubating  the  protein  with  2  U  of  SUMO  Protease  per  mg  of  test  
protein   at   room   temperature   for   2   -­‐   3   hours.   This   protein   sample   was   then   re-­‐
???????? ??? ?? ???? ???????? ??????? ??? ??????? ????? ???6-­‐SUMO   tag   and   ULP-­‐1  
protease,   along  with   any   uncleaved   fusion   protein.   Protein   from   this   repass   step  
was   then   concentrated   into   a   500   µl   final   volume   using   vivaspin   ultrafiltration  
columns    (GE  Healthcare)  with  an  appropriate  molecular  weight  cut  off  significantly  
below  the  size  of  the  protein  to  be  purified.  
  
Protein  concentration  was  calculated  by  measuring  the  absorbance  at  280  nm  using  
the   theoretical   molar   extinction   coefficient   (ExPASy,   ProtParam  
http://web.expasy.org/protparam/).  The  Concentration  of  protein  samples  used  to  
record  NMR  spectra  were  typically  in  the  range  of  50  -­‐  ???????  
  
Apo  CaBP7  1-­‐100  was  made  by  dialyzing  the  uncleaved  protein  into  20  mM  HEPES  
pH   7.0,   50   mM  NaCl,   2   mM   octylglucoside,   5  mM   EDTA,   5   mM   EGTA.   The   His6-­‐
SUMO  tag  was  cleaved  after  dialysis  as  described  above  and  cleaved  protein  diluted  
into   EDTA/EGTA-­‐free   buffer   using   a   vivaspin   ultrafiltration   column   until   the  
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?????????????????????????????????????????????????????????-­‐?????????????????????
column   to   remove   the   free   SUMO,   protease   and   uncleaved   fusion   protein   and  
subsequently  concentrated  using  a  new  vivaspin  ultrafiltration  column.  
2.9.  NMR  Spectroscopy  
Samples  for  NMR  were  prepared   in  their   respective  buffers   in  90%  H2O/10%  D2O.  
Spectra  were  acquired  on  Bruker  AVANCE  II+  600  MHz  and  800  MHz  spectrometers  
fitted  with  5  mm  triple  resonance  TCI  cryoprobes.  NMR  experiments  for  1H,  15N  and  
13C  backbone  and  side-­‐chain  assignments  included  2D  1H-­‐15N  HSQC,  1H-­‐13C  HSQC,  3D  
HNCO,   HN(CA)CO,   CBCANH,   CBCA(CO)NH,   HBHANH   and   (H)CCH-­‐TOCSY.  
Descriptions   of   these   experiments   can  be   found   in   chapter   6,   section  6.2.5,   table  
6.3.   All   NMR   spectra   were   acquired   and   processed   by   Dr   Andrew   Herbert   (NMR  
Centre   for  Structural  Biology,  University  of  Liverpool).  The  parameters  used   in  the  
experiments   for   CaBP7   1-­‐100   backbone   and   side   chain   assignments   are   listed   in  
table  2.8.  NMR  data  was  processed  using  Bruker  Topspin  2.1  and  analysed  using  the  
Analysis   program   from   the   collaborative   computing   project   for   NMR   (CCPN)  
(Vranken  et  al.,  2005)  
  
The  buffers  used  for   individual  NMR  experiments  are   indicated   in  chapter  6,  table  
6.2.   Titrations   of   octylglucoside   and   CaCl2  were   performed   by   adding   appropriate  
volumes  of  pH  matched  1  M  stock  solutions  to  give  the  concentrations  indicated  on  
individual  spectra  in  chapter  6.  Identical  acquisition  parameters  were  used  for  each  
spectrum  in  a  titration  series.  
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Table   2.8   Parameters   used   in   the   NMR   experiments   for   CaBP7   1-­‐100   backbone  
and  side  chain  assignments.  
Experiment   Parameters  
1H-­‐15N-­‐HSQC  (2D)   sw  15N  =  20ppm;  o3p=116.0  ppm;  td  f1  =  256  
HNCO    (3D)   sw  15N  =  20ppm;  sw  13C  =  14ppm;  o3p  =  116.0;  o2p  =  176;  td  
f1  =  128;  td  f2  =  128  
HN(CA)CO  (3D)   sw  15N  =  20ppm;  sw  13C  =  14ppm;  o3p  =  116.0;  o2p  =  176;  td  
f1  =  128;  td  f2  =  128  
HNCACB  (3D)   sw  15N  =  20ppm;  sw  13C  =  70ppm;  o3p  =  116.0;  o2p  =  42;  td  
f1  =  256;  td  f2  =  128  
CBCA(CO)NH  (3D)   sw  15N  =  20ppm;  sw  13C  =  70ppm;  o3p  =  116.0;  o2p  =  42;  td  
f1  =  256;  td  f2  =  128  
HBHA(CO)NH  (3D)   sw  15N  =  20ppm;  sw  1H  (f1)  =  8ppm;  o3p  =  116.0;  td  f1  =  256;  
td  f2  =  128  
HCCH-­‐TOCSY  (3D)   sw  13C  =  75ppm;  sw  1H  (f1)  =  6ppm;  o2p  =  28.5;  td  f1  =  256;  
td  f2  =  128  
1H-­‐13C-­‐HSQC  (2D)   sw  13C  =  75ppm;  td  f1  =  512;  o2p  =  28.5  
  
*f1  =  1H  dimension;  f2  =  13C  dimension;  f3  =  15N  dimension;  sw  =  spectral  width;  o2p    
=  offset  in  ppm  for  the  13C  dimension;  o3p  =  offset  in  ppm  for  15N  dimension;  td  =  
time  domain  (number  of  points  in  that  dimension).  
2.10.  Gel  mobility  assay  
Gel  mobility  shift  assays  were  performed  by  resolving  non-­‐boiled  protein  samples  in  
SDS-­‐free   loading   buffer   on   native   PAGE   gels   and   assessing   the   shift   in   apparent  
molecular  weight   in   the   presence  of   different   chelators   and   cations.   The   stacking  
gel  contained  250  mM  Tris  pH  6.8,  4%  acrylamide  and  the  separating  gel  contained  
750  mM  Tris  pH  7.5,  18%  acrylamide.  The  loading  buffer  contained  50  mM  Tris  pH  
7.5,   10%   glycerol,   10%   sucrose,   2   mM   EDTA,   2   mM   EGTA.   To   investigate   Ca2+  
binding,  10mM  CaCl2  was  added  to  the  loading  buffer.  To  investigate  Mg
2+  binding,  
10  mM  MgCl2  was  added  to  the  loading  buffer.  The  running  buffer  consisted  of  500  
mM  Tris,  385  mM  glycine.  Gels  were  run  at  140  V  for  approximately  90  mins  then  
???????? ????? ?? ????????? ?????????? ????????????? ?????????? ??? ???? ???????????????
protocol.  
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3.1.  Introduction  
Many  aspects  of  cellular  function  are  regulated  by  changes  in  [Ca2+]i(Berridge  et  al.,  
2000)  and  diverse  families  of  proteins  with  specific  Ca2+-­‐binding  motifs  have  evolved  
to   mediate   responses   to   such   [Ca2+]i   fluxes   (Clapham,   2007).   These   highly  
specialised   calcium   sensors   undergo   conformational   changes   upon   Ca2+-­‐binding  
allowing   them   to   interact  with  different  binding  partners  depending  on   their  Ca2+  
loading   status.   This   in   turn   allows   them  to   regulate  unique   signalling  pathways   in  
response  to  changes  in  [Ca2+]i(Ikura  and  Ames,  2006).  
  
Calcium   signalling   controls   numerous   fundamental   aspects   of   cellular   physiology  
and  this,  in  part,  is  brought  about  by  variation  in  the  amplitude,  timing  and  spatial  
localisation  of  the  Ca2+  signal  itself  (Boulware  and  Marchant,  2008,  Bootman  et  al.,  
2001).   Further  diversification  of   these  physiological   outcomes   is   generated  by   the  
existence  of  multiple  Ca2+-­‐sensors   that  each  have   finely   tuned  properties   to  allow  
them  to  regulate  specific  target  proteins  (Ikura  and  Ames,  2006,  Burgoyne,  2007).  
  
The   ubiquitous   and   highly   conserved   Ca2+-­‐sensor,   CaM,   which   is   present   in   all  
eukaryotes,   is   the  best  studied  Ca2+-­‐sensing  protein   (Chin  and  Means,  2000).  Each  
CaM  molecule   can   bind   four   Ca2+   ions   via   four   canonical   EF-­‐hand  motifs.   The   EF-­‐
hand  motif,   first   identified   in  parvalbumin,  has  now  been   identified   in  an  array  of  
other   proteins,   some   of   which   are   highly   related   and   constitute   distinct   families  
(Moncrief  et  al.,  1990,  Grabarek,  2006).  Examples  of  the  EF-­‐hand  containing  families  
include  the  S100  proteins   in  vertebrates   (Donato,  2001)  and  the  calcineurin  B-­‐like  
(CBL)  proteins  in  plants  (Batistic  and  Kudla,  2009,  Weinl  and  Kudla,  2009).  
  
In   neurons   changes   in   [Ca2+]i   have   many   important   effects   which   occur   on  
timescales   ranging   from  microseconds   to  many  minutes   (Berridge,   1998).   For   this  
reason,   Ca2+-­‐sensing   protein   families   which   are   expressed   specifically   in   neuronal  
cell  types  have  been  of  particular  interest  in  the  calcium  signalling  field   (Burgoyne,  
2007).   Two   families   of   neuronal   Ca2+-­‐binding   proteins   have   become  more   widely  
studied   in   recent   years:   The   NCS   proteins   (Burgoyne,   2007,   Burgoyne   and  Weiss,  
2001)   and   the   CaBP   family   (Haeseleer   et   al.,   2000,   Haeseleer   et   al.,   2002,  
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Seidenbecher  et  al.,  1998,  Laube  et  al.,  2002,  Mikhaylova  et  al.,  2006).  These  Ca2+-­‐
sensors  have  emerged  as  important  regulators  of  neuronal  function  and  have  been  
implicated   in   processes   such   as   neuronal   exocytosis,   neurotransmission,  
phototransduction   and   neurite   outgrowth   (Zheng   et   al.,   2005,   Nakajima,   2011,  
Maeda  et  al.,  2005,  Sampath  et  al.,  2005,  Weiss  et  al.,  2010,  Dieterich  et  al.,  2008).  
  
Understanding   precisely   how   these   proteins   appeared   and   expanded   during  
evolution   could   give   important   functional   clues   about   how   they   may   have  
contributed   to   the   generation   of   increasingly   complex   organism   architecture   and  
behaviour.   For   instance,   the  earliest  orthologue  of   the  NCS  proteins,   frequenin  or  
NCS-­‐1,  was   detected   as   a   single   gene   in   fungal   genomes   (Hendricks  et  al.,   1999).  
There  has  been  a  progressive  expansion  of  this  gene  family  through  evolution,  with  
three  NCS  proteins  expressed  in  Caenorhabditis  elegans  and  four  genes  encoded  by  
Drosophila  melanogaster.   Increasing  diversification  of   these   genes   split   the   family  
into  further  subtypes.  D.  melanogaster  encodes  two  frequenins,  a  neurocalcin  and  a  
single   KChIP.   Zebrafish   (Danio   rerio)   have   two   NCS-­‐1   orthologues,   eight   VILIPs,   a  
recoverin,  eight  GCAPs  and  five  KChIPs.  All  mammals  have  a  highly  conserved  set  of  
fourteen  NCS  genes  that  encode  one  NCS-­‐1,  five  VILIPs,  one  recoverin,  three  GCAPS  
and   four   KChIPs   (Burgoyne   and  Weiss,   2001).   In   addition   to   the   numerous   genes  
encoded  by  this  protein  family,  the  KCHIPs  are  expressed  as  multiple  splice  isoforms  
in  neurons  (Pruunsild  and  Timmusk,  2005).  Analogously,  the  plant  CBL  proteins  also  
show  an  increase  in  gene  number  through  evolution  with  only  one  CBL  gene  found  
in   algae   compared   to   ten   found   in   higher   plants   (Weinl   and   Kudla,   2009).   These  
findings  suggest  that  the  expansion  of  Ca2+-­‐binding  protein  families  during  evolution  
may  have  contributed  to  increased  signalling  complexity  in  higher  organisms.  
  
Here,   a   thorough   analysis   of   the   evolution   of   the   CaBP   family   of   neuronally  
expressed  Ca2+-­‐sensors   is  presented.  This  family   is   thought  to  comprise  of  the  five  
CaBP  genes  originally  described  by  Haeseleer  et  al.(Haeseleer  et  al.,  2000)  together  
with   the   independently  discovered   calneuron   I   and   calneuron   II   (Wu  et   al.,   2001,  
Mikhaylova  et  al.,  2006).  Based  on  their   shared  homology   to  CaM,  the  calneurons  
were  suggested  to  belong  to  the  same  family  as  CaBPs  1-­‐5  and  thus  are  alternatively  
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referred  to  as  CaBP7  (calneuron  II)  and  CaBP8  (calneuron  I)(Haeseleer  et  al.,  2002).  
Others  have  suggested  that  the  calneurons  in  fact  constitute  a  distinct  family  that  is  
unrelated  to  the  other  CaBPs   (Mikhaylova  et  al.,  2006).  For  the  purposes  of   these  
analyses  these  proteins  will  henceforth  be  referred  to  as  CaBP7  and  CaBP8.    
3.2.  Results  
3.2.1.  Human  CaBP  family  
There   are   six   genes   encoding   the  human  CaBP   family   of   proteins,   CABP1,   CABP2,  
CABP4,  CABP5,  CABP7  and  CABP8.  Two  of  these  genes,  CABP1  and  CABP2,  give  rise  
to   multiple   splice   isoforms.   The   CABP1   gene   generates   three   different   proteins    
(CaBP1S,  CaBP1L  and  caldendrin)  whereas  the  CABP2  gene  generates  two  proteins  
(CaBP2S   and   CaBP2L).   A   seventh   gene,   CABP3,   which   partially   overlaps   with   the  
CABP5  gene,  also  exists  but   is  only  found   in  genomic  sequences  and  expression  of  
the   protein   has   never   been   detected.   CABP3   is   therefore   thought   to   be   a  
pseudogene  and  has  not  been   included   in   the  bioinformatic  analyses.  Note   that  a  
sixth   gene   product   was   originally   discovered   but   later   found   to   belong   to   an  
unrelated  subfamily  of  Ca2+-­‐binding  proteins.  This  explains  the  absence  of  a  CaBP6  




Figure  3.1.  RNA  sequences  surrounding  the  start  codon  of  the  open  reading  frames  (ORF)  for  the  
proposed  two  isoforms  of  CaBP8.  The  second  ORF  is  more  similar  to  the  consensus  kozak  sequence  
and   has   a   conserved   purine   at   the   -­‐3   position   found   in   the   majority   of   eukaryotic   mRNAs.   This  
sequence  can  be  regarded  as  an  adequate  kozak  site  whereas  CaBP8  ORF1  lacks  both  a  purine  at   -­‐3  
and  guanosine  at  +4  and  therefore  represents  a  weak  transcriptional  start  consensus  site.  
     
Kozak  sequence:   cc
CaBP8  1st  ORF:   ccg c
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Alternative  transcripts  of  CABP8   can  be  found   in   the  Genbank  database   for  Homo  
sapiens  and  a  number  of  other  species  which  could  potentially  encode  for  short  and  
long  CaBP8  variants.  Examination  of  these  transcripts  revealed  that  the  start  codon  
in   the   long   variant  was   not   located  within   a   Kozak   consensus   sequence   and  was  
therefore  unlikely  to  be  efficiently  translated  (Figure  3.1).  Consistent  with  this  there  
is  presently  no  evidence  supporting  the  expression  of  a  long  CaBP8  variant.  The  long  
form  was  therefore  not  included  in  any  further  analyses.  
  
  
Figure   3.2   -­‐   Alignment   of   the   sequences   of   human   calmodulin   and   CaBP   proteins.   Protein  
sequences  were  compiled  and  aligned  using  ClustalW.  Residues  that  are  identical   in  more  than  one  
protein   are   highlighted   in   blue   and   residues  with   similar   properties   are   highlighted   in   yellow.   The  
black   lines  above   the  sequences   indicate   the  position  of   the  predicted  12  amino  acid  coordinating  
loop  within   the   EF-­‐hands.   In   EF-­‐hand  motifs   where   insertions   or   deletions   have   rendered   the   co-­‐
ordinating  loopinactive  in  Ca2+  binding,  the  black  bars  appears  longer  or  shorter  than  the  canonical  
12  amino  acid  loop.  The  green  bar  beneath  the  sequence  indicates  the  position  of  the  linker  region  in  
the  CaBPs  that  is  extended  in  comparison  to  CaM.  
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A  multiple  sequence  alignment  of  the  human  CaBP  protein  sequences  along  with  
human  CaM  is  shown  in  figure  3.2.  Residues  that  are  either  identical  or  similar  in  at  
least  two  of  the  sequences  are  highlighted  in  the  alignment.  Bold  black  lines  above  
the  sequences  indicate  the  positions  of  the  four  EF-­‐hand  domains  and  illustrate  the  
similarity  in  domain  structure  amongst  proteins  of  this  family  and  also  with  CaM.  
CaM,  however,  possesses  a  shorter  linker  region  between  the  N-­‐terminal  and  C-­‐
terminal  EF-­‐hand  pairs  (underlined  in  green  in  figure  3.2).  In  the  CaBPs  the  linker  is  
extended  by  4  amino  acids  and  there  is  a  high  level  of  identity  within  this  region.  It  
has  been  speculated  that  this  linker  extension  permits  the  CaBPs  to  interact  with  
targets  distinct  from  those  recognized  by  CaM  (Haeseleer  et  al.,  2000).    
  
The   C-­‐terminal   portion   of   the   protein   sequences,   containing   the   four   EF-­‐hand  
domains,   is  the  most  conserved,  with  the  N-­‐terminal  region  being  most  divergent.  
Some  of  the  EF-­‐hand  motifs  have  undergone  deletions  or  substitutions  within  their  
consensus   sequence,   most   likely   rendering   them   inactive   for   divalent   cation  
binding.  EF-­‐hand  2  in  CaBPs  1-­‐5  is  predicted  to  not  bind  cations  due  to  deletions  or  
substitutions   in   the   Ca2+-­‐binding   loop.   Biochemical   and   structural   analyses   of  
CaBP1S  have  indeed  confirmed  that  the  substitutions  within  the  loop  of  EF-­‐hand  2  
in  this  protein  prevent  coordination  of  divalent  cations  at  this  position  (Haeseleer  et  
al.,  2000,  Wingard  et  al.,  2005,  Li  et  al.,  2009,  Park  et  al.,  2011).  
  
The  pattern  of  EF-­‐hand  inactivation  in  CaBP7  and  CaBP8  differs  from  the  other  CaBP  
family   members.   Analysis   of   their   protein   sequences   predicts   they   will   have  
functional  EF-­‐hands  1  and  2  but  there  is  a  three  amino  acid  deletion  in  EF-­‐hand  3,  
and  EF-­‐hand  4  has  undergone  both  substitutions  and  insertions.  EF-­‐hands  3  and  4  in  
these  two  proteins  are  therefore  predicted  to  be  inactive  in  divalent  cation  binding.  
  
Table   3.1   shows   the   percentage   sequence   identities   between   the   various   human  
CaBP  proteins  and  CaM.  CaBP1S,  CaBP2S  and  CaBP5  exhibit   the  highest  sequence  
similarities  with  CaM  at  ~37%  identity.  The  identities  in  table  3.1  therefore  highlight  
that  the  CaBPs  show  only  limited  homology  with  CaM.  Most  of  the  CaBPs  possess  a  
significantly   extended   N-­‐terminal   region   when   compared   to   CaM   and  
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correspondingly   the   CaBPs   with   the   longest   N-­‐termini   exhibit   the   least   sequence  
identity  with  CaM.  
  
CaBP7   and  CaBP8  have   the   lowest   comparative   identities  within   the   CaBP   family.  
Despite   exhibiting  63.0%   identity  with  one  another,   the  highest   identity  observed  
with   any   other   CaBP   member   is   only   24.0%   between   CaBP7   and   CaBP2S.   The  
comparative  identities  within  caldendrin  and  CaBPs  1-­‐5,  however,  suggest  a  higher  
relatedness,   ranging   from   30.8%   to   72.6%.   These   values   are   suggestive   of   the  
existence   of   two   distinct   sub-­‐groups  within   the   CaBP   family   ?   one   encompassing  
caldendrin  and  CaBPs  1-­‐5,  the  other  comprising  CaBP7  and  CaBP8.  In  support  of  this  
theory   there   are   obvious   differences   in   the   sequence   and   domain   structure   of  
CaBP7   and   CaBP8.   Aside   from   the   differences   in   their   central   linker   region   and  
pattern   of   EF-­‐hand   inactivation,   CaBP7   and   CaBP8   also   possess   a   38   amino   acid  
extension  at  their  C-­‐terminus  when  compared  with  CaM  and  all  other  CaBP  family  
members.  This  C-­‐terminal  extension  is  highly  hydrophobic  and,  as  will  be  discussed  
in  chapter  4,  has  been  found  to  be  important  for  membrane  targeting  (McCue  et  al.,  
2009,  McCue  et  al.,  2011).  
  
Table  3.1.  Percentage  sequence  identity  of  residues  across  the  various  human  CaBPs  and  CaM  
protein  sequences  that  are  shown  in  Figure  3.1.  
  
3.2.2.  The  CaBPs  first  arose  with  the  appearance  of  vertebrates  
To  gain  insight  into  the  evolutionary  origins  of  the  CaBP  family,  NCBI  BLAST  searches  
were  performed  against  each  of  the  human  CaBP  protein  and  nucleotide  sequences.  
D.  melanogaster  and  C.   elegans  were  used  as   representative   invertebrate   species  
     Caldendrin   CaBP1S          CaBP1L          CaBP2S          CaBP2L          CaBP4            CaBP5             CaBP7   CaBP8  
CaM   16.7   36.6   27.1   37.8   28.5   22.9   36.7   20.0   20.7  
Caldendrin  
  
42.4   45.1   32.1   35.1   31.5   30.8   12.1   13.5  
CaBP1S          
     
73.5   72.6   54.9   36.3   64.9   21.7   23.2  
CaBP1L          
        
53.5   56.7   33.1   50.4   18.0   19.1  
CaBP2S          
           
74.0   40.0   58.1   24.0   21.9  
CaBP2L          
              
36.5   46.4   20.2   18.3  
CaBP4            
                 
34.5   16.4   16.1  
CaBP5            
                    
23.3   21.6  
CaBP7  
                       
63.0  
CaBP8  
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but  no  proteins  with  significant  homology  greater  than  CaM  were  detected.  Figure  
3.3  illustrates  the  8  major  nodes  in  the  evolution  of  chordates  and,  where  genomic  
sequencing   data   was   publicly   available,   BLAST   searches   were   conducted   for   an  
organism   representing   every   node.  Detailed   searches   for   specific   organisms  were  
carried   out   using   the   databases   for   specific   genome   projects   as   detailed   in   the  
materials   and   methods   chapter,   section   2.1.   Genome   searches   of   early  
deuterostomes  such  as  sea  urchin  (Strongylocentrotus  purpuratus),  sea  squirt  (ciona  
intestinalis)   and   amphioxus   (Branchiostoma   floridae),   representing   the   first   two  
nodes   in   figure   3.3,   did   not   reveal   any   candidate   CaBP   homologues.   The   top   hits  
were  CaM  or  CaM-­‐like  proteins.  Lampreys  (Petromyzon  marinus),  belonging  to  the  
superclass  Agnatha   (jawless   fish),  are   thought   to  be   the  closest   living  organism   to  
our  vertebrate  ancestor  (Figure  3.3).  The  genome  project  for  the  lamprey  is  not  yet  
complete,   however,   specific   BLAT   and   BLAST   searches   of   the   available   lamprey  
genome  databases  revealed  partial  sequences  of  two  proteins  most  closely  related  
to  human  CaBP1S  and  CaBP8  with  80.2%  and  61.4%  coverage  respectively  (Table  3.2  
a  and  b).    
  
Searches   in   the  elephant   shark   (Callorhinchus  milli)   genome,  which  was  used  as  a  
representative  organism  for  the  cartilaginous  fish  node  (Figure  3.3),  also  identified  a  
number  of  DNA  contigs  encoding  fragments  of  the  CaBPs.  Three  contigs  were  found  
with  homology  to  human  CaBP1,  CaBP2  and  CaBP5  (Table  3.3).  The  two  contigs  with  
homology   to   CaBP1   and   CaBP5   appeared   to   follow   on   from   each   other   and  
corresponded  to  exons  3  and  4  of  human  CaBP1S  or  CaBP5  (Table  3.3).  When  the  
exons  were  assembled   together   the  protein  had  46.1%  coverage   (Table  3.2a)   and  
90.0%  homology  compared  to  the  full-­‐length  human  CaBP1S  protein  sequence.  The  
third  contig  encoded  a  short  region  with  greatest  homology  to  human  CaBP2.  This  
region  corresponded  to  the  same  region  encoded  by  one  of   the  other  contigs  but  
was   not   identical   in   sequence   (Table   3.3).   This   suggests   that   the   elephant   shark  
must  have  at  least  two  proteins  with  homology  to  CaBP1  and  CaBP2  and  possibly  a  
third   protein   with   homology   to   CaBP5.   As   CaBPs   1-­‐5   are   so   similar   in   their   core  
sequence,   it   is   very   difficult   to   deduce   whether   the   fragment   with   homology   to  
CaBP5  is   indeed  an  exon  from  the  same  protein  as  one  of  the  other  fragments,  or  
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belongs   to   a   completely   separate   CaBP   protein.   This   issue   could   be   clarified   if   a  
contig  map  were  available  for  the  elephant  shark  genome.    
  
In   addition,   nine  DNA   contigs  were   identified  which   encoded   fragments   of   CaBP7  
and   CaBP8.   The   coding   regions  within   each   of   these   contigs   corresponded   to   the  
exons  of  human  CaBP7  and  CaBP8  (Table  3.3).  Fragments  encoding  all  CaBP8  exons  
were  discovered  and  all  exons  except  the  first,  N-­‐terminal,  exon  were  discovered  for  
CaBP7.   This   gave  a   total   coverage  of   83.3%  and  100%   (Table  3.2b)   for  CaBP7  and  





Figure  3.3.  Cladogram  illustrating  the  evolution  of  chordates.  A  representative  species  is  shown  for  
each  major  taxonomic  group.  The  shaded  circles  indicate  whether  the  genome  of  these  species  has  
been  sequenced,  is  partially  sequenced  or  has  not  yet  been  sequenced.  
  
  





Figure  3.4.  Alignment  of  the  sequences  of  human,   lamprey  and  elephant  shark  CaBP  proteins.  A)  
Alignment   of   human,   lamprey   and   elephant   shark   CaBP1   sequences.   B)   Alignment   of   human,  
lamprey   and   elephant   shark   CaBP7   and   CaBP8   sequences.   Protein   sequences   were   compiled   and  
aligned  using  ClustalW.  Residues  that  are  identical  in  more  than  one  protein  are  highlighted  in  blue  
and   residues   with   similar   properties   are   highlighted   in   yellow.   The   lines   above   the   sequences  
indicate   the   position   of   the   predicted   12   amino   acid   coordinating   loop  within   the   EF-­‐hands.In   EF-­‐
hand   motifs   where   insertions   or   deletions   have   rendered   the   co-­‐ordinating   loopinactive   in   Ca2+  
binding,  the  black  bars  appears  longer  or  shorter  than  the  canonical  12  amino  acid  loop.  
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Figure  3.4  A  and  B  depict  multiple  sequence  alignments  for  the  translated  lamprey  
and   elephant   shark   CaBP1S,   CaBP7   and   CaBP8   sequences   along   with   the  
corresponding   human   sequences.   These   sequences   were   constructed   using   the  
fragments   identified   in   BLAST/BLAT   searches   based   on   the   exon   structure   of   the  
human  CaBPs.  The  bold  black   lines  above   the   sequences  mark   the  position  of   the  
four   EF-­‐hands.   Despite   the   C-­‐terminal   half   of   the   elephant   shark   CaBP1S   being  
missing,  the  same  predicted  pattern  of  EF-­‐hand  inactivation  could  be  seen   in  both  
the   lamprey  CaBP  sequences  and  the  elephant  shark  CaBP7  and  CaBP8  sequences  
when  compared  to  humans.  Therefore  the  function  and  specificity  of  these  motifs  
has   remained   highly   conserved   since   the   evolution   of   early   vertebrate   species.  
Tables   3.2a   and   3.2b   show   the   percentage   coverage   for   each   of   the   CaBPs   along  
with   the   percentage   identity   to   their   human   orthologues   within   the   aligned  
sequence.  The  lamprey  and  elephant  shark  CaBP1  have  76.0%  and  90.0%  homology  
to   human   CaBP1S   respectively,   illustrating   that   this   protein   has   remained   highly  
conserved   from   early   vertebrates   to   higher  mammals.   The   elephant   shark   CaBP7  
and   CaBP8   have   84.0%   and   87.0%   homology   to   their   human   counterparts,  
respectively.   The   CaBP   in   lamprey   corresponding   to   either   CaBP7   or   CaBP8   has  
between   61.0   -­‐   65.0%   homology   with   the   human   protein   sequences   but   is   most  
similar  to  human  CaBP8.    
  
The  sequencing  projects  for  both  the  lamprey  and  elephant  shark  are  still  ongoing.  
The  elephant  shark  genome   is  complete  to  only  1.4X  coverage,  which  may  explain  
the   fragmentary   nature   of   the   data   for   this   organism.   The   lamprey   genome,  
however,  has  been  completed  to  5.9X  coverage  and  therefore   it  can  be  predicted  
with   greater   confidence   that   there   are   indeed   only   two   ancestral   CaBPs   in   the  
earliest   vertebrate   organisms   representing   CaBP1   and   CaBP8.   CaBP7   arises   later  
during  the  evolution  of  cartilaginous  fish  along  with  at  least  one  other  protein  with  
homology   to  CaBPs  1-­‐5.  The  remaining  CaBPs  may  have  arisen   later  still,  after  the  
separation   of   cartilaginous   fish   and   bony   fish.   However,   it   is   not   possible   to  
definitively   prove   this   until   sequencing   of   the   elephant   shark   genome  or   another  
fish  of  this  class  is  completed  to  a  higher  degree  of  coverage.  
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Table  3.2a.  Percentage  coverage  and  percentage  identity  between  the  CaBP1  protein  sequences  
found  in  lamprey  and  elephant  shark  compared  to  human.  
  
Table  3.2b.  Percentage  coverage  and  percentage   identity  between  the  CaBP7  and  CaBP8  protein  
sequences  found  in  lamprey  and  elephant  shark  compared  to  human.  
  
Shaded  cells  indicate  the  highest  sequence  identity  for  that  particular  orthologue.  
The  teleost  fishes,  the  zebrafish  (D.  Rerio)  and  the  pufferfish  (Tetraodon  nigroviridis)  
were  used  as  representative  organisms  of  the  Ray-­‐finned  fish  node,  which  are  the  
closest   to   the   bony   fish   ancestor   (Figure   3.3).   The   full   complement   of   the   CaBP  
family  was  identified  in  these  genomes  suggesting  an  expansion  of  the  CaBP  family  
at  the  separation  of  cartilaginous  and  bony  fish.    
  
The   sarcopterygian   fish   node,   comprising   organisms   such   as   lungfish   (Protopterus  
aesthiopicus)   and   the   coelacanth   (Latimeria   chalumnae),   would   be   closest   to   the  
tetrapod  ancestor;  however,  neither  genome  has  yet  been  completed  (Figure  3.3).  
It  would  be  expected  that  these  organisms  should  also  contain  a  full  complement  of  
the  CaBP  proteins.  The  teleost   fish  are  therefore  the  closest  sequenced  organisms  
before   the   divergence   of   tetrapods.   The   rest   of   these   analyses   will   focus   on  
zebrafish   sequences  due   to   the   completeness  of   the   genome  and  because  all   the  




%  coverage   %  Identity  
Lamprey  CaBP1   80.20%   76  
Elephant  Shark  CaBP1   46.10%   90  
  
  
CaBP7   CaBP8  
  
%  coverage   %  Identity   %  coverage   %  Identity  
Lamprey  CaBP7/8   61.40%   56   60.3   65  
Elephant  Shark  CaBP7   83.30%   84   81.7   66  
Elephant  Shark  CaBP8   102%   63   100   87  
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Table  3.3.  Protein  sequence  fragments  identified  in  BLAST  searches  against  the  elephant  shark  genome  along  with  the  sequence  of  the  corresponding  exon  in  
human  and  the  percentage  identity  between  the  two  sequences.  
  
Contig Sequence Homology Exon Human Exon Sequence % Identity
AAVX01573327.1 FDRDRDGLISCRDLGNLMRTMGYMPTEMELIELSQQINMN CaBP5 3 ELREAFLEFDKDRDGFISCKDLGNLMRTMGYMPTEMELI ELGQQIRMN 87
AAVX01478821.1 VGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFKE CaBP1 4 LGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFRE 94
AAV01407556.1 VGGRVNFEDFVE*MAPKLLAETADMIGIK CaBP2 5 SGGKVDFEDFVELMGPKLLAETADMIGVRELRDAFRE 78
AAVX01108357.1 EIRKAFKVFDRDGNGFISKQELGMAMRSLGYMPNEVELEVIIQRLDMD CaBP7 2 EIREAFKVFDRDGNGFISKQELGTAMRSLGYMPN EVELEVIIQRLDMD 95
AAVX01059912.1 GDGQVDFEEFVSLLGPRLSSAAIPEKFHGTEFDNVFWK CaBP7 3 GDGQVDFEEFVTLLGPKLSTSGIPEKFHGTDFDTVFWK 81
AAVX01059912.1 CDMQRMTVEELKRLLYEAFCEHLSMKDIENIIMTEEEGHVDNPDECPVDIDSK CaBP7 4 CDMQKLTVDELKRLLYDT FCEHLSMKDIENIIMTEEESHLGTAEECPVDVET 71
AAVX01124961.1 STQQIKQTCLRKSLICAFAIAFIISVMLIAANQVLRSGMK CaBP7 5 CSNQQIRQTCVRKSLICAFAIAFIISVMLIAANQVL RSGMK 80
AAVX01563725.1 MPFHPVHGSLLYKGSFLSESLSDTSETEQLANISEEELD CaBP8 1 MPFHHVTAGLLYKGNYLNRSLSAGSDSEQLANISVEELD 66
AAVX01190659.1 EIREAFRVLDRDGNGFISKQELGMAMRSLGYMPSEVELAIIMQRLDMDG CaBP8 2 EIREAFRVLDRDGNGFISKQELGMAMRSLGY MPSEVELAIIMQRLDMDG 98
AAVX01097552.1 DGQVDFEEFMTILGPKLLTSEVREGFHGSAIDSIFW CaBP8 3 DGQVDFDEFMTILGPKLVSSEGRDGFLGNTIDSIFWQ 77
AAVX01062942.1 QFDMQRITLEELKHILFHAFRDHLTMKDIENIIINEEESLNENSNSCQTEFEG CaBP8 4 FDMQRITLEELKHIL YHAFRDHLTMKDIENIIINEEESLNETSGNCQTEFEG 90
AAVX01282372.1 VHSQKQNRQTCVRKSLICAFGVAFIISVMLIAANQILRNGME CaBP8 5 VHSQKQNRQTCVRKSLICAFAMAFIISVMLIAA NQILRSGME 92
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3.2.3.  Zebrafish  CaBP  proteins  
All   six   CaBP   genes   corresponding   to   those   found   in   humans   were   found   in   the  
teleost   fish,   zebrafish.   (Figure   3.5   and   Table   3.4   and   3.5).   A   whole   genome  
duplication   event   is   proposed   to   have   occurred   in   ray-­‐finned   fish   after   their  
divergence  from  tetrapods  and  before   the  diversification  of  teleost   fish   (Brunet  et  
al.,  2006).   In  accordance  with  this  two  separate  genes  were  found  in  zebrafish  for  
all  of  the  CaBPs  except  CaBP4.  The  zebrafish  sequences  with  the  highest  similarity  
to   their   human   counterparts   were   selected   to   simplify   further   comparison.   Table  
3.4   shows   the   percentage   identity   between   zebrafish   and   human   orthologues.  
Values   in  bold  and  underlined   indicate   the  percentage   identity  between   identified  
orthologues.   No   distinct   splice   isoforms   for   any   of   the   CaBPs   were   identified   in  
zebrafish  and  table  3.4  shows  that  zebrafish  CaBP1  and  CaBP2  are  most  like  human  
CaBP1S  and  CaBP2L,  respectively.  Most  family  members  display  over  60.0%  identity  
with   their   human  orthologue  with   the   exception   of   CaBP4,  which  displays   44.7%.  
These   values   illustrate   the   strong   evolutionary   conservation   of   the   CaBP   protein  
sequences,  particularly  in  the  case  of  CaBP8,  which  shows  93.1%  sequence  identity  
with  its  human  counterpart  (Table  3.4  and  Figure  3.5).  
  
Figure  3.5.  Alignment  of   the  sequences  of   zebrafish   (Danio   rerio)   calmodulin  and  CaBP  proteins.  
Protein   sequences  were   compiled  and  aligned  using   ClustalW.  Residues   that   are   identical   in  more  
than   one   protein   are   highlighted   in   blue   and   residues   with   similar   properties   are   highlighted   in  
yellow.   The   lines   above   the   sequences   indicate   the   position   of   the   predicted   12   amino   acid  
coordinating   loop   within   the   EF-­‐hands.   In   EF-­‐hand   motifs   where   insertions   or   deletions   have  
rendered   the   co-­‐ordinating   loopinactive   in   Ca2+   binding,   the   black   bars   appears   longer   or   shorter  
than  the  canonical  12  amino  acid  loop.  
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Table  3.4.  Comparison  of  the  percentage  sequence  identity  of  zebrafish  (Z)  CaBPs  in  relation  to  the  
human  protein  sequences.    
Values  in  bold  and  underlined  indicate  the  percentage  identity  between  identified  orthologues.  
Table  3.5.  Percentage  sequence  identity  between  the  various  zebrafish  (Z)  CaBP  and  CaM  proteins  
shown  in  Figure  3.4.  
  
As  observed   in  the  human  proteins,  certain  EF-­‐hand  motifs  within  zebrafish  CaBPs  
are  predicted  to  be   inactive  and  this   followed  the  pattern  observed   in  the  human  
sequences   (Figure   3.6   and   Table   3.6).   In   addition   to  mutations   which   completely  
block   cation   chelation,   some   EF-­‐hands   possess   a   single   amino   acid   substitution  
which  alters  the  cation  specificity  of  the  motif.  This  is  determined  by  the  amino  acid  
at  the  12th  position  of  the  EF-­‐hand  loop.  For  instance,  the  primary  sequence  of  EF1  
in  CaM  is  DKDGDGTITTKE.  The  glutamate  (E)  at  position  12  predicts  the  motif  to  be  
a   high   affinity   Ca2+-­‐binding   site.   However   if   this   amino   acid   is   substituted   for  
aspartate  (D),  the  Ca2+  affinity  of  the  binding  site  is  diminished  (Hobson  et  al.,  2005)  
and   the  motif  will   instead   exhibit   a   preference   for   binding  Mg2+.   EF1   in   CaBP1   is  
predicted   to   co-­‐ordinate   Mg2+   in   preference   to   Ca2+   ???????? ??? ???? ????? ????
substitution.  It  has  been  confirmed  in  structural  analyses  that  this  EF-­‐hand  is  indeed  
     
Zebrafish  
  
     ZCaM   ZCaBP1          ZCaBP2          ZCaBP4          ZCaBP5          ZCaBP7   ZCaBP8  
  
CaM   100   35.5   29.6   24.0   38.7   20.1   21.1  
  
Caldendrin   16.7   37.0   36.2   28.0   30.4   13.3   13.5  
  
CaBP1S           36.6   86.8   54.3   40.7   66.6   24.3   24.2  
  
CaBP1L           27.1   63.8   44.2   32.9   50.0   19.5   19.8  
Human   CaBP2S           37.8   62.0   52.2   41.7   54.4   23.0   20.5  
  
CaBP2L           28.5   50.2   60.6   39.6   46.8   20.3   19.1  
  
CaBP4             22.9   35.4   38.1   44.7   34.5   16.7   17.3  
  
CaBP5             36.7   62.1   51.7   38.4   73.5   23.8   22.8  
  
CaBP7   20.1   22.1   18.1   17.8   22.0   77.2   60.2  
  
CaBP8     20.7   22.9   18.0   19.2   21.0   59.3   93.1  
  
     ZCaBP1           ZCaBP2           ZCaBP4            ZCaBP5           ZCaBP7   ZCaBP8  
ZCaM   35.5   29.6   24.0   38.7   19   21.0  
ZCaBP1          
  
56.5   42.9   66.2   22.7   23.7  
ZCaBP2          
     
42.2   48.9   18   19.1  
ZCaBP4            
        
38.8   16.2   10.2  
ZCaBP5          
           
22.3   22.0  
ZCaBP7  
              
59.3  
ZCaBP8  
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constitutively  Mg2+  bound  whereas  EF3  and  EF4,  which  have  glutamate  at  position  
12,  can  bind  both  Ca2+  and  Mg2+(Wingard  et  al.,  2005)(Li  et  al.,  2009).  Human  CaBP5  
also  has   an  aspartate   at   this  position   in   EF1,  which   is   therefore  predicted   to  bind  
Mg2+  in  preference  to  Ca2+.    
Figure   3.6.   Alignment   of   sequences   of   the   individual   zebrafish   CaBPs   and   their   corresponding  
human  orthologues.  Protein  sequences  were  compiled  and  aligned  using  ClustalW.  Residues  that  are  
identical   in  more  than  one  protein  are  highlighted   in  blue  and  residues  with   similar  properties  are  
highlighted  in  yellow.  Pink  boxes   indicate  the  position  of  the  predicted  12  amino  acid  coordinating  
loop   within   the   EF-­‐hands.In   EF-­‐hand  motifs   where   insertions   or   deletions   have   rendered   the   co-­‐
ordinating  loopinactive  in  Ca2+  binding,  the  pink  boxes  appears  longer  or  shorter  than  the  canonical  
12  amino  acid  loop.  
  
The   conservation   of   cation   binding   properties   for   each   of   the   EF-­‐hand   motifs   in  
zebrafish  and  human  CaBPs  was  examined  (Table  3.6).  The  same  pattern  of  EF-­‐hand  
inactivation  was  observed  for  both  species  with  an  inactive  EF2  motif  in  CaBPs  1-­‐5  
and   inactive   EF3   and   EF4   motifs   in   CaBP7   and   CaBP8.   Varying   degrees   of  
conservation   were   seen   across   the   EF-­‐hand   motif   sequences   as   a   whole   and  
differences   could  be  observed   in   the  amino  acid  present  at  position  12  of   the  EF-­‐
hand  loop  between  human  and  zebrafish  proteins.  In  general  the  most  conserved       
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Table  3.6.  Comparison  of  the  EF  hands  in  zebrafish  and  human  CaBPs.  
     EF1   EF2   EF3   EF4  
  
Zebrafish   Human   Conserved   Zebrafish   Human   Conserved   Zebrafish   Human   Conserved   Zebrafish   Human   Conserved  
CaBP1   D   D   75%   D   D   92%  (N)   E   E   83%   E   E   92%  
CaBP2   D   E   50%   D   D   78%  (N)   E   E   67%   E   E   100%  
CaBP4   D   E   42%   D   E   58%  (N)   E   E   67%   E   E   92%  
CaBP5   D   D   58%   D   D   83%  (N)   E   E   58%   E   E   92%  
CaBP7   E   E   100%   E   E   100%   E   E   100%  (N)   I   D   58%  (N)  
CaBP8   E   E   100%   E   E   100%   E   E   100%  (N)   E   E   92%  (N)  
                                        
  
The  table  indicates  whether  the  amino  acid  at  position  12  of  the  EF-­‐hand  Ca2+-­‐coordinating  loop  is  aspartate  (D)  or  glutamate  (E)  and  the  percentage  sequence  
identity  between  zebrafish  and  human  EF-­‐hand  loop  sequences.  In  the  conserved  column  it  is  indicated  if  the  EF  hand  is  predicted  to  be  non-­‐functional  (N).    
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EF-­‐hand  was  EF4.  CaBP7  and  CaBP8  both  have  100%  sequence  conservation  within  
their   first   3   EF-­‐hands   even   though   EF3   is   predicted   to   be   non-­‐functional   in   Ca2+-­‐
binding.   EF4   in   CaBP7   and   CaBP8   is   the   least   conserved   but   retains   92.0%  
conservation  in  CaBP8.  This  high  degree  of  conservation  in  non-­‐functional  EF-­‐hands  
suggests  they  must  play  an  alternative  functional  role  and  may  be  important  for  the  
maintenance  of  correct  protein  structure.  
  
Excluding  those  EF-­‐hand  motifs  with  inactivating  mutations,  the  specificity  for  Ca2+  
was   conserved   with   the   exception   of   EF1.   The   Ca2+/Mg2+   binding   properties   of  
CaBP1   and   CaBP5   remained   the   same   between   humans   and   zebrafish.   The   same  
properties  are  also  observed  in  the  lamprey  and  elephant  shark  CaBP1  sequences.  
Zebrafish   CaBP2   and   CaBP4   both   have   an   aspartate   at   position   12   of   EF1   in  
comparison   to   the   corresponding   residue   in   humans   which   is   a   glutamate.   This  
suggests  there  has  been  an  increase  in  the  number  of  specific  Ca2+-­‐binding  EF-­‐hand  
motifs  from  zebrafish  to  human.  
  
3.2.4.  CaBP7  and  8  form  a  distinct  family  of  calcium  sensing  proteins  to  CaBPs  1-­‐5  
In  order,   the  most  conserved  proteins  of  the  CaBP   family  are:  CaBP8,  CaBP1S  and  
CaBP7   (Tables  3.2a,  3.2b  and  3.4).   Interestingly   these   three  proteins,   in  particular  
CaBP1S  and  CaBP8,  were  also  the  primordial  CaBP  family  members.    
  
A  phylogenetic  tree  was  constructed  based  on  the  protein  sequences  of  human  and  
zebrafish  CaBPs  using  CaM  as  the  root  (Figure  3.7).  For  the  purposes  of  this  analysis  
the  highly  variable  N-­‐termini,  which  in  some  cases  varies  between  splice  isoforms,  
was  excluded  as  they  are  less  well  conserved  suggesting  this  region  has  experienced  
????? ??????????? ????????????? ?????????? ????? ???? ????? ????-­‐?????? ??????? ????
therefore   used   for   comparison.   The   38   amino  acid   extensions   at   the   C-­‐termini   of  
CaBP7  and  CaBP8  were  also  retained  for  this  analysis  as  this  region  exhibits  a  high  
degree   of   similarity   between   the   two   proteins   despite   being   absent   from   other  
CaBPs.   The   resulting   phylogenetic   tree   implies   that   CaBP7   and   CaBP8   form   a  
completely   different   group   of   calcium   sensors   to   CaBPs   1-­‐5.   This   hypothesis   is  
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consistent  with   the   idea   that   the   two  primordial   CaBPs,   CaBP1   and   CaBP8,   arose  
independently   of   each   other   and   with   the   appearance   of   vertebrates.   Gene  
duplications  have  driven  subsequent  expansion  of  the  two  separate  families  of  Ca2+-­‐
sensors.   Within   the   class   of   proteins   encompassing   CaBPs1-­‐5,   CaBP2   and   CaBP4  
form  a  distinct   subgroup   from  CaBP1  and  CaBP5.   Importantly   all  members  of   this  
group  show  some  relatedness  to  CaBP1  as  would  be  expected.  
  
  
Figure  3.7.  Phylogenetic   tree  depicting   relatedness  of   the  human  and  zebrafish  CaBP  proteins.  A  
consensus  maximum  likelihood  tree  based  on  the  alignment  of  the  CaBPs  was  generated  and  rooted  
to  human  calmodulin  (hCaM).  The  percentage  of  2000  bootstrap  replicates  supporting  the  topology  
is  given  at  each  node.  The  purple  box  indicates  the  subfamily  encompassing  CaBP7  and  CaBP8.  The  
Green  box  indicates  the  subfamily  encompassing  CaBPs1-­‐5.  
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3.2.5.  CaBP  proteins  of  other  species  and  evolutionary  changes  
  
Table  3.7.    The  CaBP  protein  compliment  found  in  each  major  vertebrate  taxonomic  group.  
a  and  b  represent  teleost  CaBP  duplicates  
*  This  was  the  highest  homology  observed  based  on  the  very  fragmentary  data  available  
**  Data  derived  from  primary  literature  searches  rather  than  genome  blast  
  
The  most   obvious   differences   between   the   zebrafish   and   human   CaBP   family   are  
the   lack  of   long  CaBP1  and   short  CaBP2   splice  variants   in   zebrafish,   and   variation  
within  the  N-­‐termini  of  CaBP2  and  CaBP4.  The  sequences  of  the  CaBPs  from  various  
tetrapod  species  representing  amphibians,  reptiles,  birds,  marsupials  and  placental  
mammals  were  compared  and  a  number  of  evolutionary  changes  can  be  observed.  
Table  3.7  shows  the  compliment  of  CaBP  proteins  found  in  representative  animals  
from  each  of   these  vertebrate  classes.  The   lamprey,  elephant   shark  and  zebrafish  
are  also  included  for  comparison.  All  mammals  appear  to  have  the  full  compliment  
of   CaBP   proteins,   however   there   appear   to   be   variations   in   the   numbers   seen   in  
amphibians,  reptiles,  and  birds.  The  green  anole  lizard  is  missing  only  CaBP7  but  as  
the   genome   is   not   yet   complete,   the   sequence   for   this   protein   may   yet   be  
discovered.  The  amphibian,  Xenopus   laevis,  appears   to   lack  CaBP2  and  CaBP5  and  
the  avian,  Gallus  gallus,  was  missing  sequences  with  homology  to  CaBP4  and  CaBP5.  
Scientific  Name   Common  Name   Vertebrate  Class   CaBP  
Lamprey   Lamprey   Jawless  fish   1,  7  
Callorhinchus  milii   Elephant  Shark   Cartilaginous  fish   1*,  2*,  7,  8  
Danio  Rerio   Zebrafish   Bony  fish   1a,  1b,  2a,  2b,  4,  5a,  
5b  7a,  7b,  8a,  8b  
Xenopus  laevis   Frog   Amphibian   1,  4,  7,  8  
Anolis  carolinensis   Green  Anole   Reptile   1,  2,  4,  5,  8  
Gallus  gallus   Chicken   Bird   1,  2,  4**,  7,  8  
Monodelphis  domestica   Opossum   Marsupial   1,  2,  4,  5,  7,  8  
Mus  musculus   Mouse   Mammal   1,  2,  4,  5,  7,  8  
Pan  troglodytes   Chimpanzee   Mammal   1,  2,  4,  5,  7,  8  
Homo  sapiens   Human   Mammal   1,  2,  4,  5,  7,  8  
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It   is   possible   that   these   genes   have   been   lost   during   the   course   of   evolution,  
however  these  findings  should  be  treated  tentatively.  Despite  the  apparent  absence  
of   a   CaBP4   sequence   in   the   completed   Gallus   gallus   genome,   Lee   et   al.   have  
reported  the  presence  of  CaBP4  mRNA  and  antibody  staining  of  expressed  CaBP4  
protein  in  chicken  cochlear  hair  cells  (Lee  et  al.,  2007c).    
  
The  extended  N-­‐terminal   domain  of   caldendrin,  which   is   derived   from  alternative  
splicing   of   the   CaBP1   gene,   is   encoded   in   mammals   but   not   found   in   any   other  
genomes.  The  N-­‐termini  of  the  CaBP  proteins  is  the  most  variable  region  between  
CaBP   family   members   and   the   N-­‐terminal   domains   which   define   each   of   CaBP1,  
CaBP2,   and   CaBP4   have   been   compared   across   species   to   examine   the   different  
patterns   of   evolutionary   change   (Figure   3.8).   The   C-­‐terminal   38   amino   acid  
extension,  which  is  specific  to  CaBP7  (CaBP7  178-­‐215)  and  CaBP8  (CaBP8  181-­‐219),  
has  also  been  included  in  this  analysis.  The  domain  that  defines  CaBP1L  (CaBP1L  16-­‐
75)   was   not   present   in   zebrafish   but   was   found   in   all   tetrapods.   The   sequence  
conservation   in   this   region   compared   with   human   caldendrin   was   relatively   high  
across  all   species   ranging   from  68.0%   in  amphibians   to  98.0%   in   chimpanzee.  The  
variable   N-­‐terminal   domain   of   CaBP2L   (CaBP2L   1-­‐56)   was   detected   at   very   low  
sequence   conservation   in   zebrafish   but   was   not   found   in   available   avian   or  
amphibian  genomic  databases.  Interestingly,  this  region  was  100%  conserved  in  the  
reptile,   the  green  anole,  but  showed  varying  degrees  of  conservation   in  mammals  
ranging  from  around  60.0%  in  the  opossum  and  mouse  to  96.0%  in  the  chimpanzee.  
The   variable   N-­‐terminal   region   of   CaBP4   (CaBP4   1-­‐120)   was   found   in   all   species  
from   zebrafish   onwards   apart   from   chicken   with   a   progressive   convergence   in  
sequence   identity   with   the   human   protein,   ranging   from   22.5%   in   zebrafish   to  
99.0%   in   chimpanzee.   It   is   possible   that   chicken   do   in   fact   express   both   the   long  
form   of   CaBP2   and   CaBP4,   however,   sequence   information   for   this   organism  
appears  incomplete  and  is  contradicted  by  published  results  (Lee  et  al.,  2007c).  The  
C-­‐terminal  domains  of  CaBP7  and  CaBP8  can  be  seen  across  all  organisms  examined  
and   exhibit   a   high   degree   of   sequence   conservation   throughout   evolutionary  
history.   This   is   demonstrated   by   the   89%   identity   seen   between   the   CaBP8   C-­‐
terminus  in  human  and  lamprey,  one  of  the  most  closely  related  living  organisms  to  
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our   vertebrate   ancestor.   The   high   sequence   identity   of   these   defining   regions   of  
CaBP1L,   CaBP7   and   CaBP8   across   numerous   species   implies   that   these   proteins  
must  have  an  important  vertebrate  specific  function.    
  
  
Figure   3.8.   Relative   sequence   identity   of   domains   specific   to   particular   CaBPs   between   selected  
vertebrates  and  the  corresponding  human  sequence.  The  percentage  identity  compared  to  human  
is   plotted   for   the   indicated   domains   in   the   indicated   species.   Where   no   symbol   is   present   no  
orthologous  protein  or  domain  could  be  found  from  BLAST  searches.  
  
3.2.6.  Evolutionary  expression  of  target  proteins  for  the  CaBP  family  
A  number  of  target  proteins  are  now  known  for  the  CaBP  family  of  proteins.  It  is  of  
interest  to  examine  whether  any  of  these  targets  co-­‐evolved  with  the  CaBPs  during  
the  evolution  of  vertebrates.  Several  CaBPs  have  been  suggested  to  regulate  various  
VGCCs  (Zhou  et  al.,  2005,  Cui  et  al.,  2007,  Yang  et  al.,  2006a,  Shih  et  al.,  2009,  Lee  et  
al.,  2002,  Zhou  et  al.,  2004,  Haeseleer  et  al.,  2004,  Tippens  and  Lee,  2007,  Lee  et  al.,  
2007a).  VGCCs  related  to  the  major  VGCC  types  found  in  vertebrates  are  also  found  
in   invertebrates.   For   instance,   D.   melanogaster   and   C.   elegans   possess   genes  
encoding  VGCCs  that  are  orthologues  of  the  mammalian  VGCC  ??subunits  which  are  
regulated   by   the   CaBPs.   Invertebrate   species   possess   only   three   VGCC   genes,  
however,  each  representing  one  of  the  three  families  of  VGCC  found  in  mammals:  L-­‐
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duplication  events  have  subsequently  resulted  in  the  expansion  of  the  three  VGCC  
families.  In  mammals  four  L-­‐type,  three  non-­‐L-­‐type  and  three  T-­‐type  channel  genes  
can  be  found  (Jeziorski  et  al.,  2000).  The  earliest  evidence  for  the  expansion  of  the  
VGCCs  was  reported  in  the  cartilaginous  fish  Discopyge  ommata  which  expresses  at  
least   two   L-­‐type   channel   subtypes   (Horne   et   al.,   1993).   This   expansion   in   the  
number  of  VGCCs   in  vertebrates  may  explain   the  evolutionary  pressures   selecting  
for  a  more  diverse  family  of  Ca2+-­‐sensing  proteins  to  regulate  them.  The  VGCCs  are  
critical  for  the  functioning  of  the  mammalian  central  nervous  system.  Therefore  the  
expansion   of   this   family   of   channels   and   the   proteins   which   modulate   them   has  
likely  influenced  the  evolution  of  complex  vertebrate  nervous  systems.  
  
The  IP3R,  another  known  target  for  CaBP1   (Haynes  et  al.,  2004,  Yang  et  al.,  2002a,  
Kasri  et  al.,  2004),  is  also  found  in  invertebrate  species  (Zhang  et  al.,  2007,  Iwasaki  
et  al.,  2002)  but  only  one  isoform  is  expressed.  Three  IP3R  isoforms  can  be  detected  
in   both   Xenopus   and  D.   rerio   whereas   primitive   deuterostomes   possess   only   one  
(Zhang  et  al.,  2007,  Iwasaki  et  al.,  2002,  Ashworth  et  al.,  2007).  Therefore  there  has  
been   an   expansion   in   the   number   of   IP3R   isoforms   between   the   evolution   of  
vertebrates  and  the  diversification  of  teleost  fish.  This  expansion  in  the  number  of  
IP3R   isoforms   is   consistent   with   a   requirement   to   co-­‐evolve   specific   regulatory  
proteins   that   compliment   newly   emergent   functions.   In   accordance   with   this  
theory,   both   CaBP2   and   CaBP5   were   also   shown   to   regulate   IP3Rs   in   Xenopus  
oocytes   but   differences   in   their   regulatory   properties   have   not   yet   been   studied  
(Yang  et  al.,  2002b).  
  
Caldendrin  has  been  reported  to  interact  with  jacob  protein  (Dieterich  et  al.,  2008)  
which,  interestingly,  is  also  a  vertebrate  specific  protein.  Although  only  the  shorter  
splice   variant   of   CaBP1,   CaBP1S,   is   present   in   early   vertebrates,   jacob   has   been  
demonstrated  to  bind  to  the  basic  EF-­‐hand  core  in  the  absence  of  the  extended  N-­‐
terminus   of   caldendrin.   It   is   therefore   possible   that   in   lower   vertebrates   jacob   is  
regulated  by  CaBP1S.  
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The   only   known   interacting   partner   for   CaBP7   and   CaBP8,   apart   from   a   possible  
regulatory   role   for   N-­‐type   VGCCs,   is   PI4KIII?(Mikhaylova   et   al.,   2009,   Shih   et   al.,  
2009).   This   protein   is   not,   however,   a   vertebrate   specific   protein   and   a   single  
PI4KIII?  can  be  detected  in  all  the  major  eukaryotic  taxa  from  protists  to  mammals  
(Brown   and   Auger,   2011).   PI4KIII?   is   regulated   by   other,   non-­‐vertebrate,   specific  
proteins,   in   particular,   NCS-­‐1   (de   Barry   et   al.,   2006)   and   therefore   regulation   by  
CaBP7  and  CaBP8  may  represent  an  adaptation  of  function  of  these  calcium  sensors  
in  order  to   impart  an  additional  new  and  vertebrate  specific   regulation  of  PI4KIII?  
and  intracellular  vesicular  trafficking  from  the  TGN.  
  
3.3.  Discussion     
This   phylogenomic   study   of   the   CaBP   family   of   calcium   sensors   has   highlighted   a  
number   of   key   findings   about   the   evolution   and   classification   of   these   proteins.  
Firstly,  the  CaBPs  first  arose  with  the  appearance  of  vertebrates,  around  550  million  
years   ago   (Shu   et   al.,   1999).   No   orthologues   of   the   CaBPs   could   be   found   in  
invertebrates   apart   from   CaM-­‐like   proteins   but   partial   sequences   of   two   CaBP  
proteins   with   significant   homology   to   CaBP1S   and   CaBP8   were   found   in   the  
lamprey,  P.  marinus,  the  most  closely  related  living  organism  to  our  early  vertebrate  
ancestor.   Secondly,   based   on   the   relative   sequence   identity   and   conservation,  
pattern  of  EF-­‐hand  inactivation,  and  phylogenetic  analysis,  CaBP7  and  CaBP8  appear  
to   form   a   completely   distinct   family   of   proteins   to   CaBPs   1-­‐5.   This   suggests   the  
existence  of  two  primordial  CaBP  genes  arising  independently  of  each  other  at  the  
vertebrate   node;   one   of   which   gave   rise   to   CaBPs1-­‐5   and   another   to   CaBP7   and  
CaBP8.  
  
A   number   of   whole   genome   duplication   (WGD)   events   are   proposed   to   have  
occurred   in   the   vertebrate   lineage   which   led   to   the   expansion   of   gene   families  
(Brunet  et   al.,   2006,  On  et   al.,   2008,   Jaillon  et  al.,   2004).   The   first   of   these  WGD  
events  occurred  early  in  vertebrate  evolution  around  the  time  of  the  divergence  of  
lamprey   and   hagfish   lineages.   The   two   CaBP   genes   found   in   lamprey   may   have  
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arisen   during   this  WGD   through   the   duplication   of   CaM   and   CaM-­‐like   genes   and  
subsequent  domain  shuffling  to  generate  divergent  novel  proteins.  
  
The   second  WGD   event   occurred   prior   to   the   divergence   of   cartilaginous   fish.   In  
accordance  with  this  at   least  four  CaBP  genes  can  be  detected  in  the  cartilaginous  
fish,   the   elephant   shark;   two   corresponding   to   CaBP7   and   CaBP8   and   two  
corresponding  to  CaBPs1-­‐5.  A  third  WGD  event  occurred  specific   to  the  bony   fish,  
before  the  emergence  of  teleost  fish  and  as  such,  duplicate  genes  are  found  for  all  
six  of  the  CaBP  genes  in  zebrafish.  
  
Therefore  the  appearance  of  the  two  genes  encoding  CaBP7  and  CaBP8  in  mammals  
can  be  easily  explained  through  the  duplication  of  the  primordial  CaBP8  gene  found  
in  lamprey.  However,  four  genes  encoding  CaBPs1-­‐5  are  found  in  humans  and  many  
tetrapods,   whereas   only   two   genes   were   definitively   identified   in   the   elephant  
shark.  As  the  full  complement  of  CaBP  proteins  is  found  in  zebrafish,  this  suggests  a  
transient  expansion  of  this  family  from  two  genes  in  cartilaginous  fish  to  four  genes  
in   the  bony   fish  ancestor.  Unfortunately   the   actual   complement  of  CaBP  proteins  
found   in   our   tetrapod   ancestor   cannot   currently   be   examined   as   no   genomes   of  
sarcopterygian  fish  have  been  fully  sequenced  to  date  and  thus  the  teleost  fish  are  
the   closest   representatives.   It   is   also   possible   that   there   are   more   as   yet  
undiscovered   CaBP   genes   in   both   lamprey   and   elephant   shark   which   were   not  
detected   due   to   the   incomplete   nature   of   the   available   genomic   data.   A   clearer  
picture  will   become  available  upon   the   completion  of   these   genome  projects   and  
through   the   sequencing   of   the   sarcopterygian   fish,   the   coelacanth,   which   is  




All  CaBPs  display  limited  homology  to  CaM  and  thus  it  is  assumed  that  this  family  of  
proteins  arose  through  gene  duplication  and  further  diversification  of  CaM  or  CaM-­‐
like  genes.  CaM  is  present  in  all  eukaryotic  organisms  and  exhibits  a  high  degree  of  
sequence   conservation   throughout   evolutionary   history.   Vertebrates   such   as  
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humans,  rat,  and  Xenopus,  have  evolved  multiple  CaM  genes  but  interestingly,  all  of  
these  genes  give  rise  to  an   identical  protein  product   (Karabinos  and  Bhattacharya,  
2000).  Invertebrates  however,  possess  either  a  single  CaM  gene  or  two  CaM  genes  
that  encode  different  isoforms.  Two  CaM  genes  are  found  in  amphioxus  as  well  as  
two   genes   encoding   CaM-­‐like   proteins   (Karabinos   and   Bhattacharya,   2000).   If  
amphioxus  is  used  as  an  example  of  the  chordate  ancestor,  it  could  be  assumed  that  
a  WGD   event   occurring   before   the   diversification   of   the   jawless   fish  would   have  
given  rise  to  an  excess  of  CaM  isoforms.  It  is  possible  that  various  CaM-­‐related  Ca2+-­‐
binding  protein  families  may  have  arisen  as  a  result  of  such  an  event.  
  
It   is   thought   that   the   high   conservation   of   the   CaM   protein   sequence   across  
multiple   genes   in   the   same  organism  has   occurred  because   of   the  diversity   of   its  
target   proteins   (Moncrief   et   al.,   1990).   Other   Ca2+-­‐sensors,   which   show   more  
variation   in   protein   sequence   throughout   their   evolution,   have   developed   more  
specialized   functions.   Certain   families   of   Ca2+-­‐sensors,   such   as   the   NCS   proteins  
(Burgoyne,  2007)   in  animals  and  the  CBL  proteins   (Batistic  and  Kudla,  2009,  Weinl  
and   Kudla,   2009)   in   plants,   show   a   progressive   increase   in   complexity   through  
evolution,   with   an   increase   in   the   number   of   distinct   genes.   There   is   a   general  
increase  in  the  number  of  NCS  genes  with  increasing  complexity  from  one  in  fungi  
to  fourteen  in  mammals  (Burgoyne  and  Weiss,  2001).  These  proteins  are  expressed  
predominantly   in   retinal   photoreceptors   or   in   neurons.   The   expansion   of   CaM-­‐
related   Ca2+-­‐sensing   protein   families   has   likely   allowed   the   evolution   of   specific  
proteins   to   carry   out   functions   unique   to   a   particular   cell   or   tissue   type.   This  
diversification   allows   the   fine-­‐tuning   of   processes   usually   regulated   by   CaM   and  
may   have   contributed   significantly   to   the   neuronal   complexity   observed   in  
mammals.   As   such,   the   CaBP   proteins   have   been   found   to   share   a   number   of  
interacting  binding  partners  with  CaM,   (Zhou  et  al.,  2005,  Cui  et  al.,  2007,  Yang  et  
al.,   2006a,   Shih   et   al.,   2009,   Lee   et   al.,   2002,   Zhou  et   al.,   2004,   Haeseleer   et   al.,  
2004,   Tippens   and   Lee,   2007,   Lee   et   al.,   2007a,   Haynes   et   al.,   2004,   Yang   et   al.,  
2002a,  Kasri  et  al.,  2004)  in  addition  to  a  number  of  unique  interactions  (Dieterich  
et  al.,  2008,  Nakajima,  2011,  Seidenbecher  et  al.,  2004).  The  CaBPs  sometimes  have  
different  modulatory  effects  to  those  seen  with  CaM,  however,  illustrating  that  they  
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are  not  simply  redundant  regulators  of  CaM  targets  (Few  et  al.,  2005).  Interestingly,  
investigations   into   the  functions  of   the  genes  which  are   retained  after  duplication  
events   have   observed   an   enrichment   in   development,   signalling,   behaviour   and  
regulation  related  genes  (Brunet  et  al.,  2006).  
  
Like  the  NCS  proteins,  the  CaBP  proteins  are  predominantly  expressed  in  the  retina  
and   brain   (Haeseleer   et   al.,   2000,   Mikhaylova   et   al.,   2006).      CaBP4   and   CaBP5  
regulate   different   VGCCs   in   retinal   photoreceptors   and   have   been   shown   to   play  
non-­‐redundant   roles   in   phototransduction   in   mammals   based   on   studies   in  
knockout  mice   (Haeseleer  et   al.,   2004,   Rieke  et   al.,   2008).  Mutations   in   CaBP4   in  
humans   have   also   been   shown   to   cause   congenital   visual   disorders   (Littink  et   al.,  
2009,   Zeitz   et   al.,   2006,   Aldahmesh   et   al.,   2010).   CaBP4   was   found   in   bony   fish,  
amphibians,  reptiles,  birds  and  mammals  but  CaBP5  was  missing  from  the  G.  gallus  
and  X.  laevis  genomes.  CaBP4  was  the  least  well  conserved  of  all  the  CaBP  proteins,  
with   significant   differences   in   its   N-­‐terminus   between   zebrafish   and   human  
suggesting   there   may   be   some   species   specific   differences   in   the   regulation   of  
photoreceptor   function.   This   may   also   explain   the   absence   of   CaBP5   from  
amphibians  and  birds.  
  
The   pattern   of   active   and   inactive   EF   hands   in   all   CaBPs   remained   the   same   in  
zebrafish  compared  to  human  CaBPs.  There  were,  however,  some  differences  in  the  
cation  binding  specificity  of  EF1  in  CaBP2  and  CaBP4.  In  zebrafish  these  proteins  had  
D   at   position   12   in   the   EF-­‐hand   loop   whereas   in   humans   this   residue   is   E.      The  
zebrafish  CaBP2  and  CaBP4  are  therefore  predicted  to  bind  Mg2+  at  EF1  whereas  in  
humans  this  EF-­‐hand  motif   is   specific   for  Ca2+-­‐binding.  CaBP1  and  CaBP5  are  both  
predicted   to  bind  Mg2+  at   EF1   in  both   zebrafish   and  human  proteins   and   this  has  
been   confirmed   by   structural   analyses   in   CaBP1   (Wingard   et   al.,   2005,   Li   et   al.,  
2009).  This  increase  in  the  number  of  Ca2+  specific  binding  sites  in  CaBP2  and  CaBP4  
from   zebrafish   to   humans   could   have   important   structural   and   functional  
consequences.  Structural  studies  of  CaBP1  have  shown  that  binding  of  Mg2+  to  EF1  
has  a  global  effect  on  the  conformation  of  the  protein  compared  to  the  cation-­‐free  
apo  form,  and  is  suggested  to  stabilize  the  protein  in  Ca2+  independent  interactions  
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(Wingard  et  al.,  2005).  More   limited  conformational  changes  were  observed  upon  
binding  of  Ca2+  to  the  remaining  EF-­‐hands.  CaBP2  and  CaBP4  would  potentially  lack  
an   intermediate   Mg2+-­‐stabilized   conformation   between   the   apo   and   Ca2+   bound  
forms  and  therefore  might  be  predicted  to  interact  differently  with  target  proteins.  
????? ?????????????? ??????????? ???????? ????? ???? ??????? ??? ???? ?? ?????????????? ???
position   12   of   the   EF1   loop   are   needed   to   better   understand   the   functional  
consequences  of  these  differing  cation  specificities.  
  
The   CaBPs   have   somewhat   overlapping   roles,   with   multiple   proteins   from   this  
family   capable   of   modulating   the   same   target   proteins.   They   also   share   some  
common   targets  with   CaM   such   as   the  VGCCs.   It   has   also   been   shown,   however,  
that  the  physiological  effects  of  the  CaBPs  on  the  VGCCs,  differ  from  those  of  CaM,  
and   knockout   studies  of  CaBP4  and  CaBP5   suggest  non-­‐redundant   roles   for   these  
proteins   (Catterall   and   Few,   2008,   Zhou   et   al.,   2005,   Cui  et   al.,   2007,   Yang  et   al.,  
2006a,  Shih  et  al.,  2009,  Lee  et  al.,  2002,  Zhou  et  al.,  2004,  Haeseleer  et  al.,  2004,  
Tippens  and  Lee,  2007,  Lee  et  al.,  2007a,  Maeda  et  al.,  2005,  Rieke  et  al.,  2008).  This  
is   in  agreement  with  the   idea  that  the  CaBPs  evolved  to  provide  a  further   level  of  
regulation   to   fine   tune   the   modulatory   activities   of   CaM.   The   evolution   of   CaBP  
target  proteins  was  examined   to  determine   if   there  was   any   correlation  between  
appearance  of   targets  and  the  appearance  of  the  CaBPs.   Jacob  protein   is   the  only  
interacting  partner  of  the  CaBPs  that  is  reported  to  also  be  vertebrate  specific.  The  
VGCCs  and  the   IP3Rs  arose  before  the  emergence  of  vertebrates;  however,  drastic  
changes  occurred  in  these  families  of  proteins  which  were  specific  to  the  vertebrate  
clade.  Once  again   as   a   result   of  WGDs,   there  was   an  expansion   in   the  number  of  
both  VGCCs  and   IP3Rs  which  originated   in  an  early  vertebrate  ancestor   (Iwasaki  et  
al.,  2002,  Zhang  et  al.,  2007,  Jeziorski  et  al.,  2000).    It  is  possible,  therefore,  that  this  
sudden  increase  in  complexity  in  these  families  provided  the  evolutionary  pressures  
necessary  to  select  for  new  families  of  calcium  sensing  proteins.  
  
The   existence   of   at   least   two   CaBPs   in   all   vertebrates   and   the   high   sequence  
conservation,   of   particularly   CaBP1S,   CaBP7   and   CaBP8,   suggests   that   they   have  
functionally   important  and  non-­‐redundant   roles.  The  only   characterized   target   for  
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CaBP7  and  CaBP8  is  PI4KIII?.  Both  proteins  bind  to  and  inhibit  this  enzyme  which  is  
required   to  generate  PI4P,  an  essential   lipid  for  vesicular   trafficking   from  the  TGN  
(Mikhaylova   et   al.,   2009).   PI4K   has   similar   roles   in   yeast   (Walch-­‐Solimena   and  
Novick,  1999)  and  flies  (Polevoy  et  al.,  2009)  and  therefore  this  inhibitory  control  is  
a  more  recent  mechanism  which  has  evolved   in  vertebrates  specifically.  Given  the  
presence   of   both   CaBP7   and   CaBP8   from   cartilaginous   fish   onwards   and   their  
extreme   sequence   conservation   from   elephant   shark   to   humans   (84%   and   87%,  
respectively),  it  is  highly  unlikely  that  these  two  proteins  perform  redundant  roles.  
It  will  be  important  to  identify  other,  non-­‐redundant  functions  for  these  proteins  in  
order  to  fully  appreciate  the  evolutionary  pressures  which  have   led  them  to  be  so  
strongly   conserved   in   vertebrates.   To  date   the  only   knockout   studies  of   the  CaBP  
genes  are  CaBP4  and  CaBP5  knockout  mice  (Maeda  et  al.,  2005,  Rieke  et  al.,  2008).  
Knockouts  of   the  other  four  CaBP  genes  would  prove  useful   to   test   the  functional  
redundancy  of  these  proteins.    
  
3.3.1.  Conclusions  
These   analyses   are   consistent   with   the   CaBPs   forming   two   separate   classes   of  
proteins  with  CaBPs  1-­‐5  in  one  group  and  CaBP7  and  CaBP8  in  the  other.  The  first  
appearance  of  both  these  classes  of  proteins  can  be  traced  back  to  the  emergence  
of   the   vertebrates.   CaBP1S   and   CaBP8   can   be   identified   in   the   lamprey   genome  
suggesting   these   were   the   primordial   ancestors   in   the   two   classes   of   CaBPs.   A  
subsequent   WGD   event   before   the   divergence   of   cartilaginous   fish   gave   rise   to  
CaBP7,   which,   along   with   CaBP8,   has   remained   remarkably   highly   conserved  
throughout  vertebrate  evolution.  At   least  one  other  CaBP  gene  with  homology   to  
CaBPs1-­‐5  was  also  discovered  in  the  genome  of  the  cartilaginous  fish,  the  elephant  
shark.  A  full  complement  of  the  CaBPs  can  be  found  in  teleost  fish  suggesting  that  
there   has   been   a   transient   increase   in   the   number   of   genes   corresponding   to  
CaBPs1-­‐5  between  the  emergence  of  cartilaginous  fish  and  the  divergence  of  bony  
fish.  The  appearance  and  subsequent  expansion  of  these  two  independently  arising  
families   of   calcium   sensing   proteins   also   correlates   with   an   observed   increase   in  
complexity   in   the   families   from   which   the   CaBP   target   proteins   originate.   The  
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increase   in   gene  number   and,   in  mammals,   splice   variants,   has   likely   allowed   the  
fine  tuning  of  processes  otherwise  regulated  by  CaM  in  invertebrates,  and  may  have  
contributed  significantly  to  the  increased  complexity  of  higher  organisms.    





Chapter  4:    
Subcellular  Localisation  and  Membrane  
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4.1.  Introduction  
The  calcium  ion  influences  a  diverse  array  of  processes  ranging  from  fertilisation  to  
cell  death,  gene  transcription  to  ion  channel  function,  and  phospholipid  metabolism  
to   protein   trafficking   (Berridge,   2009).   The   existence   of   a   multitude   of   different  
Ca2+-­‐????????????????? ??? ?????????? ??? ???? ??????   ability   to  exert   such  a  wide   range  of  
physiological   effects   in   response   to   a   simple   cation.   Each   Ca2+-­‐sensor   exhibits  
unique   Ca2+-­‐binding   properties   and   specific   tissue,   cellular   and   subcellular  
distributions,  which  give   rise   to   specific  and  non-­‐redundant  physiological   roles   for  
each   protein.   Ca2+   signals   vary   in   timing,  magnitude,   and   spatial   localisation,   and  
depending   on   the   precise   combination   of   these   parameters,   can   activate   distinct  
Ca2+-­‐sensors.  The  often  restricted  subcellular  localisation  of  Ca2+-­‐binding  proteins  is  
therefore  fundamental  to  their  ability  to  respond  to  specific  patterns  of  Ca2+  signal  
and  thereby  generate  selective  changes  in  cellular  activity.  
  
Members   of   the   CaM   superfamily   of   EF-­‐hand   containing   Ca2+-­‐binding   proteins  
display  broad  diversity   in   their   cation  binding  properties   and   subcellular   targeting  
mechanisms.  For  example,  members  of  the  NCS  protein  family  have  a  high  affinity  
for   Ca2+   when   compared   to   CaM   and   exhibit   specific   subcellular   localisation  
patterns.   Many   are   able   to   associate   with   membranes   via   post-­‐translational  
lipidation  (Haynes  and  Burgoyne,  2008).  Eleven  of  the  fourteen  NCS  proteins  are  N-­‐
terminally   myristoylated   and   palmitoylation   has   also   been   found   to   play   an  
important  role  in  membrane  targeting  of  the  KChIPs   (Burgoyne,  2004,  Takimoto  et  
al.,   2002).   Despite  many   of   the   NCS   proteins   sharing   the   same   post-­‐translational  
modification,   myristoylation   has   been   shown   to   affect   these   proteins   in   distinct  
ways.  In  the  case  of  NCS-­‐1  itself,  the  myristoyl  tail  is  permanently  extruded  from  the  
protein   core  directing  persistent  membrane  association  of   the  protein.  Other  NCS  
proteins,  in  contrast,  posse????????????????? ?????????????????(Decordier  et  al.,  2008).  
Hippocalcin,   neurocalcin-­‐?,   the   VILIPs   and   recoverin   all   sequester   their   myrsitoyl  
chain   within   a   hydrophobic   pocket   when   not   bound   to   Ca2+.   Upon   Ca2+-­‐binding,  
these  proteins  undergo  a  conformational  change  which  promotes  extrusion  of  the  
myrsitoyl  group  and  therefore  Ca2+-­‐dependent  membrane  association  (Haynes  and  
Burgoyne,   2008).   The   function   of   the   myristoyl   group   in   the   constitutively  
     102  
membrane  bound  GCAP  subfamily,  is  less  well  understood  but  recent  research  has  
suggested  that  GCAP2  possesses  a  reverse  myristoyl  switch  which  is  exposed  in  the  
absence  of  Ca2+  to  allow  membrane  association,  but  sequestered  inside  the  protein  
when   Ca2+-­‐bound(Schroder   et   al.,   2011,   Theisgen   et   al.,   2011).   No   switch  
mechanism  has  been  demonstrated  for  GCAP1  and  the  myristoyl  group  appears  to  
be   permanently   buried  within   a   hydrophobic   pocket  within   the   protein,   where   it  
plays  a  role  in  stabilizing  the  protein  rather  than  in  membrane  association  (Stephen  
et  al.,  2007).  The  NCS  proteins  therefore  illustrate  how  Ca2+-­‐sensors  have  diversified  
through  evolution  to  localise  to  different  subcellular  compartments  through  subtly  
different   mechanisms.   Importantly,   the   lipid   moieties   responsible   for   the  
membrane   association   of   these   proteins   has   also   been   found   to   be   required   for  
correct  protein  function  (O'Callaghan  et  al.,  2003,  Chandra  et  al.,  2011).  
  
The  CaBP   subfamily  of  CaM   related  proteins  have   recently  emerged  as   important  
regulators   of   ion   channels   and   intracellular   trafficking   enzymes   (Haeseleer   et   al.,  
2000,  Mikhaylova   et   al.,   2006,  McCue   et   al.,   2010b).   To   date   a   number   of   CaBP  
isoforms   have   been   shown   to   bind   to   specific   target   proteins   and   regulate   non-­‐
redundant  cellular  processes  (Dieterich  et  al.,  2008,  Haynes  et  al.,  2004,  Kasri  et  al.,  
2004,   Nakajima,   2011,   Haeseleer   et   al.,   2004,   Oz   et   al.,   2011,   Cui   et   al.,   2007,  
Mikhaylova  et  al.,  2009),  although  scant  functional  data  exists  for  both  CaBP2  and  
CaBP5.  CaBP1  has  three  splice  variants,  two  of  which,  CaBP1S  and  CaBP1L,  associate  
with  membranes   following  N-­‐myristoylation   on   a   glycine   residue   at   position   2   in  
each  protein.  This  myristoyl  group  has  been  shown  to  be  essential  for  some  of  the  
regulatory  roles  mediated  by  CaBP1   (Few  et  al.,  2005,  Kasri  et  al.,  2004).  The   less  
well   characterised,   CaBP2   also   carries   an   N-­‐terminal   myristoylation   consensus  
motif.  Other  members  of  the  CaBP  family,  CaBP4,  CaBP5,  and  the  third   isoform  of  
CaBP1,   caldendrin,   do   not   possess   any   obvious   consensus   motifs   for   post-­‐
translational   lipidation   and   consistent   with   this   the   proteins   are   predominantly  
cytosolic  (Dieterich  et  al.,  2008,  Haeseleer  et  al.,  2004,  Rieke  et  al.,  2008,  McCue  et  
al.,  2009).  Although  these  proteins  lack  the  means  to  directly  associate  with  specific  
subcellular   compartments,   they  will   likely  become   targeted  upon   interaction  with  
other  specifically  localised  proteins.  As  such  a  Ca2+  dependent  interaction  between  
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caldendrin   and  myristoylated   recoverin   has   been   reported   which   in   turn   permits  
Ca2+-­‐induced   translocation   of   caldendrin   to   subcellular   membranes   (Fries   et   al.,  
2010).    Although  it  has  been  difficult  to  visualize  in  vivo,  CaBP4  and  CaBP5  interact  
with   integral   membrane   VGCCs   and   therefore   are   also   able   to   localise   to  
membranes  through   interactions  with  their  specific  binding  partners   (Haeseleer  et  
al.,  2004,  Rieke  et  al.,  2008).  
  
Normal   targeting   of   Ca2+-­‐sensing   proteins   to   their   appropriate   subcellular  
compartments   has   been   shown   to   be   indispensible   for   biological   function.  
Understanding  the  precise  mechanisms  underlying  the  localisation  of  these  proteins  
is  therefore  important  for  understanding  how  different  Ca2+  signals  are  decoded  to  
generate  a  variety  of  physiological  outcomes.  Ca2+-­‐sensors  have  evolved  a  myriad  of  
subcellular   targeting   strategies   which   have   permitted   the   fine   tuning   of   specific  
cellular   pathways.   CaBP7   and   CaBP8   provide   an   additional   example   of   the  
evolutionary  diversification  of  targeting  mechanisms  amongst  Ca2+-­‐sensing  proteins.  
These   proteins   contain   no   consensus   motifs   for   post-­‐translational   acylation   yet  
initial   examination   of   the   localisation   of   the   overexpressed   proteins   in   N2A   cells  
revealed   a   distinct   membrane   localisation   for   both   proteins   (section   4.2.1   and  
(McCue  et  al.,  2009)).  The  aim  of  this  chapter  was  to  examine  the  exact  subcellular  
localisation  of  CaBP7  and  CaBP8,  and  the  mechanism  by  which  these  proteins  are  
able  to  associate  with  cellular  membranes.    
4.2.  Results  
4.2.1.  Localisation  of  human  CaBP  isoforms  in  N2A  cells  
All  members  of   the  CaBP   family  exhibit   the  greatest  expression   levels   in  neuronal  
tissues   (Haeseleer   et   al.,   2000,   Wu   et   al.,   2001,   Mikhaylova   et   al.,   2006)   and  
therefore  initial  characterisation  of  their  subcellular  localisation  was  carried  out  in  a  
neuronal   cell   line.   N2A   cells   are   a   model   neuroblastoma   cell   line   that   can   be  
differentiated   to   a   neuronal   like   morphology   upon   retinoic   acid   treatment  
(Pankratova  et  al.,  1994).  N2A  cells  were  transfected  with  colour  tagged  constructs  
encoding   each   of   the   CaBPs,   and   images   taken   24   hours   after   retinoic   acid  
treatment  (Figure  4.1).  The  N-­‐myristoyl  groups  of  CaBP1L,  CaBP1S,  and  CaBP2  allow  
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these   proteins   to   target   to   membranes.   As   such,   CaBP1L,   CaBP1S   and   CaBP2  
localised  to  both  the  PM  and  to  a  perinuclear  region  resembling  the  Golgi  apparatus  
(Figure   4.1B-­‐D).   CaBP1L   also   exhibited   stronger   cytoplasmic   localisation   than  
CaBP1S   illustrating   that   there   are   differences   in   the   targeting   of   the   two   splice  
isoforms   of   CaBP1   even   though   both   associate   with   membranes   via   N-­‐
myristoylation  at  an  identical  consensus  sequence.  
  
None   of   the   remaining   CaBPs   possess   consensus   sequences   for   post-­‐translational  
lipidation   and   caldendrin,   CaBP4   and   CaBP5   exhibited   a   predominantly   cytosolic  
localisation,   as   expected   (Figure   4.1A,   E   and   F).   Caldendrin   also   appeared   to  
concentrate  in  specific  areas  of  the  nucleus  resembling  nucleoli  (Dundr  and  Misteli,  
2001).   CaBP7   and   CaBP8,   despite   lacking   consensus   motifs   for   acylation,   both  
localised   to   membranes   in   N2A   cells   (Figure   4.1G-­‐H).   Both   proteins   localised  
predominantly   to   a   perinuclear   compartment   resembling   the   Golgi   apparatus,  
intracellular   vesicles   and,   in   some   cells,   the   PM.   This   unexpected   membrane  
association  prompted   further   investigation   into   the  precise  subcellular   localisation  
of  CaBP7  and  CaBP8  and  the  mechanism  by  which  they  are  targeted.  
  
  
Figure  4.1.   Intracellular  distribution  of   fluorescently   tagged  human  CaBP   isoforms.   The   indicated  
constructs  were  used   to  determine   the   localisation  of   caldendrin,  CaBP1S,  CaBP1L,  CaBP2,  CaBP4,  
CaBP5,  CaBP7  and  CaBP8  expressed  exogenously  in  retinoic  acid  differentiated  N2A  cells.    Scale  bars  
=  10  µm.  
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Figure   4.2.   Co-­‐localisation   of   CaBP7   and   CaBP8   with   TGN   markers   in   differentiated   N2A   cells.  
Localisation  of  CaBP7  and  CaBP8  (red)  with  an  EYFP  tagged  cis/medial  Golgi  marker  (A,B,  green)  or  
the   TGN   specific  markers,   anti-­‐syntaxin   6   (C,D,   FITC,   green)   and   ts045   VSVG-­‐GFP   (E,F,   green)  was  
examined.  Regions  of  co-­‐localisation  appear  yellow  in  the  merged  images.    Scale  bars  =  10  µm.  
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4.2.2.  CaBP7  and  CaBP8  colocalise  with  TGN  markers  in  N2A  cells.  
The   localisation  of  CaBP7  and  CaBP8  to   the  Golgi-­‐apparatus  was  confirmed  by  co-­‐
transfecting  differentiated  N2A  cells  with  the  mCherry  tagged  proteins  along  with  a  
YFP  tagged  cis/medial  Golgi  marker,  EYFP-­‐Golgi  (Figure  4.2A  and  B).  Only  partial  co-­‐
localisation  was  observed,  however,  and  since  CaBP1L  and  CaBP1S  have  previously  
been  determined  to   localise   to   the  TGN,  markers  of  this  Golgi  compartment  were  
next  investigated.  Two  TGN  specific  markers,  syntaxin  6  (Teng  et  al.,  2001)  and  the  
constitutive   secretory   cargo,   vesicular   stomatitis   virus-­‐G   protein   (VSVG)   (Pelham,  
2001)),   were   used   to   examine   TGN   localisation   of   CaBP7   and   CaBP8.   N2A   cells  
overexpressing   mCherry   tagged   CaBP7   or   CaBP8,   immunostained   with   a   specific  
syntaxin   6   antibody   highlighted   extensive   co-­‐localisation   of   both   CaBPs   with   the  
TGN  marker   (Figure  4.2C  and  D).  To   investigate   the  co-­‐localisation  of   the  proteins  
with  VSVG,  a  temperature  sensitive  GFP  tagged  mutant  of  the  cargo  protein  (ts045  
VSVG-­‐GFP)   was   exploited.   Ts045   VSVG-­‐GFP   exhibits   a   temperature   sensitive  
reversible   folding   defect   which   traps   the   protein   in   the   ER   at   40°C.   Cells   were  
maintained   at   40°C   overnight   post-­‐transfection   and   subsequently   transferred   to  
20°C  to  permit  correct   folding  of  the  protein  and  hence  trafficking  from  the  ER  to  
the   TGN.  Maintenance   of   cells   at   20°C   blocked   further   trafficking   from   the   TGN.  
Cells  overexpressing  either  CaBP7  or  CaBP8  showed  extensive  co-­‐localisation  with  
ts045   VSVG-­‐GFP   at   the   TGN      under   these   conditions   (Figure   4.2E   and   F)  which   is  
consistent  with  anti-­‐syntaxin  6  colocalisation.  
4.2.3.  Identification  of  putative  C-­‐terminal  TMDs  in  CaBP7  and  CaBP8  
Examination   of   the   primary   sequence   of   CaBP7   and   CaBP8   revealed   that   both  
proteins   were   predicted   to   possess   a   TMD   at   their   extreme   C-­‐termini  
(http://www.ch.embnet.org/software/TMPRED_form.html).   In   CaBP7   this   spanned  
residues  189-­‐205,  and  in  CaBP8,  residues  193-­‐209.  Both  TMDs  were  17  amino  acids  
long,   the  optimal   length   for  TGN   localisation   in  preference   to  PM  targeting  which  
generally   requires   an   extended   transmembrane   helix   (Watson   and   Pessin,   2001).  
The  remaining  CaBPs  were  also  examined  for  the  presence  of  putative  TMDs.  Only  
CaBP1L  and  CaBP2  were  predicted  to  contain  a  TMD  although  the  confidence  scores  
in   these   instances   were   significantly   lower   than   observed   for   CaBP7   and   CaBP8.  
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Since   it   has   been  previously   shown   that  N-­‐terminal  myristoylation   is   essential   for  
membrane  localisation  of  CaBP1L  and  CaBP2,  characterisation  of  the  putative  TMDs  
of  CaBP7  and  CaBP8  became  the  focus  of  this  work.  
  
  
Figure  4.3.  Analysis  of  the  function  of  the  putative  TMD  of  CaBP7  and  CaBP8  in  differentiated  N2A  
cells.   Cells   were   transfected   with   ts045   VSVG-­‐GFP   (green)   as   a   TGN  marker   and   either   mCherry-­‐
CaBP71?188   or   mCherry-­‐CaBP81?192   TMD   deletion   mutants   (A,B,   red);   CaBP7TMDKKK-­‐mCherryor  
CaBP8TMDKKK-­‐mCherryTMD  triple  lysine  mutants  (C,D,  red).  Co-­‐localisation  appears  yellow  in  merged  
images.    Scale  bars  =  10  µm.  
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4.2.4.  The  predicted  TMDs  of  CaBP7  and  CaBP8  are  required  for  correct  
membrane  localisation  
Truncation   mutants   of   CaBP7   and   CaBP8   were   created   which   terminated   at   the  
amino  acid  directly  preceding  the  start  of  the  predicted  TMD  in  order  to  investigate  
the   requirement   of   this   region   for  membrane   targeting.   Figures  4.3A  and  B   show  
the   subcellular   localisation   of   the   proteins   expressed   from   these   constructs  
(mCherry-­‐CaBP71-­‐188  and  mCherry-­‐CaBP81-­‐192)  along  with  VSV-­‐G  as  a  marker  for  the  
TGN.  Removal  of   the  TMD   from  CaBP7  and  CaBP8  ablated  membrane  association  
and   resulted   in   a   predominantly   cytosolic   localisation   with   loss   of   co-­‐localisation  
with  TGN  specific  markers.  Other  variants  of  CaBP7  and  CaBP8,  used  to  further  test  
the  function  of  the  predicted  TMDs,  were  generated  by  mutating  the  central  three  
amino   acids   of   this   region   to   lysine   residues   (mCherry-­‐CaBP7TMDKKK   and  mCherry-­‐
CaBP8TMDKKK).   This   was   predicted   to   abolish   TMD   function  
(http://www.ch.embnet.org/software/TMPRED_form.html)   and   when  
overexpressed   in  N2A  cells,   the   triple   lysine  mutants  exhibited   increased  cytosolic  
localisation   compared   to   the   full-­‐length   wild-­‐type   proteins   that   was   more  
pronounced   for  CaBP7TMDKKK   than   for  CaBP8TMDKKK  (Figure  4.3C  and  D).  Collectively  
these   data   indicated   that   disruption   of   the   predicted   TMDs   of   CaBP7   and   CaBP8  
caused  extensive  mislocalisation  of  both  proteins  to  the  cytosol.  
4.2.5.  CaBP7  and  CaBP8  TMDs  alone  are  sufficient  to  target  normally  cytosolic  
proteins  to  the  TGN  
To   investigate  properties  of  the  TMDs   in   isolation,  these  sequences  were  fused  to  
normally  cytosolic  proteins.  Chimaeric  constructs  encoding  the  C-­‐terminus  of  both  
CaBP7   (residues   189-­‐215)   or   CaBP8   (residues   193-­‐219)   fused   to   either   CaBP5-­‐
mCherry   (CaBP5CaBP7TMD-­‐mCherry   and   CaBP5CaBP8TMD-­‐mCherry)   or   mCherry   alone  
(mCherryCaBP7TMD)  were  made.   In   contrast   to   the   normally   cytosolic   localisation  of  
wild-­‐type   CaBP5   (Figure   4.1F),   both   CaBP5CaBP7TMD-­‐mCherryand   CaBP5CaBP8TMD-­‐
mCherry  colocalised  extensively  with  the  TGN  marker  ts045  VSVG-­‐GFP  (Figure  4.4A  
and  B).  Similarly,  the  TMD  of  CaBP7  fused  to  mCherry  was  able  to  direct  a  pool  of  
this  chimaeric  protein  to  the  TGN  (Figure  4.4C).  These  observations  indicate  that  the  
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putative  TMDs  of  CaBP7  and  CaBP8  alone  are  sufficient  to  accurately  target  proteins  
to  membranes  of  the  TGN.    
  
  
Figure  4.4.  Analysis  of  CaBP5  and  mCherry  chimaeric  constructs  in  retinoic  acid  differentiated  N2A  
cells.CaBP5CaBP7TMD-­‐mCherry   or   CaBP5CaBP8TMD-­‐mCherrychimaeras   (A,B,   red),   or   mCherryCaBP7TMD   (C,  
red)  were   co-­‐expressed  with   ts045  VSVG-­‐GFP   (green)   as   a   TGN  marker.   Regions   of   co-­‐localisation  
appear  yellow  in  merged  images.    Scale  bars  =  10  µm.  
4.2.6.  The  position  of  the  fluorescent  colour  tag  does  not  affect  targeting  of  CaBP7  
or  CaBP8  
The   putative   TMDs   of   CaBP7   and   CaBP8   are   positioned   10   amino   acids   from   the  
carboxy-­‐terminus   of   the   proteins.   Neither   protein   possesses   a   signal   peptide   and  
since   the   TMD   exits   the   ribosome   very   close   to   translation   termination   during  
synthesis,   these   proteins   are   unlikely   to   be   inserted   into   membranes   co-­‐
translationally   as   is   the   case   for   the  majority   of  membrane   proteins.   This   finding  
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suggested  that  CaBP7  and  CaBP8  may  be  members  of  a  special  class  of  membrane  
protein,   the   tail  anchored   (TA)  proteins,  which  are   inserted   into  membranes  post-­‐
translationally.   This   class   of  membrane   protein   is   defined   by   the   occurrence   of   a  
single  transmembrane  domain  less  than  30  amino  acids  from  the  carboxy-­‐terminus  
(Borgese   et   al.,   2003).   Extension   of   the   region   C-­‐terminal   to   the   TMD  beyond   30  
amino   acids   can   result   in   a   shift   from   post-­‐translational   to   co-­‐translational  
membrane  insertion,  with  the  protein  instead  being  processed  as  a  classical  type  II  
membrane  protein.  (Brambillasca  et  al.,  2006).  As  all  the  constructs  examined  thus  
far  have  encoded  a  C-­‐terminal  colour  tag,  and  therefore  artificially  extended  the  C-­‐
termini   of   each   protein  beyond   the   30   amino   acid   threshold,   it  was   important   to  
investigate  whether  the  position  of  the  colour  tag  affected  the  correct  targeting  of  
CaBP7   and   CaBP8.   CaBP7   and   CaBP8  were   re-­‐cloned   into   an  N-­‐terminally   tagging  
vector  and  the  constructs  co-­‐expressed  with  their  C-­‐terminally  tagged  counterparts.  
Figures  4.5A  and  B  illustrate  that  the  position  of  the  colour  tag,  whether  C-­‐terminal  
or   N-­‐terminal,   does   not   alter   the   localisation   of   CaBP7   and   CaBP8   and   the   two  
colour  tagged  fusion  proteins  in  each  case  completely  co-­‐localised.  
  
  
Figure   4.5.   The   effect   of   the   position   of   the   colour   tag   fused   to   CaBP7   and  CaBP8.     C-­‐terminally  
mCherry  tagged  CaBP7  (red,  A)  and  CaBP8  (red,  B)  were  co-­‐expressed  with  N-­‐terminally  EYFP  tagged  
variants   of   the   same   proteins   (green,   A,B).   Regions   of   co-­‐localisation   appear   yellow   in   merged  
images.    Scale  bars  =  10  µm.  
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4.2.7.  Localisation  of  human  CaBP  isoforms  in  HeLa  cells  
A   high   throughput   siRNA   screen   in   HeLa   cells   reported   a   phenotype   upon  
knockdown  of  CaBP7  (Neumann  et  al.,  2010)  suggesting  that  its  expression  may  not  
be   restricted   to   neuronal   cell   types.   This   prompted   further   investigation   into  
whether   HeLa   cells   expressed   CaBP7   endogenously.   Figures   4.6A   and   B   show  
immunostaining  and  an  immunoblot  using  an  anti-­‐CaBP7  antibody   illustrating  that  
HeLa   cells   do   express   an   anti-­‐CaBP7   reactive   endogenous   protein   of   the   correct  
molecular  weight   for   CaBP7.   Endogenous   CaBP7   appears   to   localise   to   numerous  
vesicles  throughout  the  cell  which  concentrate  in  a  perinuclear  region.  This  finding  
agreed   with   exogenous   CaBP7   localisation   in   N2A   cells   although   the   punctate  
structures   appeared   less   numerous   in   N2A   cells   and   tended   to   accumulate  more  
tightly   in  the  region  of  the  TGN  (Figure  4.1G  vs.  Figure  4.6A).  As  HeLa  cells  have  a  
preferable  morphology  for  studying  subcellular  localisation  in  detail,  this  cell  system  






Figure   4.6.   Expression   of   endogenous   CaBP7   in   HeLa   cells.      A)   HeLa   cells   immunostained  with   a  
CaBP7  specific  antibody  and  detected  with  an  Alexa  568  conjugated  anti-­‐rabbit  secondary  antibody.  
B)  Western  blot  detection  of  endogenous  CaBP7  expression  in  HeLa  cell  lysate  using  the  same  CaBP7  
specific  antibody.  (marker  =  36  kDa).  Scale  bar  =  10  µm  
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All  human  CaBP  isoforms  were  individually  transfected  into  HeLa  cells  to  check  their  
localisation   in   a   non-­‐neuronal   cell   line   compared   to   that   observed   in   N2A   cells  
(Figure  4.7).  As   in  N2A  cells,   caldendrin,   CaBP4  and  CaBP5  all  displayed  a  diffuse,  
cysosolic   distribution   (Figure   4.7A,   E   and   F),   with   caldendrin   accumulation   in  
discrete  regions  of  the  nucleus  resembling  nucleoli.  As  expected  for  N-­‐myristoylated  
proteins,   CaBP1L,   CaBP1S   and   CaBP2   all   localised   to   the   PM   and   subcellular  
membranes   resembling  the  Golgi  apparatus  and  other  punctate  structures   (Figure  
4.7B,  C  and  D).  CaBP1L  again  exhibited  greater  cytosolic  fluorescence  than  CaBP1S  
(Figure   4.7C).   Exogenously   expressed   CaBP7   and   CaBP8   localised,   similarly   to  
endogenous   CaBP7   (Figure   4.6A),   to   punctate   structures   throughout   the   cytosol  
which  appeared  to  cluster  in  a  perinuclear  region  resembling  the  TGN  (Figure  4.7  G  
and  H).  mCherry-­‐CaBP7  and  mCherry-­‐CaBP8  showed  partial  colocalisation  with  the  
TGN   specific   marker   p230   in   many   cells   (Figure   4.8A   and   C)   whereas   in   others  
almost   no   TGN   localisation   was   observed   (Figure   4.8B   and   D)   and   instead   the  




Figure   4.7.   Intracellular   distribution   of   fluorescently   tagged   human   CaBP   isoforms   in   HeLa   cells.   
The   indicated   constructs   were   used   to   determine   the   localisation   of   caldendrin,   CaBP1S,   CaBP1L,  
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Figure  4.8.  Localisation  of  fluorescently  tagged  CaBP7  and  CaBP8  in  HeLa  cells  compared  with  the  
TGN  marker  p230.  A  and  B)  Exogenously  expressed  mCherry-­‐CaBP7  (red)  and  immunostained  p230  
(Anti-­‐p230,  FITC,  green).  C  and  D)  Exogenously  expressed  mCherry-­‐CaBP8  (red)  and  immunostained  
p230  (Anti-­‐p230,  FITC,  green).  A  and  C)  show  examples  where  the  exogenous  protein  (red)  and  the  
TGN  marker,  p230  (green),  overlap  in   localisation  (yellow).  B  and  D)  show  examples  where  there  is  
little  or  no  overlap  in  localisation  of  the  exogenous  protein  (red)  and  the  TGN  marker  p230  (green).  
Scale  bars  =  10  µm.    
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Figure   4.9.   Localisation   of   fluorescently   tagged   CaBP7   and   CaBP8   in   HeLa   cells.   A)   Exogenously  
expressed  C-­‐terminally  tagged  CaBP7-­‐mCherry  (red)  and  N-­‐terminally  tagged  EYFP-­‐CaBP7  (green).  B)  
Exogenously   expressed   C-­‐terminally   tagged   CaBP8-­‐mCherry   (red)   and   N-­‐terminally   tagged   EYFP-­‐
CaBP8   (green).   C   and   D)   Exogenously   co-­‐expressed   N-­‐terminally   EYFP-­‐   (green)   or   mCherry-­‐   (red)  
tagged  CaBP7  and  CaBP8.  E)  Exogenously  expressed  N-­‐terminally   tagged  mCherry-­‐CaBP8   (red)  and  
immunostained  endogenous  CaBP7   (Anti-­‐CaBP7,  FITC,  green)   in  HeLa   cells.  Co-­‐localisation  appears  
yellow  in  merged  image.  Scale  bars  =  10  µm.  
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The  localisation  of  exogenous  and  endogenous  CaBP7  and  CaBP8  in  HeLa  cells  was  
further  examined  by  co-­‐transfection  of  cells  with  different  combinations  of  N-­‐  and  
C-­‐terminally  tagged  constructs.  Figure  4.9A  and  B  demonstrate  that,  as  seen  in  N2A  
cells,   the  position   of   the   colour   tag  did   not   affect   the   localisation   of   exogenously  
expressed   CaBP7   and   CaBP8.   Complete   co-­‐localisation   was   observed   in   co-­‐
transfections  of  N-­‐  and  C-­‐terminally  tagged  variants  of  each  protein.  Co-­‐expression  
of  N-­‐terminally  tagged  CaBP7  and  CaBP8  (Figure  4.9C  and  D)  resulted   in  extensive  
overlap  in  the  localisation  of  the  two  proteins  to  the  same  vesicular  structures.  The  
different  colour  tags  also  failed  to  influence  the  co-­‐localisation  of  the  two  proteins.  
Staining   of   CaBP8   transfected   cells   with   anti-­‐CaBP7   confirmed   that   exogenous  
CaBP8  protein  co-­‐localised  to  the  same  vesicles  as  endogenous  CaBP7  (Figure  4.9E).  
Collectively  these  data  confirmed  that  tagging  of  CaBP7  and  CaBP8  at  either  the  C-­‐  
or   N-­‐terminus   had   no   impact   on   normal   protein   localisation   and   that   CaBP7   and  
CaBP8  localise  to  the  same  subcellular  membranes.  
4.2.8.  Trypsin  protection  analysis  of  CaBP7  and  CaBP8  membrane  topology  
CaBP7  and  CaBP8  have  a  similar  architecture  to  TA  proteins,  with  a  putative  TMD  10  
amino  acids  from  their  extreme  C-­‐termini.  TA  proteins  typically  have  a  cytosolically  
oriented   N-­‐terminus   and   short   luminal   C-­‐terminus   (Figure   4.10Ai).   Trypsin  
protection   assays   were   used   in   order   to   confirm   whether   this   was   also   the  
membrane   topology   of   CaBP7   and   CaBP8.   A   number   of   alternative   arrangements  
were   also   possible   including:   1)   N-­‐   and   C-­‐   termini   facing   the   cytosol,   with   only  
partial   membrane   insertion   of   the   TM   helix   (Figure   4.10Aii),   or   2)   A   luminal   N-­‐
terminus  and  cytosolic  C-­‐terminus  (Figure  4.10Aiii).   It  was  important  to  distinguish  
between   these   different   topologies   in   order   to   characterise   CaBP7   and   CaBP8   as  
true  TA  proteins  and  also  to  provide  a  topological  basis  for  the  published  interaction  
with  the  cytosolic  Golgi-­‐associated  enzyme,  PI4KIII??(Mikhaylova  et  al.,  2009).  
  
To  address  this  issue  an  imaging  based  protocol  was  employed  whereby  HeLa  cells  
were  triply  transfected  with  ECFP  (as  a  soluble  marker)  and  CaBP7  or  CaBP8  tagged  
at  either  the  N-­‐terminus  with  EYFP  or  the  C-­‐terminus  with  mCherry.  This  approach  
was  based  on  a  well-­‐characterised  method  for  studying  the  topology  of  membrane  
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Figure   4.10.   Possible   CaBP7   and   CaBP8   membrane   topologies   and   representative   fluorescence  
protease  protection  assay   images.  A)  Potential  membrane  topologies   for  CaBP7  and  CaBP8  across  
biological  membranes:   (i)   Type   II  membrane  protein  orientation;   (ii)   Peripheral  membrane  protein  
orientation;   (iii)   Type   I   membrane   protein   orientation.   Protein   domains   are:   Green   ?   N-­‐terminal  
domain;   Yellow   ?   Transmembrane   domain   and   Purple   ?   C-­‐terminal   domain.   The   lipid   bilayer   is  
shown  in  blue.  (From  (McCue  et  al.,  2011))  B)  HeLa  cells  transfected  with  ECFP  (blue)  and  N-­‐  and  C-­‐
terminally  tagged:  CaBP7-­‐mCherry  (red)  and  EYFP-­‐CaBP7  (green)  or  CaBP8-­‐mCherry  (red)  and  EYFP-­‐
?????????????????????????????????????????????????????????????????????????????????????????????  (40  µM)  
and   ±   trypsin   (4   mM)   treatment.   Controls   are   shown   before   (i   and   v)   and   after   (iii   and   vii)  
digitonintreatment  but  without   trypsin   treatment   for  CaBP7  and  CaBP8   respectively.  Experimental  
cells   are   shown   prior   to   digitonin   application   (ii   and   vi)   and   following   both   digitonin   and   trypsin  
treatment  (iv  and  viii)  for  CaBP7  and  CaBP8  respectively.  Scale  bars  =  10  µm.  
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proteins  resident  on  various  organelles  including  the  Golgi  apparatus  (Lorenz  et  al.,  
2006).  Digitonin  was  applied  to  the  cells  to  selectively  permeabilise  the  PM.  Loss  of  
cytosolic   ECFP   fluorescence  was   used   to  monitor   permeabilisation.   Perfusion  was  
then  switched  to  media  containing  trypsin  which  could  now  access  the  cytosol  and  
degrade   any   proteins   not   protected   within   intracellular   membranes.   EYFP   and  
mCherry  fluorescence  intensity  at  the  TGN  was  monitored  over  time  to  assess   the  
susceptibility   of   their   environment   to   trypsin   digestion.   Using   Figure   4.10A   as   a  
guide   it   can  be   reasoned   that   if   the   topology  matches   that  depicted   in   (i),   the  N-­‐
terminal   fluorescent  tag  should  be  exposed  to  trypsin  digestion   in  the  cytosol  and  
the   fluorescence   signal   lost,  whereas   the   C-­‐terminal   tag   should   remain   protected  
inside  the  lumen  of  the  TGN.  If  the  topology  is  as  depicted  in  Figure  4.10A(ii),  both  
colour  tags  should  be  digested  upon  trypsin  treatment.  Finally  if  the  protein  adopts  
the  same  topology  as  in  Figure  4.10A(iii),  the  C-­‐terminal  fluorescent  signal,  not  the  
N-­‐terminal  fluorescent  signal,  would  be  lost.  
  
In   control   experiments,   cells   were   perfused   with   KHM   buffer   until   a   steady  
fluorescence  baseline  was  achieved  (CaBP7:  Figure  4.10B(i),  CaBP8:  Figure  4.10B(v)).  
Cells   were   permeabilised   with   digitonin   but   not   subsequently   challenged   with  
trypsin   (CaBP7:   Figure   4.10B(iii),   CaBP8:   Figure   4.10B(vii)).   The   loss   of   ECFP  
fluorescence  confirmed  that   the  PM  had  been  effectively   compromised  and   there  
was  no  significant  loss  of  EYFP  or  mCherry  fluorescence  at  the  TGN  in  the  absence  
of   trypsin.   Representative   fluorescence   intensity   traces   are   show   in   figure   4.11A  
(CaBP7)  and  4.11C  (CaBP8).  
  
In  cells  treated  with  both  digitonin  and  trypsin,  there  was  a  time  dependent  loss  of  
the   N-­‐terminal   EYFP   signal   in   both   CaBP7   and   CaBP8   transfected   cells   (CaBP7  
pretreatment:   Figure   4.10B(ii),   versus   CaBP7   post   digitonin/trypsin   treatment:  
figure   4.10B(iv),   and   CaBP8   pretreatment:   figure   4.10B(vi),   versus   CaBP8   post  
digitonin/trypsin  treatment:  figure  4.10B(viii)).   In  contrast,  the  C-­‐terminal  mCherry  
signal   was   preserved   in   both   CaBP7   and   CaBP8   expressing   cells   (Figure   10B   and  
representative  traces  in  Figure  4.11B  (CaBP7)  and  Figure  4.11D  (CaBP8)).  The  results  
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Figure  4.11.  Example  fitted  curves  from  individual  fluorescence  protease  protection  assays.  A  and  
C)  Control  experiments  without  trypsin  treatment  for  CaBP7  and  CaBP8  respectively.  B  and  D)  CaBP7  
and  CaBP8  treated  with  both  digitonin  (40µM)  and  trypsin  (4  mM).  Solid  lines  represent  C-­‐terminally  
mCherry  tagged  CaBP7  or  CaBP8,  dashed  lines  represent  N-­‐terminally  EYFP  tagged  CaBP7  or  CaBP8  
and  dotted  lines  represent  ECFP  fluorescence.  Frame  rate  =  1  frame/8  seconds.  E-­‐G)  Histograms  for  
averaged   fluorescence   protease   protection   assay   results.   E   and   G)   Control   experiments   without  
trypsin  treatment   for  CaBP7  and  CaBP8  respectively.  F  and  H)  CaBP7  and  CaBP8  treated  with  both  
digitonin   (40µM)   and   trypsin   (4   mM).   Key:   Black   =   before   treatment   with   digitonin,   Grey   =   after  
treatment  with  digitonin,  White  (Controls  E  and  G)  =  End  of  experiment  with  no  trypsin  treatment,  
White   (F   and  H)   =   End  of   experiment  post-­‐trypsin   treatment.   (E)  n=7   cells,   (F)   n=12   cells,   (G)  n=7  
cells,  (H)  n=7  cells.  Data  are  plotted  as  mean  ±  SEM.  F/F0is  the  mean  fluorescence  intensity  (F)  at  a  
given  time  point  divided  by  the  mean  fluorescence  intensity  at  the  start  of  the  experiment  (F0).  
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from   multiple   independent   experiments   were   averaged   (Figure   4.11E-­‐H)   and  
demonstrated  specific  protection  of  the  C-­‐terminal  mCherry  tag  and  degradation  of  
the   N-­‐terminal   EYFP   tag   upon   treatment   with   trypsin   (Figure   4.11F   (CaBP7)   and  
Figure   11H   (CaBP8)).   These   data   were   consistent   with   a   cytosolic   N-­‐terminus,  
susceptible   to   trypsin   digestion,   and   a   luminal   C-­‐terminus,   protected   from  
proteolysis  within   the  TGN   lumen  ?   the   topology   typical  of  TA  proteins.  This  data  
also  confirmed  that  CaBP7  and  CaBP8  possess  a  TMD  which  spans  the  membrane  at  
the  TGN.  
  
To   further   validate   the   results   of   this   imaging   assay,   biochemical   assays   were  
carried   out   to   confirm   the   topology   of   CaBP7.   HeLa   cells   were   transfected   with  
CaBP7   tagged   with   mCherry   at   either   the   C-­‐terminus   or   the   N-­‐terminus   and  
challenged   with   trypsin   in   the   manner   outlined   above.   In   these   experiments,  
protection  of  the  colour  tags  was  monitored  by  western  blotting  with  an  mCherry  
specific  antibody   (Anti-­‐RFP,   figure  4.12).  Control   lysate  from  cells   transfected  with  
mCherry  alone  and  not   treated  with   trypsin  gave  a   clear   immunoreactive  band  at  
~26   kDa   as   expected   for   free  mCherry   protein   (Figure   4.12,  mCherry   (-­‐)).   Lysates  
from  control  cells  transfected  with  either  N-­‐terminally  (Figure  4.12,  mCherry-­‐CaBP7  
(-­‐))  or  C-­‐terminally    (Figure  4.12,  CaBP7-­‐mCherry  (-­‐))  mCherry-­‐tagged  CaBP7  gave  an  
immunoreactive  band  at  ~50  kDa.  Consistent  with  the   imaging  studies,  when  cells  
were  treated  with  digitonin  and  trypsin,  the  signal  from  cell  lysates  transfected  with  
mCherry-­‐CaBP7  was   lost   (Figure  4.12,  mCherry-­‐CaBP7   (+))   suggesting   that   this   tag  
was   oriented   towards   the   cytosol   and   therefore   susceptible   to   proteolysis.   In  
contrast,   the   immunoreactive   band   from   cell   lysates   transfected   with   CaBP7-­‐
mCherry   (Figure   4.12,   CaBP7-­‐mCherry   (+),   indicated   by   the   arrow)   shifted   in  
molecular  weight  to  ~30  kDa.  This  suggested  that  the  full-­‐length  fusion  protein  was  
being  partially  degraded  at   its   cytosolically  exposed  N-­‐terminus  whereas   the  TMD  
and  mCherry  tag  remained  protected  within  the  membrane  and  lumen  of  the  TGN.  
Therefore   an   N-­‐terminally   truncated   protein   with   apparent   molecular   mass   of  
30kDa   was   generated.   Quantitation   by   densitometry   indicated   that   the   protein  
remaining  in  trypsin  treated  mCherry-­‐CaBP7  samples  was  25±11.9%  of  that  present  
in   trypsin   treated  CaBP7-­‐mCherry   samples   (n=3   independent  experiments,  ±SEM).  
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Figure  4.12.  Biochemical  protease  protection  assay.  HeLa  cells  expressing  mCherry  control  protein,  
mCherry-­‐CaBP7  or  CaBP7-­‐mCherry  were  permeabilised  using  40  µM  digitonin  followed  by  incubation  
±   4   mM   trypsin.   Cells   were   lysed,   protein   resolved   on   SDS-­‐PAGE   and   mCherry   detected   by  
immunoblotting   with   polyclonal   anti-­‐RFP   antibody.   (*)   -­‐   Denotes   full   length   mCherry-­‐CaBP7   or  
CaBP7-­‐????????? ???? -­‐   Denotes   the   major   proteolytic   fragment   generated   from   CaBP7-­‐mCherry  
following   trypsin   digestion.   Molecular   weight   standards   (kDa)   are   shown   on   the   left   side   of   the  
image.  
4.2.9.  Antibody  accessibility  experiments  to  assess  the  membrane  topology  of  
CaBP7  and  CaBP8  
As   discussed   earlier,   fusion   of   peptide   tags   longer   than   30   amino   acids   to   the   C-­‐
terminal  end  of  a  TA  protein  has  been  shown  to  cause  aberrant  processing  of   the  
resultant   chimera  as   a   type-­‐II  membrane  protein,  with   the  protein  being   inserted  
into   the  membrane   co-­‐translationally,   rather   than  post-­‐translationally   (Borgese  et  
al.,  2003,  Borgese  et  al.,  2007,  Kutay  et  al.,  1995,  Kim  et  al.,  1997).  For  this  reason  
further  experiments  were  performed  to  assess  whether  fusion  of  a  large  fluorescent  
protein   tag   at   the   C-­‐terminus   of   CaBP7   or   CaBP8   had   caused   them   to   adopt   an  
incorrect   membrane   topology.   The   c-­‐myc   epitope   tag   is   only   10   amino   acids   in  
length  and  could  therefore  be  fused  to  the  C-­‐termini  of  CaBP7  and  CaBP8  without  
exceeding  the  experimentally  determined  30  amino  acid  limit  for  correct  TA  protein  
processing.  Epitope  accessibility  was   then  used   to   assess   the  position  of  both   the  
myc  tag  and  the  N-­‐terminus  of  the  protein  in  relation  to  the  membrane  (Kuroda  et  
al.,   1996).   Cells   were   transfected   with   either   mCherry-­‐CaBP7-­‐myc   or   mCherry-­‐
CaBP8-­‐myc   and   subsequently   treated   with   either   digitonin,   to   selectively    
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Figure  4.13.  Epitope  accessibility  analysis  of  C-­‐terminally  myc  tagged  CaBP7  and  CaBP8.  A,B,E  and  
F)   Digitonin   permeabilisation   -­‐   HeLa   cells   expressing   mCherry-­‐CaBP7-­‐myc   or   mCherry-­‐CaBP8-­‐myc  
(mCh-­‐CaBP7-­‐myc  and  mCh-­‐CaBP8-­‐myc,  red)  were  treated  with  digitonin  to  selectively  permeabilise  
the  PM,   fixed  and  processed  for   immunofluorescence  with  an  anti-­‐c-­‐myc  antibody  (Anti-­‐myc,  FITC,  
green.   A:  mCh-­‐CaBP7-­‐myc,   red.   E:  mCh-­‐CaBP8-­‐myc,   red.)   or   an   anti-­‐RFP   antibody   (Anti-­‐RFP,   FITC,  
green.   B:   mCh-­‐CaBP7-­‐myc,   red.   F:   mCh-­‐CaBP8-­‐myc,   red.).   C,   D,   G   and   H)   Triton-­‐X-­‐100  
permeabilisation   -­‐   HeLa   cells   expressing   mCh-­‐CaBP7-­‐myc   or   mCh-­‐CaBP8-­‐myc   were   fixed,   treated  
with   Triton-­‐X-­‐100   to   permeabilise   all   cellular  membranes   and   processed   for   immunofluorescence  
with  an  anti-­‐c-­‐myc  antibody  (Anti-­‐myc,  green.  C:  mCh-­‐CaBP7-­‐myc,  red.  G:  mCh-­‐CaBP8-­‐myc,  red.)  or  
an  anti-­‐RFP  antibody  (Anti-­‐RFP,  green.  D:  mCh-­‐CaBP7-­‐myc,  red.  H:  mCh-­‐CaBP8-­‐myc,  red.).  Regions  of  
colocalisation  appear  yellow  in  overlay  images.  Scale  bars  =  10  µm.  
  
  
permeabilise  the  PM,  or  with  Triton  X-­‐100  to  permeabilise  all  cellular  membranes.  
Fixed,  permeabilised  cells  were  incubated  with  either  anti-­‐RFP  or  anti-­‐myc  and  the  
subsequent  staining  pattern  assessed  to  deduce  the  membrane  topology.  Following  
digitonin   permeabilisation   of   the   PM,   mCherry   fluorescence   was   present   but   no  
anti-­‐myc   immunofluorescence  was   detectable   (Figure   4.13A,  mCh-­‐CaBP7-­‐myc   and  
Figure  4.13E,  mCh-­‐CaBP8-­‐myc)  indicating  that  the  myc  antibody  did  not  have  access  
to   the   C-­‐terminus   of   the   protein.   In   similarly   treated   cells,   anti-­‐RFP  
immunofluorescence   was   detected   demonstrating   that   the   N-­‐terminus   of   the  
protein  was  cytosolic  and  the  mCherry  tag  freely  accessible  to  the  RFP  antibody.  In  
control  cells,  non-­‐selectively  permeabilsed  with  Triton  X-­‐100,   immunofluorescence  
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from   both   anti-­‐RFP   and   anti-­‐myc   was   observed.   Therefore,   consistent   with   the  
trypsinisation  assays   (Section  4.2.8),   the  C-­‐terminal  myc-­‐tag  was   resident  within  a  
sub-­‐cellular  membrane  bounded  compartment  that  was  only  accessibile  to  anti-­‐myc  
following   Triton   permeabilisation   of   all   cellular   membranes.   The   N-­‐terminal  
mCherry   tag   was   freely   accessible   to   anti-­‐RFP   antibody   after   PM-­‐selective  
permeabilisation   using   digitonin.   Collectively,   these   data   indicate   that   CaBP7   and  
CaBP8  adopt  the  membrane  topology  of  true  TA  proteins.  
4.2.10.  Localisation  of  CaBP7  and  CaBP8  Chimeras  in  HeLa  cells  
  
Figure  4.14.  Analysis  of  localisation  of  CaBP5  and  mCherry  chimaeric  constructs  in  HeLa  cells.  HeLa  
cells  exogenously  expressing    or  CaBP5CaBP8TMD-­‐mCherry  chimaeras  (A,B,  red),  or  mCherry-­‐CaBP7TMD  (C,  
red)  immunostained  with  a  CaBP7  antibody  (Anti-­‐CaBP7,  FITC,  green)  to  detect  endogenous  protein  
(NB  Anti-­‐CaBP7  is  specific  to  the  N-­‐terminus  of  the  protein  so  does  not  detect  the  transmembrane  
domain   fused   to   either   CaBP5   or   mCherry).   Regions   of   co-­‐localisation   appear   yellow   in   merged  
? ?????????????????????????  
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As   previously   indicated,   exogenously   expressed   CaBP7   and   CaBP8   localise   to   the  
same   structures   in   HeLa   cells.   It   was   found   that   HeLa   cells   express   CaBP7  
endogenously   and   anti-­‐CaBP7   immunostaining   confirmed   that   exogenous   and  
endogenous  protein  localised  to  the  same  subcellular  compartments  (section  4.2.7).  
Chimeras  of  the  TMD  of  either  CaBP7  or  CaBP8  fused  to  normally  cytosolic  proteins  
also   localised  like  the  full   length  wild-­‐type  protein  in  N2A  cells  (section  4.2.5).  The  
localisation   of   these   chimeras  was   also   assessed   in   HeLa   cells   to   ensure   that   the  
proteins  were  not  processed  differently  in  this  non-­‐neuronal  cell   line  (Figure  4.14).  
Cells  were   immunostained  with  anti-­‐CaBP7  to  confirm  that  the  proteins  resided   in  
the   same   compartments   as   endogenous   CaBP7.   CaBP5CaBP7TMD-­‐mCherryand  
CaBP5CaBP8TMD-­‐mCherry   exhibited   extensive   colocalisation  with   endogenous   CaBP7  
on   intracellular   vesicles   (Figure   4.14A   and   B).   Chimeras   had   increased   cytosolic  
fluorescence   and   some   localisation   to   the   PM.   mCherryCaBP7TMD   localised   to   anti-­‐
CaBP7   labelled   vesicles   in   some   cells,   but   in   others   a   more   reticular   pattern   of  
fluorescence  was  observed  (Figure  4.14C).  The  observed  partial  colocalisation  with  
endogenous  protein  suggested  that  a  proportion  of  the  chimearic  protein  was  being  
targeted  correctly  in  HeLa  cells.  
  
Trypsin   protection   and   antibody   accessibility   experiments   confirmed   that   CaBP7  
and  CaBP8  belong  to  the  TA  class  of  integral  membrane  proteins  (section  4.2.8).  As  
such,   these   proteins  must  be   inserted   into  membranes  post-­‐translationally   rather  
than  co-­‐translationally.  Typically,  TA  proteins  are   initially   inserted  into  membranes  
of  either  the  ER  or  the  mitochondria  (Borgese  et  al.,  2001).  The  reticular-­‐like  pattern  
of   localisation   of   mCherryCaBP7TMD   suggested   that   CaBP7   and   CaBP8   are   initially  
inserted  into  the  ER  membrane  and  then  subsequently  trafficked  to  the  TGN  and  to  
post-­‐Golgi   vesicles.   For   this   reason,   the   extent   of   co-­‐localisation   of   full-­‐length  
mCherry-­‐CaBP7  (Figure  4.15A  and  B)  or  mCherryCaBP7TMD  (Figure  4.15C  and  D)  with  
the   mitochondrial   marker,   TOM20,   or   the   ER   marker,   calnexin   was   assessed.   In  
these  cells   full   length  CaBP7   labelled  vesicular  structures  which  were  untagged  by  
either  antibody.  mCherryCaBP7TMD  did  not  co-­‐localise  with  the  mitochondrial  marker  
but   did   exhibit   partial   co-­‐localisation   with   calnexin,   consistent   with   an   ER  
localisation  for  a  pool  of  the  chimaera  (Figure  4.15C  and  D).    
     124  
  
  
Figure  4.15.  Analysis  of  localisation  of  mCherry-­‐CaBP7  or  mCherryCaBP7TMD  compared  with  markers  
of   the  mitochondria  and   the  ER.  HeLa  cells  exogenously  expressing  mCherry-­‐CaBP7   (A,  B,   red),  or  
mCherry-­‐CaBP7TMD   (C,   D,   red)   immunostained   with   either   the   mitochondrial   marker   TOM20   (anti-­‐
TOM20,  A,  C,  FITC,  green)  or  the  ER  marker,  calnexin  (anti-­‐calnexin,  B,  D,  FITC,  green).  Regions  of  co-­‐
?????????????????????????????? ??????? ?????????????????????????  
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4.2.11.  Identification  of  CaBP7  and  CaBP8  positive  vesicles  in  HeLa  cells  
As  shown  in  figure  4.8,  CaBP7  and  CaBP8  displayed  partial  co-­‐localisation  with  the  
TGN  specific  marker  p230,  but  also  localised  to  discrete  puncta  throughout  the  cell  
cytosol.  The  identity  of  these  punctate  structures  was  examined  by  performing  co-­‐
transfections   of   mCherry   tagged   CaBP7   and   CaBP8   with   EYFP   tagged  markers   of  
defined   subcellular   compartments   (Figure   4.16).   No   co-­‐localisation  with   the   early  
endosome   marker,   Rab5a   (Figure   4.16A   and   D),   or   the   autophagosome   marker,  
LC3?   (Figure   4.16B   and   E),   was   observed,   however   there   was   extensive   co-­‐
localisation  of   CaBP7   and  CaBP8  with   the   lysosomal  marker   LAMP1   (Figure   4.16C  
and  F).    
  
To  further  characterise  this  localisation,  cells  were  transfected  with  mCherry-­‐CaBP7  
(as   a   model   for   both   CaBP7   and   CaBP8),   and   immunostained   with   antibodies   to  
various  markers  of  endosomes  and   lysosomes   (Figure  4.17).  No-­‐colocalisation  was  
observed  with   the  endosomal  and  multivesicular  body   (MVB)  marker,  HRS,  or   the  
recycling   endosome  marker,   Rab11   (Figure   4.17A   and   B).   Colocalisation  with   late  
endosome/lysosome  markers,   LAMP1   and   CD63,   was   observed,   although   in   both  
cases  there  was  a  population  of  CaBP7-­‐positive  vesicles  which  did  not  label  with  the  
antibodies   and   vice   versa   (Figure   4.17D   and   E).   Lysosomes   are   typically  
characterised   by   the   absence   of   mannose-­‐6-­‐phosphate   receptors   (M6PR).  
Consistent  with   this,   immunostaining   of  mCherry-­‐CaBP7  overexpressing   cells  with  
M6PR   antibody   indicated   that   there   was   no   co-­‐localisation   between   the   two  
proteins  (Figure  4.17C).  This  is  in  agreement  with  the  co-­‐localisation  observed  with  
exogenously   expressed   LAMP1-­‐YFP   in   figure   4.16.   Cells   co-­‐immunostained   with  
anti-­‐CaBP7  and  either  anti-­‐LAMP1  or  anti-­‐CD63  confirmed  that  endogenous  CaBP7  
co-­‐localised  with   the   same  markers   as   the   exogenously   expressed  protein   (Figure  
4.18A   and   B).   mCherry-­‐CaBP7   completely   colocalised   with   the   acidotropic   dye,  
???????????????????????????????????????????????????????????????????????????????????
organelles.    
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Figure   4.16.   Analysis   of   localisation   of   mCherry-­‐CaBP7   or   mCherry-­‐CaBP8   in   HeLa   cells   co-­‐
expressing   fluorescently   tagged  markers  of   various  organelles.  HeLa  cells  exogenously  expressing  
mCherry-­‐CaBP7  (A,  B,  C,  red),  or  mCherry-­‐CaBP8  (D,  E,  F,  red)  with  EYFP  fusions  of  either:  the  early  
endosomal  marker,  Rab5A  (A  and  D;  Rab5A-­‐YFP,  green),  the  autophagosome  marker,  LC3?  (B  and  E;  
LC3-­‐YFP,   green),   or   the   lysosomal   marker,   LAMP1   (C   and   F;   LAMP1-­‐YFP,   green).   Regions   of   co-­‐
?????????????????????????????? ??????? ?????????????????????????  
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Figure   4.17.   Analysis   of   localisation   of   mCherry-­‐CaBP7   compared   with   markers   of   various  
intracellular   compartments.   The   figure   shows   HeLa   cells   exogenously   expressing   mCherry-­‐CaBP7  
(mCh-­‐CaBP7)   immunostained   for   A)   the   recycling   endosome   marker,   Rab11   (Anti-­‐Rab11,   FITC,  
green),   B)   the  endosome  and  MVB  marker,  HRS   (anti-­‐HRS,   FITC,   green),   C)   the  endosome  marker,  
M6PR  (anti-­‐M6PR,  FITC,    green),  D)  the  late  endosome  and  lysosome  marker,  CD63  (Anti-­‐CD63,  FITC,  
green),  E)  the  late  endosome  and  lysosome  marker,  LAMP1  (Anti-­‐LAMP1,  FITC,  green).  Regions  of  co-­‐
localisati???????????????????? ??????? ??????????????????????????  
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Figure   4.18.   Co-­‐localisation   of   endogenous   CaBP7   or   exogenous,   mCherry-­‐CaBP7   with   various  
lysosmal  markers.  A)  HeLa  cells  co-­‐immunostained  with  antibodies  to  CaBP7  (anti-­‐CaBP7,  Alexa  568,  
red)   and   the   lysosomal  marker   LAMP1   (anti-­‐LAMP1,   FITC,   green).  B)  HeLa   cells   co-­‐immunostained  
with  antibodies  to  CaBP7  (Anti-­‐CaBP7,  Alexa  568,   red)  and  the  lysosomal  marker  CD63  (Anti-­‐CD63,  
FITC,  green).  C)  HeLa  cells  exogenously  expressing  mCherry-­‐CaBP7  (red)  after  a  30  minute  incubation  
??????????????????????????????????????????????????????????????????????? ??????????????????????????
top  right  corner  of  each  image.  Regions  of  co-­‐localisation  appear  yellow  in  merged  images  for  A  and  
B  and  pink  in  the  merged  image  for  C?????????????????????  
  
  
VAMP7  is  a  tail  anchored  v-­‐SNARE  protein  which  is  resident  on  late  endosomal  and  
lysosomal  membranes   (Martinez-­‐Arca  et  al.,   2003).   The   localisation  of  CaBP7  was  
therefore   compared   with   that   of   both   endogenous   and   exogenously   expressed  
VAMP7   as   a   representative   TA   protein   with   a   similar   localisation   (Figure   4.19).  
Extensive   overlap   was   observed   in   the   localisation   of   overexpressed   CaBP7   and  
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VAMP7   in  HeLa   cells   (Figure   4.19A)   and   the   same  was   observed  when   cells  were  




Figure   4.19.   Co-­‐localisation   of   exogenous   and   endogenous   CaBP7   with   the   late   endosomal   and  
lysosomal   TA  protein,  VAMP7.  A)  HeLa  cells   exogenously  co-­‐expressing  mCherry-­‐CaBP7   (Red)  and  
GFP-­‐VAMP7   (Green).   B)   HeLa   cells   immunostained   for   endogenous   CaBP7   (Alexa   568,   red)   and  
VAMP7  (FITC,  green).    Zoomed  regions  of  interest  are  shown  in  the  top  right  corner  of  each  image.  
Regions  of  co-­‐?????????????????????????????? ??????? ??????????????????????????  
  
  
It  was  previously  shown  (Figure  4.2),   that  CaBP7  and  CaBP8  co-­‐localise  with  ts045  
VSVG-­‐GFP  at  the  TGN  and  in  vesicles  in  N2A  cells.  Co-­‐localisation  of  CaBP7  with  this  
marker   in   vesicles   was   also   examined   in   HeLa   cells.   Cells   transfected   with   the  
temperature   sensitive   VSVG   mutant,   ts045   VSVG-­‐GFP,   were   incubated   at   a  
permissive  temperature  (37°C)  for  VSVG  trafficking  from  the  TGN.  Complete  overlap  
was  observed  in  the  localisation  of  ts045  VSVG-­‐GFP  with  endogenous  CaBP7  (Figure  
4.20A).   VSVG   is   believed   to   be   a   marker   of   the   constitutive   secretory   pathway,  
however,  this  is  at  odds  with  the  apparent  localisation  of  CaBP7  to  late  endosomal  
and  lysosomal  compartments.  To  further  investigate  this,  HeLa  cells  overexpressing  
ts045   VSVG-­‐GFP   were   immunostained   with   the   late   endosome   and   lysosome  
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Figure  4.20.  Co-­‐localisation   of  CaBP7  with  VSVG  but  not  with  a  potential  marker  of   constitutive  
secretory  vesicles.  A)  HeLa  cells  exogenously  expressing  ts045  VSVG-­‐GFP  (Green)  immunostained  for  
endogenous  CaBP7  (Anti-­‐CaBP7,  Alexa  568,  red).  B)  HeLa  cells  exogenously  expressing  ts045  VSVG-­‐
GFP   (Green)   immunostained   for   the   late  endosome  and   lysosome  marker,  CD63   (Anti-­‐CD63,  Alexa  
594,  red).  C)  HeLa  cells  exogenously  expressing  ts045  VSVG-­‐GFP  (Green)  immunostained  for  the  late  
endosome   and   lysosome  marker,   LAMP1   (Anti-­‐LAMP1,   Alexa   594,   red).   D)  HeLa   cells   exogenously  
expressing   mCherry-­‐CaBP7   (Red)   immunostained   with   the   constitutive   secretory   vesicle   marker,  
SNAP29  (Anti-­‐SNAP29,  FITC,  green).  Zoomed  regions  of  interest  are  shown  in  the  top  right  corner  of  
each  image.  Regions  of  co-­‐localisation  appe????????????? ??????? ??????????????????????????  
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markers,   CD63   and   LAMP1   (Figure   4.20B   and   C).   Interestingly,   extensive   co-­‐
localisation  was  also  observed  with   these  markers   suggesting   that  VSVG  does  not  
localise   exclusively   to   the   TGN   and   constitutive   secretory   vesicles   (CSVs).   In   an  
extension   of   these   investigations,   cells   overexpressing   mCherry-­‐CaBP7   were  
immunostained   with   a   potential   endogenous   marker   of   CSVs,   SNAP29   (Figure  
4.20D).  SNAP29  is  a  post-­‐Golgi  SNARE  protein  which  has  been  shown  to  be  required  
for  constitutive  secretion  (Gordon  et  al.,  2010).  SNAP29  has  been  shown  previously  
to  localise  to  the  TGN,  PM  and  cytosol  (Wong  et  al.,  1999,  Su  et  al.,  2001,  Feldmann  
et  al.,  2009),  however  there  are  no  reports  of  endogenous  SNAP29  immunostaining  
in  HeLa  cells.  Figure  4.20D  illustrates  immunostaining  of  SNAP29  in  HeLa  cells  which  
is   consistent   with   a   localisation   to   the   PM   and   PM   ruffles.   SNAP29   was   also  
observed  in  small  punctate  structures  distributed  throughout  the  cytosol  which  may  
represent   a   pool   of   CSVs.   No   co-­‐localisation   of   SNAP29   with   overexpressed  
mCherry-­‐CaBP7  was  observed  suggesting  that  CaBP7  does  not  localise  to  the  same  
population  of  vesicles  as  SNAP29.  
4.2.12.  Dependency  of  CaBP7  and  CaBP8  localisation  upon  Ca2+-­‐binding  
The  dependence  of  CaBP7  and  CaBP8  localisation  on  functional  Ca2+-­‐binding  activity  
was  assessed  using  mCherry-­‐tagged  mutants  which  were  defective   in  Ca2+-­‐binding  
at  either  EF1,  EF2  or  both  functional  EF-­‐hand  motifs.  These  mutants  were  created  
by  site  directed  mutagenesis  of  the  wild-­‐type  constructs  to  mutate  the  glutamate  at  
the  12th  position  in  each  of  the  Ca2+-­‐binding  loops  to  a  glutamine  residue.  This  type  
of   mutation   has   been   proven   to   abolish   Ca2+-­‐binding   in   a   number   of   EF-­‐hand  
containing   Ca2+-­‐binding   proteins   (Faurobert   et   al.,   1996,   Hasdemir   et   al.,   2005,  
Weiss  et  al.,  2000).  Each  of  the  EF-­‐hand  mutants  was  co-­‐transfected  into  HeLa  cells  
with   the  corresponding  wild-­‐type  protein  tagged  with  EYFP.  Figure  4.21   illustrates  
that   each   of   the  mutant   proteins   displays   complete   overlap   in   localisation   to   the  
same  vesicular  structures  as  the  corresponding  wild-­‐type  protein  This  indicates  that  
targeting  to  these  vesicles  is  unlikely  to  be  Ca2+  dependent.  
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Figure   4.21.   Localisation   of   exogenously   expressed   Ca2+-­‐binding   deficient  mutants   of   CaBP7   and  
CaBP8  compared  with  the  wild-­‐type  proteins.  A-­‐C)  HeLa  cells  exogenously  co-­‐expressing  wild-­‐type  
EYFP-­‐CaBP7  (green)  with  either  A)  a  CaBP7  mutant  which  cannot  bind  Ca2+  at  EF1  (mCh-­‐CaBP7  EF1',  
red),  B)  a  CaBP7  mutant  which  cannot  bind  Ca2+  at  EF2  (mCh-­‐CaBP7  EF2',  red)  or  D)  a  CaBP7  mutant  
which  cannot  bind  Ca2+  at  either  EF1  or  EF2  (mCh-­‐CaBP7  EF1'  EF2',  red).  D-­‐F)  HeLa  cells  exogenously  
co-­‐expressing  wild-­‐type  EYFP-­‐CaBP8  (green)  with  either  D)  a  CaBP8  mutant  which  cannot  bind  Ca2+  at  
EF1  (mCh-­‐CaBP8  EF1',  red),  E)  a  CaBP8  mutant  which  cannot  bind  Ca2+  at  EF2  (mCh-­‐CaBP8  EF2',  red)  
or   F)   a   CaBP8   mutant   which   cannot   bind   Ca2+   at   either   EF1   or   EF2   (mCh-­‐CaBP8   EF1'   EF2',   red).  
Regions  of  co-­‐localisation  appear  yellow  in  merged  images.  Scale  bars  ????????  
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4.2.13.  Localisation  of  potential  lysosomal  targeting  mutants  of  CaBP7  and  CaBP8  
The  primary  sequences  of  CaBP7  and  CaBP8  were  searched  for  motifs  which  could  
be   responsible   for   targeting   to   lysosomal   membranes.   Sorting   information   for  
known   lysosomal  membrane   proteins   is   encoded   in   their   short   cytoplasmic   tails.  
LIMP2  utilises  a  dileucine  motif,  whereas  LAMP1,  LAMP2,  CD63,  LIMP1  and  LAP  all  
utilise   tyrosine  motifs   of   the   form  Y-­‐X-­‐X-­‐??????????? ??? ???? ??????????? ?????? ?????
hydrophobic   residue   (Obermuller   et   al.,   2002).   CaBP7   and   CaBP8   each   possess   a  
number   of   potential   dileucine   and   tyrosine   motifs   which   may   each   contribute  
towards  effective  lysosomal  targeting.  Only  one  tyrosine  motif  appears  at  the  same  
position  in  both  CaBP7  and  CaBP8  when  compared  in  multiple  sequence  alignments  
although  the  exact   sequence  of  the  motif   is  not   identical.   In  CaBP7,  the  sequence  
LLYDTF   is   located  47   amino  acids   from   the   start   of   the  TMD  and   consists  of   both  
dileucine   and   tyrosine   sorting   motifs.   In   CaBP8   the   corresponding   sequence,  
ILYHAF,   resides  48  amino  acids   from  the  start  of   the  TMD.  The  effect  of  mutating  
the  potential   lysosomal   targeting  motifs  was  examined  by  changing  LLY   to  AAA   in  
CaBP7   and   LY   to   AA   in   CaBP8.   Protein   localisation   was   unaffected   by   these  
mutations   as   illustrated   by   extensive   overlap   of   each   mutant   with   the  
corresponding   wild-­‐type   protein   (Figure   4.22A   and   B).   In   addition,   the   tyrosine  
sorting  mutants  colocalised  with  antibody  staining  for  the  late  endosome/lysosomal  
markers  CD63  and  LAMP1  (Figure  4.22C  and  D).  These  data  indicated  that  mutation  
of  potential  tyrosine  motifs  in  CaBP7  and  CaBP8  had  no  significant  effect  upon  their  
localisation  to  lysosomes.  As  previously  described  in  section  4.2.10,  the  TMD  alone  
was   sufficient   to   target   normally   cytosolic   proteins   to   the   same   subcellular  
compartments   as   labeled   by   the   wild-­‐type   protein.   It   therefore   follows   that   any  
targeting  motifs  preceding   the  TMD  are  unlikely   to  have  a  substantial  effect  upon  
targeting  of  these  proteins  to  lysosomal  membranes.  Tyrosine  motifs  along  with  the  
dileucine  motifs  present  in  these  proteins  may  however  confer  more  subtle  effects  
in  modulating  the  targeting  efficiency  of  these  proteins.  The  trafficking  dynamics  of  
the   tyrosine   mutants   compared   to   the   wild-­‐type   proteins   was   not   examined   in  
detail  here.  
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Figure  4.22.  Localisation  of  exogenously  expressed      tyrosine  motif     mutants  of  CaBP7  and  CaBP8  
compared  with  the  wild-­‐type  proteins  and  lysosome  specifc  markers.  A)  HeLa  cells  co-­‐expressing  a  
CaBP7  tyrosine  mutant  tagged  with  mCherry  (mCherry-­‐CaBP7  lyso,  red)  and  wild-­‐type  CaBP7  protein  
tagged  with  YFP   (EYFP-­‐CaBP7,  green).  B)  HeLa  cells   co-­‐expressing  a  CaBP8   tyrosine  mutant   tagged  
with  mCherry  (mCherry-­‐CaBP8  lyso,  red)  and  wild-­‐type  CaBP8  protein  tagged  with  YFP  (EYFP-­‐CaBP8,  
green).   C)  HeLa   cells   expressing  mCherry-­‐CaBP7   lyso   and   immunostained  with   the   late   endosome  
and   lysosome   specific   marker,   CD63   (Anti-­‐CD63,   FITC,   green).   D)   HeLa   cells   expressing   mCherry-­‐
CaBP8  lyso  and  immunostained  with  the  late  endosome  and  lysosome  specific  marker,  LAMP1  (Anti-­‐
LAMP1,  FITC,  green).  Regions  of  co-­‐localisation  appear  yell?????? ??????? ?????????????????????????  
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4.3.  Discussion  
The  findings   in  this  chapter  highlight  the   importance  of  the  single  transmembrane  
segment   found   in   the   extreme   C-­‐termini   of   CaBP7   and   CaBP8   for   normal   protein  
localisation   in   both   neuronal   and   non-­‐neuronal   cell   types.   In   differentiated   N2A  
cells,   CaBP7   and   CaBP8   localised   to  membranes   of   the   TGN   as   evidenced   by   co-­‐
localisation  with  TGN  specific  markers.  The  existence  of  a  17  amino  acid  TMD  was  
initially   identified  through  examination  of  the  primary  amino  acid  sequence  of  the  
proteins   using   the   online   TMD   prediction   server,   TMPred.   The   location   of   the  
putative   TMDs   10   amino   acids   from   the   C-­‐termini   of   the   proteins   suggested   that  
CaBP7  and  CaBP8  might  belong  to  a  specific  sub-­‐class  of  integral  membrane  protein,  
the  TA  proteins.  The  relevance  of  the  predicted  TMDs  for  correct  protein  targeting  
was  assessed  by  the  design  of  specific  TMD  mutants.  CaBP7  and  CaBP8  lacking  their  
TMDs  were  completely  cytosolic  and  unable  to  associate  with  cellular  membranes.  
As   the   removal   of   the   C-­‐terminus   could   have   potentially   affected   protein-­‐folding  
leading   to   mislocalisation,   the   properties   of   these   domains   were   investigated  
further.   Substitution   of   the   central   three   amino   acids   within   the   TMD   to   lysine  
residues   was   predicted,   using   the   TMPred   algorithm,   to   completely   abolish   TMD  
function.  Proteins  containing  this  mutation  targeted  less  efficiently  than  their  wild-­‐
type   counterparts   when   expressed   in   N2A   cells.   The   lysine  mutants   exhibited   an  
increase   in   cytosolic   localisation   coupled   to   diminished   membrane   association  
which  was  more   severe   for  CaBP7TMDKKK   than   for  CaBP8TMDKKK.  These  data  verified  
that   the   putative   TMDs  were   necessary   for   the   normal   subcellular   localisation   of  
CaBP7   and   CaBP8.   It   is   possible   that   amino   acid   sequences   flanking   the   TMD   are  
responsible   for  mediating   the  residual  membrane  association  observed   for  CaBP8.  
As   such,   the   minimal   domain   requirement   for   PM   trafficking   of   the   TA   protein,  
syntaxin   1A,   includes   the   TMD   and   a   number   of   positively   charged   residues  
preceding  the  TMD.  Truncation  mutants  encoding  the  TMD  and  lacking  the  flanking  
charged  residues  distributed  in  a  pattern  resembling  the  ER  (Hong,  2005).    
  
To  evaluate  whether  the  TMDs  alone  were  sufficient  to  correctly  target  the  proteins  
to   subcellular   membranes,   chimeras   of   normally   cytosolic   proteins   fused   to   the  
TMD   containing   C-­‐termini   of   CaBP7   and   CaBP8   were   generated.   CaBP5   chimeras  
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were   able   to   localise   to   subcellular   compartments   with   a   distribution   strongly  
resembling  that  of  wild-­‐type  CaBP7  and  CaBP8.    Direct  fusion  of  the  TMD  of  CaBP7  
to   mCherry   also   efficiently   targeted   the   fluorescent   protein   to   subcellular  
membranes.  Cumulatively,  these  data  illustrated  that  the  hydrophobic  C-­‐termini  of  
CaBP7  and  CaBP8  are  necessary   and   sufficient   for   correct  membrane   targeting  of  
these   proteins   and   that   both   proteins   appear   to   possess   a   functional   TMD   at   a  
location  in  the  peptide  which  is  consistent  with  TA  protein  architecture.  
  
To   rigorously   demonstrate   that   CaBP7   and   CaBP8   possess   a  membrane-­‐spanning  
domain   and   classify   them   as   true   TA   proteins,   a   series   of   experiments   were  
performed   to   assess   their  membrane   topology.   Trypsin   protection   assays   in  HeLa  
cells   transfected  with   CaBP7  or   CaBP8   tagged  N-­‐   or   C-­‐terminally  with   fluorescent  
protein  variants  demonstrated   that  only  C-­‐terminal   tags  were  afforded  protection  
from  proteolysis.  This  observation  implied  that  the  N-­‐termini  of  the  proteins  reside  
within   the   cytosol   and  were   freely   accessible   to   trypsin   digestion  whereas   the   C-­‐
termini  were   shielded   from   proteolysis  within   the   lumen   of   the   TGN.   These   data  
confirm  that  the  TMDs  of  CaBP7  and  CaBP8  fully  insert  across  the  lipid  bilayer  and  
that  the  proteins  adopt  the  standard  TA  topology  with  a  relatively  long  cytosolic  N-­‐
terminus  and  short  luminal  C-­‐terminus.    
  
Addition  of  a  26  kDa  GFP-­‐based  fluorescent  tag  to  the  C-­‐terminus  of  TA  proteins  has  
the  potential  to  cause  aberrant  processing  and  membrane  insertion  of  the  protein.  
Positioning  of  the  TMD  less  than  30  amino  acids  from  the  carboxyl  terminus  in  TA  
proteins   dictates   that   these   proteins   are   inserted   into   membranes   post-­‐
translationally.   Extending   the   C-­‐terminus   of   TA   proteins   so   that   the   TMD   is   no  
longer  in  such  close  proximity  to  the  extreme  C-­‐terminus  may  result  in  the  protein  
being  inserted  co-­‐translationally  as  a  type  II  membrane  protein.  To  ensure  that  the  
results  of  trypsin  protection  assays  were  not  an  artefact  of  extending  the  C-­‐termini  
of  the  proteins,  variants  of  CaBP7  and  CaBP8  with  a  N-­‐terminal  mCherry  tag  and  a  
C-­‐terminal  myc  tag  were  generated.  Addition  of  the  myc  tag  extended  the  C-­‐termini  
of   CaBP7   and   CaBP8   to   only   20   amino   acids   so   should   not   affect   the   post-­‐
translational  membrane  insertion  of  either  protein.  The  accessibility  of  the  mCherry  
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tag  and  the  myc  epitope  in  cells  transfected  with  these  variants  was  assessed  under  
different   membrane   permeabilisation   conditions.   As   expected,   in   controls   where  
total   cellular   membranes   were   non-­‐specifically   permeabilised   using   Triton   X-­‐100,  
both   tags  were   accessible   to   their   respective   antibodies.   However,  when   the   PM  
was  selectively  permeabilised  with  digitonin,  only  the  N-­‐terminal  mCherry  tag  was  
accessible  and  no  anti-­‐myc   immunostaining  was  detectable.  Hence,   in  accordance  
with   trypsin   protection   data,   CaBP7   and   CaBP8   have   a   cytosolically   accessible   N-­‐
terminal   domain,   a   single   transmembrane-­‐spanning   segment   and   a   luminal   C-­‐
terminal   tail,   and   can   be   classified   as   true   TA   proteins.   CaBP7   and   CaBP8   might  
therefore   be   inserted   into   membranes   post-­‐translationally   via   a   dedicated   TA  
specific  mechanism  (Borgese  et  al.,  2003).  
  
Tethering   of   CaBP7   and   CaBP8   to   membranes   through   a   C-­‐terminal   tail   anchor  
represents  a  novel  example  of  how  CaM-­‐related  Ca2+-­‐sensing  proteins  have  evolved  
distinct   targeting   strategies   to   permit   their   sorting   into   specific   target   organelles.  
The   Ca2+-­‐sensing   protein   subfamily   comprising   CaBP7   and  CaBP8   appears   to   have  
arisen   with   the   divergence   of   vertebrate   species   (McCue   et   al.,   2010a)   and,  
interestingly,   examination   of   the   number   of   TA   proteins   in   yeast   and   humans  
indicates   an   expansion   of   this   type   of   protein   during   the   evolution   of   higher  
organisms:  55  TA  proteins  can  be  identified  in  yeast  (Beilharz  et  al.,  2003),  but  over  
300  are  present  in  humans  (Kalbfleisch  et  al.,  2007).  TA  proteins  represent  2.02%  of  
all  coding  open  reading  frames  in  the  human  genome  (Borgese  and  Righi,  2010)  and  
have   been   implicated   in   many   important   aspects   of   cell   physiology   including  
mitochondrial  function,  apoptosis  and  vesicular  trafficking  (Stefer  et  al.,  2011).  
  
Insertion  of  most  transmembrane  proteins  into  biological  membranes  requires  the  
activity   of   protein-­‐conducting   channels   which   facilitate   the   translocation   of   the  
exoplasmic   domain   and   integration   of   the   hydrophobic   transmembrane   segment  
into   the   lipid   bilayer   (Hong,   2005).   Translocon   proteins   themselves   must   also  
become   integrated   into   the   ER  membrane   and   so   the   question   arises   concerning  
how   this   machinery   can   be   initially   inserted   in   the   absence   of   any   assistance  
(Brambillasca  et  al.,  2006)??????????????????????????????????????????????????????????
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the  translocon  machinery  and  are  also  TA  proteins  (Favaloro  et  al.,  2010,  Falcone  et  
al.,  2011).  TA  proteins  are  conserved  throughout  evolution  and  may  represent  one  
of  the  most  primitive  mechanisms  for  membrane  association.  Therefore  this  class  of  
protein  may   have   arisen   before   the   evolution   of   translocon   channels.   As   such,   a  
number   of   prokaryotic   TA   proteins   and   at   least   one   eukaryotic   TA   protein,  
cytochrome  b5,  can  insert  unassisted  into  protein-­‐free  lipid  bilayers  (van  Dalen  and  
de   Kruijff,   2004,   Brambillasca   et   al.,   2005).   Various   studies   have   examined   the  
requirement   of   co-­‐factors   during   post-­‐translational   membrane   insertion   of   TA  
proteins   and   at   least   three   distinct   pathways   have   been   described   (Rabu   et   al.,  
2009,  Borgese  and  Fasana,  2011).  The  membrane  insertion  pathway  for  a  particular  
TA   protein   appears   to   be   dictated   by   the   degree   of   hydrophobicity   within   the  
transmembrane  helix  (Kalbfleisch  et  al.,  2007).  Based  on  the  hydrophobicity  scores  
of   the   TMDs   of   CaBP7   and   CaBP8   (50.7   and   48.1   (Kyte   and   Doolittle,   1982),  
respectively)   it   can   be   speculated   that   they   might   utilise   either   the   Asna-­‐1  
(Stefanovic  and  Hegde,  2007)  or  signal  recognition  particle  (SRP)  (Abell  et  al.,  2004)  
mediated  pathway  for  membrane  insertion.  As  such,  a  recent  study  has  reported  a  
direct   interaction  of  CaBP8  and  Asna-­‐1  (Hradsky  et  al.,  2011).  This   interaction  was  
confirmed   through   heterologous   co-­‐immunoprecipitation   experiments,   co-­‐
purification   of   co-­‐expressed   recombinant   proteins,   proximity   ligation   assays   and  
bioluminescence   resonance  energy   transfer   (BRET).  Weak   immunoprecipitation  of  
Sec61??? ?? ???????? ??? ???? ?????? ???????? ?????????????? ?????????????? ??? ???????????
with   the   SRP   complex,   was   also   observed   (Hradsky   et   al.,   2011).  Whether   these  
proteins  are  required  for  membrane  insertion  of  CaBP7  or  CaBP8  has  not  yet  been  
investigated.  
  
The   CaBP7   and  CaBP8  membrane   topology  determined   in   this   study   is   consistent  
with  a  reported  interaction  with  the  cytosolic  enzyme  PI4K,  an  important  regulator  
of   TGN   to   PM   trafficking   (Mikhaylova   et   al.,   2009).   NCS-­‐1   is   also   an   important  
effector  in  this  pathway  but  associates  with  the  TGN  membrane  via  an  N-­‐myristoyl  
group.   CaBP7   and   CaBP8   inhibit   the   activity   of   PI4K   at   resting   [Ca2+]i   causing   a  
decrease   in   PI(4,5)P2   production   and   a   concomitant   decrease   in   TGN   to   PM  
trafficking.  Upon  [Ca2+]i  elevation,  NCS-­‐1  competes  with  CaBP7  or  CaBP8  for  binding  
     139  
to   PI4K   and   activates   the   enzyme   thereby   increasing   TGN   to   PM   trafficking  
(Mikhaylova   et   al.,   2009).      Both   NCS-­‐1,   and   CaBP7/CaBP8   are   therefore   able   to  
localise   to   the   same   subcellular   compartment   and   regulate   the   same   effector  
despite   being   targeted   through   unique   membrane   association   mechanisms.   This  
raises   the   question   of   why   distinct   membrane   association   mechanisms,   which  
ultimately  target  related  Ca2+-­‐binding  proteins  to  the  same  organelle,  have  evolved.  
One  hypothesis   is   that  the  diversification   in  membrane  targeting  permits  different  
Ca2+-­‐sensors   to   associate   with   different   membrane   microdomains.   In   addition,  
although   related   Ca2+-­‐sensors   may   co-­‐localise   when   at   the   TGN,   their   post-­‐Golgi  
trafficking  routes  are  often  unique  suggesting  that  they  may  associate  with  distinct  
classes   of   transport   vesicle   and/or   sorting  machineries.   Differences   in  membrane  
targeting  mechanisms   could   therefore   influence   the  wider   cellular   distribution   of  
particular   Ca2+-­‐sensors   to   different   subcellular   platforms   thereby   specifying   the  
target-­‐proteins  available  for  interaction.    
  
No   other   CaM-­‐related   small   EF   hand   containing   Ca2+-­‐binding   proteins   have   been  
reported   to   localise   via   a   tail   anchor   suggesting   this  may   be   a   feature   unique   to  
CaBP7   and   CaBP8.   Other   unrelated   EF-­‐hand   containing   proteins,   however,   have  
been  reported  which  target  in  this  manner.  The  mitochondrial  Rho  GTPases,  Miro-­‐1  
and  Miro-­‐2  each  have  two  GTPase  domains  separated  by  a  linker  containing  a  pair  
of  EF-­‐hands  and  are  localised  to  the  outer  mitochondrial  membrane  by  a  C-­‐terminal  
tail  anchor  (Fransson  et  al.,  2006).  Members  of  the  TA  family  of  membrane  proteins  
are  specifically  directed  to  either  the  ER  or   to   the  mitochondrial  outer  membrane  
for  membrane  insertion  depending  on  the  composition  of  their  TMD.  As  such  some  
TA   proteins   display   a   dual   localisation   and   are   able   to   target   to   both   organelles  
(Borgese  et  al.,  2001).  No  colocalisation  was  observed  between  mCherry-­‐CaBP7  and  
antibodies   for   specific  mitochondrial   or   ER  markers.  mCherryCaBP7TMD,   however,   in  
addition   to   targeting   in   a   similar   distribution   to   wild-­‐type   CaBP7   in   many   cells,  
accumulated  in  a  reticular  pattern  in  other  cells,  where  it  co-­‐localised  with  calnexin,  
an   ER   resident   marker.   Although   this   accumulation   is   likely   to   be   an   effect   of  
overexpression,   it  hints  that  CaBP7  might  first  be   inserted  post-­‐translationally   into  
the   ER  membrane   and   subsequently   trafficked   through   the  Golgi   to   the   TGN   and  
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other  vesicular  structures.  As  such,  other  TA  proteins  are  found  in  compartments  of  
the  secretory  and  endocytic  pathways  and  include  members  of  the  SNARE  family  of  
proteins  (Hong,  2005).  
  
Data  presented  in  this  chapter  has  since  been  confirmed  by  the  work  of  Hradsky  et  
al.   (Hradsky   et   al.,   2011).   This   groupinvestigated   the   membrane   topology   of  
overexpressed   CaBP8   at   the   PM   by   assessing   the   accessibility   of   an   N-­‐   or   C-­‐
terminally   fused   GFP   tag   to   a   GFP   antibody   in   live,   unpermeabilised   cells.   In  
accordance  with  the  data  presented  in  this  chapter,  CaBP8  possessed  a  cytosolic  N-­‐
terminus   and   an   extracellular   C-­‐terminus.   PM   localisation   of   CaBP7   and   CaBP8  
appears   to   be   an   artefact   of   overexpression,   however,   as   when   HeLa   cells   are  
immunostained  for  endogenous  CaBP7,  no  signal  is  detected  at  the  PM  (Figure  4.6).  
Additionally,  Hradsky  et  al.   repeated   the   fluorescence  protease  protection  assays,  
as  presented  in  this  chapter,  and  were  able  reproduce  the  same  effect.  Hradsky  et  
al.   also   made   a   number   of   TMD   mutants   to   deduce   the   minimal   domain  
requirement  for  correct  subcellular  targeting  of  CaBP7  and  CaBP8.  mCherry  fused  to  
the  17  amino  acid  TMD  predicted  by  TMPred  was  able  to  correctly  localise  a  pool  of  
CaBP7  and  CaBP8  to  the  TGN  but  many  cells  exhibited  a  diffuse  cytosolic  localisation  
or   ER   localisation   in   COS-­‐7   cells.   Hradsky   et   al.   suggested   that   a   longer   TMD  
segment   might   be   required   for   correct   localisation   and   found   that   fusion   of   a  
proposed   23   amino   acid   TMD   (CaBP8   192-­‐214)   was   able   to   improve   Golgi  
recruitment  of  CaBP8  compared  to  the  17  amino  acid  fusion.  In  accordance  with  the  
data   shown   in   this   chapter,   Hradsky   et   al.   found   that   fusion   of   the   full   length   C-­‐
terminal  region  of  CaBP8  containing  the  TMD  was  able  to  efficiently  localise  GFP  to  
the  Golgi.   The   ER   localisation   of   the   17   amino   acid   TMD  GFP   fusion   is   consistent  
with  the  ER  localisation  of  the  C-­‐terminal  domain  mCherry  fusion  presented  in  this  
chapter.  This  is  in  agreement  with  initial  CaBP7  and  CaBP8  insertion  into  the  ER  and  
subsequent   trafficking   to  Golgi   and   post-­‐Golgi   compartments.   In   accordance  with  
this   Hradsky   et   al.   found   that   treatment   of   cells   overexpressing   CaBP8   with  
brefeldin  A  to  disrupt  ER  to  Golgi  transport  caused  CaBP8  to  accumulate  in  the  ER.  
The  work  of  Hradsky  et  al.   is   therefore   consistent  with   the  data  presented   in   this  
thesis.  There  is,  however,  some  discrepancy  about  the  length  of  the  TMD.  Hradsky  
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et   al.   suggest   that   the   length   of   the   TMD   is   critical   for   the   correct   localisation  of  
CaBP7   and  CaBP8,   however,   the   ER   localisation   of   the   17   amino   acid   TMD   fusion  
protein  suggests  it  is  sufficient  for  membrane  insertion.  An  alternative  viewpoint  is  
that   the   short   luminal   tail  of  CaBP7  and  CaBP8  may  encode   targeting   information  
which   is   essential   for   their   correct   subcellular   localisation.   Further   work   will   be  
required  to  distinguish  between  these  possibilities.  
  
Immunostaining  with  an  anti-­‐CaBP7  antibody  confirmed  observations  from  a  recent  
high  throughput  siRNA  screen  (Neumann  et  al.,  2010)  that  HeLa  cells  express  CaBP7  
endogenously.  The  localisation  of  CaBP7  and  CaBP8  was  therefore  further  examined  
in   HeLa   cells   which   are   amenable   to   high-­‐resolution   subcellular   localisation  
analyses.   Co-­‐localisation   studies  demostrated   that  both  CaBP7  and  CaBP8   localise  
to  the  same  subcellular  structures.  In  addition,  the  over-­‐expressed  and  endogenous  
proteins   also   colocalised   and   the   fluorescent   tag   variant   used   did   not   affect   the  
localisation  of  either  protein.  As  in  N2A  cells,  CaBP7  and  CaBP8  co-­‐localised  with  a  
marker  of   the  TGN,  p230,   in  many  cells,  however   in  others   little  co-­‐localisation  at  
the  TGN  was  observed  with  most  of   the  protein   localised   to   intracellular   vesicles.  
Intracellular   vesicles   were   also   observed   in   N2A   cells   over-­‐expressing   CaBP7   or  
CaBP8,  however  the  smaller  cell  bodies  and  more  rounded  morphology  meant  that  
these  structures  were  less  well  distributed  and  appeared  to  accumulate  near  to  the  
TGN.    
  
The  identity  of  CaBP7  and  CaBP8  positive  intracellular  vesicles  was  investigated  first  
by  co-­‐expression  of  CaBP7  and  CaBP8  with  colour  tagged  variants  of  three  specific  
organelle  markers.  No  co-­‐localisation  was  observed  with  either  the  early  endosome  
marker,   Rab5a,   or   a   marker   of   autophagosomes,   LC3?.   Extensive   overlap   was,  
however,   observed   in   the   distribution   of   CaBP7   and   CaBP8   with   the   lysosomal  
marker   LAMP1.   To   confirm   this   localisation,   CaBP7   transfected   cells   were  
immunostained  with  antibodies  for  vesicle  specific  markers.  No  co-­‐localisation  with  
the   endosome/MVB  marker,   HRS,   the   recycling   endosome  marker,   Rab11,   or   the  
endosome   marker,   M6PR,   was   observed.   Extensive   co-­‐localisation   with   the   late  
endosome/lysosome   markers,   CD63   and   LAMP1   was,   however,   observed.  
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was   complete   co-­‐localisation   between   CaBP7   and   acidic   compartments   including  
lysosomes.   HeLa   cells   immunostained   for   CaBP7   and   either   CD63   or   LAMP1  
confirmed   that   endogenous   protein   shares   this   localisation.   Lysosomes   are  
membrane-­‐bound  organelles  containing  hydrolytic  enzymes  which  are  most  active  
at  acidic  pH  and  can  be  distinguished  from  endosomes  due  to  the  absence  of  M6PR  
(Luzio  et   al.,   2001).   Therefore   the   absence   of   co-­‐localisation   of   exogenous   CaBP7  
with  endogenous  M6PR  is  consistent  with  a  predominantly  lysosomal  localisation.  
  
Lysosomes  are  generally  regarded  as  the  terminal  degradation  compartment  of  the  
endocytic   pathway   with   important   roles   in   phagocytosis,   autophagy,   crinophagy  
and   the   proteolysis   of   cytosolic   proteins   transported   across   the   lysosomal  
membrane  (Luzio  et  al.,  2001).  Advances  in  the  understanding  of  how  endocytosed  
material   is   delivered   to   lysosomes   and   the  discovery   of   other   important   roles   for  
lysosomes,   for   instance   in   secretion,   have   challenged   the   classical   view   of  
lysosomes   simply   as   the   waste   disposal   sites   of   the   cell   (Luzio   et   al.,   2007).   In  
mammalian   cells,   dynamic   interactions   between   compartments   of   the   late  
endocytic   pathway   results   in   heterogeneity   between   organelles   constituting   late  
endosomes   and   lysosomes.   It   has   been   suggested   that   late   endosomes   and  
lysosomes   may   fuse   to   form   hybrid   organelles   allowing   the   degradation   of  
components   carried   by   the   endosome   before   subsequent   reformation   of   the  
lysosome   (Luzio   et   al.,   2000).   Using  markers   of   various   compartments  within   the  
endo-­‐lysosomal   pathway,   the   data   presented   in   this   chapter   demonstrate   that  
CaBP7  does  not  localise  to  early  endosomes  (Rab5a),  recycling  endosomes  (Rab11),  
MVBs   (HRS),   or   M6PR   positive   late   endosomes.   Convincing   co-­‐localisation   with  
???????????????????????????????????????????????????????-­‐localisation  with  M6PR,  
suggests   that   the  majority  of  CaBP7  resides   specifically  on   lysosomes.   In  addition,  
extensive  co-­‐localisation  of  CaBP7  and  the   late-­‐endosomal  and   lysosomal   resident  
TA  protein,  VAMP7,  was  observed.  VAMP7   (also  known  as  TI-­‐VAMP)   is  a   v-­‐SNARE  
which   is   involved   in  both  exo-­‐  and  endocytosis  and   in   late-­‐endosome-­‐to-­‐lysosome  
transport.   Like,   CaBP7,   VAMP7   localisation   to  membranes   requires   its   C-­‐terminal  
tail   anchor,  however   correct   subcellular   targeting  of  VAMP7,   as  with  other  VAMP  
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proteins  (Zeng  et  al.,  2003),  relies  on  sequence  information  encoded  in  its  cytosolic  
N-­‐terminal   domain   ?   the   longin   domain   (Martinez-­‐Arca   et   al.,   2003).   The   longin  
domain  mediates  VAMP7  localisation  to  late  endosomes  and  lysosomes  through  an  
interaction  with  the  adaptor  protein,  AP3  (Martinez-­‐Arca  et  al.,  2003),  and  correct  
localisation   of   other   late   endosomal   and   lysosmal   markers   including   LAMP1   and  
CD63  are  also  dependent  on  AP3  (Nishimura  et  al.,  2002,  Dell'Angelica  et  al.,  1999).  
It  will  be  interesting  to  deduce  whether  CaBP7  traffics  through  a  similar  pathway  in  
future  work.  
  
Extensive   overlap   of   ts045   VSVG-­‐GFP   and   CaBP7   was   observed   in   both   N2A   and  
HeLa   cells.   Hradsky  et   al.   also   observed   overlap   in   the   localisation   of   CaBP8  with  
GFP-­‐VSVG   at   the   Golgi   and   in   post-­‐Golgi   intermediates   and   suggest   that   CaBP8  
trafficks  to  the  PM  via  the  same  secretory  pathway  as  VSVG  (Hradsky  et  al.,  2011).  
VSVG  is  commonly  used  as  a  marker  of  CSVs,  however  immunostaining  of  HeLa  cells  
overexpressing   ts045   VSVG-­‐GFP   with   CD63   and   LAMP1   demonstrated   a   late  
endosomsal   and   lysosomal   distribution   for   this   protein.   In   addition,   no   co-­‐
localisation  was  observed  with  SNAP29,  a  post-­‐Golgi  SNARE  which  has  been  shown  
to  be  important  in  constitutive  secretion  (Gordon  et  al.,  2010).  SNAP29  localised  to  
the  PM  and  PM  ruffles  which  is  consistent  with  previous  observations  (Wong  et  al.,  
1999,  Su  et  al.,  2001,  Feldmann  et  al.,  2009)  and  also   localised  to  numerous  small  
punctate  structures  which  may  be  consistent  with  a  pool  of  CSVs.  The  exact  identity  
of   these   vesicles   remains   to   be   determined,   however.   Therefore   these   data  
demonstrate   that  both  CaBP7  and  VSVG   reside  on   vesicles  of   the   late   endosomal  
and   lysosomal   pathway   and   that   VSVG   localisation   is   not   specific   to   CSVs.  
Interestingly,   export   of   both  VSVG   and   LAMP1   from   the   TGN   is  mediated   by  AP3  
and  overexpression  of  VSVG  was  found  to  saturate  the  AP3  machinery  and  caused  
LAMP1  to  traffic  to   lysosomes  via  an  alternative  pathway   (Nishimura  et  al.,  2002).  
Overexpression  of  VSVG  can  therefore  cause  undesirable  trafficking  artefacts  when  
examining  the  subcellular  localisation  of  proteins.  
  
As   some   members   of   the   NCS   protein   family   have   been   shown   to   display   Ca2+-­‐
dependent  membrane  association  via   their  N-­‐myristoyl  chains,   the  dependence  of  
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CaBP7  and  CaBP8  localisation  upon  Ca2+-­‐binding  was  assessed  by  creating  a  number  
of   Ca2+-­‐binding   defective  mutants.   Variants  with  mutations   in   one   or   both   of   the  
functional   EF-­‐hands   of   CaBP7   and   CaBP8   were   able   to   localise   to   the   same  
subcellular   compartments   as   wild-­‐type   protein   illustrating   that   localisation   to  
lysosomes   is   Ca2+-­‐independent.   Similarly,   treatment   of   HeLa   cells   overexpressing  
either   CaBP7   or   CaBP8   with   the   Ca2+   ionophore   ionomycin,   in   the   presence   of  
extracellular   Ca2+   to   elevate   [Ca2+]i,   had   no   effect   on   the   localisation   of   either  
protein  (data  not  shown).  
  
Lysosomal  membrane  proteins  have  been  discovered  to  possess   specific   targeting  
motifs   which   are   essential   for   their   correct   intracellular   compartmentalization.  
These  motifs  are  typically  either  tyrosine  based  of  the  form  Y-­‐X-­‐X-­‐??????????????????
?????? ????? ???? ?? ??? ??? ?????? ????? ????? ?? ???????????? ????? ??????? ??? ??????????
based  in  the  form,  L-­‐X,  where  X  can  be  L,  I,  M,  V  or  F  (Bonifacino  and  Traub,  2003).  
These  motifs  are  recognized  by  the  clathrin  adaptor  protein  complexes  AP-­‐1,  AP-­‐2,  
AP-­‐3   and   AP-­‐4,   which   bind   to   these   sites   on   transmembrane   proteins   and   direct  
their  correct  compartmentalization  (Bonifacino  and  Traub,  2003).  CaBP7  and  CaBP8  
possess  motifs   of   both  classes  however  only  one  appears  at   the   same  position   in  
both   proteins.   As   these   proteins   display   63%   sequence   identity   (McCue   et   al.,  
2010a)   and   appear   to   traffic   identically   it   was   decided   to   study   the   effect   of  
mutating   this   common  motif   only.   No   significant   difference   was   observed   in   the  
localisation  of   the   tyrosine  motif  mutants  of  CaBP7  and  CaBP8  when  compared   in  
co-­‐transfections   with   the   wild-­‐type   proteins   or   when   transfected   cells   were  
immunostained  with  the  lysosomal  markers,  CD63  or  LAMP1.  As  such,  chimaeras  of  
CaBP7   and   CaBP8   TMDs   fused   to   normally   cytosolic   proteins   co-­‐localised   with  
endogenous  CaBP7  indicating  that  motifs  encoded  in  the  N-­‐terminus  of  the  protein  
are  not  required  for  correct  localisation.  It  is  possible,  however,  that  the  numerous  
tyrosine  and  dileucine  motifs  found  in  the  cytosolic  domain  of  CaBP7  (two  tyrosine  
and  four  dileucine  motifs)  and  CaBP8  (one  tyrosine  and  two  dileucine  motifs)  may  
contribute  more  subtly   to   the   localisation  of  these  proteins.  A  detailed  analysis  of  
the  trafficking  dynamics  of  the  tyrosine  mutants  would  clarify  this  issue.    
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No  lysosomal  membrane  proteins  shown  to  require  tyrosine  or  dileucine  motifs  for  
targeting  are  TA  proteins.  As  CaBP7  and  CaBP8  are  TA  proteins  which  are  processed  
differently   to   other   types   of   membrane   protein,   they   may   also   require   different  
motifs  for  lysosomal  targeting.  There  do  not  appear  to  be  strict  rules  governing  how  
TA  proteins  are  localised  and  examples  exist  showing  the  importance  of  numerous  
different   domains   depending   on   the   individual   protein.   The   length   and  
hydrophobicity   of   the   TMD   has   been   shown   to   influence   the   targeting   of   TA  
proteins.   Proteins   with   longer   or   more   hydrophobic   TMDs   are   more   likely   to   be  
targeted  to  the  cell  surface  and  proteins  with  shorter  or  less  hydrophobic  TMDs  are  
more   likely  to  reside  within  the  ER   (Pedrazzini  et  al.,  1996,  Bulbarelli  et  al.,  2002).  
The  late  endosome  resident  SNARE  protein,  VAMP7  has  been  shown  to  require  its  
N-­‐terminal  domain  for  correct  targeting  to   late  endosomal  vesicles   (Martinez-­‐Arca  
et  al.,  2003)  whereas  the  luminal  domain  of  cytochrome  b5  has  been  shown  to  be  
essential   for   its   retention   within   the   ER   (Honsho   et   al.,   1998).   A   more   detailed  
analysis   of   the   domains   required   for   CaBP7   and   CaBP8   localisation   is   needed   in  
order  to  understand  how  these  proteins  are  able  to  specifically  target  to  lysosomes.  
  
As   previously   discussed   a   number   of   new   roles   for   lysosomes   have   recently  
emerged.   Of   particular   importance   is   the   growing   evidence   that   lysosomes   can  
store   Ca2+   at   similar   concentrations   to   that   found   in   the   lumen   of   the   ER  
(Gerasimenko  and  Tepikin,  2005).  Research  to  date  indicates  that  NAADP  stimulates  
Ca2+  release  from  highly  localised  and  discrete  areas  of  the  cell  through  binding  to  a  
Ca2+-­‐releasing  receptor  on  lysosomes  (Galione  et  al.,  2010).  It  has  become  apparent  
that  NAADP-­‐induced  Ca2+  signals  often  act  as  a  trigger  for  regenerative  Ca2+  waves  
through  stimulation  of  IP3Rs  or  RyRs  on  the  ER  by  a  CICR  mechanism  (Brailoiu  et  al.,  
2010).  Recent  progress  has  identified  the  two  pore  channel  (TPC)  family  of  proteins  
as   NAADP   activated   receptors   which   are   resident   in   the   membranes   of   acidic  
compartments   (Zhu  et  al.,   2010b).  The  TPCs  are   a   family  of  Ca2+   release   channels  
which   are   related   to   voltage   dependent   Ca2+   and  Na+   channels.   Three   TPC   genes,  
TPCN1-­‐3,  have  been   identified   in  vertebrate  species  but  key   findings   indicate   that  
TPC2   underpins   NAADP-­‐induced   Ca2+   release   from   lysosomal   stores   (Ruas   et   al.,  
2010,  Zhu  et  al.,  2010a,  Pitt  et  al.,  2010).  TPC1  and  TPC3  are  localised  to  endosomal  
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membranes,  and  have  also  been  found  to  influence  NAADP-­‐dependent  Ca2+  release  
from   acidic   stores   (Ruas   et   al.,   2010).   Identification   of   CaBP7   and   CaBP8   as   late  
endosome   and   lysosome   resident   Ca2+-­‐sensing   proteins   further   strengthens   the  
view  of  these  acidic  organelles  as  important  calcium  signaling  platforms.  
  
CaBP7  and  CaBP8  have  been  demonstrated  to  be  important  physiological  regulators  
of  vesicle  trafficking  through  regulation  of  PI(4,5)P2  production  by  PI4K  (Mikhaylova  
et  al.,  2009).  Another  study  (Shih  et  al.,  2009)  reported  attenuation  of  N-­‐type  Ca2+-­‐
channel  activity  upon  overexpression  of  CaBP8  in  bovine  chromaffin  cells.  The  same  
effect   was   not   seen   with   a   transmembrane   deficient   mutant   suggesting   correct  
localisation  of  the  protein  to  membranes  was  essential  for  this  function  (Shih  et  al.,  
2009).   The   observed   attenuation   may   have   been   due   to   a   direct   interaction  
between   CaBP8   and   the   calcium   channels,   however,   the   possibility   that   CaBP8  
overexpression  may  affect  channel  trafficking  to  the  PM  was  not  explored.    
4.3.1.  Conclusion  
The   data   presented   in   this   chapter   provides   evidence   that   CaBP7   and   CaBP8   are  
unique  Ca2+-­‐sensors  which  utilise  a  C-­‐terminal   tail  anchor   to   localise   to  vesicles  of  
the   late  endosomal  and   lysosomal  pathway.  This   is   the   first  observation  of  a  CaM  
related  EF-­‐hand  protein  targeting  to  membranes  via  a  tail  anchor.  The  evolution  of  
distinct  mechanisms  to  target  different  types  of  Ca2+-­‐sensors  allows  them  to  localise  
to   the   specific   subcellular   domains   required   to   mediate   their   dedicated  
physiological   functions.   To   date,   no   other   EF-­‐hand   containing   Ca2+-­‐sensors   that  
reside  in  the  lysosomal  membrane  have  been  described  which  pinpoints  CaBP7  and  
CaBP8   as   potential   regulators   of   essential   Ca2+-­‐mediated   processes   within   this  
compartment.  
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5.1  Introduction  
Proliferation   and   cell   division   are   fundamental   processes   to   the   growth   and  
maintenance  of  multicellular  organisms,  including  mammals,  and  deregulation  of  the  
pathways   involved  can  ultimately   lead   to  cancer   (Decordier  et  al.,  2008).  Although  
calcium  signalling  has  been  shown  to  regulate  almost  all   cellular  processes   ranging  
from  fertilisation  to  cell  death,  the  role  of  Ca2+  at  the  various  stages  of  the  cell  cycle  
has   remained   relatively   unstudied.   It   has   been   shown   that   injection   of   cells   with  
calcium  chelators  can  block  progression  through  the  cell  cycle   (Tombes  and  Borisy,  
1989)   but   the  most   convincing   evidence   for   a   role   of   Ca2+   in   the   cell   cycle   is   the  
involvement   of   the   ubiquitous   Ca2+-­‐binding   protein,   CaM.   CaM   acts   at   multiple  
stages,  stimulating  the  expression  of  genes  and  activating  enzymes  involved  in  DNA  
replication,   nuclear   envelope   breakdown   and   cytokinesis   (Takuwa   et   al.,   1995).  
Furthermore,   two  of  CaM's  key   interacting  partners,  Ca2+/CaM-­‐dependent  kinase   II  
and  calcineurin  are  also   implicated   in   cell   growth   regulation   (Takuwa  et  al.,  1995),  
demonstrating   an   important   regulatory   role   for   Ca2+   during   mitosis.   Despite   this,  
measuring  changes  in  [Ca2+]i  in  the  dividing  cell  has  thus  far  proven  problematic.  The  
majority  of  studies  detecting  Ca2+  transients  in  the  cell  cycle  have  been  carried  out  in  
sea   urchin   oocytes,   however,   transients   marking   the   key   phases   of   the   cell   cycle  
observed  in  these  studies  have  not  been  replicated  in  other  cell  types  (Hepler,  1994).  
It   is   speculated   that   Ca2+   signals   may   become   highly   spatially   and   temporally  
localised  during  division  making  them  challenging  targets  for  detection.  
  
Calcium   signalling   has   also   been   specifically   implicated   in   the   regulation   of  
cytokinesis,   although   the   mechanism   of   this   control   is   only   partially   understood.  
Studies  employing  zebrafish  embryos  have  detected  transient  Ca2+  signals  at  multiple  
stages   of   cytokinesis   and   Ca2+   elevation   at   the   position   of   the   cleavage   furrow  
preceded   furrow   contraction   (Webb   et   al.,   2008).   Ca2+   transients   have   also   been  
observed   in   Xenopus   oocytes,   although   these   differ   from   those   seen   in   zebrafish  
(Muto  et  al.,  1996,  Noguchi  and  Mabuchi,  2002).  A  role  for  Ca2+  signalling  is  further  
supported   by   the   observation   that   treatment   of   cells   with   Ca2+   chelators   such   as  
BAPTA   (Webb   et   al.,   2008,   Noguchi   and   Mabuchi,   2002)   and   EGTA   (Baker   and  
Warner,  1972)  elicit  cytokinesis  failure  and  stimulation  of  Ca2+  release  can  induce  the  
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formation  of  extra  furrows  (Mitsuyama  et  al.,  1999,  Schroeder  and  Strickland,  1974).  
A  study  using  a  permeabilised  cell  model  for  cytokinesis  observed  that  incubation  of  
the   cell   with   both   high   or   low   concentrations   of   Ca2+   inhibited   furrow   ingression  
(Cande,   1980)   suggesting   that   the   precise   levels   of   Ca2+   in   the   cell  must   be   tightly  
regulated  to  ensure  efficient  completion  of  cytokinesis.    
  
It   is   not   clear   what   proteins   are   required   for   Ca2+   regulation   during   cytokinesis,  
however,   CaM   has   been   found   to   redistribute   to   interzonal  microtubules   and   the  
intercellular  bridge   (Li  et  al.,   1999).   Loss  of  CaM  or   treatment  with  CaM   inhibitors  
disrupts  or  prevents  the  completion  of  cytokinesis   (Liu  et  al.,  1992,  Yu  et  al.,  2005).  
MLCK  (myosin  light  chain  kinase),  an  effector  of  CaM,  has  also  been  implicated  in  the  
regulation  of  cytokinesis  (Wong  et  al.,  2007).  Other  Ca2+-­‐sensors  that  may  play  a  role  
in   cytokinesis   include   calpain   II   and   Annexin   XI.   Calpain   II   redistributes   to   the  
midbody   in   telophase   and   injection   of   calpain   II   into   metaphase   cells   caused  
premature  disassembly  of  the  mitotic  spindle  and  onset  of  anaphase   (Schollmeyer,  
1988).   Annexin   XI   is   also   recruited   to   the   midbody   during   telophase   in   some   cell  
types  and  appears  to  be  necessary  for  formation  of  the  midbody  and  completion  of  
cytokinesis  (Tomas  et  al.,  2004).    
  
A   role   for   calcium   signalling   during   cytokinesis   is   therefore   very   apparent   but   the  
precise  mechanisms  by  which  Ca2+  coordinates  this  process  are  not  yet  clear  (Atilla-­‐
Gokcumen   et   al.,   2010).   In   a   recent   high   throughput   RNAi   screen   in   HeLa   cells,  
designed  to  identify  proteins  with  a  mitotic  phenotype,  depletion  of  CaBP7  resulted  
in  a  binuclear  phenotype   (Neumann  et  al.,  2010).  CaBP7  was  one  of  the  few  genes  
selected   for   more   rigorous   validation   from   the   572   genes   identified   in   total.   A  
binucleate   phenotype   was   observed   with   4   independent   siRNA   sequences,  
suggesting  that  this  was  not  an  off-­‐target  effect.  Furthermore,  complementation  by  
stable  expression  of  the  RNAi-­‐resistant  mouse  CaBP7  orthologue  was  able  to  prevent  
this  phenotype.  In  detail  examination  of  the  CaBP7  knockdown  phenotype  using  high  
resolution   four-­‐dimensional   confocal   microscopy   showed   that   after   normal  
chromosome   segregation,   CaBP7   knockdown   cells   failed   to   undergo   cytokinesis  
resulting  in  cells  with  two  nuclei  and  four  centrosomes.  Cells  were  able  to  undergo  
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subsequent  rounds  of  division,  however  this  resulted  in  the  formation  of  multipolar  
spindles  and  aberrant  chromosome  segregation.  This  coupled  to  cytokinesis  failure,  
gave  rise  to  large  polylobed  nuclei.  CaBP7  was  therefore  characterised  as  a  bona  fide  
regulator  of   cytokinesis  and   this   could   infer  a  novel   role   for   the  protein   in   calcium  
signalling  during  cell  division.  
  
The   data   presented   by   Neumann   et   al.   more   specifically   suggested   that   CaBP7  
knockdown  cells  were  able  to  undergo  furrow  formation  as  normal  but  failed  at  the  
stage   of   abscission   leading   to   eventual   furrow   regression   and   the   generation   of  
binucleate   cells   (Neumann   et   al.,   2010).   Abscission   is   generally   the   least   well  
understood  stage  in  cytokinesis  (Atilla-­‐Gokcumen  et  al.,  2010).  The  severing  process  
between  the  two  daughter  cells  must  be  very  carefully  controlled  in  order  to  avoid  
the  generation  of  a  puncture  in  the  PM.  Various  processes  are  involved  in  this   final  
stage   including   vesicle   trafficking,   membrane   remodelling   and   removal   of   the  
intercellular  bridge.  Vesicle  transport  is  thought  to  play  an  important  role  generating  
a  membrane  barrier  to  seal  the  daughter  cells  before  they  sever  (Atilla-­‐Gokcumen  et  
al.,   2010).   As   such,   membrane   trafficking   is   known   to   play   a   vital   role   in   plant  
cytokinesis.   During   division,   plant   cells   form   a   structure   called   the   phragmoplast  
which  acts  as  a   scaffold   for   vesicle  delivery  during  cytokinesis.  Vesicles   fuse  at   the  
midpoint  between  the  two  daughter  cells  forming  a  cell  plate  which  grows  along  the  
cell  division  plane  until  the  two  cells  become  completely  separated   (Van  Damme  et  
al.,  2008).  
  
The  dependency  of  vesicle  transport  upon  calcium  signalling  in  other  systems  is  well  
documented  and,  likewise,  altering  Ca2+  levels  during  cytokinesis  has  been  shown  to  
affect  membrane  remodelling  and  vesicle  fusion  (Li  et  al.,  2008,  Shuster  and  Burgess,  
2002).  Research  examining  membrane  traffic  during  cytokinesis  has  focused  on  the  
involvement   of   recycling   endosomes   and   secretory   vesicles   (McKay   and   Burgess,  
2011,  Neto  et  al.,  2011).  The  involvement  of  lysosomes  in  mitosis  has  received  very  
little   attention   to   date,   however,   a   redistribution   of   these   organelles   to   the  
intercellular  bridge  has  been  reported  (Bergeland  et  al.,  2001).    
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Importantly,   lysosomes   have   recently   been   demonstrated   to   act   as   Ca2+   release  
platforms   which   are   stimulated   by   the   second   messenger   NAADP   (Galione   et   al.,  
2010).   NAADP   is   the   most   potent   Ca2+   releasing   second   messenger   thus   far  
characterised  and  NAADP-­‐induced  Ca2+  signals  often  act  as  a  trigger  for  regenerative  
Ca2+   waves   propagated   by   activation   of   IP3Rs   or   RyRs   on   the   ER   through   CICR  
(Brailoiu   et   al.,   2010).   The   TPCs   have   recently   been   identified   as  NAADP-­‐activated  
Ca2+  channels  which  are  resident  in  the  membranes  of  acidic  compartments   (Zhu  et  
al.,   2010a).   Interestingly,   in   the   same   RNAi   screen   that   identified   CaBP7   as   a  
regulator   of   cytokinesis,   knockdown   of   TPC1   and   TPC2   also   resulted   in   mitotic  
defects.  Cell  death  and  binuclear  phenotypes  were  observed  in  knockdowns  of  TPC1,  
whereas   in   the   case   of   TPC2,  metaphase   delay,  metaphase   alignment   defects   and  
cell   death   were   observed   (www.mitocheck.org)   (Neumann   et   al.,   2010).   This  
potentially   indicates   a   more   general   requirement   for   endolysosomal   calcium  
signalling  machinery  during  key  mitotic  processes.  
  
The  aim  of  this  chapter  was  to  investigate  the  role  of  CaBP7  in  mitosis  and  whether  
this   could   be   linked   to   a   novel   role   for   calcium   signalling   from   lysosomes   during  
cytokinesis.    
5.2.  Results  
5.2.1.  Localisation  of  CaBP7  during  mitosis  
Figure   5.1   shows   confocal   images   of   HeLa   cells   at   different   stages   in   mitosis,  
? ???????????????????????????????????????????????-­‐tubulin.   In   interphase,   (Figure  
5.1  A)  CaBP7-­‐positive  vesicles  distributed  throughout  the  cytosol  and,  as  discussed  in  
chapter   4,   often   concentrated   in   a   perinuclear   region   resembling   the   TGN.   At  
metaphase   (Figure  5.1  B),   the  vesicles  appeared  enlarged,  were  distributed  around  
the  periphery  of  the  cell  and  were  excluded  from  the  central  spindle  region.  At  early  
anaphase   (Figure   5.1   C),   large   CaBP7-­‐positive   vesicles   were   still   visible   at   the  
periphery  of  the  cells  but  during  late  anaphase  (Figure  5.1  D)  these  vesicles  began  to  
redistribute.   At   early   telophase   (Figure   5.1   E),   the   vesicles   had   redistributed   to  
opposite  poles  of  the  spindle  and  to  the  midzone,  concentrating  around  the    
  





Figure  5.1.  Distribution  of  endogenous  CaBP7  in  HeLa  cells.  A-­‐F)  HeLa  cells  immunostained  with  anti-­‐
CaBP7      (Alexa   568,   r???? ???? ??? ?-­‐tubulin   antibody      (Anti-­‐DM1A,   FITC,   green),   at   various   stages   of  
mitosis.  Nuclei  are  stained  with  DAPI  (blue).  Scale  bars  =10  µm.  
     
     153  
intercellular   bridge.   In   late   telophase   (Figure   5.1   F),   as   the   intercellular   bridge  
becomes   thinner,   CaBP7-­‐positive   vesicles   remained   in   the   vicinity   of   the  midzone  
and  also  at  the  opposite  poles  of  the  cell.  CaBP7-­‐positive  vesicles  did  not  adopt  their  
more   dispersed   interphase   distribution   until   the   two   daughter   cells   had   fully  
separated.  
  
5.2.2.  CaBP7  co-­‐localises  with  lysosomes  during  mitosis  
The   data   in   chapter   4   illustrated   that   CaBP7   localised   to   vesicles  which   co-­‐stained  
with  markers   specific   for   late   endosomes   and   lysosomes.   Co-­‐localisation   with   the  
lysosomal  integral  membrane  protein,  CD63,  was  examined  at  different  stages  of  the  
cell   cycle   (Figure   5.2).   During   all   stages   of   the   cell   cycle   there   was   extensive   co-­‐
localisation  of  endogenous  CaBP7  with  CD63  implying  that  there  is  no  redistribution  
of  CaBP7   to  other  organelles   in   a   cell-­‐cycle  dependent  manner.   The   localisation  of  
CaBP7  to  lysosomes  and  the  reported  binucleate  phenotype  upon  CaBP7  knockdown  
suggest  a  potentially  important  role  for  lysosomes  during  cytokinesis.  
  
Figure  5.3  shows  the  localisation  of  CaBP7  during  cytokinesis  in  HeLa  cells  compared  
to   various   vesicular  markers.   In   accordance  with   localisation   studies   in   interphase  
cells  shown  in  chapter  4,  endogenous  CaBP7  showed  complete  co-­‐localisation  with  
ts045   VSVG-­‐GFP   during   cytokinesis   (Figure   5.3A).   Cytokinetic   cells   overexpressing  
CaBP7   and   immunostained   for   Rab11   as   a  marker   of   recycling   endosomes   (Figure  
5.3B)  showed  no  co-­‐localisation.   In  agreement  with  previous  studies   (Wilson  et  al.,  
2005),   Rab11   accumulated   in   the   midzone   during   cytokinesis   and   coincided   with  
anti-­‐?-­‐tubulin   immunostaining  of   the   interzonal  microtubules   (Figure  5.3B,  merge).  
This  is  in  contrast  to  CaBP7  localisation  to  vesicles  around  the  cleavage  furrow  and  at  
the   opposite   pole   of   the   cell.   No   co-­‐localisation   of   overexpressed   CaBP7   was  
observed   with   anti-­‐M6PR   immunostaining   suggesting   that   CaBP7   predominantly  
localises   to   lysosomes,   rather   than   late   endosomes,   during   cytokinesis.   Finally,   co-­‐
immunostaining   of   HeLa   cells   with   antibodies   to   CaBP7   and   VAMP7   showed  
extensive   co-­‐localisation   as   observed   in   interphase   cells   in   Chapter   4.   These  
observations   support   the   conclusion   that   CaBP7   does   not   redistribute   to   an  
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alternative   subcellular   compartment   during   cytokinesis.   CaBP7   localises   to   CD63-­‐  







Figure  5.2.  Co-­‐localisation  of  endogenous  CaBP7  with  the  lysosomal  marker,  CD63  in  HeLa  cells.  A-­‐
D)  HeLa  cells  immunostained  with  anti-­‐CaBP7  (Alexa  568,  red)  and  anti-­‐CD63  (FITC,  green),  at  various  
stages  of  mitosis.  Nuclei  are  stained  with  DAPI  (blue)  and  regions  of  co-­‐localisation  appear  yellow  in  
the  merged  images.    Scale  bars  =10  µm.  
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Figure  5.3.  Localisation  of  CaBP7  at  cytokinesis  in  HeLa  cells  with  various  antibody  markers.  A)  HeLa  
cells  co-­‐transfected  with  mCherry-­‐CaBP7  (red)  and  ts045  VSVG-­‐GFP  (Green)  and  immunostained  with  
anti-­‐?-­‐tubulin  (Anti-­‐Tubulin,  Alexa  405,  blue).  B)  HeLa  cells  transfected  with  mCherry-­‐CaBP7  (red)  and  
immunostained  with   anti-­‐Rab11   (FITC,   green)   and   anti-­‐?-­‐tubulin   (Anti-­‐Tubulin,   Alexa   405,   blue).   C)  
HeLa   cells   transfected  with  mCherry-­‐CaBP7   (red)   and   immunostained  with   anti-­‐M6PR   (FITC,   green)  
and  anti-­‐?-­‐tubulin   (Anti-­‐Tubulin,   Alexa  405,   blue).   D)  HeLa   cells   co-­‐immunostained  with   anti-­‐CaBP7  
(Alexa   568,   red)   and   anti-­‐VAMP7   (FITC,   green)   with   DAPI-­‐stained   nuclei   (Blue).   Regions   of   co-­‐
localisation  appear   yellow   (where   red  and  green   channels  overlap)  or   aqua   (where  green  and  blue  
channels  overlap)  in  the  merged  images.    Scale  bars  =10  µm.  
  
5.2.3.  Knockdown  of  CaBP7  leads  to  an  increase  in  the  number  of  binucleate  cells  
To   verify   the   reported   defect   in   cytokinesis   upon   knockdown  of   CaBP7,  HeLa   cells  
were   transfected  with   either   a   scrambled   shRNA   construct   or   an   shRNA   construct  
specifically  targeting  CaBP7.  Figure  5.4A  and  5.4B  show  western  blot  analysis  of  HeLa  
cell   lysates   from   cells   co-­‐transfected   with   mCherry-­‐CaBP7   or   mCherry-­‐CaBP8   and  
either  of  the  two  shRNA  constructs  for  72  hrs.  Immunoblotting  with  an  anti-­‐RFP  






Figure   5.4.   CaBP7   Knockdown   in   HeLa   cells.   A)   Western   blot   showing   reduction   of   exogenously  
expressed  mCherry-­‐CaBP7  protein   through  treatment  with  CaBP7-­‐specific  shRNA  but  not  scrambled  
shRNA.   B)   Western   blot   showing   resistance   of   exogenously   expressed   mCherry-­‐CaBP8   protein   to  
knockdown   by   CaBP7-­‐specific   shRNA   and   scrambled   shRNA.  Molecular   weight   standards   (kDa)   are  
shown  on  the  left  side  of  western  blot  images.  C)  Example  images  of  HeLa  cells  treated  with  CaBP7-­‐
specific  shRNA  or  scrambled  shRNA.  GFP  (green)  acts  as  a  marker  for  shRNA-­‐transfected  cells.  Nuclei  
are  stained  with  DAPI  (red  in  untransfected  cells,  yellow  in  transfected  cells).  White  arrows  indicated  
multinucleate   cells.   D)   Histogram   showing   the   average   percentage   of   abnormal   nuclei   observed   in  
multiple  fields  of  view  ±  SEM  (n=100  cells  in  two  independent  experiments).  
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antibody   to   detect   the   mCherry   tag   on   exogenously   expressed   proteins   showed  
efficient   knockdown   which   was   specific   to   CaBP7   and   not   CaBP8.   Confocal  
microscopy   was   used   to   image   cells   transfected   with   shRNAs   and   the   number   of  
nuclei   in   transfected   cells   was   quantified.   The   shRNA   construct   encoded   free   GFP  
under  a  separate  promoter  as  a  transfection  marker  (Figure  5.4C)  and  all  cells  were  
additionally  stained  with  DAPI  to  examine  their  DNA  content.  Cells  transfected  with  a  
CaBP7-­‐specific   shRNA   exhibited   an   increase   in   the   number   of   binucleate   or  
polylobed  nuclei  as  indicated  by  the  white  arrows  in  figure  5.4C.  Approximately  100  
cells   were   scored   for   each   condition   from   two   independent   transfections   and   the  
number  of   abnormal  nuclei   quantified   (Figure  5.4D).   There  was   an  approximate  3-­‐
fold   increase   in   the   number   of   abnormal   nuclei   in   CaBP7   shRNA   transfected   cells  
compared  to   the  scrambled  control.  This  data  confirms  that  there   is  an   increase   in  
the  number  of  cells  with  abnormal  nuclei  upon  depletion  of  CaBP7  protein  levels.  
  
A  number  of  mCherry-­‐tagged  shRNA  resistant  variants  of  CaBP7  were  generated  to  
attempt  to   rescue  the  binucleate  phenotype.  Resistant  variants   included:  wild   type  
CaBP7;  a  mutant  defective  in  Ca2+-­‐binding  at  both  functional  EF-­‐hand  motifs;  and  a  
mutant   lacking   the   C-­‐terminal   domain   containing   the   TMD.   These   variants   were  
selected  to  assess  the  dependence  of  CaBP7  function  in  cytokinesis  on  Ca2+-­‐binding  
and  normal  subcellular  localisation.  Figure  5.5A-­‐C  show  example  images  of  HeLa  cells  
transfected  with  each  of   these   constructs   and   all   three   variants   appear   to   localise  
similarly   to   their   non-­‐resistant   counterparts   (see   chapter   4).   Figure   5.5D   shows   a  
western  blot  of  HeLa  cells  co-­‐transfected  with  CaBP7  specific  shRNA  and  each  of  the  
rescue  constructs.  Immunoblotting  with  an  anti-­‐RFP  antibody  to  detect  the  mCherry  
colour   tag   illustrated   that   all   three   rescue   constructs   were   indeed   resistant   to  
knockdown   by   CaBP7   specific   shRNA.   Cells   co-­‐transfected   with   CaBP7   shRNA   and  
either   mCherry   as   a   control   or   the   wild-­‐type   shRNA-­‐resistant   CaBP7   construct  
showed  no   significant  differences   in   the  number  of  abnormal  nuclei   counted   (data  
not   shown).   A   multinucleate   phenotype   is   not,   however,   reversible   (Uetake   and  
Sluder,  2004)  and  therefore  correction  of  the  phenotype  should  ideally  be  shown  by  
complementation  rather   than  by  rescue.  There  needs  to  be  a  high  enough   level  of  
protein  expressed  from  the  resistant  construct  before  the  shRNA-­‐driven  depletion  of  
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the   endogenous   protein   is   complete,   otherwise   the   cytokinesis   defects   and  
multinucleate  phenotype  may  occur  before  the  rescue  has  taken  effect.  In  transient  
transfections,   both   constructs  will   be   expressed   at   the   same   time,   however,   there  
will  be  a  period  of  time  where  the  shRNA  is  being  expressed,  but  protein  synthesis  
from  mRNA  transcribed  from  the  resistant  construct  has  not  started  or   is  only  at  a  
low   level.   For   this   reason   the   use   of   stable   cell   lines   expressing   the   resistant  
constructs,  or   inducible  shRNA  constructs  would  be  necessary  to  truly  examine  the  
ability   of   the   rescue   constructs   to   correct   the   CaBP7   binucleate   phenotype.  




Figure  5.5.   shRNA-­‐resistant  CaBP7   constructs.  A)  Localisation  of  shRNA-­‐resistant  mCherry-­‐CaBP7   in  
HeLa   cells.   B)   Localisation  of   shRNA   resistant  mCherry-­‐CaBP7  1-­‐188   in  HeLa   cells.   C)   Localisation  of  
shRNA-­‐resistant   mCherry-­‐CaBP7   Double   EF   hand   mutant   (mCherry-­‐CaBP7   EF1'   EF2')   in   HeLa   cells.  
Scale   bars   =10   µm.   D)  Western   blot   showing   that   exogenous  wild   type  mCherry-­‐CaBP7   is   knocked  
down   by   treatment   with   CaBP7-­‐specific   shRNA,   whereas   expression   of   the   three   shRNA-­‐resistant  
constructs   is  not.   ?-­‐?? ??????????????????????????????????????????? ???? ?????????? ???????? ?????????????
CaBP7  shRNA.  Molecular  weight  standards  (kDa)  are  shown  on  the  left  side  of  western  blot  images.  
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5.3.  Discussion  
Cellular  depletion  of  CaBP7  by  shRNA  targeting  has  been  previously  shown  to  result  
in  an  increase  in  binucleate  cells  (Neumann  et  al.,  2010).  The  data  presented  in  this  
chapter  confirms  this  observation.  Knockdown  of  CaBP7  in  HeLa  cells  resulted  in  an  
approximately   3-­‐fold   increase   in   the   number   of   abnormal   nuclei,   72   hours   after  
transfection  with  a  CaBP7  specific  shRNA  construct.    RNAi-­‐resistant  variants  of  CaBP7  
were   generated   to  use   as   rescue   constructs   and   confirm   that   this  was  not   an   off-­‐
target   effect.   Unfortunately,   transient   co-­‐transfection   of   cells   with   shRNA   and  
resistant   constructs   was   not   suitable   to   assess   the   prevention   of   the   binuclear  
phenotype   as   the   shRNA  may  have  been   expressed   and   the   phenotype   generated  
before   the   resistant   protein   reached   compensatory   levels   of   expression.  
Complementation  assays  should  be  carried  out  using  cells  stably  transfected  with  the  
resistant   constructs   to  ensure   that   levels  of   exogenous  protein   are  optimal   before  
knockdown  of  endogenous  CaBP7  is  initiated.  Alternatively,  an  inducible  expression  
vector  could  be  used  to  induce  CaBP7  specific  shRNA  after  the  resistant  protein  has  
been  transiently  expressed  for  a  number  of  days.  Unfortunately  this  was  not  possible  
within   the   scope   of   the   current   project,   however,   in   the   original   RNAi   screen  
Neumann  et   al.   were   able   to   prevent   the   CaBP7   related   binucleate   phenotype   by  
employing  stable  cell  lines  expressing  the  RNAi  resistant  mouse  orthologue  of  CaBP7  
(Neumann   et   al.,   2010).   RNAi-­‐resistant   constructs   encoding   two   mutants,   one  
defective  in  Ca2+-­‐binding,  and  one  lacking  the  TMD  essential  for  correct  localisation,  
were   also   generated.   Creation   of   stable   cell   lines   expressing   these   constructs   in  
future   work   would   permit   an   examination   of   how   Ca2+-­‐binding   and   correct  
localisation  contribute  to  the  apparent  role  of  CaBP7  in  cytokinesis.    
  
Examination  of  the  localisation  of  CaBP7  at  different  stages  of  mitosis  revealed  that  
at  the  onset  of  cytokinesis,  CaBP7-­‐positive  vesicles  accumulated  at  opposite  poles  of  
the  spindle  and  around  the  intercellular  bridge.  Co-­‐localisation  with  CD63  confirmed  
that   these   vesicles   were   lysosomes   and   that   there   had   been   no   redistribution   of  
CaBP7   into  other  vesicular  organelles  during  mitosis.  Further   investigation  revealed  
that  there  was  no  co-­‐localisation  with  the  recycling  endosome  marker  Rab11  or  the  
late  endosome  marker  M6PR.  Extensive  co-­‐localisation  was,  however,  observed  with  
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ts045  VSVG-­‐GFP  and  endogenous  VAMP7  as  also  demonstrated  in  interphase  cells  in  
chapter  4.  This   localisation,  coupled  with   the  observed  binucleate  phenotype  upon  
depletion  of  CaBP7,  implies  that  lysosomes  may  play  an  important  functional  role  in  
cytokinesis.    
  
Numerous   studies   have   reported   a   role   for   membrane   trafficking   and   vesicle  
transport  during  cytokinesis,  however  this  research  has  thus  far  focused  on  the  role  
of   the   recycling   endosome   and   secretory   vesicle   pathways   (McKay   and   Burgess,  
2011,  Neto  et  al.,  2011).  The  role  of  recycling  endosomes  was  first  discovered  after  
the   observation   that   Rab11   is   required   for   cellularisation   in   Drosophila   embryos  
(Pelissier  et  al.,  2003)  and  knockdown  of  Rab11  in  HeLa  cells  results  in  an  increase  in  
the   number   of   binucleate   cells   (Wilson   et   al.,   2005).   Rab11-­‐positive   vesicles  
accumulate  at  the  midbody  (Wilson  et  al.,  2005)  and  Rab11  mutants  exhibit  defects  
in  both  furrow  ingression  and  in  the  contractile  ring  which  either  fails  to  contract  or  
disassembles  during  late  telophase  (Giansanti  et  al.,  2007).    
  
The   secretory   pathway   involves   the   sorting   of   protein   at   the   Golgi   apparatus   and  
packaging  into  vesicles  to  be  delivered  to  the  PM  (McKay  and  Burgess,  2011).  SNARE  
proteins   are   essential   for   every   vesicular   fusion   step   along   the   secretory   pathway  
(Yang   et   al.,   2006b)   and   the   importance   of   this   pathway   for   normal   cytokinesis   is  
illustrated   by   the   cytokinesis   defects   generated   upon   disruption   of   various   SNARE  
proteins.   In   Madin-­‐Darby   Canine   Kidney   (MDCK)   cells,   syntaxin   2   is   necessary   for  
abscission  but  not  for  furrow  ingression  (Low  et  al.,  2003).  Inhibition  of  VAMP8  (Low  
et  al.,  2003)  and  depletion  of  syntaxin  16  (Song  et  al.,  2009)  lead  to  similar  abscission  
defects.   In   addition,   studies   in   Drosophila   and   C.   elegans   have   demonstrated   an  
essential   role   for   syntaxins   in   the   successful   completion   of   cytokinesis   (Xu   et   al.,  
2002,  Jantsch-­‐Plunger  and  Glotzer,  1999).  
  
Such  observations  demonstrate  an   important   role   for  membrane   trafficking  during  
cytokinesis  and  interestingly,  proteomic  analysis  of  isolated  midbodies  from  Chinese  
hamster  ovary  (CHO)  cells  showed  that  the  largest  category  of  proteins  (33%  of  160  
identified   proteins)   were   associated   with   membrane   trafficking   or   secretory  
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functions   (Skop   et   al.,   2004).   The   exact   role   of   membrane   trafficking   during  
cytokinesis   is  poorly  understood  but  a  prevailing  view   is   that   the  midbody   forms  a  
platform  for  the  assembly  of  the  protein  complexes  required  for  abscission  (Neto  et  
al.,  2011).  It  is  thought  that  the  trafficking  of  vesicles  into  the  midzone  facilitates  the  
delivery   of   key   components   to   the  midbody.   Through   fusion   events   with   the   PM,  
different   species  of   vesicles   are   also   thought   to   increase  PM  surface  area  allowing  
the  intercellular  bridge  to  thin  prior  to  the  final  abscission  event  (Neto  et  al.,  2011).  
  
Interestingly,   live   cell   imaging   experiments   in   BSC1   cells   overexpressing   the  
temperature-­‐sensitive   VSVG   mutant   also   demonstrated   that   Golgi-­‐derived,   VSVG-­‐
positive  vesicles  accumulate  at  the  midbody  during  cytokinesis.  Using  total   internal  
reflection  fluorescence  (TIRF)  microscopy,  direct  docking  and  fusion  of  these  vesicles  
at  the  midzone  was  observed  (Goss  and  Toomre,  2008).  Goss  and  Toomre  suggested  
that   this   pool   of   VSVG-­‐positive   vesicles   was   distinct   from   both   endosomal   and  
lysosomal  compartments  (Goss  and  Toomre,  2008).  Initially  this  observation  appears  
contradictory   to   the   observation   that   CaBP7   co-­‐localises   with   both   VSVG   and  
markers  of  late  endosomes  and  lysosomes,  however,  the  use  of  LAMP1  as  a  marker  
for   lysosomes   casts   some   doubt   on   this   conclusion.   Both   LAMP1   and   VSVG   have  
been  shown  to  be  dependent  on  the  AP3  machinery  for  their  subcellular  trafficking  
from   the   TGN.   Overexpression   of   VSVG   has   been   shown   to   saturate   the   AP3  
machinery  and  cause  LAMP1  to  traffic  via  an  alternative  pathway   (Nishimura  et  al.,  
2002).   Therefore,   overexpression   of   VSVG   in   the   experiments   of   Goss   et   al.   could  
have   resulted   in   the   mistargeting   of   LAMP1   and   therefore   explain   the   conflict  
between  their  data  and  the  results  presented  in  this  chapter.  
  
To   date,   there   have   been   few   studies   examining   the   contribution   of   lysosomes   to  
membrane   trafficking   events   during   cytokinesis,   however,   lysosomes   have   been  
shown  to  redistribute  to  the  midzone  of  dividing  cells   (Bergeland  et  al.,  2001).  The  
view   of   lysosomes  merely   as   the  waste   disposal   unit   for   the   cell   has   begun   to   be  
challenged   by   the   emergence   of   new   and   important   roles   for   this   organelle.   In  
particular,   lysosomes   have   been   shown   to   behave   as   Ca2+-­‐regulated   exocytotic  
vesicles   in  a  number  of  cell   lines   (Gerasimenko  et  al.,  2001).  This  process  has  been  
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shown   to  be   important   in  PM  repair  and   therefore   is  of   interest  when  considering  
how,  during  cytokinesis,  two  daughter  cells  are  able  to  separate  without  creating  a  
hole  in  the  PM  (Finger  and  White,  2002).  Wound  healing  by  lysosomal  exocytosis  is  
triggered  by  the  large  influx  of  extracellular  Ca2+  which  accompanies  damage  to  the  
PM,  but   lysosomal  exocytosis  can  also  be  initiated  when  [Ca2+]i   ????????????????????
(Martinez  et  al.,  2000).  Mediated  by  the  Ca2+-­‐sensing  protein  synaptotagmin  VII,  the  
elevation   in  [Ca2+]i   leads  to  rapid  homotypic  fusion  of   lysosomes  and  their  exocytic  
fusion  with   the  PM  thus   repairing   the  damage  through  delivery  of  new  membrane  
(Finger  and  White,  2002).  This  process  represents  an  alternative  mechanism  for  the  
donation   of   membrane   during   abscission   in   cytokinesis.   Both   wound   healing   and  
cytokinesis   are   sensitive   to   treatment   with   brefeldin   A   (BFA)   which   causes   the  
tubulation   of   endosomes   and   lysosomes,   and   hence   is   consistent   with   a   role   for  
lysosomes   in   the   successful   abscission  of   two  daughter   cells   (McNeil   and  Terasaki,  
2001).  
  
Although   there   is   no   direct   evidence   for   an   essential   role   of   lysosomes   during  
cytokinesis,  proteins  which  are  important  for  late  endosome  to  lysosomal  trafficking  
have  been  implicated.  ESCRT  (endosomal  sorting  complexes  required  for  transport)  
proteins  are  involved  in  the  sorting  and  trafficking  of  membrane  proteins  into  MVBs  
(Dukes  et  al.,  2008).  ESCRT  proteins  such  as  charged  MVB  protein  (CHMP)  2,  4  and  5  
are   localised   to   the   midbody   during   the   late   stages   of   cytokinesis.   A   dominant  
negative  mutant  of  CHMP3  which  has  been  shown   to  alter  endosome  morphology  
and  inhibit  trafficking  to  the  lysosomes  was  also  shown  to  inhibit  cytokinesis  (Dukes  
et  al.,  2008).  CHMP3  did  not  co-­‐localise  with  Rab11  in  recycling  endosomes  and  this  
data  suggested  that  proteins  involved  in  late  endosomal  function  are  also  important  
for   the   completion   of   cytokinesis   (Dukes   et   al.,   2008).   Extensive   co-­‐localisation   of  
CaBP7  and  the  late  endosomal  and  lysosomal  protein,  VAMP7  was  demonstrated  in  
both   interphase   cells   (chapter   4)   and   cytokinetic   cells.   Interestingly   a   dominant  
negative   mutant   of   VAMP7   has   also   been   shown   to   inhibit   cytokinesis.  
Overexpression  of  the  cytosolic  longin  domain  of  VAMP7  caused  strong  inhibition  of  
cytokinesis   inducing   multiploidy   of   transfected   cells.   This   was   coupled   with   a  
significant  reduction  in  both  the  recovery  of  PM  surface  area  and  the  appearance  of  
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LAMP1  at  the  cell  surface  (Boucrot  and  Kirchhausen,  2007).  In  accordance  with  this,  
overexpression   of   the   VAMP7   longin   domain   has   also   been   shown   to   inhibit  
lysosomal   exocytosis   (Proux-­‐Gillardeaux   et   al.,   2007).   Normal   VAMP7   function   is  
therefore  required  for  cytokinesis  and  is  suggestive  of  an  important  role  for  CaBP7-­‐  
and   VAMP7-­‐positive   vesicles,   of   late   endosome   or   lysosome   origin,   in   exocytosis  
during  cytokinesis.  
  
A   role   for   Ca2+-­‐stimulated   lysosomal   exocytosis   in   cytokinesis   has   not   yet   been  
explored  in  detail,  however  Boucrot  et  al.  demonstrated  the  appearance  of  LAMP1-­‐
positive   cell   surface   blebs   during   PM   recovery   in   cytokinesis   (Boucrot   and  
Kirchhausen,   2007).   A   decrease   in   the   number   of   blebs   was   observed   upon  
treatment  with   the  myosin   II   inhibitor,  blebistatin  which  also   caused  a  decrease   in  
the  internalisation  of  LAMP1.  These  observations  were  consistent  with  a  role  for  PM  
fusion  of   late  endosomes  and   lysosomes  which   is  dependent  on  myosin   II   function  
(Boucrot  and  Kirchhausen,  2007).  Importantly,  myosin  II  has  been  shown  to  play  an  
important  role  in  Ca2+-­‐dependent  exocytosis  in  membrane  repair  and  wound  healing  
(Togo  and  Steinhardt,  2004).    
  
Localised  elevations  of  [Ca2+]i  are  associated  with  many  stages  of  mitosis.  It  has  been  
suggested  that  the  highly   localised  spatio-­‐temporal  nature  of  mitotic  Ca2+  signals   is  
responsible   for   their   elusiveness   and   underlies   their   lack   of   detection   to   date  
(Whitaker,  2006).  As  such  the  ER  has  been  shown  to  cluster  in  close  proximity  to  the  
spindle   and   forms   a   close   association  with  microtubules   (Terasaki   and   Jaffe,   1991,  
Zaal   et   al.,   1999).   In   sea   urchins   the   Ca2+   transient   which   occurs   at   the   onset   of  
mitosis  is  often  confined  to  a  small  perinuclear  region,  consistent  with  the  existence  
of   Ca2+  microdomains   (Wilding   et   al.,   1996).   The   activation   of   CaM   has   also   been  
shown  to  occur  in  discrete  regions  of  the  cell,  first  in  a  perinuclear  region  and  then  at  
the   spindle   poles   (Torok   et   al.,   1998).   Unfortunately,   there   are   very   few   reports  
where   calcium   signals  have  been  detected   from   these  putative  Ca2+  microdomains  
(Whitaker,  2006).    
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There   is   growing   evidence   that   lysosomes   can   store   Ca2+   at   concentrations  
comparable   to   those   measured   in   the   major   Ca2+   storage   organelle,   the   ER  
(Gerasimenko  and  Tepikin,  2005).  Ca2+  release  from  lysosomes  is  stimulated  by  the  
potent   second  messenger,   NAADP,   which   binds   to   receptors   specifically   found   on  
acidic  organelles   (Galione  et  al.,  2010).  Recent  research  has  revealed  that  the  TPCs  
are  a   family  of  Ca2+   release  channels   located   in  the  membranes  of  endosomes  and  
lysosomes  which  are  activated  by  NAADP  binding   (Zhu  et  al.,  2010b).   Interestingly,  
knockdown  of  TPC1  or  TPC2  results  in  defects  in  mitosis  suggestive  of  a  role  for  Ca2+  
signalling   from   acidic   organelles   during   cell   division   (www.mitocheck.org   and  
(Neumann   et   al.,   2010)).   The   extremely   localised   nature   of   NAADP-­‐mediated   Ca2+  
signals  make  lysosomal  Ca2+  stores  an  attractive  candidate  for  the  generation  of  Ca2+  
microdomains   during   cytokinesis.   To   date,   no   Ca2+-­‐sensor   has   been   identified   to  
interact  with  the  TPCs  or  regulate  the  process  of  Ca2+  release  at  the  lysosomes.  As  an  
integral  membrane  protein   specifically   targeted  to   the  acidic   compartments  of   the  
late  endosomal  and  lysosomal  pathway,  CaBP7  represents  a  potential  candidate  for  
this  role.    
  
5.3.1.  Conclusion  
The   data   presented   in   this   chapter   provide   evidence   for   a   role   of   CaBP7   during  
cytokinesis.   The   observation   that   CaBP7   positive   lysosomes   redistribute   to   the  
intercellular   bridge   during   cytokinesis   infers   an   important   role   for   lysosomal  
trafficking  in  the  successful  abscission  of  two  daughter  cells.  Furthermore,  extensive  
co-­‐localisation   of   CaBP7  with   both   VSVG   and   VAMP7   is   suggestive   of   an   essential  
role  for  CaBP7-­‐positive  vesicles  during  cytokinesis.  VSVG-­‐positive  vesicles  have  been  
shown  to  dock  and  fuse  at  the  PM  during  cytokinesis  (Goss  and  Toomre,  2008)  and  a  
dominant  negative  mutant  of  VAMP7,  shown  to  impair  lysosomal  exocytosis  (Proux-­‐
Gillardeaux   et   al.,   2007),   has   also   been   shown   to   inhibit   cytokinesis   (Boucrot   and  
Kirchhausen,  2007).  Much  more  work  is  needed  to  deduce  the  exact  role  of  CaBP7,  
the  contribution  of  lysosomes  during  cytokinesis,  and  the  Ca2+  dependency  of  these  
processes.   Investigation   of   the   emerging   roles   of   lysosomes   as   important   calcium  
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signalling   platforms   and   their   ability   to   undergo   Ca2+-­‐regulated   exocytosis   in   the  
context  of  cell  division  will  be  of  particular  interest.  
  





Structural  Characterisation  of  CaBP4  and  
CaBP7  using  NMR  
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6.1.  Introduction  
NMR   spectroscopy   and   X-­‐ray   crystallography   are   currently   the   only   techniques  
which   can   provide   the   data   required   to   determine   atomic   resolution   protein  
structures.  The  use  of  these  two  techniques  is  not  mutually  exclusive  and  they  are  
increasingly  being  used  as   complimentary  approaches   for   structure  determination  
(Snyder   et   al.,   2005,   Yee   et   al.,   2005).      X-­‐ray   crystallography   allows   a   three-­‐
dimensional   image   of   a  molecule   to  be   constructed   based   on   its   X-­‐ray  diffraction  
properties.  To  do  this  the  molecule  must  first  be  crystallised,  as  scattering  from  an  
individual   molecule   is   too   weak   to   detect.   The   formation   of   suitable   crystals  
concentrates   the   scattering   in   discrete   directions   to   give   a   particular   diffraction  
pattern.   X-­‐ray   crystallography   derives   higher   resolution   structural   data   than  NMR  
but  requires  that  the  protein  form  stable,  well  diffracting  crystals   (Yee  et  al.,  2005,  
MacArthur  et  al.,  1994).  A  limitation  of  this  technique  for  some  structural  studies  is  
the  inability  to  monitor  protein  dynamics  under  changing  conditions   (MacArthur  et  
al.,   1994),   however,   discrete   structural   forms   of   a   particular   protein   may   be  
crystallised  individually  and  the  structures  compared.  
  
An   important   property   of   Ca2+-­‐sensors   is   their   ability   to   undergo   conformational  
changes  in  response  to  alterations  in  [Ca2+]i(Berridge  et  al.,  2000).  In  addition,  many  
Ca2+-­‐sensors   have   been   shown   to   undergo   unique   conformational   changes   in  
response   to   the   presence   of  Mg2+   ions   (Wingard   et   al.,   2005,   Lusin   et   al.,   2008).  
Depending   on   the   exact   cation   binding   status,   the   protein   can   exist   in   various  
conformations,   which   in   turn   allow   the   protein   to   interact   with   specific   binding  
partners.  The  intrinsically  dynamic  nature  of  these  proteins  therefore  represents  an  
important   consideration   during   structure   determination.   Despite   the   lower  
resolution   structures   generated   by   NMR,   the   ability   to   carry   out   experiments   in  
solution  means  data  can  be  obtained  in  a  setting  that  more  closely  approximates  a  
native   protein   environment,   where   protein   dynamics   can   be   monitored   on  
molecular  interaction  timescales.    
  
NMR   works   on   the   basis   that   protons   have   spin   and   can   therefore   generate   a  
magnetic  field  (MacArthur  et  al.,  1994).  Certain  atomic  nuclei,  usually  those  with  an  
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odd  mass   number,   possess   a  magnetic  moment.   If   such   nuclei   are   exposed   to   an  
external   magnetic   field,   they   will   precess   around   an   axis   either   parallel   or   anti-­‐
parallel   to   the   direction   of   the   applied  magnetic   field.   This   corresponds   to   upper  
and   lower   energy   levels   respectively.   The   energy   difference   between   these   two  
levels  is  characteristic  of  the  particular  type  of  nucleus  and  is  modified  by  the  small  
induced   fields   of   neighboring   atoms.   Therefore   by   monitoring   the   shift   in   the  
resonance   (known  as   chemical   shift)   of   a  particular   type  of   atom,   a   characteristic  
??????????????????????????????????????????????????????????????????????????????
spin   states   is   induced   by   applying   electromagnetic   radiation   to   a   sample   at   an  
appropriate   frequency   and   the   transverse   magnetisation   is   then   detected   as   a  
unique  NMR  spectrum  (MacArthur  et  al.,  1994).  
  
NMR   is   an   intrinsically   dynamic   process   and   is   therefore   an   extremely   useful  
technique   for   monitoring   structural   changes   as   sample   conditions   are   altered  
(Cooke,   1997,   MacArthur   et   al.,   1994).   This   allows   simple   screening   of   different  
buffer  conditions  for  the  optimisation  of  NMR  spectra,  and  subsequently,  titrations  
can   be   carried   out   to   investigate   the   effect   of   different   molecules   and   ions   on  
protein   conformation   e.g.   Ca2+   or   Mg2+.   NMR   is   therefore   amenable   to   the  
structural  characterisation  of  Ca2+-­‐sensors.  
  
As   in  X-­‐ray  crystallography,  NMR  sample  preparation   is  critical.  The  target  protein  
must  exhibit  certain  key  features  including  the  capacity  to  remain  soluble  and  stable  
for   periods   of   weeks   to   allow   the   acquisition   of   the   data   required   for   structure  
determination   (MacArthur   et   al.,   1994).   One   of   the   biggest   limitations   of   NMR  
spectroscopy   is  the  size  of  the  protein   -­‐  generally  proteins   larger   than  30  kDa  can  
prove   problematic   (Snyder   et   al.,   2005).   The   CaBP   family   of   proteins,   with   the  
exception   of   caldendrin,   fall   below   this   molecular   weight   threshold   and   are  
therefore  suitable  candidates  for  NMR  analysis.  
  
The  structure  of  CaBP1  has  been  recently  solved  by  both  NMR  spectroscopy  and  X-­‐
ray   crystallography   and   provides   some   potentially   important   insights   into   the  
structure   of   related   CaBPs   (Findeisen   and   Minor,   2010,   Park   et   al.,   2011).   NMR  
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studies  have  determined  that  CaBP1  contains  two  independent  domains  separated  
by   a   flexible   linker   in   its   fully   Ca2+-­‐bound   form,.   The   first   18   residues   of   the   N-­‐
terminus  are   structurally  disordered  and  could  not  be  assigned.  The   remainder  of  
the  N-­‐terminal  domain  contains  EF1  and  EF2  in  a  closed  conformation  whereas  the  
C-­‐terminal   domain   contains   EF3   and   EF4   in   the   usual   Ca2+-­‐bound   open  
conformation  as  seen  in  CaM  (Park  et  al.,  2011).EF1  is  assumed  to  be  constitutively  
Mg2+-­‐bound   under   physiological   conditions   due   to   a   glutamate   to   aspartate  
substitution   at   the   12th   position   of   the   EF-­‐hand   loop   which   results   in   equal  
selectivity  for  both  Mg2+  and  Ca2+.  EF2  is  unable  to  bind  to  Ca2+  due  to  a  glycine  at  
position  5  of  the  EF-­‐hand  loop.  EF3  and  EF4  both  have  a  canonical  glutamate  at  the  
12th   position   of   the   Ca2+-­‐binding   loop   and   hence   were   found   to   bind   to   Ca2+  
specifically  with  little  affinity  for  Mg2+.  Mg2+  binding  to  the  apo  form  of  the  protein  
induced  a  global  shift  in  conformation  from  a  molten  globule  state  to  a  more  folded  
conformation   (Wingard   et   al.,   2005).   Subsequent   addition   of   Ca2+   resulted   in  
binding  at  EF3  and  EF4  and  a  related  shift  in  conformation  localised  to  these  two  EF-­‐
hands.   Mg2+   and   Ca2+   therefore   induce   distinct   conformational   changes   and  
markedly   increase  the  folding  stability  of  CaBP1   (Wingard  et  al.,  2005).  The  crystal  
structure  of  CaBP1  generated  partly  contradictory  results.  Findeisen  et  al.  described  
a  more  compact  structure  and  a  well-­‐ordered  interlobe  linker  (Findeisen  and  Minor,  
2010).   The   largest   discrepancies  were   seen   in   the  N-­‐terminal   domain   and   can   be  
explained   by   differences   in   the   binding   status   of   the   EF-­‐hands:   in   the   crystal  
structure,  EF1  was  not  Ca2+-­‐bound  despite  the  presence  of  millimolar  [Ca2+]  during  
crystallisation.   A   complete   structural   comparison   would,   therefore,   require  
crystallographic   data   for   the   Mg2+/Ca2+-­‐bound   CaBP1   protein.   The   well   ordered  
interlobe  linker  was  unique  to  the  crystal  structure  (Findeisen  and  Minor,  2010).  
  
CaBP1  structural  information  has  subsequently  been  applied  to  investigate  and  map  
regions  which  are   important  for   interactions  with   IP3Rs  (Li  et  al.,  2009)  and  Cav1.2  
channels  (Findeisen  and  Minor,  2010).    In  addition,  comparisons  with  the  structure  
of   CaM   have   been   made.   The   most   striking   difference   was   a   solvent-­‐exposed  
hydrophobic  surface  seen  on  the  front  face  of  the  Ca2+-­‐bound  C-­‐terminal  domain  of  
CaBP1  which  is  more  expansive  than  that  present  in  CaM.  This  hydrophobic  patch,  
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surrounded   by   charged   residues,   may   form   an   important   binding   site   for   target  
proteins,   and  may   explain   the   differences   in   interacting   partners   and  modulatory  
effects  of  CaBP1  compared  to  CaM  (Li  et  al.,  2009,  Park  et  al.,  2011).  
  
The  NMR  and  crystal  structures  of  CaBP1  have  proven  valuable  for  the  elucidation  
of   structure-­‐function   relationships   and   may   serve   as   a   model   for   predicting   the  
structures   of   related   CaBPs.   There   are,   however,   important   differences   in   the  
sequence   properties   of   the   various   CaBPs   and   it   will   be   important   to   investigate  
how  these  differences  affect  the  structure  of  the   individual  proteins.   In  particular,  
for   reasons   discussed   in   Chapter   3,   CaBP7   and   CaBP8   differ   significantly   in   their  
domain  properties  compared  to  the  rest  of  the  CaBPs.    
  
Unlike  CaBP1,  CaBP7  and  CaBP8  have  only  two  functional  EF-­‐hand  motifs,  EF1  and  
EF2,  which,  as  determined  by  ITC,  form  high  affinity  Ca2+-­‐binding  sites  (Mikhaylova  
et  al.,  2006).  Mikhaylova  et  al.  reported  that  Ca2+  binding  to  CaBP7  or  CaBP8  follows  
a  one  set  of  sites  model  with  a  Ca2+-­‐binding  affinity  of  0.2  -­‐  0.5  µM,  which  is  around  
ten-­‐fold  higher  than  that  seen  for  caldendrin  in  similar  experiments   (Mikhaylova  et  
al.,  2006).   ITC  experiments  also  indicated  that,  unlike  CaBP1,  CaBP7  and  CaBP8  do  
not   bind   to   Mg2+   (Mikhaylova   et   al.,   2009,   Wingard   et   al.,   2005).   This   data   was  
supported   by   fluorimetry   experiments   examining   CaBP8  with   both  Mg2+   and   Ca2+  
(Mikhaylova  et  al.,  2009,  Mikhaylova  et  al.,  2006):  Mg2+  did  not  induce  a  detectable  
conformational  change  in  the  protein  whereas  a  large  shift  in  fluorescence  intensity  
was  observed  upon  the  addition  of  Ca2+.  The  perturbation  in  fluorescence  was  more  
substantial  than  observed  for  caldendrin  in  similar  experiments  (Mikhaylova  et  al.,  
2006).  These  data  indicate  that  CaBP7  and  CaBP8  behave  differently  to  caldendrin  
and   CaBP1   when   binding   divalent   cations.   Moreover,   the   C-­‐terminal   regions   of  
CaBP7  and  CaBP8,  containing  their  unique  TMDs,  share  little  sequence  identity  with  
other   Ca2+-­‐sensors   (McCue   et   al.,   2011,  McCue   et   al.,   2009).   As   demonstrated   in  
chapter  3,  CaBP7  and  CaBP8  appear  to  form  a  distinct  group  of  proteins,  unlike  any  
other  known  Ca2+-­‐sensor  family  and  likewise  may  exhibit  divergent  structures  when  
compared  with  CaBP1  (McCue  et  al.,  2010a).  
  
     171  
Important  differences  also  exist  between  the  more  closely  related  CaBPs  1-­‐5  which  
might  elicit  structural  diversity.  In  particular  CaBP2  and  CaBP4  are  predicted  to  have  
different   cation   binding   properties   compared   with   CaBP1.   Whereas   CaBP1  
constitutively   binds   Mg2+   at   EF-­‐1,   this   is   predicted   to   form   a   high   affinity   Ca2+-­‐
binding   site   in   CaBP2   and  CaBP4.   This  may  have   significant   consequences   for   the  
structure   and   dynamics   of   these   proteins   in   comparison   to   CaBP1.   Most   of   the  
diversity  between  the  CaBPs,  however,  resides  within  their  N-­‐termini.  CaBP4  is  the  
most   divergent   protein   amongst   CaBPs1-­‐5   and   possesses   the   most   extended   N-­‐
terminal  region  with  the  exception  of  caldendrin  (McCue  et  al.,  2010a,  Haeseleer  et  
al.,  2000).    
  
This   chapter   presents   experimental   efforts   towards   solving   the   NMR   solution  
structures  of  both  CaBP4  and  CaBP7.  These  two  proteins  were  selected  due  to  their  
distinguishing   features   as   discussed   above   and   also   because  of   their   documented  
cellular  physiological  roles.  CaBP4  is  the  most  functionally  characterised  member  of  
the  CaBP  family.  It  has  been  shown  to  interact  with  and  regulate  various  VGCCs  (Cui  
et  al.,  2007,  Lee  et  al.,  2007c,  Haeseleer  et  al.,  2004,  Yang  et  al.,  2006a)  and  plays  a  
critical   role   in   phototransduction   in   the   mammalian   retina   (Maeda   et   al.,   2005,  
Haeseleer  et  al.,  2004,  Zeitz  et  al.,  2009,  Littink  et  al.,  2010,  Haeseleer,  2008,  Zeitz  
et  al.,  2006,  Littink  et  al.,  2009,  Aldahmesh  et  al.,  2010,  Lee  et  al.,  2007b).  Various  
mutations  have  been   identified   in  human  CaBP4,  which   give   rise   to   rod  and   cone  
synaptic  disorders  (Zeitz  et  al.,  2009,  Littink  et  al.,  2010,  Zeitz  et  al.,  2006,  Littink  et  
al.,  2009,  Aldahmesh  et  al.,  2010)  and  CaBP4  homozygous  knockout  mice  exhibit  a  
night   blindness   phenotype   (Haeseleer   et   al.,   2004).   A   role   regulating   Ca2+-­‐  
dependent   inactivation   of   L-­‐Type   Cav1.3   channels   in   auditory   inner   hair   cells   has  
also  been  postulated  for  CaBP4  (Cui  et  al.,  2007).    
  
CaBP7   is   less  well-­‐characterised  but   its   implicated  role   in  cytokinesis   (Neumann  et  
al.,   2010),   as   discussed   in   chapter   5,   marks   CaBP7   as   a   potentially   important  
candidate  for  structural  characterisation.  CaBP7  has  also  been  shown  to  bind  to  and  
?????????????????????????????????????????????? ???????????????????????????????????????
trafficking   (Mikhaylova   et   al.,   2009).   It   will   be   important   to   elucidate   the   key  
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structural  differences  between  the  Ca2+-­‐sensing  protein   families   comprising  CaBPs  
1-­‐5,  and  CaBP7  and  CaBP8.    
6.2.  Results  
6.2.1.  Protein  expression  of  CaBP4,  CaBP7  and  CaBP8  
The  sequences  encoding  human  CaBP4,  CaBP7  and  CaBP8  were  first  cloned   into  a  
glutathione-­‐S-­‐transferase  (GST)  fusion  vector  for  production  of  GST-­‐tagged  proteins  
in   E.   coli.   The   GST   tag   (26   kDa)   must   be   cleaved   following   recombinant   protein  
purification  and  ????? ?????????????????????????????????????????????????????  
  
Suitability   of   expression   levels   and   purity   of   the   GST   fusion   proteins   for   NMR  
analysis  were  trialled  using  BL21  (DE3)  E.  coli  as  a  host  organism  (Table  6.1).  E.  coli  is  
the  most  commonly  used  host  organism  for  the  expression  of  recombinant  proteins  
and  is  particularly  suited  to  the  production  of  proteins  for  NMR  due  to  its  ability  to  
synthesise   amino   acids   from   a   simple   carbon   source   and   nitrogen   salt.   This  
facilitates   the   cost   effective   production   of   isotopically   labelled   proteins,   which   is  
vital  for  the  generation  of  high  resolution  NMR  spectra.  The  inherent  signal  overlap  
and  unfavourable  line  widths  associated  with  the  typically   large  molecular  weights  
of   proteins   are   fundamental   problems   for   protein  NMR   spectroscopy,  but   can  be  
largely   resolved   through   the   use   of  multidimensional   hetero-­‐nuclear   experiments  
(Hill,   2008,   Cooke,   1997).   High   resolution   NMR   spectroscopy   requires   the   use   of  
nuclei  with  half  integral  spin  (MacArthur  et  al.,  1994).  The  most  abundant  isotopes  
of  carbon  (12C)  and  nitrogen  (14N)  are,  therefore,  unsuitable,  but  can  be  substituted  
relatively   easily   with   stable   isotopes   (13C   and   15N)   which   have   a   spin   quantum  
number  ?  ½.    This  is  achieved  by  expressing  proteins  in  minimal  medium  containing  
13C-­‐labelled   glucose   and   15N-­‐labelled   ammonium   chloride   as   the   sole   carbon   and  
nitrogen   sources.   This   allows   the   acquisition   of   two   dimensional   (2D)   and   three  
dimensional   (3D)   NMR   experiments   which   give   the   necessary   information   to  
perform  backbone  and  side  chain  assignments  and  also  allow  structure  calculations.  
  
High   purity   (>90%)   and   concentration   (>300   ?M)   is   preferable   for   acquisition   of  
structure  quality  NMR  data.  BL21  (DE3)  E.  coli  grow  rapidly  and  can  produce   large    
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amounts  (>50  mg/litre  culture)  of  recombinant  protein,  however,  overexpression  of  
exogenous   protein   can   result   in   the   formation   of   insoluble   protein   aggregates   or  
inclusion  bodies.  Therefore,  a  balance  must  be  struck  between  high  expression  and  
protein   solubility.  There  are  various  parameters  which  may  be  altered   in  order   to  
obtain  a  maximal  yield  of  soluble  protein.  Slowing  the  expression  rate,  by  reducing  
IPTG   concentration,   altering   the   induction   temperature,   or   varying   the   length   of  
induction  was  tested  for  each  of  the  proteins  investigated  (Table  6.1).  
  
The   expression   of  GST-­‐tagged  CaBP4,   CaBP7   and  CaBP8  was   insufficient  under   all  
induction  conditions  tested.  As  determined   in  chapter  4,  CaBP7  and  CaBP8  are  TA  
membrane  proteins  and  producing  a  high  yield  of  full-­‐length  soluble  protein  is  likely  
to  prove  problematic  due  to  the  hydrophobicity  of  their  C-­‐termini.  As  such,  most  of  
the   expressed   protein   was   insoluble   and   remained   in   the   pellet   fraction   as  
visualised  on  SDS-­‐PAGE  (data  not  shown).  In  an  attempt  to  improve  the  solubility  of  
CaBP7  and  CaBP8,  truncations  of  both  proteins,  lacking  their  C-­‐terminal  TMDs,  were  
generated   (CaBP7   1-­‐188   and   CaBP8   1-­‐192).   This   improved   the   solubility   of   both  
proteins,   however,   the   expression   yield   remained   too   low   to   obtain   sufficient  
quantities  for  NMR.  
  
As   changing   the   induction  conditions  and  creating  TMD  deficient  mutants  did  not  
sufficiently   improve  protein   yield,   alternative  host  expression   strains  were   tested.  
Efficient  production  of  heterologous  protein  in  E.  coli  is  often  limited  by  the  rarity  of  
certain   tRNAs   which   are   more   common   in   eukaryotes.   Forced   overexpression   of  
heterologous   proteins   can   deplete   the   limited   pool   of   these   rare   tRNAs   and   stall  
translation,  resulting  in  a  poor  expression  yield  of  full-­‐length  protein.  To  overcome  
this,  modified  BL21  strains  are  commercially  available  that  have  been  engineered  to  
over-­‐express   rare   tRNAs   (Kleber-­‐Janke   and   Becker,   2000).   BL21-­‐CodonPlus®(DE3)-­‐
RP,  BL21-­‐CodonPlus®(DE3)-­‐????????????????????????????????????????????????????????
process  of  testing  induction  conditions  was  repeated  for  each  new  BL21  strain.  The  
use  of  BL21s   encoding   rare   tRNAs   generally   improved   the  expression  of  CaBP7  1-­‐
188  and  CaBP8  1-­‐192,  but  once  again  the  yield  was  not  sufficient  for  NMR  analysis.    
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Table  6.1.  Summary  of  recombinant  protein  expression  and  conditions  tested.Expression  conditions  are  described  for  each  of  CaBP4,  codon  
optimised  CaBP4  (Opt  CaBP4),full  length  CaBP7  (CaBP7  FL),  full  length  CaBP8  (CaBP8  FL)  and  the  truncations:  CaBP8  1-­‐192,  CaBP7  1-­‐188,  codon  
optimised  CaBP7  1-­‐188  (Opt  CaBP7  1-­‐188)  and  codon  optimised  CaBP7  1-­‐100  (Opt  CaBP7  1-­‐100).  Different  proteins  are  separated  by  
alternating  blocks  of  blue  and  white  cells.  Res.  column  indicates  the  antibiotic  resistance  encoded  by  the  expression  vector.  Tag  column  lists  the  
affinity  tag  encoded  by  the  expression  vector.  Bact.  Res  column  indicates  the  antibiotic  resistance  the  expression  bacteria.  M9  =  M9  minimal  




Protein Plasmid Res. Tag Expression bacteria Bact. Res. Media IPTG (mM) Temp oC Time, hrs Purification Yield Additional Info
1 CaBP4 pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.50 22 Overnight Glutathione Sepharose Poor Mainly insoluble
1 CaBP4 pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.05 18 Overnight Glutathione Sepharose Poor Mainly insoluble
1 CaBP4 pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.20 18 Overnight Glutathione Sepharose Good Low purity, poor cleavage
1 CaBP4 pOPIN-­‐s Amp His-­‐SUMO RIL codon Plus Cmp SB 0.20 30 5 Talon Very poor Low purity
1 CaBP4 TrcHisTEV Amp His RIL codon Plus Cmp SB 0.20 30 5 Talon Poor Improved cleavage
2 Opt CaBP4 SUMO-­‐Pro kan His-­‐SUMO BL21 -­‐ M9 1.00 37 3 Talon Good
2 Opt CaBP4 SUMO-­‐Pro kan His-­‐SUMO BL21 -­‐ M9 1.00 18 Overnight Talon Very good Efficient cleavage, high purity
4 CaBP8 FL pETM11 Amp His BL21 -­‐ SB 0.10 30 5 Talon Very poor Insoluble
4 CaBP8 FL pETM11 Amp His rosetta Cmp SB 0.10 30 5 Talon Very poor Insoluble
4 CaBP8 FL pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.05 20 Overnight Glutathione Sepharose Very poor Mainly insoluble
4 CaBP8 FL pGEX-­‐6P1 Amp GST RP codon Plus Cmp M9 0.10 20 Overnight Glutathione Sepharose Very poor Mainly insoluble
4 CaBP8 FL pGEX-­‐6P1 Amp GST RP codon Plus Cmp SB 0.10 30 5 Glutathione Sepharose Very poor plus 0.5% tween, insoluble
4 CaBP8 FL pGEX-­‐6P1 Amp GST RP codon Plus Cmp SB 0.10 30 5 Glutathione Sepharose Very poor plus 0.5% CHAPS, insoluble
4 CaBP8 FL TrcHisA Amp His Rosetta Cmp M9 0.10 20 Overnight Talon Non No bacterial growth
4 CaBP8 FL TrcHisA Amp His Rosetta Cmp SB 0.10 30 7 Talon Non Insoluble
4 CaBP8 FL TrcHisA Amp His RP codon Plus Cmp SB 0.10 18 Overnight Talon Poor Low purity
4 CaBP8 FL TrcHisA Amp His RP codon Plus Cmp M9 0.50 30 Overnight Talon Poor Low purity
5 CaBP7 FL pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.05 20 Overnight Glutathione Sepharose Very poor Mainly insoluble
5 CaBP7 FL pGEX-­‐6P1 Amp GST RP codon Plus Cmp M9 0.10 20 Overnight Glutathione Sepharose Very poor Mainly insoluble
6 CaBP7 1-­‐188 pETM11 Amp His Rosetta Cmp SB 0.10 30 7 Talon Very poor Low expression
6 CaBP7 1-­‐188 pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.10 20 Overnight Glutathione Sepharose Poor Mainly insoluble, double bands observed, poor cleavage
6 CaBP7 1-­‐188 pGEX-­‐6P1 Amp GST Rosetta Cmp SB 0.10 20 Overnight Glutathione Sepharose Good
6 CaBP7 1-­‐188 pGEX-­‐6P1 Amp GST RP codon Plus Cmp M9 0.10 20 Overnight Glutathione Sepharose Poor Mainly insoluble, cleavage inefficient
6 CaBP7 1-­‐188 pGex-­‐N2 Amp GST Arctic express RIL codon + Cmp SB 0.50 10 Overnight Glutathione Sepharose Non
6 CaBP7 1-­‐188 pGex-­‐N2 Amp GST RIL codon Plus Cmp SB 0.50 30 5 Glutathione Sepharose Very poor
6 CaBP7 1-­‐188 TrcHisA Amp His RIL codon Plus Cmp M9 0.50 30 Overnight Talon Very good Precipitation after dialysis or concentrating
6 CaBP7 1-­‐188 TrcHisA Amp His RIL codon Plus Cmp M9 0.50 22 Overnight Talon Very good Double bands observed
6 CaBP7 1-­‐188 TrcHisTEV Amp His RIL codon Plus Cmp SB 0.20 30 5 Talon Poor Improved cleavage
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Table   6.1   continued.   Summary   of   recombinant   protein   expression   and   conditions   tested.Expression   conditions   are   described   for   each   of  
CaBP4,   codon  optimised  CaBP4   (Opt   CaBP4),   full   length   CaBP7   (CaBP7  FL),   full   length   CaBP8   (CaBP8   FL)   and   the   truncations:   CaBP8  1-­‐192,  
CaBP7  1-­‐188,  codon  optimised  CaBP7  1-­‐188  (Opt  CaBP7  1-­‐188)  and  codon  optimised  CaBP7  1-­‐100  (Opt  CaBP7  1-­‐100).  Different  proteins  are  
separated  by  alternating  blocks  of  blue  and  white  cells.  Res.  column  indicates  the  antibiotic  resistance  encoded  by  the  expression  vector.  Tag  
column  lists  the  affinity  tag  encoded  by  the  expression  vector.  Bact.  Res  column  indicates  the  antibiotic  resistance  the  expression  bacteria.  M9  





Protein Plasmid Res. Tag Expression bacteria Bact. Res. Media IPTG (mM) Temp oC Time, hrs Purification Yield Additional Info
7 CaBP8 1-­‐192 pGEX-­‐6P1 Amp GST BL21 -­‐ M9 0.10 20 Overnight Glutathione Sepharose Poor Mainly insoluble, double bands observed, poor cleavage
7 CaBP8 1-­‐192 pGEX-­‐6P1 Amp GST Rosetta Cmp SB 0.10 20 Overnight Glutathione Sepharose Good Double bands observed
7 CaBP8 1-­‐192 pGEX-­‐6p-­‐1 Amp GST RP codon Plus Cmp M9 0.10 20 Overnight Glutathione Sepharose Poor Mainly insoluble, inefficient cleavage
7 CaBP8 1-­‐192 pGex-­‐N2 Amp GST Arctic express RIL codon + Cmp SB 0.50 10 Overnight Glutathione Sepharose Non
7 CaBP8 1-­‐192 pGex-­‐N2 Amp GST RIL codon Plus Cmp SB 0.50 30 5 Glutathione Sepharose Very poor
7 CaBP8 1-­‐192 TrcHisA Amp His RIL codon Plus Cmp M9 0.50 30 Overnight Talon Very good Precipitation after dialysis or concentrating
7 CaBP8 1-­‐192 TrcHisA Amp His RIL codon Plus Cmp M9 0.50 22 Overnight Talon Very good Double bands observed
7 CaBP8 1-­‐192 TrcHisA Amp His RIL codon Plus Cmp M9 0.50 22 Overnight Talon Very good Low purity
7 CaBP8 1-­‐192 TrcHisA Amp His RIL codon Plus Cmp M9 0.80 22 Overnight Talon Very good Low purity
7 CaBP8 1-­‐192 TrcHisA Amp His Rosetta Cmp M9 0.10 20 Overnight Talon Very poor No Bacterial growth
7 CaBP8 1-­‐192 TrcHisA Amp His Rosetta Cmp SB 0.10 30 7 Talon Good Double bands observed
7 CaBP8 1-­‐192 TrcHisA Amp His RP codon Plus Cmp SB 0.10 18 Overnight Talon Poor Low purity
7 CaBP8 1-­‐192 TrcHisA Amp His RP codon Plus Cmp SB 0.50 18 Overnight Talon Very good
7 CaBP8 1-­‐192 TrcHisA Amp His RP codon Plus Cmp M9 0.50 30 Overnight Talon Good Low purity
8 Opt CaBP7 1-­‐188 SUMO-­‐Pro kan His-­‐SUMO BL22 -­‐ SB 1.00 37 3 Talon Excellent Did not precipitate
8 Opt CaBP7 1-­‐188 SUMO-­‐Pro kan His-­‐SUMO BL22 -­‐ M9 1.00 37 3 Talon Very good Precipitation after dialysis
8 Opt CaBP7 1-­‐188 TrcHisA Amp His RIL codon Plus Cmp SB 0.50 18 Overnight Talon Very poor Low purity
9 Opt CaBP7 1-­‐100 SUMO-­‐Pro kan His-­‐SUMO BL22 -­‐ SB 1.00 37 3 Talon Excellent Did not precipitate
9 Opt CaBP7 1-­‐100 SUMO-­‐Pro kan His-­‐SUMO BL22 -­‐ M9 1.00 37 3 Talon Good Precipitation after dialysis
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Production  of  a  GST  tag  can  be  energetically  costly  for  expression  bacteria  and  the  
use  of  a  smaller  affinity  tag  can  improve  protein  expression  (Waugh,  2005).  For  this  
reason   the   use   of   hexa-­‐histidine   (His6)-­‐tagging   vectors   was   investigated.   Various  
His6-­‐tagging   vectors   were   evaluated,   each   having   unique   properties   (Appendix  
Table  A1).  Expression  of   CaBP4,  CaBP7  1-­‐188  and  CaBP8  1-­‐192   from  the  pTrcHisA  
vector   improved   recombinant   protein   yield.   The   His6   tag   encoded   by   pTrcHisA   is  
removable  by  treatment  with  enterokinase.  This  protease  is  less  efficient  than  other  
commercially  available  enzymes  and  therefore,  in  order  to  enhance  the  efficiency  of  
tag  removal,  a  TEV  cleavage  site  was  cloned  into  the  vector.  CaBP4  and  CaBP7  1-­‐188  
were   cloned   into   this   new   plasmid   (pTrcHis-­‐TEV)   and   efficient   TEV   protease  
cleavage  of  the  recombinant  proteins  was  acheived.  
  
Despite   the   improved   expression   using   the   pTrcHisA   expression   plasmid,   new  
problems  were  encountered.  A  protein  doublet  was  frequently  observed  in  eluates  
of  CaBP7  1-­‐188  and  CaBP8  1-­‐192,   suggesting   that  either  proteolysis  or  premature  
translation  termination  was  occurring.  In  addition,  when  the  proteins  were  dialysed  
to  remove  imidazole  which  is  present  in  the  elution  buffers,  the  proteins  exhibited  a  
propensity   to   precipitate.   Protein   loss   was   also   observed   using   ultrafiltration  
columns   for   buffer   exchange   and   concentration,   suggesting   that   the   protein  may  
have  also  precipitated  during   this  process  or  was  associating  non-­‐specifically  with  
the  ultrafiltration  membrane.  
  
The  possible  premature  translation  termination,  and  the  observed  improvement  in  
expression   upon   transformation   into  modified   E.   coli,   suggested   that   there  was   a  
potential  issue  with  rare  tRNA  use  in  the  gene  encoded  by  these  plasmids.  For  this  
reason  synthetic,  E.  coli  codon  optimised,  clones  were  generated.  Codon  optimised  
CaBP7  1-­‐188,  cloned  into  the  pTrcHisA  vector,  exhibited  reduced  protein  expression  
compared  with  the  non-­‐optimised  sequence.  For  this  reason,  the  codon  optimised  
clones  were   cloned   into   an  alternative  expression  plasmid  ?   pE-­‐SUMOPRO,  which  
employs   a   His6   affinity   tag   in   conjunction   with   the   yeast   Small   Ubiquitin-­‐like  
Modifier   (SUMO)   protein,   Smt3.   Fusion   of   ubiquitin   or   ubiquitin-­‐like   proteins   has  
been   shown   to   exert   chaperoning   effects   on   fusion   proteins   made   in   yeast   and  
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bacteria   thereby   improving   yield   and   solubility   (Zuo   et   al.,   2005).   It   has   been  
suggested   that   the   increased   solubility  observed   in   these   fusions   is   related   to   the  
outer  hydrophillicity  and  inner  hydrophobicity  of  SUMO,  generating  a  detergent-­‐like  





Figure   6.1.   Example   SDS-­‐PAGE   gels   illustrating   the   expression   and   tag   cleavage  of   15N   -­‐   labelled  
His6-­‐SUMO-­‐CaBP4   and   His6-­‐SUMO-­‐CaBP7   1-­‐188.      A   i)   His6-­‐SUMO-­‐CaBP4;   ii)   His6-­‐SUMO-­‐CaBP4  
cleaved  directly  from  affinity  resin  B  i)  His6-­‐SUMO-­‐CaBP7  1-­‐188;  ii)  His6-­‐SUMO-­‐CaBP7  1-­‐188  cleaved  
directly   from  beads.   E1,  ???? ????????? ????????? ?????????? ????????????? ??????? ? ???????? ????????? ????
and  Bi)  or   from  after   sumo  protease   treatment  of  protein   immobilized  on  affinity   resin   to   remove  
SUMO   tag   (Aii   and   Bii).   B   =   protein   bound   to   affinity   resin.   Each   lane   represents   the   amount   of  
protein  in  5  µl  of  the  indicated  fraction.  
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Use   of   SUMO   fusions   is   emerging   as   an   efficient  method   for   the   optimisation   of  
expression   and   solubility   of   difficult   to   express   proteins   (Butt   et   al.,   2005).   In  
addition,   contrary   to   the   other   fusion   tags   discussed   here,   SUMO   can   be  
proteolytically   removed   without   leaving   residual   amino   acids   (Malakhov   et   al.,  
2004).  SUMO  protease  achieves  this  by  primarily  recognising  the  tertiary  structure  
of  the  SUMO  protein  rather  than  a  particular  consensus  amino  acid  sequence.  The  
expression  of  both  codon  optimised  CaBP4  and  CaBP7  1-­‐188  was  greatly  improved  
using  this  vector  system  in  standard  BL21  cells,  increasing  yields  by  up  to  40-­‐fold  in  
rich  media  protein  preparations,  compared  to  recombinant  protein  expressed  from  
pTrcHisA.   Labelled   minimal   media   protein   preparations   were   therefore   trialled  
using  these  constructs  (Figure  6.1).    
  
His6-­‐SUMO-­‐tagged   CaBP4   and   CaBP7   1-­‐188   also   precipitated   upon   removal   of  
imidazole  by  either  dialysis  or  ultrafiltration.  Imidazole  must  be  removed  in  order  to  
allow  purification  of  the  protein  away  from  the  SUMO  tag  following  cleavage  with  
SUMO  protease.  Multiple  buffer  conditions  were  tested,  but  all  proved  incapable  of  
preventing   protein   precipitation.   Although   up   to   50%   of   the   protein   was   lost  
through  precipitation,   sufficient  amounts  of  protein   remained   in   solution   to  allow  
the  generation  of  preliminary  NMR  spectra.    
  
6.2.2.  Optimisation  of  CaBP4  for  NMR  analysis  
Prior  to  the  collection  of  large  amounts  of  NMR  data,  the  protein  sample  should  be  
optimised  for  concentration,  ionic  strength,  pH  and  temperature  to  maximise  NMR  
spectra  quality  (Muskett,  2011).  Acquisition  of  the  data  required  for  backbone  and  
side-­‐chain   assignments   can   take   several   weeks,   therefore   the   sample   must   be  
stable  over  extended  periods  of  time.  A  15N-­‐labelled  protein  sample  was,  therefore,  
synthesised,   then   various   buffer   conditions   were   assessed   by   monitoring   the  
improvement  or  deterioration  of  NMR  spectra.    
  
Initially,   1H-­‐15N-­‐heteronuclear   single-­‐quantum   correlation   (HSQC)   spectra   for  
uncleaved  His6-­‐SUMO-­‐CaBP4  were  recorded.  The  fusion  protein  was  left  uncleaved  
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Figure  6.2.  Overlay  of  2D  1H-­‐15N  HSQC  NMR  spectra  of  His6-­‐SUMO-­‐CaBP4.  Black  =  His6-­‐SUMO-­‐CaBP4  
in  50  mM   sodium  phosphate  buffer  pH  7.0,   300  mM  NaCl,   200  mM   imidazole.  Red  =  His6-­‐SUMO-­‐
CaBP4  in  25  mM  Tris.HCl  pH  6.5,  50  mM  NaCl,  50  mM,  arginine  50  mM  glutamine.    
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to   optimise   buffer   conditions,   whilst  minimising   aggregation   and   precipitation   by  
having   the   SUMO   tag   present   to   enhance   fusion-­‐protein   solubility.   HSQC   spectra  
correlate   the   chemical   shifts   of   the   1H   and   15N   nuclei   for   each   amide   group.   The  
peaks   in  each   spectrum  therefore   represent   the  main  chain  and   side   chain  amide  
groups   of   the  protein.   This  provides   a   residue   specific   fingerprint   of   an   individual  
?????????? ????????????? ?????? ?? ?????? ???? ??? ???????????? ??????? ???? ?????? ????
overlaid   spectra   for   uncleaved   CaBP4:   one   captured   immediately   after   protein  
????????????? ??? ??????? ???????? ????? ???? ??? ? ????????? ???? ?????? ????????? ?????
????????? ????????? ????? ???? ???????? ??????????? ??? ??? ????????? ???? ???? ?????
glutamine   (E)   (see   table  6.2  for  detailed  descriptions  of  NMR  buffer  components).  
The  addition  of  free  amino  acids  such  as  glutamine  and  arginine  has  been  shown  to  
increase   the   stability   and   solubility   of   recombinant   proteins   (Golovanov   et   al.,  
2004).   Addition   of   these   amino   acids   failed   to   prevent   precipitation   of   CaBP4,  
however,   enough   soluble  protein   (~   150  ???   remained   to  permit   acquisition  of  a  
1H-­‐15N-­‐HSQC   under   these   buffer   conditions.   Figure   6.2   highlights   that   there   was  
little  difference  in  NMR  spectrum  quality  obtained  under  the  two  buffer  conditions.    
  
Protein  dialysed   into  RE  buffer  was  cleaved  using  SUMO  protease  and   free  SUMO  
removed  by  re-­‐passing  over  affinity  resin.  An  NMR  spectrum  of  the  cleaved  material  
was  then  acquired  (Figure  6.3,  black).  The  1H-­‐15N-­‐HSQC  spectrum  of  cleaved  CaBP4  
is   poorly   resolved   with   narrow   chemical   shift   dispersion   in   the   amide   proton  
dimension   ranging   between   8.5   and   7.5   ppm.   The   number   of   observed   peaks   is  
lower  than  expected  (74  versus  275)  and  there  is  a  mixture  of  very  sharp  and  very  
weak  peaks.  The  weak  peaks  may  have   low   intensity  due  to  exchange  broadening  
caused   by   either   dimerisation   or   conformational   heterogeneity   (Wingard   et   al.,  
2005,  Cavanagh  et  al.,  2007c).  The  poor  chemical  shift  dispersion  is  indicative  of  an  
unstructured   protein   in   a   molten   globule   state.   Sharp   peaks   often   represent   an  
unstructured,  flexible  peptide  region  and  this  spectrum  exhibits  features  consistent  
with  this.  CaBP1  has  been  previously  shown  to  possess  a  structurally  disordered  N-­‐
terminus   (Park  et  al.,  2011)  and  the  sharp  peaks  observed   in  the  CaBP4  spectrum  
may,   likewise,   represent   the   extended   N-­‐terminal   region   of   the   protein.   In  
accordance   with   this,   the   PSIPRED   protein   secondary   structure   prediction   server  
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(http://bioinf.cs.ucl.ac.uk/psipred/)   predicted   a   region   of   coiled   coil   extending  
between  residues  7  -­‐  105.    
  
Table  6.2.  Table  of  Buffers  used  for  preparation  of  NMR  samples.    
  
Buffer  Name   Buffer  Components  
  
RE  Buffer   25  mM  Tris.HCl  pH  6.5,  50  mM  NaCl,    
50  mM  Arginine  (R),  50  mM  Glutamine  (E)  
  





25  mM  Tris.HCl  pH  6.5,  150mM  NaCl,    
5  mM  CaCl2???? ???????????????????? ???-­‐mercaptoethanol  
  




25mM  sodium  phosphate  buffer  pH  7.0,  150  mM  NaCl,    
25  mM  imidazole  
  
HEPES  Buffer   20  mM  HEPES  pH  7.5,  50  mM  NaCl,    
10  mM  octylglucoside  
  
EDTA/EGTA  Buffer   20  mM  HEPES  pH  7.5,  50  mM  NaCl,    




20  mM  HEPES  pH  7.5,  50  mM  NaCl,    




Structural   studies   of   CaBP1   reported   a   poorly   resolved   structure   suggestive   of   a  
molten   globule   conformation   in   the   absence   of   Mg2+   and   Ca2+   (Li   et   al.,   2009).  
Addition   of   Mg2+   or   Ca2+   dramatically   changed   the   spectrum   of   CaBP1,   with   a  
greater  number  of  peaks  appearing  and  at  a  more  uniform  intensity  (Li  et  al.,  2009).  
Addition   of   these   metal   ions   also   substantially   improved   the   chemical   shift  
dispersion   of   peaks   in   the   spectra.   In   particular,   two   downfield   shifted   peaks  
appeared  in  the  Mg2+  spectra  and  three  appeared  in  the  Ca2+  spectra,  which  could  
be   assigned   to   the   glycine   residues   at   the   6th   postion   of   the   three   functional   EF-­‐
hands   of   CaBP1   (Li   et   al.,   2009).   This   is   a   characteristic   feature   of   NMR   spectra  
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belonging  to  EF-­‐hand  containing  Ca2+-­‐binding  proteins  (Lusin  et  al.,  2008,  Schwenk  
et  al.,  2008,  Aravind  et  al.,  2008,  Wingard  et  al.,  2005).  In  order  to  assess  whether  
CaBP4  might   behave   in   a   similar   fashion,   1  mM   CaCl2   was   added   to   the   cleaved  
sample  (Figure  6.3,   red).  Figure  6.3   illustrates  that  the  spectra  with  and  without  1  
mM  CaCl2   completely  overlaid  and  no  changes  or   improvements  upon  addition  of  
Ca2+  were  observed.  
  
Up   to  50%  of  CaBP4   recombinant  protein  was   lost  during   the  purification  process  
due  to  a  combination  of  precipitation  and  multiple  purification  steps.  In  an  attempt  
to   improve   CaBP4   solubility   and   to   obtain   a   more   concentrated   sample,  
recombinant   protein   was   not   eluted   from   the   affinity   resin.   Instead,   the   resin-­‐
bound   protein   was   washed   directly   in   an   appropriate   NMR   buffer   followed   by  
SUMO  protease  addition.  This  had  the  effect  of  simultaneously  cleaving  the  SUMO  
tag  from  the  protein  while  purifying  both  the  tag  and  protease  (which  is  itself  a  his6-­‐
tagged  protein)  away  from  the  free  CaBP4  in  a  one  step  process.  Most  importantly,  
this  method   avoids  dialysis  where   the  majority   of   the   expressed   protein  was   lost  
through   precipitation.   An   example   SDS-­‐PAGE   image   (Figure   6.1A)   shows   CaBP4,  
before  and  after  cleavage  directly  from  affinity  resin,  using  this  approach.  
  
Buffer  conditions  were  modified   in  an  attempt  to  aid   the  solubility  of  the  cleaved  
protein.  NMR  studies  of  the  KChIP  subfamily  of  NCS  proteins  (Schwenk  et  al.,  2008,  
Lusin  et  al.,  2008)  reported  that  addition  of  octylglucoside  stabilised  these  proteins  
and  prevented  aggregation.  Therefore   the  effect  of  octylglusoside  on  CaBP4  NMR  
spectra  was  assessed.  Cleavage  directly  from  affinity  resin  was  not  efficient  at  high  
concentrations  of  octylglucoside  (20  mM),  therefore  a  concentration  of  2  mM  was  
????????????????????????????????????????????????????????????????????????????????????????
also   increases   the   solubility  of  proteins   and  decreases   aggregation,   therefore  150  
mM  NaCl  was   included.  This   is   the   recommended  maximum  concentration  of   salt  
which  can  be  used  in  NMR  studies  due  to  dielectric  losses  experienced  at  high  ionic  
strength  (Muskett,  2011).  As  addition  of  Ca2+  has  generally  been  shown  to  improve  
the   spectra   of   Ca2+-­‐binding   proteins,   5   mM   CaCl2   was   included   in   all   buffers.  
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Figure  6.3.  Overlay  of  2D  1H-­‐15N  HSQC  NMR  spectra  of  cleaved  CaBP4  in  the  presence  and  absence  
of  CaCl2.  Black  =  0  mM  CaCl2.  Red  =  1  mM  CaCl2.  The  sample  was  prepared  in  25  mM  Tris.HCl,  pH  6.5,  
50  mM  NaCl,  50  mM  arginine,  50  mM  glutamine.  
  
  
????????? ?????? ??? ????? ???? ????????? ???????? ??? ??????? ?-­‐mercaptoethanol   was  
included  to  reduce  disulphide  bonds.    
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The  spectrum  obtained  under  these  conditions  was  greatly   improved  compared  to  
the  original  spectra  (Figure  6.4A  versus  Figure  6.3).  A  greater  number  of  structured  
peaks  can  be  observed  with  wider  chemical  shift  dispersion.  Of  particular  note  is  the  
appearance  of  a  downfield  shifted  peak  in  the  region  that  is  characteristic  of  an  EF-­‐
hand  glycine  at  the  6th  position  (circled  in  green,  Figure  6.4A).  There  were  a  greater  
number   of   weaker   peaks   and   the   sharp   peaks   originally   observed   in   figure   6.3  
intensified.  The  appearance  of  an  increased  number  of  weak  peaks,  representing  an  
intermediate   conformational   exchange   (Cavanagh   et   al.,   2007c),   may   be   due   to  
either   an   increase   in   protein   concentration,   improved   buffer   conditions,   or   both.  
The  remaining  sharp  peaks  are  again  indicative  of  an  unstructured  region  within  the  
protein.  
  
Elevation   of   sample   temperature   in   NMR   experiments   can   improve   the   signal   to  
noise  ratio  provided  the  protein  does  not  thermally  denature  over  the  temperature  
range  employed.  Figure  6.4C  shows  an  overlay  of  five  CaBP4  NMR  spectra  recorded  
at   increasing   temperatures.  The   initial   spectrum  discussed  above  was   recorded  at  
298   K   and   the   temperature   was   increased   stepwise   to   318   K   (Figure   6.4B).  
Increasing   the   temperature   increased   signal   to   noise   and   many   more   widely  
dispersed  weak  peaks  became  visible,  along  with  a  drop  in  intensity  of  the  original  
sharp   peaks.   The   number   of   visible   peaks   is   proportional   to   the   increasing  
temperature  (Figure  6.4D)  with  126  peaks  counted  in  the  298  K  spectrum  and  208  
peaks   in   the   318   K   spectrum.   Importantly,   three   downfield   shifted   peaks   can   be  
seen  in  the  318  K  spectrum  in  the  characteristic  region  for  EF-­‐hand  glycines  (circled  
in   green,   Figure   6.4B).   This   is   in   agreement  with   the   three   active   EF-­‐hand  motifs  
identified  in  CaBP4.  Only  one  glycine  is  apparent  in  the  298  K  spectrum,  two  at  303  
K   and   308   K,   and   three   in   the   313   K   and   318   K   spectra,   indicating   a   gradual  
improvement   in   spectral   resolution   with   increasing   temperature.   Despite   the  
substantial   enhancement   of   CaBP4  NMR   spectra   after   sample   optimisation,   there  
remained   insufficient   peaks   to   represent   all   CaBP4   residues.   The   spectra   quality,  
although  improved,  lacked  the  resolution  to  warrant  expression  of  a  15N/13C  double-­‐
labelled  CaBP4  sample.    
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Figure  6.4  A  and  B.2D  1H-­‐15N  HSQC  NMR  spectra  of  cleaved  CaBP4  at   increasing  temperatures.  A)  
CaBP4  spectrum  at  298  K;  B)  CaBP4  spectrum  at  318  K.  The  peaks  circled  in  green  represent  glycines  
at   the   6th   position   of   the   three   EF-­‐hand   Ca2+   binding   loops   in   CaBP4.   One   is   visible   at   298   K   (A)  
whereas  three  are  visible  at  318  K  (B).  The  sample  was  prepared  in  25  mM  Tris.HCl  pH  6.5,  150  mM  
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Figure   6.4   C   and   D.   C)   Overlay   of   1H-­‐15N   HSQC   NMR   spectra   of   cleaved   CaBP4   at   increasing  
temperatures:   298   K,   303   K,   308   K,   313   K   and   318   K.   The   colour   changes   from   pale   lilac   to   dark  
purple  as  temperature   increases.  D)  Graph  showing  the   increase   in   the  number  of  peaks  observed  
with   increasing   acquisition   temperature   as   a   percentage   of   the   expected   number   of   peaks.   The  
sample  was  prepared  in  25  mM  Tris.HCl  pH  6.5,  15  mM  NaCl,  5  mM  CaCl2,  2  mM  octyl-­‐glucoside,  1  
????-­‐mercaptoethanol.      
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6.2.3.  Optimisation  of  CaBP7  1-­‐188  for  NMR  analysis  
As   observed   with   CaBP4,   precipitation   of   recombinant   CaBP7   1-­‐188   was  
encountered.   Therefore   the   SUMO   tag  was   cleaved  whilst   immobilised  on  affinity  
resin   to   avoid   dialysis   steps   which   had   proven   costly   for   protein   yield   in   CaBP4  
preparations  (Figure  6.1B).  Figure  6.5A  shows  a  1H-­‐15N  HSQC  spectrum  of  CaBP7  1-­‐
???? ??? ??????????????????? ????????????????????????????2+.  Peaks  arising   from  folded  
regions  of  the  protein  can  be  observed  and  there  are  two  downfield  shifted  peaks  
(circled   in   green,   Figure   6.5A   and   B)   which   likely   represent   glycines   at   the   6th  
position   of   the   two   functional   EF-­‐hands.   These   characteristic   downfield   shifted  
peaks   are   generally   only   seen   when   the   EF-­‐hands   are   occupied   by   Ca2+.   This,  
therefore,   suggests   this   protein  was   not   in   the  apo   form.  No  defined   peaks  were  
present   in   the   central   region   of   the   spectrum   and   substantial   peak   overlap   was  
observed,   characteristic   of   an   aggregated   protein.   CaBP7   1-­‐188   has   five   cysteine  
residues  and  this  may  increase  the  likelihood  of  aggregation  through  the  formation  
of  incorrect  disulphide  bonds  between  protein  monomers.  
  
Titrations   of   octylglucoside   and   CaCl2   were   performed   on   the   sample   to  monitor  
any  changes  in  the  quality  of  the  CaBP7  1-­‐188  spectra.  Figure  6.5C  shows  an  overlay  
of   the   spectra   obtained   at   increasing   octylglucoside   concentrations.   When   the   0  
mM  (Figure  6.5A)  and  the  30  mM  (Figure  6.5B)  spectra  are  compared,  there   is  an  
increase  in  both  the  number  and  resolution  of  peaks  at  the  higher  concentration  of  
detergent  (circled  in  red,  Figure  6.5B).  A  possible  interpretation  of  this  data  is  that  
the   presence   of   octylglucoside   reduced,   but   did   not   completely   prevent   protein  
aggregation.  
  
A  CaCl2  titration  was  next  performed  to  examine  if  this  would  further   improve  the  
spectra  (Figure  6.6).  Subtle  changes  were  observed  and  some  peaks  became  more  
defined  and  less  overlapped  (circled  in  red,  Figure  6.6A  and  B)  whilst  others  became  
weaker  and  less  resolved  (circled  in  green,  Figure  6.6A  and  B).  Preparation  of  CaBP7  
1-­‐????????????????????? ??????????????????????????????????????????????????????????????
improve  the  1H-­‐15N  HSQC  spectrum  (Figure  6.7).  
     







Figure   6.5   A   and   B.   Two-­‐dimensional   1H-­‐15N   HSQC   NMR   spectra   of   cleaved   CaBP7   1-­‐188   with  
increasing   concentrations   of   octylglucoside.   A)   0   mM   octylglucoside;   B)   30   mM   octylglucoside.  
Peaks  circled  in  green  represent  glycines  at  the  6th  position  of  the  two  EF-­‐hand  Ca2+  binding  loops.  
Peaks  circled   in   red  only  appear   in   the  spectra  acquired   in   the  presence  of  30  mM  octylglucoside.    
The  sample  was  prepared  in  20  mM  Tris.HCl  pH  6.5,  150  mM  NaCl.  
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Figure   6.5   C.   Overlay   of      1H-­‐15N   HSQC   NMR   spectra   of   cleaved   CaBP7   1-­‐188   with   increasing  
concentrations  of  octylglucoside:    0  mM  (peach),  5  mM  (blue),  10  mM  (yellow),  20  mM  (lilac)  and  30  
mM  (pink)  octylglucoside.  The  sample  was  prepared  in  20  mM  Tris.HCl  pH  6.5,  150  mM  NaCl.  




Figure   6.6   A   and   B.   2D  1H-­‐15N   HSQC   NMR   spectra   of   cleaved   CaBP7   1-­‐188   with   increasing   CaCl2  
concentration.  A)  0  mM  CaCl2  B)  10  mM  CaCl2.  Peaks  which  became  more  defined  with   increasing  
CaCl2   are   circled   in   red   and  peaks  which   became   less   defined   and  more   overlapped   are   circled   in  
green.  The  sample  was  prepared  in  20  mM  Tris.HCl  pH  6.5,  150  mM  NaCl,  30  mM  octylglucoside.  
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Figure  6.6  C.  Overlay  of   1H-­‐15N  HSQC  NMR  spectra  of   cleaved  CaBP7  1-­‐188  with   increasing  CaCl2  
concentration:  0  mM  (blue),  2  mM  (pink)  and  5  mM  (orange)  CaCl2.  The  sample  was  prepared  in  20  
mM  Tris.HCl  pH  6.5,  150  mM  NaCl,  30  mM  octylglucoside.  




Figure  6.7.  Two-­‐dimensional  1H-­‐15N  HSQC  NMR  spectrum  of  cleaved  CaBP7  1-­‐188.  The  sample  was  
prepared   in   20  mM   Tris.HCl   pH   6.5,   150  mM   NaCl,   5   mM   CaCl2?? ?? ??? ???????????????? ?? ??? ?-­‐
mercaptoethanol.  
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The  persistent  aggregation  of  CaBP7  1-­‐188  under  all  experimental  conditions  tested  
prevented  structure  determination  within  the  timescale  of  this  project.  A  potential  
explanation   for   the   aggregation   lies   with   the   5   cysteine   residues   found   in   the  
protein  C-­‐terminus.   For   this   reason  a  new  expression  construct  was  generated  by  
inserting   a   stop   codon   after   the   first   100   amino   acids   of   CaBP7   1-­‐188   in   pE-­‐
SUMOPRO.  This  construct  encoded  the  cysteine  free  N-­‐terminus  of  CaBP7  (CaBP7  1-­‐
100)  which   exhibits  higher   sequence   similarity  with   CaM  and  CaBP1S   than   the   C-­‐
terminus  and  encompasses   the   two  active  EF-­‐hands  of  CaBP7.  This  portion  of   the  
protein   is   therefore  useful   for   comparison  of   the   structure  of   the   functional  Ca2+-­‐
binding  motifs  with  related  domains  in  other  Ca2+-­‐sensors.  
  
6.2.4.  Optimisation  of  CaBP7  1-­‐100  for  NMR  analysis  
His6-­‐SUMO-­‐CaBP7  1-­‐100  expressed  at   levels  comparable  with  His6-­‐SUMO-­‐CaBP7  1-­‐
188  using  standard  BL21  E.  coli  (Figure  6.8A)  and,  like  CaBP7  1-­‐188,  precipitated  on  
removal  of  imidazole.  Unlike  CaBP4  (30.4  kDa)  and  CaBP7  1-­‐188  (21.6  kDa),  CaBP7  
1-­‐100   (11.4kDa)   was   more   manageable   in   size   even   with   His6-­‐SUMO   (12.3   kDa)  
attached.   Therefore,   to  avoid  problems  with  precipitation,  NMR  optimisation  was  
performed  on  the  SUMO  tagged  protein.  
  
  
Figure   6.8.   Example   SDS-­‐PAGE   gels   illustrating   the   expression   and   tag   cleavage  of   15N   -­‐   labelled    
His-­‐SUMO-­‐CaBP7   1-­‐100.   A)   His6-­‐SUMO-­‐CaBP7   1-­‐100;   B)   CaBP7   1-­‐100   cleaved   and   repassed   over  
nickel   resin.   E   =   elution   fraction,   R   =   repass   fraction   (after   cleavage).   Each   lane   represents   the  
amount  of  protein  in  5  µl  of  the  indicated  fraction.  
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Figure  6.9  shows  the  1H-­‐15N  HSQC  spectrum  of  SUMO-­‐CaBP7  1-­‐100  in  black,  overlaid  
with  the  spectrum  of  SUMO  in  red.  His6-­‐SUMO-­‐CaBP7  1-­‐?????????????????????????
Imidazo????????????????????????????????????????????????????????????????????????????????
spectrum  that  are  at   similar  positions   to   those   in   the   red   spectrum  belong  to   the  
SUMO   tag.  Many   non-­‐overlapping   peaks   can   also  be   seen,  belonging   to   CaBP7   1-­‐
100.   These   peaks   were   well   dispersed,   suggesting   that   the   protein   was   well  
structured.   The   two   characteristic   downfield   shifted   folded   peaks   of   the   EF-­‐hand  
glycines   were   also   visible,   once   again   suggesting   that   the   EF-­‐hands   were   already  
occupied  by  Ca2+.  
  
An  octylglucoside   titration  was   carried  out  on   this   sample   from  0  mM  to  50  mM.  
Figure   6.10D   shows   an   overlay   of   the   spectra   obtained.   Increasing   detergent  
concentration   improved   signal   to   noise,   with   many   peaks   gaining   in   intensity  
(circled   in   red,   Figure   6.10B).   At   the   highest   concentration   (Figure   6.10C),   the  
spectrum  deteriorated  and  exhibited   increasing  peak  overlap   in   the   centre  of   the  
spectrum  causing  poor  resolution  (circled  in  green,  Figure  6.10C).  This  suggests  that  
higher  concentrations  of  octylglucoside  caused  protein  aggregation.  The  spectrum  
with   the   greatest   signal   to   noise   and  without   significant   loss   of   resolution   in   the  
central  region  was  obtained  at  30  mM  octylglucoside  (Figure  6.10B).  
  
A  calcium  titration  (data  not  shown)  induced  subtle  improvements  in  the  quality  of  
the   spectra.  Peak   sharpening  was  observed  at  5  mM  compared  with  0  mM  CaCl2.  
These  peaks  weakened  and  there  was  more  peak  overlap  when  CaCl2  was  increased  
to   10   mM   providing   further   evidence   of   oligomerisation/aggregation   at   this  
concentration.    
  
A  new  sample  of   15N   labelled  CaBP7  1-­‐?????????????????????????????? ????? ???????
?????????????????????????????????????????????????????????????????????????????????????
30   mM   by   direct   addition   following   protein   dialysis.   Protein   precipitation   under  
these   conditions   was   minimal   and   this   sample   was   used   in   subsequent   NMR  
experiments  to  derive  spectra  for  assignment  of  the  CaBP7  1-­‐100  backbone.    
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Figure  6.9.  Two-­‐dimensional   1H-­‐15N  HSQC  NMR  spectrum  of  SUMO-­‐  CaBP7  1-­‐100  (Black)  overlaid  
with  the  spectrum  of  SUMO  (Red).  SUMO-­‐CaBP7  1-­‐100  was  prepared  in  25  mM  Na2PO4  pH  7.0,  150  
mM  NaCl,  25  mM  imidazole.  SUMO  was  prepared  in  50  mM  Tris.HCl  pH  6.5,  50  mM  NaCl.  
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Figure  6.10  A-­‐C.  Two-­‐dimensional  1H-­‐15N  HSQC  NMR  spectra  of  SUMO-­‐CaBP7  1-­‐100  with  increasing  
concentrations   of   octylglucoside.   A)   0   mM   B)   30   mM   C)   50   mM   octylglucoside.   Peaks   which  
improved  in  intensity  are  circled  in  red.  Peaks  which  decreased  in  resolution  are  circled  in  green.  The  
sample  was  prepared  in  25  mM  Na2PO4  pH  7.0,  150  mM  NaCl,  25  mM  imidazole.  
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Figure   6.10   D.   Overlay   of   1H-­‐15N   HSQC   NMR   spectra   of   SUMO-­‐CaBP7   1-­‐100   with   increasing  
octylglucoside     concentration:  0  mM  (pink),  10  mM  (blue),  20  mM  (orange),  30  mM  (lilac),  50  mM  
(peach)  octylglucoside.  The  sample  was  prepared   in  25  mM  Na2PO4  pH  7.0,  150  mM  NaCl,  25  mM  
imidazole.  
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6.2.5.  Backbone  assignment  of  CaBP7  1-­‐100  
Assignment  of  resonances  to  the  protein  backbone  is  essential  in  order  to  carry  out  
detailed   structural   studies   of   proteins   by   NMR.   Complete   proton   assignments   of  
both   the   backbone   and   side   chains   are   required   in   order   to   determine   a   high-­‐
resolution   structure,   or   less   complete   assignments   can   be   sufficient   for   specific  
studies   characterising   the   dynamics   or   interacting   surfaces   of   a   protein.   A   triple  
resonance  approach  is  the  most  efficient  method  for  both  backbone  and  side  chain  
assignment  and  requires  a  double  13C/15N  labelled  sample  for  the  acquisition  of  3D  
NMR  data.  
  
The  triple-­‐resonance  experiments  used  to  assign  the  backbone  and  side  chains  of  a  
protein  are  described  in  table  6.3.  These  experiments  correlate  the  1H  and  15N  shifts  
?????????????????????de  (NH)  group  with  one  or  more  carbon  or  proton  resonances  
of   the   current   residue   (i)   or   the   preceding   residue   (i-­‐1)   (Figure   6.11).   In   the  
assignment   procedure,   intra   residue   13C   chemical   shifts   are   first   assigned   to  each  
detected  NH  group   in  the   1H-­‐15N  HSQC  spectra  and  grouped  within  a  spin-­‐system.  
This   information   is  then  used  to  assemble  the  spin  systems  in  sequential  order  by  
finding  matching  peaks  from  one  spin  system  and  those  of  the  next   (Figure  6.12).  
For   instance  a  HNCO  experiment  provides  the  chemical  shift  of  a  particular  amino  
?????????-­‐1)  carbonyl  carbon  (13???????????????????????????????????? ?????????????
the  chemical  shift  for  13??????????????-­‐1.  Therefore,  the  chemical  shift  of  13????????? ???
the   HN(CA)CO   experiment   can   be  matched  with   that   of   the   i-­‐1   13??? ??? ???? ?????
experiment   in   order   to   establish   a   sequential   link.   The   same   approach   applies   to  
CBCA(CO)NH  and  HNCACB  experiments  which  derive  information  concerning  C?  and  
C??for  i  and  i-­‐1  (Table  6.3  and  Figures  6.11  and  6.12).  These  experiments  are  used  in  
conjunction  to  find  the  best  possible  match  out  of  all  the  identified  spin  systems.    
  
A   stretch   of   sequential   spin   systems   is   assigned   to   a   particular   region  within   the  
amino  acid  sequence  by  searching  for  spin  systems  with  distinct  chemical  shifts  that  
are  characteristic  of  particular  amino  acids.  Alanine,   glycine,   serine  and   threonine  
all  give  distinctive  chemical  shifts  which  can  be  used  to  verify  the  sequential  links.  If  
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the  pattern  of  occurrence  of   these  distinctive   spin   systems  matches   the  expected  
sequence  of  the  protein,  this  region  can  then  be  assigned  (Figure  6.12).    
  





     
Experiment   Description   Detected  chemical  shifts  
1H-­‐15N-­‐HSQC  
(2D)  
Magnetisation  is  transferred  from  1H  to  the  
attached  15N  nuclei.  The  chemical  shift  is  
evolved  on  the  nitrogen  and  transferred  back  




(Backbone  amide  groups  
and  Asn/  gln  15N?-­‐
1H???15N?-­‐1H???and  Trp  
15N?-­‐1H?  side  chains.)  
HNCO    
(3D)  
Magnetisation  is  transferred  from  1H  to  the  
15N  nuclei  and  then  to  the  attached  13????????








Magnetisation  is  transferred  from  1H  to  the  
15N  nuclei  then  to  13C?  of  i  and  i-­‐1.  From  there  
it  is  transferred  to  the  attached  13C???The  










Magnetisation  is  transferred  from  1H  ??and  
1H  ??
to  13C  ??and  
13C  ??respectively  and  then  from  
13C  
??to  
13C  ???Subsequently,  the  magnetization  is  












Magnetisation  is  transferred  from  1H  ??and  
1H  ??
to  13C  ??and  
13C  ??respectively  and  then  from  
13C  
??to  
13C  ???Subsequently  the  magnetization  is  












Magnetisation  is  transferred  from  1H??and  
1H??
to  13C??and  
13C??respectively  and  then  from  
13C??
to  13C???Subsequently  the  magnetization  is  












Magnetization  is  transferred  from  the  side  
chain  hydrogens  to  their  attached  carbons.  
Magnetisation  is  passed  between  the  various  
carbon  atoms  and  then  back  to  the  side  chain  








1H-­‐13C-­‐HSQC   Magnetisation  is  transferred  from  1H  to  the  















Figure  6.11.  A)   Schematic  diagram  showing   the  molecular   structure  of  an  amino   acid   illustrating  
how  each  atom  is  defined.  B)  Flow  diagram  showing  the  process  involved  in  backbone  assignment.  
  
Search  for  matching  C?????????
peaks  in  the  CBCA(CO)NH  
spectrum.  These  are  the  C?????????
for  the  previous  residue.  
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Figure   6.12.   Strip-­‐plot   illustrating   sequence-­‐specific   assignment   of   a   stretch   of   five   amino   acids  
from  CaBP7  1-­‐100.  Five  spin  systems  are  connected  sequentially  through  chemical  shift  matches  in  
the   HNCACB   and   CBCA(CO)NH   spectra.   Chemical   shifts   of   C?   and   C?   for   i   are   detected   in   the  
CBCA(CO)NH  spectrum  and  are  shown  in  red.  Chemical  shifts  of  C?  (green)  and  C?  (blue)  for  i  and  i-­‐1  
are  detected   in   the  HNCACB   spectrum.  Vertical  dotted   lines   indicate   the   1H  chemical   shift  of  each  
spin   system.  The   15N  chemical   shift   is   indicated   in   the  bottom   left   corner  of   each   strip.  Horizontal  
dashed   lines   illustrate   how   the   C?   (green   dashed   line)   and   C?   (blue   dashed   line)   for   i   from   the  
CBCA(CO)NH  spectra   (red  peaks)   can  be  matched  with  C?   and  C?   (green  and  blue  peaks)   for   i-­‐1  of  
another   spin   system   by   searching   for   corresponding   13C   chemical   shifts   in   the   HNCACB   spectrum.    
This  process  is  used  to  make  sequential  links  between  spin  systems.  The  three  spin  systems  shown  in  
bold  italics  have  distinct  chemical  shifts  and  can  therefore  be  matched  to  a  corresponding  sequence  
in  the  protein.  Gly-­‐Thr-­‐Ala-­‐X-­‐X  appears  only  once  in  CaBP7  1-­‐100  therefore  these  spin  systems,  and  
sequentially  attached  spin  systems,  can  be  unambiguously  assigned  to  the  corresponding  stretch  of  
amino   acids   in   the   protein   sequence.   In   this   case   the   sequence   is   assigned   as   59Gly-­‐60Thr-­‐61Ala-­‐
62Met-­‐63Arg.    
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A   cleaved   double-­‐labelled   CaBP7   1-­‐100   sample   (Figure   6.8B)   was   produced   in  
?????????????????????????????????????????????????????????????????????????????2.  
In  NMR  spectra  for  this  sample,  there  was  significant  chemical  shift  dispersion  and  
uniform  peak  intensities  were  observed  suggesting  that  the  protein  was  structurally  
homogeneous  and  stably  folded.  Figure  6.13  shows  an  overlay  of  the  cleaved  CaBP7  
1-­‐100   spectrum   with   the   cleaved   CaBP7   1-­‐188   spectrum.   Some   of   the   dispersed  
peaks,   indicating   structured   regions   in   the   CaBP7   1-­‐100   spectrum,   also   appear   in  
the   CaBP7   1-­‐188   spectrum   (circled   in   red,   Figure   6.13)   suggesting   that   the   N-­‐
terminal  domain  was  partly  folded  in  CaBP7  1-­‐188.  There  are  also  dispersed  peaks  
in  the  CaBP7  1-­‐188  spectrum  (circled  in  green,  Figure  6.13),  which  do  not  correlate  
with  the  CaBP7  1-­‐100  spectrum,  implying  that  at  least  some  of  the  C-­‐terminus  was  
also  folded  in  CaBP7  1-­‐188.    
  
More  than  85%  of  the  NMR  resonances  were  assigned  as   indicated   in  Figure  6.14.  
Assignments   were   not   obtained   for   residues   1-­‐13   due   to   weak   peak   intensities  
which  may  be  due  to  chemical  exchange  broadening   (Cavanagh  et  al.,  2007c).   It   is  
possible  that  this  region  may  be  unstructured  as  seen  for  the  extreme  N-­‐termini  of  
CaBP1   and   DREAM   (Lusin   et   al.,   2008,   Park   et   al.,   2011,   Wingard   et   al.,   2005).  
Appendix  Table  A2  displays  a  summary  table  illustrating  the  percentage  of  the  total  
backbone  that  was  assigned.  The  side-­‐chain  assignments  were  also  completed  as  far  
as  the  data  obtained  would  allow  (summarised  in  appendix  table  A2).  Data  from  the  
HBHA(CO)NH  experiment  allowed  determination  of  the  chemical  shifts  of  side  chain  
1H?  and  
1H?.  Using  this  information  in  combination  with  data  from  the  HCCH-­‐TOCSY  
experiment,   the   side   chains   could   be   assigned.   There  was   some   ambiguity   in   the  
assignment  of   certain   side   chains,  which   should   be   resolved  by   the   acquisition   of  
NOESY   experiments.   Data   from   NOESY   experiments   provide   information   about  
resonances   that   are   close   together   in   space   and   can   be   used   both   to   generate  
restraints   for   structure   calculations   and   aid   disambiguation   of   spectral   overlap.  
Unfortunately,  this  was  not  possible  within  the  time  constraints  of  this  project.  The  
side  chain  assignments  for  CaBP7  1-­‐100  can  be  found  in  Table  A3  of  the  appendix.    
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Figure   6.13.   Overlay   of   1H-­‐15N   HSQC   NMR   spectra   for   cleaved   CaBP7   1-­‐188   (Black)   and   cleaved  
CaBP7  1-­‐100  (Red).  CaBP7  1-­‐188  was  prepared  in  20  mM  Tris.HCl  pH  6.5,  150  mM  NaCl,  5  mM  CaCl2,  
30  mM  octylglucoside.  CaBP7  1-­‐100  was  prepared  in  20  mM  HEPES  pH  7.5,  50  mM  NaCl,  5  mM  CaCl2,  
30  mM  octylglucoside.  Peaks  circled  in  red  were  found  in  both  spectra.  Peaks  circled  in  green  were  
unique  to  the  CaBP7  1-­‐188  spectra.  
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Figure   6.14.   Assigned   two-­‐dimensional   1H-­‐15N   HSQC   NMR   spectra   of   cleaved   CaBP7   1-­‐100.   The  
sample  was   prepared   in   20  mM  HEPES   pH   7.5,   50  mM  NaCl,   5  mM  CaCl2,   30  mM  octylglucoside.  
???????????????????????????????????????????????????????????????????????????????????????????????????
at  303  K.    
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6.2.6.  Calculation  of  CaBP7  1-­‐100  secondary  structure  
Figure  6.15A  shows  a  primary  sequence  alignment  of  CaBP7  with  CaM  and  CaBP1S.  
This,   along  with   the   sequence   identity   table   (Figure  6.15B),   illustrates   that   CaBP7  
shares  35%  sequence  similarity  with  the  N-­‐termini  of  CaM  and  CaBP1S,  reducing  to  
10%  sequence  similarity  across  their  C-­‐termini.  This  makes   the  N-­‐terminal  domain  
the  most   informative   in   comparisons  of   similarity  across   the  CaBPs  and  CaM.  The  
secondary  structure  of  CaBP7  1-­‐100  was  calculated  using  data  obtained  from  NMR  
experiments.   Chemical   Shift   Index   (CSI)   determines   the   secondary   structure   of   a  
protein  based  on   the  chemical   shifts  of   specific  nuclei   (C?,  C????????????)   (Wishart  
and   Sykes,   1994).   DANGLE   (Dihedral   ANgles   from   Global   Likelihood   Estimate)  
calculates   secondary   structure   based   on   chemical   shift   data   and   correlation   to   a  
database  of  known  protein  structures  (Cheung  et  al.,  2010).  
  
Figure  6.15C  shows  the  calculated  secondary  structure  of  CaBP7  1-­‐100  from  CSI  and  
DANGLE,  aligned  with  the  known  secondary  structure  of  Ca2+-­‐bound  CaM  (PDB  1CLL  
(Chattopadhyaya   et   al.,   1992))   and   CaBP1S   (Park   et   al.,   2011)   N-­‐termini.   The  
secondary  structure  of  all  three  proteins  appears  relatively  similar.  Each  protein  has  
four   helices   that   occur   in   approximately   identical   positions   and   all   three   proteins  
have  short  beta-­‐strands   in   the  same  positions  before   the  second  helix   in  each  EF-­‐
hand.   This   comparison   reveals   general   structural   similarities   between   these  
proteins  and  is  consistent  with  both  CaBP7  and  CaBP1S  being  evolutionarily  related  
to  CaM.  The  two  secondary  structure  calculations  generated  slightly  differing  results  
with   the   first   defined   helix   extended   by   four   amino   acids   in   the   CSI   calculation  
compared  to  DANGLE,  but  overall  the  outputs  were  consistent.    
  
6.2.7.  Ca2+-­‐binding  of  CaBP7  1-­‐100  
Two   downfield   shifted   peaks   at   1H   10.0   -­‐   10.5   ppm   in   CaBP7   1-­‐100   spectra  were  
assigned  to  two  glycines  at  the  6th  position  of  the  two  EF-­‐hands  (Figure  6.14).  The  
characteristic  chemical  shift  of  these  glycines  indicated  that  the  protein  was  already  
Ca2+-­‐bound  when   the   spectra   were   acquired.   Apo   CaBP7   1-­‐100   was   prepared   by  
?????????? ???????? ????? ??????????? ???????? ??????? ?????? ??? ?????????????? ??? ????
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Figure  6.15.  Secondary  structure  calculation  of  CaBP7  1-­‐100.  A)  Multiple  sequence  alignment  of  full  
length  CaM,  CaBP1S  and  CaBP7.  Residues  highlighted  in  blue  are  identical  and  residues  highlighted  in  
yellow   are   similar   across   sequences.   B)   Percentage   sequence   identity   of   CaM   and   CaBP1S   with  
CaBP7.  C)  Secondary  structure  of  CaBP7  1-­‐100  calculated  with  CSI  and  DANGLE  and  aligned  with  the  
known   secondary   structure   of   the   Ca2+-­‐bound  CaM   (PDB   1CLL   (Chattopadhyaya   et   al.,   1992))   and  
CaBP1S  (Park  et  al.,  2011)  N-­‐termini.  Residues  highlighted  in  pink  are  found  in  regions  of  alpha-­‐helix  
and  residues  highlighted  in  green  are  found  in  regions  of  beta-­‐sheet.  CaBP7  is  highlighted  based  on  
the  DANGLE  prediction.  In  the  CSI  prediction  bars  above  the  line  indicate  beta  sheet  and  bars  below  
the   line   indicate  alpha  helix.   In   the  DANGLE  prediction,  arrows   indicate  beta   sheet  and  the  helices  
represent  alpha  helix.    
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protein   was   observed   during   this   process.   The   chelator   concentration   was  
subsequently   reduced   (<50   ?M)   by   ultrafiltration   into   ????? ??????????????? ??????
???????? ???????????????????????????? ???? ??????? ?????????????????? ??-­‐passed  over  a  
nickel  affinity  column  to  remove  free  SUMO  tag,  SUMO  protease  and  any  uncleaved  
material.   During   this   stage   precipitation   was   observed.   2mM   octylglucoside   was  
included  in  all  buffers  as  a  stabiliser.    
  
Figure  6.16A  depicts  the  spectrum  obtained  from  this  sample   in  the  presence  of  2  
mM  octylglucoside.   Few   peaks  were   visible   and   the   signal   intensities  were  weak.  
Addition  of  30  mM  octylglucoside  (Figure  6.16B)   led  to  a  vast   improvement   in  the  
quality   of   the   spectrum   with   more   peaks   visible,   exhibiting   increased   intensities.  
This   further   demonstrates   the   important   role   that   the   detergent   played   in  
stabilising  the  protein  and  preventing  aggregation.  
  
  The   downfield   shifted   glycines   that   were   observed   in   the   assigned   1H-­‐15N-­‐HSQC  
spectrum   (Figure   6.14)   were   not   visible   in   the   apo   spectrum   (Figure   6.16B),   but  
there   were   two   previously   unobserved   peaks   in   the   region   typical   for   glycine  
residues,   indicating   that   this   is   indeed   the   apo   form   of   CaBP7   1-­‐100.   There   was  
good  peak  dispersion  in  the  apo  spectrum  indicating  that  the  protein  was  folded  in  
the  absence  of  Ca2+.  Various  EF-­‐hand  containing  proteins  have  been  shown  to  also  
bind  to  Mg2+  as  well  as  Ca2+  ions  and  undergo  Mg2+  induced  conformational  changes  
(Wingard   et   al.,   2005,   Lusin   et   al.,   2008).   As   free   Mg2+   levels   in   resting   cells   is  
estimated  between  0.5   -­‐   5  mM   (Romani   and   Scarpa,   1992),   it   is   thought   that   the  
protein  conformation  in  the  presence  of  Mg2+  is  more  physiologically  relevant  than  
the  apo  form.  For  this  reason,  the  effect  of  adding  5  mM  MgCl2  to  apo  CaBP7  1-­‐100  
was   tested.  Unfortunately,   the  presence  of  MgCl2   in   the   sample   triggered  protein  
precipitation.  
  
A  new  sample  of  apo  CaBP7  1-­‐100  was  prepared  employing  the  above  protocol  with  
octylglucoside  added  to  30  mM  (Figure  6.17A)  and  the  effect  of  adding  5  mM  CaCl2  
investigated   (Figure   6.17B).   The   presence   of   Ca2+   did   not   cause   the   protein   to
precipitate  and  a  shift  from  the  apo  form  to  the  Ca2+-­‐bound  form  was  observed.  As  
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Figure  6.16.  Two-­‐dimensional  1H-­‐15N  HSQC  NMR  spectra  of  cleaved  apo  CaBP7  1-­‐100.  Apo  CaBP7  1-­‐
100  was  prepared  by  dialysis   into  20  mM  HEPES  pH  7.5,  50  mM  NaCl,  5  mM  EDTA,  5  mM  EGTA,  2  
mM  octylglucoside  prior  to  SUMO-­‐Protease  treatment.  Material  was  re-­‐passed  over  affinity  resin  to  
remove   free   SUMO,   SUMO-­‐protease   and   uncleaved   material,   then   buffer   exchanged   by  
ultrafiltration  into  20  mM  HEPES  pH  7.5,  50  mM  NaCl,  2  mM  octylglucoside.  A)  Spectrum  obtained  
from  original  sample  with  only  2  mM  octylglucoside.  B)  spectrum  obtained  after  addition  of  30  mM  
octylglucoside.  
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expected  this  spectrum  was  extremely  similar  to  the  spectrum  which  was  assigned  
(Figure  6.14)  and  the  majority  of  the  backbone  amide  assignments  could  be  directly  
transferred.    
  
The   most   notable   difference   between   the   apo   and   Ca2+-­‐bound   spectra   was   the  
disappearance   of   two   glycine   peaks   (circled   in   red,   Figure   6.17A)   and   the  
appearance  of  the  two  downfield  shifted  51G  and  87G  peaks  (circled  in  red,  Figure  
6.17B).   The   spectrum   of   the   apo   form   is   completely   different   to   that   of   the   Ca2+  
bound  protein  and  very  few  of  the  apo  resonances  could  be  matched  with  those  in  
the   assigned,   Ca2+-­‐bound,   1H-­‐15N-­‐HSQC   (Figure   6.14).   Therefore   there   is   a   Ca2+-­‐
induced  conformational  change  in  the  protein.  107  peaks  were  counted  in  the  apo  
spectrum   compared   to   99   peaks   in   the   Ca2+-­‐saturated   spectrum.   93   peaks   are  
expected   due   to   the   presence   of   7   prolines   in   the   sequence,   which   can   not   be  
detected  in  the  1H-­‐15N-­‐HSQC  because  they  lack  an  amide  proton.  The  discrepancy  in  
the  number  of  peaks  is  likely  caused  by  overlapping  peaks  and  peak  broadening  due  
to  conformational  heterogeneity  (Wingard  et  al.,  2005,  Cavanagh  et  al.,  2007c).  An  
excess  number  of  observed  peaks  can  also  arise  due  to  protein  degradation  or  the  
presence   of   other   contaminants.   The   peaks   in   the   spectrum   for   the   Ca2+-­‐bound  
protein  show  improved  chemical  shift  dispersion  and  reduced  peak  overlap.  Many  
of  the  more  dispersed  peaks  found  in  the  spectrum  for  the  Ca2+-­‐bound  protein  can  
be   assigned   to   residues   found   within   the   Ca2+-­‐binding   loops   of   the   two   EF-­‐hand  
motifs.  These  include  47R,  48D,  49G,  51G,  53I,  54S,  55K,  83M,  85G,  87G,  89V,  90D  
(circled  orange,  Figure  6.17D)  and  the  side  chain  of  88Q  (circled  pink,  Figure  6.17D).  
In  addition  there  were  two  glycines   in   the  apo  form  which  appeared  to  map  onto  
59G   and   66G   but   which   underwent   significant   shifts   when   the   spectrum   were  
compared  (circled   in  purple,  Figure  6.17D).  59G   is   found   in  the  helix   following  the  
Ca2+-­‐binding  loop  of  EF1  and  66G  is  found  in  the  linker  region  between  the  two  EF-­‐
hand   motifs.   Interestingly   there   are   also   conserved   glycine   residues   at   the  
corresponding  positions  in  CaBP1S  and  CaM  (Figure  6.15A).  
  
As   the   addition   of   Ca2+   did   not   appear   to   negatively   affect   the   stability   of   the  
protein,   the  effect  of   adding   saturating  Mg2+  was   tested  on   the  Ca2+-­‐bound   form.
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Figure   6.17   A-­‐C.   2D   1H-­‐15N   HSQC   NMR   spectra   of   apo   and   Ca2+   saturated   CaBP7   1-­‐100.      A)   Apo  
CaBP7  1-­‐100.  B)  CaBP7  1-­‐100  after  addition  of  5  mM  CaCl2  C)  CaBP7  1-­‐100  after  addition  of  5  mM  
CaCl2  and  5  mM  MgCl2.  Peaks  corresponding  to  the  glycines  at  the  6th  position  of  the  two  EF-­‐hands  
are  circled  in  red  in  A  and  B.  The  side  chain  peak  which  increased  in  intensity  upon  Mg2+  addition  is  
circled  in  green  in  C.  The  sample  was  prepared  as  described  in  Figure  6.16.  
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Figure  6.17  D.  Overlay  of  CaBP7  1-­‐100  spectra  in  the  apo  form  (red),  with  5  mM  CaCl2  (blue)  and  
with  5  mM  CaCl2  and  5  mM  MgCl2   (Green).  Residues  circled   in  purple  underwent  significant  shifts  
upon  Ca2+  addition.  Dispersed  peaks   from  the  Ca2+  saturated  spectrum  which  are   found   in  the  Ca2+  
binding  loops  of  the  two  EF-­‐hands  are  circled  in  orange.  The  side  chains  from  88Q  are  circled  in  pink.  
These  peaks   are   labelled  with   their   residue  assignments   as   shown   in   Figure  6.14.   The   sample  was  
prepared  as  described  in  Figure  6.16.  
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The   presence   of   Mg2+   ions   under   these   conditions   again   induced   protein  
precipitation,   therefore   only   a  weak   spectrum  was   obtained   (Figure   6.17C).  Most  
peaks   reduced   in   intensity   due   to   aggregation   and   precipitation   of   the   protein,  
however   subtle   differences   in   the   spectra   were   observed,   which   could   not   be  
ascribed   to   the  effects  of  precipitation  alone.   There  were  minor   shifts   in   some  of  
the  peaks,  but  the  most  notable  difference  was  the   increase   in   intensity  of  one  of  





Figure  6.18.  Native  PAGE  gel  of  SUMO  and  CaBP7  1-­‐100  in  the  presence  or  absence  of  10  mM  Ca2+  
or  10  mM  Mg2+.  
  
  
Native  PAGE  was  used  to  further  investigate  the  effects  of  both  Ca2+  and  Mg2+  upon  
the   conformation   of   CaBP7   1-­‐100.   Samples   were   prepared   in   a   loading   buffer  
containing  2  mM  EGTA  and  2  mM  EDTA   to   strip   the  protein  of  all   Ca2+   and  Mg2+.  
Ca2+   (10   mM),  Mg2+   (10   mM)   or   both   in   combination   were   then   added   to   these  
samples   to   examine   any   subsequent   changes   in   the   apparent   protein   molecular  
weight   on   native   PAGE   gels.   Control   SUMO   protein   exhibited   no   change   in  
electrophoretic  mobility  under  the  conditions  tested  (Figure  6.18).  Mg2+  alone  failed  
to   influence   the  migration  of  CaBP7  1-­‐100  when  compared  to  Ca2+-­‐free/Mg2+-­‐free  
conditions   (Figure   6.18).   Ca2+   alone   induced   a   significant   retardation   in   the  
migration   rate   of   CaBP7   1-­‐100   and   this   was   unaffected   by   the   presence   of   an  
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equimolar  concentration  of  Mg2+  (Figure  6.18).  Collectively,  these  data  suggest  that  
the   protein   does   not   bind   Mg2+   or   that   Mg2+   binding   causes   no   significant  
conformational  change.  Furthermore,  this  analysis  demonstrates  a  Ca2+-­‐dependent  
shift   in   electrophoretic  mobility   of   CaBP7   1-­‐100,  which   is   consistent  with   specific  
Ca2+-­‐binding  to  this  protein.  These  data  are  in  agreement  with  previously  published  
ITC  data  demonstrating  that  CaBP7  does  not  bind  to  Mg2+.  
  
6.3.  Discussion  
Various   protein   expression   systems  were   tested   during   the   course   of   this   project  
with  the  majority  proving  unsuitable  for  production  of  the  amounts  of  pure  protein  
necessary  for  NMR  analysis.  The  use  of  codon  optimised  genes  in  conjunction  with  
the  pE-­‐SUMOPRO  vector   improved  the  expression  of   soluble  protein  by  up   to  40-­‐
fold  compared  with  other  expression  systems  investigated.  The  SUMO  tag  has  been  
proven  to   improve  the  solubility  and  stability  of  many  difficult  to  express  proteins  
and  has   the  advantage  that  the   tag  can  be  efficiently  cleaved  without   leaving  any  
residual   amino   acids   beyond   those   encoded   by   the   gene   of   interest   (Butt   et   al.,  
2005,   Malakhov   et   al.,   2004).   Although   expression   of   soluble   CaBP4   and   a   TMD  
deficient   CaBP7   1-­‐188   mutant   in   this   system   was   improved,   optimisation   for  
acquisition  of  NMR  data  proved  problematic.    
  
CaBP4   spectra   contained   insufficient  peak   resonances   to   represent   the   full   length  
protein.   Initial   spectra   acquired   at   ambient   temperature   displayed   a   mixture   of  
sharp   peaks   in   the   unfolded   region   of   the   spectra   and   weaker   more   dispersed  
peaks,   including  a  downfield  shifted  peak  characteristic  of  an  EF-­‐hand  glycine.  The  
dispersed  peaks  were  suggestive  of  partial  protein  folding,  whereas  the  sharp  peaks  
were   indicative   of   an   unstructured   flexible   region,   which  may   correspond   to   the  
extended  N-­‐terminus  of  CaBP4.  NMR  analysis  of  CaBP1  has  revealed  that   its  short  
N-­‐terminal   extension   (amino   acids   1-­‐18)   forms   a   structurally   disordered   domain  
(Park  et   al.,   2011,   Li  et  al.,   2009)   and,   likewise,   secondary   structure  prediction  of  
CaBP4  suggests  that   residues  7-­‐105  form  a   region  of   random  coil.  Double   15N/13C-­‐
labelling  of  CaBP4  would  permit  the  acquisition  of  the  data  required  to  assign  these  
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peaks   in   order   to   deduce   if   they   form   a   contiguous   stretch   of   amino   acids   that  
resides  within  the  N-­‐terminus  of  CaBP4.  At  30.4  kDa,  CaBP4  is  at  the  upper  size  limit  
of   proteins  which   are   viable   for   study   by  NMR.   If   it   could   be   proven   that   the   N-­‐
terminus   is   unstructured,   then   a   new   expression   construct   could   be   designed   to  
remove  these  residues  and  reduce  the  protein  to  a  more  manageable  size  for  NMR.  
This   modification   would   theoretically   improve   spectral   quality   for   the   folded   C-­‐
terminus  of  the  protein.  
  
Increasing  the  temperature  of  acquisition  from  298  K  resulted  in  an  increase  in  the  
number   of   peaks   observed   in   the   spectra   and   the   intensity   of   the   peaks   became  
more   uniform.   In   particular,   the   sharp   peaks   seen   at   298   K   became  weaker   and  
some  disappeared  entirely.  Without  assigning  the  sharp  peaks  observed  in  the  298  
K  spectrum  the  reason  why  the  intensities  of  these  resonances  decreased  cannot  be  
deduced.  The  number  of  downfield  shifted  glycine  peaks  in  CaBP4  spectra  increased  
progressively  from  one  at  298  K,  to  two  at  303  K  and  308  K,  and  finally  three  at  313  
K   and   318K.   There   are   three   Ca2+-­‐selective   EF-­‐hands   in   CaBP4   and   as   all   spectra  
were  acquired  in  the  presence  of  5  mM  Ca2+,  it  would  be  predicted  that  all  three  of  
the  EF-­‐hands  should  be  Ca2+-­‐bound.  Increasing  the  temperature  therefore  appears  
to   increase   the   signal   to   noise   ratio   so   that   all   three   downfield   shifted   glycine  
residues  of  the  Ca2+-­‐bound  EF-­‐hands  became  visible  at  temperatures  above  313  K.  It  
is  also  possible  that  the  signal  is  weaker  at  298  K  due  to  protein  aggregation,  which  
is   lost   at   higher   temperatures   hence,   improving   resonance   intensity   and   peak  
dispersion.    
  
Divalent  cation  binding  properties  of  CaBP4  are  predicted  to  differ  from  CaBP1.  The  
first  EF  hand  of  CaBP1  is  constitutively  Mg2+  bound  due  to  an  glutamine  to  aspartate  
substitution  at  the  12th  position  of  the  Ca2+-­‐binding  loop  that  gives  the  motif  equal  
selectivity  for  Mg2+  and  Ca2+  (Wingard  et  al.,  2005).  In  CaBP4  there  is  a  glutamine  at  
this  position   in  EF1   indicating  that  this  motif  should  display  preferential  selectivity  
for  Ca2+  (Haeseleer  et  al.,  2000,  McCue  et  al.,  2010a).  Mg2+  binding  to  CaBP1  confers  
a   global   conformational   change   and   subsequent   Ca2+-­‐binding   induces   localised  
conformational  changes  at  EF3  and  EF4   (Wingard  et  al.,  2005).  The  cation  binding  
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properties  of  CaBP4  were  not  studied  in  detail  here,  but  should  prove  interesting  in  
future  work.  
  
CaBP7  1-­‐188   spectra   contained  evidence  of  protein   folding  however   there  were  a  
large  number  of  overlapping  peaks  in  the  centre  of  the  spectra  which  could  not  be  
resolved,  suggestive  of  protein  aggregation.  The  presence  of  two  downfield  shifted  
peaks  in  the  region  characteristic  of  EF-­‐hand  glycines,  suggested  that  the  EF-­‐hands  
of   the  protein  were   at   least   partially   folded   and   that   they  were   Ca2+-­‐bound   even  
without   the   addition   of  Ca2+to   the   buffer.  Minimal  media   contains   CaCl2   and   it   is  
possible  that,  since  CaBP7  has  a  high  affinity  for  Ca2+  (0.2  -­‐  0.5  ?M)  (Mikhaylova  et  
al.,   2006,  Mikhaylova   et   al.,   2009),   they   may   have   been   occupied   from   an   early  
stage   in   the   purification   process.   For   this   reason   there   was   little   change   in   the  
spectra   upon   addition   of   5   mM   CaCl2.   An   octylglucoside   titration   was   also  
performed  and  at  higher   concentrations  more   resonances   could  be  distinguished,  
suggesting   that   it  was  potentially   reducing  protein  aggregation.  The   improvement  
upon   addition   of   octylglucoside   was   minor,   however,   and   did   not   increase  
resolution  sufficiently  to  facillitate  further  investigation  of  this  protein.  
  
A  second  truncation  of  CaBP7,  encoding  the  first  100  amino  acids,  was  generated  in  
an   attempt   to   overcome   the   problems   encountered  with   expression   of   CaBP7   1-­‐
188.   CaBP7   1-­‐100   encompasses   the   two   functional   EF-­‐hands   of   the   protein   and  
represents   the   most   highly   conserved   portion   of   the   protein   when   compared   to  
other  Ca2+-­‐binding  proteins.  This  fragment  expressed  to  a  high  level  and  generated  
well-­‐resolved   spectra   with   dispersed   peaks   indicative   of   a   folded   protein.  
Octylglucoside   and   CaCl2   titrations   were   performed   on   the   uncleaved   protein   in  
order   to   deduce   optimal   conditions   for   acquiring   NMR   spectra.   Octylglucoside  
improved  the  spectra  of  CaBP7  1-­‐100  at  concentrations  of  up  to  30  mM,  but  at  50  
mM   there   were   indications   of   increased   protein   aggregation.   No   significant  
conformational   change   was   observed   upon   addition   of   CaCl2.   As   the   downfield  
shifted  glycines  were  already  visible   in  the  spectra  at  0  mM  CaCl2,  the  protein  had  
likely  become  Ca2+-­‐bound  at  a  prior  stage  of  the  purification  process.  The  addition  
of  CaCl2  did,  however,  improve  the  quality  of  the  spectra  at  concentrations  up  to  5  
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mM  but   induced  spectral  changes  characteristic  of  aggregation  when   increased  to  
10  mM.    
  
A   double   labelled,   cleaved   sample   of   CaBP7   1-­‐100   was   produced   using   the  
conditions  determined   to  be  optimal   for   acquiring   structure  quality  NMR  spectra.  
87%  of   the   CaBP7   1-­‐100   backbone  was   assigned   and   it  was   verified   that   the   two  
most  downfield  shifted  peaks  represented  the  glycines  at  the  6th  position  of  the  EF-­‐
hands   (51G   and   87G).   Other   downfield   shifted   peaks   were   also   observed,   which  
corresponded   to   residues   within   the   two   EF-­‐hand   Ca2+-­‐binding   loops.   These  
included  53I  and  89V  at  the  8th  position  and  90D  and  54S  at  the  9th  position  of  the  
EF1  and  EF2  loops,  respectively.    
  
Secondary  structure  calculations  for  CaBP7  1-­‐100  gave  a  similar  linear  arrangement  
of   alpha   helices   as   found   in   CaM   and   CaBP1.   The   main   difference   between   the  
calculations   from  CSI  and  DANGLE  was   the   length  of   the   first  helix  of   the   first  EF-­‐
hand.  CSI  predicted   this   to  be  4  amino  acids   longer   than  the  DANGLE  calculation.    
The   DANGLE   calculation   appears   to   be   consistent   with   the   known   secondary  
structures   of   Ca2+-­‐bound   CaM   and   CaBP1S   N-­‐termini   with   the   alpha   helices   and  
short   regions   of   beta   sheet   occurring   in   approximately   the   same   positions   in   all  
three  proteins.  
  
Further   structural   modelling   of   CaBP7   1-­‐100   was   not   possible   within   the   time  
constraints  of  this  project,  although  the  process  of  side  chain  assignment  has  been  
started.   The   secondary   structure   calculations   imply   that   CaBP7   1-­‐100   appears  
similar   to   Ca2+-­‐bound   CaM   and   CaBP1S.   This   is   in   accordance  with   the   calculated  
sequence  homology  between  the  three  proteins  (~35%).  In  contrast,  the  C-­‐terminus  
has  limited  sequence  homology  to  CaM  or  CaBP1S  (<  10%).  As  described  in  chapter  
3,   CaBP7   is   extremely   well   conserved   through   the   evolution   of   vertebrates   and  
there   is  72%  sequence  conservation  of   the  CaBP7  C-­‐terminus,  excluding  the  TMD,  
between   elephant   shark   and   human.   This   suggests   that   there   is   a   conserved  
function  for  this  region  of  the  protein.  Unlike  in  CaBPs  1-­‐5,  the  C-­‐terminus  of  CaBP7  
does  not  contain  functional  EF-­‐hands,  and  interestingly,  in  BLAST  searches  using  this  
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region,  no  other  Ca2+-­‐sensing  proteins  are  retrieved.  Using  similar  NMR  analyses,  it  
would   be   interesting   to   investigate   if   the   C-­‐terminus   of   CaBP7   exhibits   structural  
homology  to  other  Ca2+-­‐sensors  or  if  a  unqiue  structural  domain  has  evolved.    
  
Extensive  protein  aggregation  was  evident  in  CaBP7  1-­‐188  spectra  which  displayed  
a   large   degree   of   peak   overlap.   This   was   not   observed   in   CaBP7   1-­‐100   spectra  
suggesting   that   residues   101-­‐188   may   be   key   in   determining   the   degree   of  
precipitation.   The   C-­‐terminus   of   CaBP7   1-­‐188   contains   5   cysteine   residues   which  
could   form   incorrect   disulphide   bridges   between   monomers   resulting   in  
aggregation.   Successful   expression   of   CaBP7   101-­‐188   might   therefore   require  
mutagenesis  or  alkylation  (Crankshaw  and  Grant,  2001)  of  these  residues  in  order  to  
obtain  stable,  soluble  protein.  In  accordance  with  the  aggregation  described  in  this  
chapter,  Hradsky  et  al.  have  observed   that  CaBP7  and  CaBP8   form  soluble  dimers  
and  higher  order  oligomers  when  produced  recombinantly   in  bacteria   (Hradsky  et  
al.,   2011).   In   further   investigations,   pull   down   assays   revealed   that   CaBP7   and  
CaBP8   can   form   both   homo-­‐   and   hetero-­‐dimers   with   each   other   in   a   Ca2+-­‐
independent  manner.  Using  gel  filtration  and  dynamic  light  scattering  experiments,  
Hradsky   et   al.   show   that   CaBP8   may   have   two   dimerisation   interfaces:   the  
hydrophobic   TMD   and   the   cytosolic   EF-­‐hand   containing   domain.   BRET   and  
fluorescence   complementation   assays   in   HEK293T   and   COS-­‐7   cells,   respectively,  
confirmed  that  CaBP8  also  forms  parallel  dimers   in  vivo  (Hradsky  et  al.,  2011).  The  
propensity  of   the  N-­‐terminal  domain   to   form  dimers  may  explain   the  aggregation  
observed  during   the  production  of   recombinant   CaBP7  1-­‐100  and  CaBP7  1-­‐188  as  
described  in  this  chapter.  
  
NMR  spectra   for   apo  CaBP7  1-­‐100  were  obtained  and   showed  markedly  different  
peak  resonances  compared  with  Ca2+-­‐bound  CaBP7  1-­‐100.  This  implies  that  the  two  
forms   have   distinct   conformations.   There   was   less   peak   dispersion   in   the   apo  
spectrum,   however,   the   protein   displayed   signature   characteristics   of   a   natively  
folded  protein.  Upon  binding  to  Ca2+,residues  that  underwent  the  most  significant  
shifts  in  the  spectrum  generally  resided  within  the  Ca2+-­‐binding  loops  of  the  two  EF-­‐
hand  motifs.  Native  PAGE  analysis  confirmed  that  there  is  a  Ca2+-­‐dependent  shift  in  
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electrophoretic  mobility   indicative  of  Ca2+-­‐binding.  The  apo  form  migrated  quicker  
on  the  gel  suggesting  that  it  may  have  a  more  compact  conformation  than  the  Ca2+-­‐
saturated   protein   or   that   the   protein   was   forming   dimers   when   Ca2+-­‐bound.   A  
similar   mobility   shift   on   native   PAGE   has   been   reported   for   CaM   and   recoverin  
(Lambrecht   and   Koch,   1992,   Burgess   et   al.,   1980).   Using   semi-­‐native   SDS-­‐PAGE  
Hradsky  et  al.  observed  that  full   length  recombinant  CaBP8  migrates  as  two  bands  
corresponding  to  a  monomer  and  a  dimer.   In  addition,  HeLa  cell   lysates  subjected  
to  native  PAGE  and  immunoblotting  with  a  CaBP7  specific  antibody,  detected  bands  
corresponding   to   the  molecular   weights   of  monomeric,   dimeric   and   higher   order  
oligomeric   forms   of   endogenous   CaBP7.   Ca2+   dependency  was   not   investigated   in  
these  experiments,  but  data   from  gel   filtration   suggested   that  dimer   formation   is  
largely  Ca2+-­‐independent  (Hradsky  et  al.,  2011).  In  contrast,  only  a  single  band  was  
observed   for  both   the  apo  and  Ca2+-­‐bound   forms  of  CaBP7  1-­‐100  on  native  PAGE  
gels   presented   in   this   chapter.   This   suggests   that   the   shift   in   mobility   observed  
under  these  conditions  was  unlikely  due  to  dimer  formation.  
  
As  the  secondary  structure  of  CaBP7  1-­‐100  approximates  that  of  CaBP1S  and  CaM  
N-­‐termini,  it  may  undergo  similar  conformational  changes  upon  Ca2+-­‐binding.  In  the  
Ca2+-­‐free   form  of   CaBP1S   the   two  helices   of   EF1   are   almost   perpendicular   to   the  
corresponding  helices  of  EF2.  In  the  Ca2+-­‐bound  form,  however,  Ca2+-­‐binding  to  EF1  
induces   a  90°   reorientation  between   the   two  EF-­‐hands   so   that   the   two  helices  of  
EF1  are  more  parallel  to  those  of  EF2.  This  conformational  change  enables  ?-­‐sheet  
formation   and   gives   a  more   closed   structure   than   that   of   the   Ca2+-­‐free   or  Mg2+-­‐
bound  CaBP1S  N-­‐terminal  domain   (Park  et  al.,  2011).   In  contrast,   the  apo   form  of  
the   CaM   N-­‐terminal   domain   adopts   a   more   closed   conformation   and   shifts   to   a  
more  open  conformation  upon  Ca2+-­‐binding  to  both  EF1  and  EF2  (Chin  and  Means,  
2000).  It  is  therefore  difficult  to  infer  how  Ca2+-­‐binding  affects  the  conformation  of  
CaBP7  1-­‐100.  The  slower  mobility  of  Ca2+-­‐bound  CaBP7  1-­‐100  compared  to  the  apo  
form   may   suggest   a   shift   from   a   more   closed   conformation   to   a   more   open  
conformation  similar  to  CaM.  The  cation  binding  properties  of  CaBP7  1-­‐100  are  also  
more  similar  to  CaM  as  both  bind  Ca2+   ions  at  EF1  and  EF2  whereas  CaBP1S  binds  
Ca2+  at  EF1  only.  The  global  Ca2+  ???????????????????????????(Mikhaylova  et  al.,  2006)  
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is  much  higher   than   that  of  CaM   (~4.0  ?  ???????? (Schaad  et  al.,   1996),   however,  
suggesting  there  are  likely  important  structural  differences  bewteen  their  EF-­‐hands.    
  
Native  PAGE  was  also  used  to  investigate  whether  Mg2+  is  similarly  able  to  influence  
the  electrophoretic  mobility  of  CaBP7  1-­‐100.  Samples  prepared  in  the  presence  of  
excess  Mg2+  exhibited  no  difference   in  migration   rate  when  compared  to   the  apo  
form  of  CaBP7  1-­‐100  implying  that,  as  previously  published,  CaBP7  does  not  bind  to  
Mg2+   (Mikhaylova   et   al.,   2009).   The   shift   in   mobility   on   native-­‐PAGE   gels   is  
commonly   believed   to   be   due   to   a   conformational   change   causing   the  protein   to  
migrate  at  a  different  rate.  As  binding  to  Ca2+  would  cause  the  protein  to  gain  four  
extra   positive   charges   this   could   also   explain   why   the   Ca2+-­‐bound   form  migrates  
slower  on  the  gel.  The  fact  that  there  is  no  change  in  the  mobility  of  the  protein  in  
the   presence   of  Mg2+   therefore   suggests   that   the   protein   is   not   binding   to  Mg2+  
under   these   conditions.   This   appears   contradictory   to   the   results   obtained   from  
NMR  experiments,  where  CaBP7  1-­‐100  precipitated  upon  the  addition  of  Mg2+,  and  
suggests  that  the  precipitation  did  not  result  as  a  consequence  of  Mg2+-­‐binding  to  
the   EF-­‐hands.   Interestingly,  magnesium  precipitation   is   a  widely   used  method   for  
the   purification   of   proteins   such   as   ribonclueoproteins   (Palmiter,   1974),   tubulins  
(Weisenberg  and  Timasheff,  1970),  and  also  in  the  extraction  of  certain  membrane  
proteins  (Feric  et  al.,  2011),  although  the  exact  mechanism  of  how  this  occurs  is  not  
clear.   The  precipitation  of   acidic  proteins  using  divalent   cations   such   as  Mg2+   has  
also  been  documented   (Takeuchi  et  al.,  2008)  and,  with  a  pI  of  4.21,  CaBP7  1-­‐100  
may  precipitate  in  a  similar  way.  
  
6.3.1.  Conclusion  
This   chapter   documents   the   first   steps   toward   solving   the   atomic   resolution  
structures   of   CaBP4   and   CaBP7.   The  NMR   data   acquired   for   CaBP4   indicates   that  
this   protein   may   become   amenable   to   NMR   analysis   if   the   problems   with  
aggregation  are  overcome.  CaBP7  was   truncated   to   the   first   100  amino  acids   and  
secondary   structure   calculations   based   on   initial   NMR   data   suggest   this   peptide  
forms  a  domain  which   is   similar   to  the  N-­‐termini  of  Ca2+-­‐bound  CaM  and  CaBP1S.  
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Once  the  side  chain  assignments  are  completed  and  NOE  data  acquired,  generation  
of   a  high  quality  3D   structural  model  may   be  possible.  Due   to   the   high   sequence  
homology   between   CaBP7   and   CaBP8   (63%),   structural   data   obtained   for   CaBP7  
may  be  used  to  infer  the  structure  of  CaBP8.  As  such,  a  prediction  of  the  secondary  
structure   of   the   N-­‐terminus   of   CaBP8   using   PSIPRED   largely   approximates   the  
secondary  structure  of  CaBP7  1-­‐100  calculated  using  CSI  and  DANGLE.  The  sequence  
identity   of   the   C-­‐terminus   of   CaBP7   with   other   Ca2+-­‐sensors   is   very   low   with   a  
maximum   of   10%   homology   with   CaM.   The   divergent   nature   of   the   C-­‐termini   of  
CaBP7   and   CaBP8   compared   to   other   CaBP   proteins   is   unusual   and   further  
investigation   into   the   structure   of   this   domain   will   be   critical   in   understanding  
functional  differences  that  exist  between  these  proteins  and  CaBPs  1-­‐5  and  CaM.  
  
Solving   the   structures   of   CaBP4   and   CaBP7   will   facillitate   further   scientific  
investigation.   Initially   it   will   be   important   to   characterise   the   conformational  
changes  that  occur  upon  cation  binding.  This  will  provide  clues  regarding  the  Ca2+-­‐
dependencies  of  target  interactions.    It  should  be  possible  to  locate  specific  binding  
sites   for   interacting   proteins   under   both   Ca2+-­‐dependent   and   -­‐independent  
conditions   and   subsequently   solve   the   structure   of   the   complexes.   Informed  
mutational   studies   could  be   carried  out   in  order   to  map   residues   critical   for   such  
interactions.  This  may  be  of  particular  interest  when  considering  the  interactions  of  
CaBP4   with   VGCCs   due   to   the   various   mutations   which   have   been   identified   in  
human   CaBP4.   These   mutations   have   been   shown   to   result   in   cone-­‐rod   synaptic  
disorders  of   the   retina.  NMR  could  be  used  to   screen   for   the   structural  effects  of  
these  mutations  and  how  they  affect  CaBP4  binding  to  target  proteins.  Investigating  
the  structure-­‐function  relationships  of  the  CaBPs  will  reveal  important  mechanistic  
information  about  the  physiological  processes  that  they  modulate.    
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The  CaBP  family   is  a   family  of  small  EF  hand  containing  Ca2+-­‐binding  proteins  with  
limited   homology   to   CaM.   The   family   comprises   seven   genes   that   can   be   divided  
into   two  groups,  CaBPs  1-­‐5   and  CaBP7  &  8,  based  on  differences   in   their   domain  
structures  (McCue  et  al.,  2010a).  CaBPs  1-­‐5  interact  with  a  number  of  known  CaM  
target  proteins  but  exert  unique  regulatory  roles  and  have  been  shown  to  modulate  
the  activity  of  numerous  Ca2+   channels   (Tippens  and  Lee,  2007,  Zhou  et  al.,   2004,  
Cui   et   al.,   2007,   Haeseleer   et   al.,   2004,   Few   et   al.,   2005,   Haynes   et   al.,   2004,  
Kinoshita-­‐Kawada  et  al.,  2005).  A  number  of  interacting  binding  partners  have  also  
been   identified   which   do   not   overlap   with   those   of   CaM   (Dieterich   et   al.,   2008,  
Nakajima,   2011,   Seidenbecher   et   al.,   2004)   and   knockout   studies   have   revealed  
non-­‐redundant  roles  for  CaBP4  and  CaBP5  (Maeda  et  al.,  2005,  Rieke  et  al.,  2008).  
Much   less   is   known   about   the   functions   of   CaBP7   and   CaBP8.   Using   a   range   of  
techniques,   including   bioinformatics   analysis,   confocal   microscopy   and   NMR  
spectroscopy,   the   research   presented   in   this   thesis   has   focused   on   the  
characterisation   of   CaBP7   and   CaBP8.   A   number   of   features,   including   a   distinct  
pattern  of  EF-­‐hand   inactivation  and   the  presence  of  a  38  amino  acid  hydrophobic  
domain   at   their   C-­‐termini,   distinguish   these   proteins   from   other  members   in   this  
protein   family   and   prompted   further   investigation   into   the   importance   of   these  
properties.   In   addition   to   a   regulatory   role   in   TGN   to   PM   trafficking   through   an  
interaction   with   PI4KIII?? (Mikhaylova   et   al.,   2009),   roles   for   CaBP7   in   cytokinesis  
(Neumann  et  al.,  2010)  and  for  CaBP8  in  the  regulation  of  VGCCs  (Shih  et  al.,  2009)  
have  also  been  suggested.    
  
The   first   aim   of   this   thesis  was   to   perform   a   bioinformatics   analysis   of   the   CaBP  
family   in   order   to   deduce   when   these   proteins   first   arose   in   evolution   and   the  
degree   of   sequence   conservation   they   have   retained.   Phylogenomic   analyses  
confirmed  that  CaBPs  1-­‐5  and  CaBP7  and  CaBP8  form  two  separate  families  of  Ca2+-­‐
sensors   that   likely   evolved   independently   of   each   other   from   a   CaM-­‐related  
ancestor.  The  first  appearance  of  the  CaBPs  was  evident  in  early  vertebrate  species.  
Partial   sequences   with   homology   to   CaBP1   and   CaBP8   were   identified   in   the  
genome   of   the   jawless   fish,   lamprey,   the   closest   living   species   to   the   early  
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vertebrate  ancestor.  No  orthologues  of  the  CaBPs  were  found  in  invertebrates  apart  
from  CaM-­‐like  proteins.    
  
A   whole   genome   duplication   (WGD)   event   occurring   prior   to   the   divergence   of  
cartilaginous   fish   likely   led   to   the   expansion   of   the   CaBP   family.   As   such,   at   least  
four   CaBP   genes   can   be   identified   in   the   genome   of   the   cartilaginous   fish,   the  
elephant   shark:   two   corresponding   to   CaBP7   and   CaBP8   and   at   least   two  
corresponding  to  CaBPs  1-­‐5.  Another  WGD  event  occurred  specific  to  the  bony  fish,  
and  accordingly,  duplicate  genes  are  found  for  the  full  complement  of  CaBP  genes  
in   the   teleost   fish,   the   zebrafish.  This   suggests   that  whereas   the  cartilaginous   fish  
possess   only   four   CaBP   genes,   ancestors   of   the   bony   fish   lineage   must   have  
possessed  the  full  complement  of  CaBP  genes.  The  appearance  of  CaBP7  and  CaBP8  
is  easily  explained   through   the  duplication  of   the  primordial  CaBP8  gene   found   in  
Lamprey.  The  expansion   in  the  number  of  genes  corresponding  to  CaBPs  1-­‐5  from  
two   in   cartilaginous   fish   to   four   in   the   bony   fish   ancestor,   however,   cannot   be  
explained   by   WGDs.   This   therefore   suggests   that   there   has   been   a   transient  
expansion,  between  the  emergence  of  cartilaginous  fish  and  the  divergence  of  the  
bony   fish   ancestor,   in   the   number   of   genes   corresponding   to   CaBPs   1-­‐5.   No  
genomes  of  species   representing  the  sarcopterygian   fish  node  have  yet  been   fully  
sequenced   and   therefore   the   actual   complement   of   CaBP   genes   in   the   tetrapod  
ancestor   could  not  be  examined.   The   genome  project   for   the   sarcopterygian   fish,  
the  coelacanth  is  currently  underway,  and  once  complete  a  clearer  picture  of  how  
the  full  complement  of  CaBP  genes  arose  can  be  obtained.  
  
The   CaBPs,   particularly   CaBP1S,   CaBP7   and   CaBP8,   remain   highly   conserved  
throughout  the  evolution  of  vertebrates,  suggestive  of  functionally   important  non-­‐
redundant   roles   for   the   CaBPs.   To   help   understand   the   evolutionary   pressures  
which  have  led  this  family  of  Ca2+-­‐sensors  to  remain  highly  evolutionarily  conserved,  
an  analysis  of  the  emergence  of  known  CaBP  target  proteins  was  also  carried  out.  
As   such,  a  general  expansion  of  both   the  VGCC  and   IP3R   families  of  Ca
2+   channels  
coincided  with  the  emergence  of  the  vertebrate  clade.  It  can  therefore  be  reasoned  
that   the   sudden   increase   in   complexity   of   these   families   provided   the   necessary  
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evolutionary   pressures   to   select   for   new   families   of   Ca2+-­‐sensing   proteins.   CaBP7  
and  CaBP8  have  not,  however,  been  shown  to  directly  interact  with  VGCCs  or  IP3Rs,  
although   an   effect   of   CaBP8   overexpression   upon   Ca2+   influx   through   VGCCs   has  
been   described   (Shih   et   al.,   2009).   The   evolutionary   pressures   controlling   the  
remarkable  degree  of  sequence  conservation  of  these  two  proteins  is  therefore  less  
easy   to   explain.   There   is   84%   and   87%   sequence   identity   between   the   elephant  
shark  and  human  CaBP7  and  CaBP8  proteins,  respectively,  indicating  that  these  two  
proteins   are   unlikely   to   perform   non-­‐redundant   roles.   The   remaining   chapters   of  
this   thesis   therefore   focused   on   the   cellular   and   biochemical   characterisation   of  
these  two  proteins  in  the  hope  of  gaining  a  greater  understanding  of  their  function.  
  
Initially   the   subcellular   localisation  and   targeting  mechanism  of  CaBP7  and  CaBP8  
was   examined   in   both   neuronal   and   non-­‐neuronal   cell   types.   CaBP7   and   CaBP8  
localise   to   cellular   membranes   via   a   distinct   mechanism   from   CaBP1   and   CaBP2,  
which  associate  with  membranes  through  a  post-­‐translationally  attached  myristoyl  
group   (Haeseleer   et   al.,   2000).   CaBP7   and   CaBP8   do   not   possess   a   consensus  
sequence  for  N-­‐myristoylation  and  were  instead  found  to  possess  a  single  TMD,  10  
amino  acids  from  their  extreme  C-­‐termini.  Generation  of  a  number  of  TMD  mutants  
demonstrated   that   this   TMD   was   essential   and   sufficient   for   correct   subcellular  
localisation.  The  use  of  trypsin  protection  protease  assays  and  antibody  accessibility  
studies  subsequently  confirmed  that  the  proteins  maintained  a  topology  typical  of  a  
special  class  of  membrane  protein,  the  tail  anchored  (TA)  proteins.  TA  proteins  have  
a   cytosolic   N-­‐terminal   domain,   a   short   luminal   C-­‐terminal   domain   and   a   single  
membrane-­‐spanning  segment  which  is  less  than  30  amino  acids  from  their  extreme  
C-­‐terminus   (Kutay   et   al.,   1993,   Rabu   et   al.,   2009).   The   positioning   of   the   TMD   in  
close  proximity  to  the  C-­‐terminal  end  of  a  protein  dictates  that  this  type  of  protein  
must   be   inserted   into  membranes   post-­‐translationally.   Insertion   of   TA   proteins   is  
therefore   independent   of   the   Sec61   translocon   which   is   responsible   for   the   co-­‐
translational   insertion   of   typical   type   II   membrane   proteins   (Brambillasca   et   al.,  
2006).   At   least   three   pathways   have   been   identified   for   the   post-­‐translational  
insertion  of  TA  proteins  and  the  particular  pathway  engaged  appears  to  be  dictated  
by  the  overall  hydrophobicity  of  the  TMD  (Borgese  and  Fasana,  2011,  Kalbfleisch  et  
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al.,  2007).  The  hydrophobicity   scores  of  CaBP7  and  CaBP8  suggest   that  either   the  
Asna1   or   SRP   pathways   may   facilitate   membrane   insertion   of   these   proteins.   As  
such,   a  direct   interaction  of  CaBP8  with  Asna1  and  a  weaker   interaction  with   the  
SRP  associated  Sec61  translocon  subunit,  Sec61?????????????????????? (Hradsky  et  
al.,   2011).  Direct   evidence   that   these  proteins   are   required   for   CaBP7   and  CaBP8  
membrane  insertion  has  not  been  demonstrated.  Asna1  is  an  ATPase  and  has  been  
demonstrated   to   mediate   membrane   insertion   of   VAMP4   and   Sec61?? ??? ????
absence   of   other   cytosolic   factors   (Favaloro   et   al.,   2010).   This   mechanism   was  
shown   to   be   dependent   on   the   presence   of   ADP   or   ATP.   In   future   work   the  
dependence   of   CaBP7   and   CaBP8   membrane   insertion   upon   Asna1,   and   the  
presence  of  ADP  or  ATP,  could  also  be  assessed  using  reconstituted  microsomes  in  a  
cell  free  system.  
  
CaBP7   and   CaBP8   were   shown   to   co-­‐localise   with   markers   of   the   TGN   in   both  
neuronal   and   non-­‐neuronal   cell   lines.   In   accordance   with   this   Hradsky   et   al.  
performed   protein-­‐lipid   overlay   assays   and   demonstrated   that   CaBP8   strongly  
associates  with  PI4P,  PI(4,5)P2  and  PI(3,4,5)P3  which  are  lipids  enriched  at  the  TGN  
and   PM   (Hradsky   et   al.,   2011).   The   TA   protein   topology   and   the   observed   TGN  
localisation  is  consistent  with  the  known  regulatory  role  of  CaBP7  and  CaBP8  in  TGN  
to   PM   traf???????? ???????? ??? ???????????? ????? ???? ?????????? ???????? ?????????
(Mikhaylova  et  al.,  2009).      
  
Further   investigation   into   the   subcellular   localisation  of  CaBP7  and  CaBP8   in  HeLa  
cells   revealed   extensive   co-­‐localisation   of   CaBP7  with  markers   of   late   endosomal  
and   lysosomal   compartments.   Heterogeneity   is   often   observed   between  
compartments  of  the  late  endosomal  and  lysosomal  pathway  with  the  fusion  of  late  
endosomes,  lysosomes,  autophagosomes  and  MVBs  giving  rise  to  the  formation  of  
hybrid   organelles   (Luzio   et   al.,   2000,   Fader   et   al.,   2009,   Mullock   et   al.,   1998).  
Autophagosomes   and  MVBs   fuse   to   form   the   amphisome,   a   prelysosomal   hybrid  
organelle,  and  subsequent  fusion  of  the  amphisome  with  the   lysosome  allows  the  
degradation   of  MVB   and   autophagosome   contents   (Fader   et   al.,   2009).   Likewise,  
late  endosomes  have  been  shown  to  transfer  their  contents  to  lysosomes  by  direct  
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fusion   and  hybrid  organelle   formation   rather   than   vesicular   transport   (Mullock  et  
al.,  1998).  The  lysosome  can  then  be  subsequently  reformed  after  the  degradation  
process   is   complete   (Luzio  et  al.,   2000).   This  heterogeneity   could   therefore   cause  
difficulty   discerning   the   exact   species   of   vesicle   in   which   CaBP7   and   CaBP8   are  
resident.  As  no  co-­‐localisation  was  observed  between  CaBP7  and  markers  of  MVBs,  
autophagosomes,  or  M6PR-­‐positive  late  endosomes,  it  can  be  reasoned  that  CaBP7  
and  CaBP8  reside  predominantly  on  lysosomes.  
  
Interestingly,   almost   complete   overlap   was   also   observed   in   the   localisation   of  
CaBP7  and  with  both  VSVG  and  VAMP7.  VSVG   is  a   commonly  used  marker  of   the  
constitutive   secretory   pathway   (Polishchuk   et   al.,   2003).   Data   presented   in   this  
thesis,   however,   demonstrated   that   VSVG   also   co-­‐localised   extensively   with  
markers   of   the   late   endosomes   and   lysosomes.   This   is   consistent  with   CaBP7   co-­‐
localisation   with   the   same   markers   and   suggests   that   VSVG   localisation   is   not  
specific   for  constitutive  secretory  vesicles.   In  accordance  with  this  observation,  no  
co-­‐localisation   was   observed   between   CaBP7   and   SNAP29,   a   post-­‐Golgi   SNARE  
which   has   been   shown   to   be   important   in   constitutive   secretion   (Gordon   et   al.,  
2010).  
  
  VAMP7   is   a   v-­‐SNARE   that   is   important   for   late   endosome   to   lysosome   fusion,  
amphisome  to  lysosome  fusion  and  lysosomal  exocytosis  (Fader  et  al.,  2009,  Proux-­‐
Gillardeaux  et  al.,  2007,  Martinez-­‐Arca  et  al.,  2003).   Interestingly,  VAMP7   is  also  a  
TA  protein  and  it  will  be  interesting  to  examine  whether  the  targeting  of  CaBP7  and  
CaBP8   to   lysosomes   utilises   a   similar   post-­‐Golgi   pathway   in   future   work.   Correct  
localisation  of  VAMP7  to  late  endosomes  and  lysosomes  not  only  requires  an  intact  
TMD  but  also  the  cytosolic  longin  domain.  Trafficking  of  VAMP7  has  been  shown  to  
be   reliant   on   an   interaction   between   the   longin   domain   and   the   AP3   complex  
(Martinez-­‐Arca  et  al.,  2003).    
  
The   adaptor   protein   complexes,   AP1,   AP2,   AP3   and   AP4,   are   each   involved   in  
different   trafficking   pathways   (Bonifacino   and   Traub,   2003).   AP1   and   AP4   deliver  
cargo   from   the  TGN   to   the  PM,  AP2   is   important   for   endocytosis   and  AP3  directs  
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but  similar  type  of   tyrosine  motif  which  determine   the  trafficking  and  turnover  of  
many   membrane   proteins   (Bonifacino   and   Traub,   2003).   Analysis   of   the   protein  
sequences  of  CaBP7  and  CaBP8   identified  a  potential   lysosomal   tyrosine   targeting  
motif   residing   at   the   same   position   in   both   proteins.   The   effect   of  mutating   this  
tyrosine  motif  was  therefore  explored.  No  obvious  difference  between  the  tyrosine  
mutants   and   wild   type   proteins   was   noted,   however,   the   possibility   that   these  
tyrosine  motifs  may  contribute  to  the  trafficking  dynamics  of  the  proteins  cannot  be  
discounted.    
  
The  dynamics  of   lysosomal   trafficking  can  prove  difficult   to  monitor  and  the  most  
common  approach  employs  35S  methionine  pulse  chase  experiments   (Dell'Angelica  
et   al.,   1999).   Subach   et   al.   have   described   an   alternative   method   to   accurately  
measure  the  dynamics  of  protein  trafficking  (Subach  et  al.,  2009).  Through  the  use  
of   monomeric   fluorescent   timers   which   mature   and   change   colour   over   time,  
Subach   et   al.   were   able   to   monitor   the   dynamics   of   LAMP2A   trafficking   to  
lysosomes  (Subach  et  al.,  2009).  A  similar  method  could  be  employed  to  deduce  the  
exact   trafficking   pathway   of   CaBP7   and   CaBP8   and   subsequently   monitor   the  
trafficking  dynamics  of  various  targeting  mutants.  
  
Correct   localisation   of   chimaeras   of   the   normally   cytosolic   CaBP5   fused   to   the   C-­‐
terminal   domain,   encompassing   the   TMD   of   CaBP7   or   CaBP8,   suggests   that   the  
cytosolic  N-­‐terminal  domain  does  not  direct   lysosomal  targeting  of  these  proteins.  
Compartmentalisation   of   CaBP7   and   CaBP8   to   lysosomes   may   therefore   be  
dependent  on   information  encoded   in   the   luminal  C-­‐terminal  domain  or  may   rely  
solely  on   the  TMD.  Hradsky  et  al.   generated  a  number  of  TMD  mutants  of  CaBP8  
fused   to   GFP   and   found   that   the   isolated   17   amino   acid   TMD   (as   predicted   by  
TMPRED)   mislocalised   the   protein   to   the   ER   (Hradsky   et   al.,   2011).   A   proposed  
longer  23  amino  acid  TMD  was  able  to  correctly  localise  the  protein  to  the  TGN,  as  
was   a   C-­‐terminal   fragment   encompassing   both   the   TMD   and   the   luminal   domain  
(Hradsky   et   al.,   2011).   Although   Hradsky   et   al.   suggest   this   is   an   effect   of   TMD  
length,  this  was  not  formally  proven.  It   is  possible  that  the  observed  improvement  
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in   subcellular   localisation   was   due   to   the   presence   of   targeting   determinants  
encoded  within   the   luminal  domain  which  were  not  present   in   the  17  amino  acid  
fusion.   Future   work   should   include   an   in   depth   analysis   of   all   potential   motifs  
required   for   correct   lysosomal   targeting.   A   mutagenesis   approach   may   help   to  
determine  the  actual  length  of  the  TMD  and  the  contribution  of  the  luminal  domain  
for  correct  protein  compartmentalisation.  
  
CaBP7  and  CaBP8  are  the   first   reported   instance  of  CaM-­‐related  Ca2+-­‐sensors  that  
target   to   cellular  membranes   via   a   C-­‐terminal   tail   anchor.   Furthermore,   no   other  
lysosomal   resident   EF-­‐hand   containing   proteins   have   been   described   to   date.  
Coupled  with  the  emerging  evidence  that  lysosomes  function  as  important  calcium  
signalling   platforms,   this   localisation   is   suggestive   of   a   role   for   CaBP7   and   CaBP8  
regulating  Ca2+-­‐mediated  processes  in  acidic  organelles.  This  is  of  particular  interest  
when  considering  the  observation  that  CaBP7  depletion  causes  failure  of  cytokinesis  
(Neumann  et  al.,  2010).  
  
The   data   presented   in   chapter   5   demonstrated   that,   as   previously   shown   by  
Neumann   et   al.   (Neumann   et   al.,   2010),   treatment   of   HeLa   cells   with   shRNA  
targeting   CaBP7   expression,   caused   an   increase   in   the   number   of   multinucleate  
cells.  Using  high-­‐resolution   four-­‐dimensional  confocal  microscopy,  Neumann  et  al.  
demonstrated   that   this   phenotype   arose   as   a   consequence   of   cytokinesis   failure  
after   normal   chromosome   segregation.   Cells   were   observed   to   undergo   furrow  
formation  but  failed  at  the  stage  of  abscission  (Neumann  et  al.,  2010).  Neumann  et  
al.   were   able   to   prevent   the  multinucleate   phenotype   through   complementation  
with  an  RNAi  resistant  mouse  CaBP7  orthologue,  suggesting  that  the  phenotype  did  
not   result   from   an   off   target   effect.   Unfortunately,   due   to   time   restraints,   the  
results   from   these   complementation   assays   were   not   replicated   in   this   thesis.   A  
number  of  RNAi  resistant  CaBP7  variants  were  generated  however,  and  production  
of  stable  cell  lines  expressing  these  constructs  will  permit  a  more  in  depth  analysis  
of   the   requirements   for   CaBP7   function   during   mitosis.   Along   with   a   wild   type  
resistant  construct,  both  a  transmembrane  deficient  mutant  and  a  mutant  defective  
in  Ca2+-­‐binding  were  also  generated.    Treatment  of  stable  cell  lines  expressing  these  
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constructs  with   CaBP7   specific   shRNA  will   allow  dissection   of   the   localisation   and  
Ca2+  dependency  of  this  process.  
  
Examination   of   the   subcellular   localisation   of   CaBP7   in   dividing   cells   revealed   a  
redistribution   of   CaBP7-­‐positive   vesicles   to   the   vicinity   of   the   midbody   and   to  
opposite   poles   of   the   spindle   during   cytokinesis.   Co-­‐immunostaining   for  
endogenous   CaBP7   and  CD63  demonstrated   that   CaBP7   retains   a   late   endosomal  
and   lysosomal   distribution.   Likewise   complete   co-­‐localisation   with   VSVG   and  
VAMP7   was   observed   as   also   shown   in   interphase   cells   in   chapter   4.   No   co-­‐
localisation   was   observed   with   M6PR-­‐positive   endosomes   or   Rab11-­‐positive  
recycling  endosomes.    
  
The   role   of   lysosomes   in   cytokinesis   remains   relatively   unstudied   with   most  
research   focusing   on   the   roles   of   recycling   endosomes   and   secretory   vesicles  
(McKay  and  Burgess,  2011,  Neto  et  al.,  2011).  Despite  this  there  is  strong  evidence  
to   suggest   that   membrane   delivery   from   late   endosomes   and   lysosomes   is  
important   for   PM   surface   area   recovery   and   abscission   during   cytokinesis.   The  
appearance  of  LAMP1-­‐positive  cell  surface  blebs  during  PM  surface  area  recovery  in  
cytokinesis   has   been   reported   (Boucrot   and   Kirchhausen,   2007)   and   dominant  
negative  mutants  of  CHMP3    and  VAMP7,  two  proteins  involved  in   late  endosome  
to  lysosome  fusion,  have  been  shown  to  induce  cytokinesis  failure  and  multiploidy  
(Dukes   et   al.,   2008,   Boucrot   and   Kirchhausen,   2007).   Overexpression   of   the  
cytosolic   longin   domain   of   VAMP7   additionally   causes   a   reduction   in   PM   surface  
area  recovery  during  cytokinesis  and  a  reduction  in  the  appearance  of  LAMP1  at  the  
cell   surface   (Boucrot   and   Kirchhausen,   2007).   Interestingly,   the   longin   domain   of  
VAMP7   was   also   shown   to   inhibit   lysosomal   secretion   in   an   independent   study  
(Proux-­‐Gillardeaux   et   al.,   2007).   Together   these   observations   are   suggestive   of   a  
crucial   involvement   for   the   fusion  of   late  endosomes   and   lysosomes  with   the  PM  
during  cytokinesis.  The  localisation  of  CaBP7  to  VAMP7-­‐positive  vesicles  infers  that  
CaBP7  may   be   involved   in   calcium   signalling   events   controlling  membrane   fusion,  
hence   explaining   the   shared   binucleate   phenotype   upon   disruption   of   either  
protein.   Interestingly,   direct   docking   and   fusion   of   VSVG-­‐positive   vesicles   at   the  
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midzone   has   also   been   demonstrated   consistent   with   the   presence   of   CaBP7   on  
VSVG  containing   vesicles   (Goss   and  Toomre,  2008).   The  use  of  pHluorin   tags  may  
allow  the  fusion  of  CaBP7-­‐positive  vesicles  at  the  cleavage  furrow  to  be  monitored  
in   real   time.   pHluorins   are   commonly   used   to  monitor   the   dynamics   of   proteins  
associated   with   endo-­‐   and   exo-­‐cytotic   vesicles   (Mahon,   2011).   The   technology   is  
based  on  the  pH  sensitivity  of  GFP  variants.  pHluorin  exhibits  a  bimodal  excitation  
spectrum  with   peaks   at   395   nm   and   475   nm,   and   emission   at   509   nm.   In   acidic  
environments,  such  as  the  lumen  of  the  lysosome,  excitation  at  395  nm  decreases,  
with  a  corresponding  increase  in  excitation  at  475  nm.  This  effect  is  reversed  upon  
transfer  to  a  more  alkaline  environment  upon  exocytosis  (Mahon,  2011).  Therefore  
by   fusing   a   pHluorin   tag   to   the   luminal   C-­‐terminus   of  wild   type   CaBP7   and   other  
variants,  the  dynamics  of  lysosomal  exocytosis  in  cells  at  both  interphase  and  during  
mitosis  could  be  monitored.  
  
Calcium  signalling  is  fundamental  for  vesicle  transport  and  likewise  perturbations  of  
Ca2+   levels   during   cytokinesis   have   been   shown   to   affect   membrane   remodelling  
and   vesicle   fusion   (Li   et   al.,   1999,   Shuster   and   Burgess,   2002).   Importantly,   PM  
recovery   during   cytokinesis   has   been   shown   to   be   perturbed   upon   treatment   of  
cells   with   the   myosin   II   inhibitor,   blebistatin   (Boucrot   and   Kirchhausen,   2007).  
Myosin  II  plays  an  important  role  in  Ca2+  dependent  exocytosis  in  membrane  repair  
and   wound   healing   (Togo   and   Steinhardt,   2004).   Both   wound   healing   and  
cytokinesis  are  also  sensitive  to  treatment  with  BFA  which  causes  the  tubulation  of  
endosomes   and   lysosomes   (McNeil   and   Terasaki,   2001).   This   is   consistent  with   a  
potential  role  for  Ca2+  mediated  lysosomal  exocytosis  for  the  efficient  abscission  of  
two  daughter  cells.  
  
Although   there   is   strong   evidence   to   suggest   an   important   role   for   calcium  
signalling  during  cytokinesis,  Ca2+  transients  during  different  stages  of  the  cell  cycle  
have  proven  difficult  to  record   (Whitaker,  2006).   It  has  been  suggested  that  highly  
localised  Ca2+  elevations  may  control   the  different  stages   in   the  cell   cycle  and  this  
may  underlie  the  elusive  nature  of  mitotic  Ca2+  signals  (Whitaker,  2006).  Lysosomes  
represent   important   platforms   for   the   generation   of   highly   localised   Ca2+   signals  
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upon  stimulation  by  NAADP   in   interphase  cells   (Galione  et  al.,  2010).  The  NAADP-­‐
sensitive  Ca2+-­‐release  channel,  TPC2,  has  been  shown  to  underpin  this  process  (Pitt  
et  al.,  2010).  Interestingly,  depletion  of  TPC2  was  observed  to  cause  mitotic  defects  
in  the  same  high  throughput  screen  which  identified  a  mitotic  phenotype  for  CaBP7  
(Neumann  et  al.,  2010).  Knockdown  of  TPC2  caused  metaphase  delay,  metaphase  
alignment  problems  and  cell  death.  Knockdown  of  the  related  protein,  TPC1,  which  
is   resident   on   late   endosomes,   also   induced   mitotic   defects   causing   a   binuclear  
phenotype   and   cell   death   (Neumann   et   al.,   2010).   Acidic   organelles   therefore  
represent   interesting  candidates  for  the  generation  of   localised  Ca2+  signals  during  
mitosis.   The   generation   of   a   lysosomally   targeted   Cameleon   may   allow   the  
detection   of   localised   [Ca2+]ielevations   at   the   surface   of   lysosomes   during   the  
process   of   cytokinesis.   Cameleons   are   fluorescent   Ca2+   indicators   which   function  
based   on   the   Ca2+   dependent   binding   of   CaM   to   a   target   binding   peptide,   M13  
(Emmanouilidou  et  al.,  1999).  The  indicator  consists  of  a  fusion  of  ECFP,  CaM,  M13,  
and  EYFP  and  works  on  the  basis  that  upon  elevation  of  [Ca2+]i,  CaM  binds  the  M13  
peptide   bringing   the   two   fluorescent   proteins   into   close   proximity   and   allowing  
fluorescence   resonance  energy   transfer   (FRET)   to   occur.   Imaging  of   localised   Ca2+  
signals   using   a   cameleon   targeted   to   secretory   granules   has   previously   been  
described  (Emmanouilidou  et  al.,  1999).    
  
Further   investigation   is   therefore   necessary   to   understand   the   molecular  
mechanisms  underlying  a   role   for  CaBP7   in   cytokinesis.   Localisation  analyses  have  
demonstrated  that  CaBP7  co-­‐localises  with  markers  of  vesicles  previously  shown  to  
undergo   fusion  with   the  PM  during   cytokinesis.  This   could   implicate  CaBP7   in   the  
regulation  of  Ca2+  signalling  events   involved  in  the  process  of   lysosomal  exocytosis  
??????? ???????????? ???? ????? ?????? ????????? ??? ?????? ??? ?? ????? ??????????? ?????????
(Mikhaylova   et   al.,   2009).   Interestingly   PI4K   homologs   in   Schizosaccharomyces  
pombe   and   Drosophilamelanogaster   have   been   shown   to   be   important   for   the  
completion  of   cytokinesis   (Park  et  al.,  2009,  Polevoy  et  al.,  2009).  Deletion  of   the  
yeast  homolog  PIK1  is  lethal,  however,  ectopic  expression  of  a  loss  of  function  allele  
in   PIK1   null   yeast   allowed   normal   cell   proliferation   but   exhibited   a   defect   in  
septation   (Park   et   al.,   2009).   Knockout   of   the   Drosophila   homolog,   Fwd,   is   not  
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lethal,  however,  male  flies  are  sterile  and  exhibit  multinucleate  cells  characteristic  
of  a  meiotic  cytokinesis  defect  (Polevoy  et  al.,  2009).  Expression  of  Fwd  mutants  in  
Drosophila   spermatocytes   cause   defects   in   late   cytokinesis   resembling   the  
phenotype   observed   for   CaBP7:   the   cleavage   furrow   is   able   to   constrict   but  
becomes  unstable  and  later  regresses  resulting  in  multinucleate  cells.  Interestingly,  
the   cytokinesis   defects   in   Fwd   null   drosophila   have   been   attributed   to   loss   of  
regulation  of  Rab11.  Fwd   is   required   for   the   localisation  of  Rab11   in  dividing  cells  
and   is   also   required   for   the   formation   of   PI4P   containing   secretory   vesicles   that  
localize  to  the  midzone  (Polevoy  et  al.,  2009).  C???????????????????????????????????????
in  mammalian   cells   (Mikhaylova   et   al.,   2009)   and   does   not   appear   to   co-­‐localise  
with   Rab11   in   interphase   cells   or   in   dividing   cells.   Additionally,   CaBP7   is   not  
expressed   in   yeast   or   Drosophila,   and   its   role   regulating   PI4K   is   specific   to  
vertebrate  species.  Although  it  therefore  seems  unlikely  that  the  cytokinesis  defects  
observed   in  CaBP7  deficient   cells   are  due   to  deregulation  of  PI4K   this  mechanism  
cannot  be  discounted.  CaBP7  mutants  defective  in  PI4K  binding  could  be  generated  
and  their  ability  to  prevent  the  binucleate  phenotype  upon  CaBP7  knockdown  could  
be  assessed  in  order  to  rule  this  possibility  out.  
  
The  ability  of  Ca2+-­‐sensors  to  regulate  essential  Ca2+  dependent  processes  relies  on  
their   ability   to   undergo   drastic   conformational   changes   upon   binding   to   Ca2+.  
Different  Ca2+-­‐sensors  behave  differently  depending  on  their  Ca2+-­‐binding  affinities  
and   structural   properties.   In   order   to   better   understand   the   differences   between  
CaBPs  1-­‐5  and  CaBP7  &  8,  NMR  analyses  of   representative  proteins   from   the   two  
sub-­‐families,   CaBP4   and   CaBP7,   were   attempted.   Problems   with   aggregation  
hindered   the   progress   of   this   project   but   preliminary   steps   were   made   towards  
solving  the  structures  of  these  two  proteins.  
  
CaBP4   is  at   the  upper   size   limit   (??30  kDa)   for  proteins  which  can  be   analysed  by  
NMR.  This  was  reflected  in  the  NMR  data  obtained  for  this  protein.  An  insufficient  
number  of  peaks  were  recorded  in  NMR  spectra  to  represent  the  275  amino  acids  in  
this  protein.   In  addition,  a   relatively   large  number  of  sharp  peaks  characteristic  of  
an   unstructured   region   of   the   protein  were   observed.   The  N-­‐termini   of   the   CaBP  
     233  
proteins  are  the  most  divergent  region  of  this  family  of  Ca2+-­‐sensors.  NMR  and  X-­‐ray  
crystallography   have   shown   that   this   portion   of   the   protein   is   unstructured   in  
CaBP1.   The   N-­‐terminal   region   of   CaBP4,   preceding   the   start   of   the   first   EF-­‐hand  
motif,   is   greatly   extended   compared   with   the   other   CaBP   proteins   with   the  
exception   of   caldendrin.   Interestingly,   in   secondary   structure   predictions,   the   N-­‐
terminus   of   CaBP4   forms   a   region   of   random   coil.   It   can   be   reasoned,   therefore,  
that   the   sharp   peaks   observed   in   CaBP4   spectra   may   represent   an   unstructured  
extended  N-­‐terminus.  In  future  work  in  may  be  possible  to  assign  the  sharp  peaks  in  
order  to  deduce  if  they  correspond  to  a  contiguous  stretch  of  amino  acids  at  the  N-­‐
terminus   of   CaBP4.   If   this   can   be   confirmed,   a   new   construct   encoding   CaBP4  
without   the   extended   N-­‐terminal   region   could   be   generated   to   produce   a  
recombinant  protein  that  is  more  amenable  to  NMR  analysis.    
  
CaBP4   represents  an   important  member  of   the  CaBP   family  of  proteins  due   to   its  
proven  non-­‐redundant  role  in  photostransduction  pathways  of  the  retina  (Maeda  et  
al.,  2005).  CaBP4  is  thought  to  mediate  these  roles  through  interactions  with  Cav1.3  
and  Cav1.4  VGCCs  (Haeseleer  et  al.,  2004,  Lee  et  al.,  2007b).  It  will  be  interesting  to  
discover   which   regions   are   important   for   CaBP4   interactions   with   various   VGCCs  
and  whether  they  differ  from  interactions  of  CaBP1  with  related  VGCCs.  It  has  been  
deduced   that   interactions   between   CaBP1   and   Cav1.2   channels   are   mediated  
through   interactions   with   the   N-­‐terminus,   the   S3-­‐S4   linker   and   the   IQ   domain  
(Findeisen  and  Minor,  2010).  CaBP4  is  of  particular  interest  due  to  the  identification  
of   various   CaBP4  mutations   in   patients   exhibiting   cone-­‐rod   synaptic   disorders   of  
varying  severity   (Aldahmesh  et  al.,  2010,  Littink  et  al.,  2009,  Zeitz  et  al.,  2006).  By  
deducing   the   critical   regions   needed   for   CaBP4   interactions   with   VGCCs,   and   by  
examining  the  nature  of  the  mutations  detected  in  humans,  the  molecular  basis  for  
these   visual   disorders   can   be   investigated.   Using   NMR   the   structure   of   CaBP4   in  
complex   with   interacting   peptides   could   be   solved   and   the   effect   of   different  
mutations  on  peptide  binding  directly  examined.  
  
Problems  encountered  because  of  protein  aggregation  precluded  NMR  analysis  of  
full   length   CaBP7   and   a   mutant   lacking   the   TMD   (CaBP7   1-­‐188).   A   fragment  
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encoding  the  first  100  amino  acids  of  CaBP7  (CaBP7  1-­‐100)  proved  more  amenable  
to  analysis  by   this   technique.  Over  85%  of   the  CaBP7  1-­‐100  backbone  assignment  
was  completed  and  progress  towards  assigning  the  side  chains  of  this  fragment  was  
made.   The   assigned   NMR   spectrum   exhibited   features   characteristic   of   a   Ca2+-­‐
bound  Ca2+-­‐sensor,  namely   the   two  downfield   shifted  peaks   corresponding   to   the  
glycine   residues   at   the   6th   position   of   each   EF-­‐hand.   The   peaks   in   the   assigned  
spectrum  were  well   dispersed,   consistent  with  a  well-­‐folded  protein  and  many  of  
the  more  downfield  shifted  peaks  corresponded  to  amino  acids  within  the  two  EF-­‐
hand   motifs.   Assignment   of   the   CaBP7   1-­‐100   backbone   and   side   chains   allowed  
secondary   structure   calculations   to   be   carried   out   using   CSI   and   DANGLE.   The  
output   secondary   structure   closely   approximated   that   of   CaM   and   CaBP1S   N-­‐
termini.   In  order   to   solve   the   tertiary   structure  of   CaBP7   1-­‐100   data   from  NOESY  
experiments  will   be   required.  NOESY   experiments   provide  data   about   resonances  
that  are  close  together  in  space  and  can  be  used  to  generate  restraints  for  structure  
calculations  and  aid  disambiguation  of  spectral  overlap  (Cavanagh  et  al.,  2007b).  
  
Spectra   for   the   apo   form   of   CaBP7   1-­‐100   were   also   obtained   and   compared   to  
spectra  after  addition  of  saturating  Ca2+.  The  two  spectra  were  completely  different  
suggesting  a  significant  conformational  change  upon  the  addition  of  Ca2+.  This  was  
in  accordance  with  previously  published  data   from  fluorimetry  assays   (Mikhaylova  
et  al.,  2009).  In  addition  a  significant  mobility  shift  was  observed  between  Ca2+-­‐free  
and  Ca2+-­‐bound  CaBP7  1-­‐100  on  native  PAGE  gels.  In  the  same  experiment  no  shift  
in  mobility  was  observed  upon  addition  of  Mg2+.  This  data  suggested  that  CaBP7  1-­‐
100  binds  specifically  to  Ca2+  and  not  to  Mg2+.    
  
Differences   in  the  conformational  changes  of  CaBP1  and  CaM  N-­‐termini  upon  Ca2+  
binding  have  been  observed  with  CaBP1  adopting  a  more  closed  conformation  and  
CaM  adopting  a  more  open  conformation  (Park  et  al.,  2011,  Chin  and  Means,  2000).  
These   differences   may   be   explained   through   the   differences   in   cation   binding  
properties   of   the   two   proteins.  Whereas   the   N-­‐terminal   domain   of   CaM   can   co-­‐
ordinate   a   Ca2+   ion   at   each   of   its   two   EF-­‐hands,   CaBP1   has   a   non-­‐functional   EF2  
motif  and  therefore  binds  Ca2+  only  at  EF1  (Chin  and  Means,  2000,  Wingard  et  al.,  
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2005).   Like   CaM,   CaBP7  has   functional   EF1   and   EF2  motifs   and   therefore  may  be  
predicted  to  behave  similarly.  Differences  in  the  Ca2+  affinities  of  CaBP7  (??????????
(Mikhaylova  et  al.,  2009)  and  CaM  (?  4  -­‐  ???????(Schaad  et  al.,  1996)  may,  however,  
suggest  there  are  likely  to  be  structural  differences  between  their  EF-­‐hand  motifs.  It  
will  therefore  be  important  to  deduce  the  structures  of  both  the  Ca2+-­‐free  and  the  
Ca2+-­‐bound   forms   of   CaBP7   1-­‐100   in   order   to   assess   how   the   associated  
conformational  change  compares  to  that  of  related  Ca2+-­‐sensors.  
  
The  N-­‐terminal  domain  of  CaBP7,  containing  the  first  pair  of  EF-­‐hands  and  encoded  
by  CaBP7  1-­‐100,  displays  significantly  higher  homology  to  CaM  and  CaBP1  than  the  
C-­‐terminal  domain.  Despite  a  maximum  of  10%  sequence   identity  of  the  CaBP7  C-­‐
terminus   with   CaM,   this   region   has   remained   remarkably   conserved   through  
evolution.   The   C-­‐terminus   of   CaBP7   contains   amino   acid   sequences   loosely  
resembling  a  second  pair  of  EF-­‐hand  motifs.  Deletions,  insertions  and  substitutions  
have,   however,   rendered   these   motifs   inactive   for   cation   binding.   Although   the  
domain   does   not   participate   in   Ca2+   binding,   the   high   sequence   conservation  
through  evolution  implies  that  it  imparts  an  important  functional  role.    Elucidation  
of   the   structure  of   the  C-­‐terminus   therefore   represents  an   important   task   for   the  
future  to  permit  a  full  understanding  of  CaBP7  structure.  NMR  spectra  of  CaBP7  1-­‐
188  exhibited  dispersed  peaks  which  did  not  correspond  to  the  spectra  of  CaBP7  1-­‐
100   suggesting   that   the   C-­‐terminal   portion   of   this   protein   was   at   least   partially  
folded.   A   large   degree   of   overlap,   characteristic   of   protein   aggregation,   was  
observed  in  the  centre  of  CaBP7  1-­‐188  spectra  which  was  not  observed  in  CaBP7  1-­‐
100  spectra.  Therefore  the  C-­‐terminus  of  CaBP7  may  be  critical  in  the  formation  of  
aggregates.  Hradsky  et  al.   have  demonstrated   that  CaBP7,  and  the  closely   related  
CaBP8,  are  able  to  form  dimers  and  higher  order  oligomers  which  may  go  some  way  
toward  explaining  the  aggregation  problems  encountered  (Hradsky  et  al.,  2011).  In  
addition,  the  C-­‐terminus  of  CaBP7  1-­‐188  contains   five  cysteine  residues.  Cysteines  
can  often  cause  problems  with  recombinant  protein  solubility  due  to  the  formation  
of   incorrect  disulphide  bridges  between  monomers.  Expression  of   sufficient   levels  
of   soluble   CaBP7   1-­‐188   or   the   CaBP7   C-­‐terminal   domain   may   therefore   require  
mutation  or  modification  of  these  residues.    
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Due   to   the   limited   information   known   about   CaBP7   and   CaBP8   function,  
identification  of  interacting  binding  partners  should  constitute  a  key  area  for  future  
research.   With   this   aim   in   mind,   yeast-­‐2-­‐hybrid   library   screens   were   attempted  
during  the  course  of  this  PhD  project  using  CaBP7  and  CaBP8  as  bait  proteins,  with  
and   without   their   respective   TMDs   (data   not   shown).   The   proteins   displayed   a  
propensity   for   autoactivation,   therefore   the   data  was  not  used   in   this   thesis.   Pull  
down   assays,   and   subsequent   mass   spectroscopy,   represent   an   alternative  
technique  for  the  identification  of  unique  binding  partners  of  CaBP7  (Haynes  et  al.,  
2006).    
  
Once   more   is   known   about   the   functions   of   CaBP7,   NMR   will   prove   useful   for  
determining  the  interaction  surfaces  required  for  CaBP7  binding  to  target  proteins.  
???? ????????????? ??????? ???????????? ??? ??????????? ????????? ?????? ??? ?????????? ???
this  way.  Binding  assays  between  different  fragments  of  the  two  proteins  will  allow  
the  binding   interface(s)  to  be  mapped.  Once  this   is  deduced,  NMR  can  be  used  to  
monitor  the  dynamics  of  the  binding  process.  Changes  to  the  NMR  spectra  of  CaBP7  
upon  addition  of  the  binding  peptide  can  be  monitored  and,   if  assigned,  will  allow  
the   identification   of   critical   amino   acid   residues.   Reciprocal   experiments,  
isotopically   labelling   either   CaBP7   or   the   target   peptide,   would   also   enable   the  
structure  of   the  complex   to  be   solved.  NMR  therefore   represents  a  powerful   tool  
for  the  analysis  of  protein-­‐protein  interactions.  
  
Conclusion    
A  combination  of  bioinformatics,  cell  biology  and  structural  biology  techniques  have  
been   used   to   generate   the   data   presented   in   this   thesis   which   focused   on   the  
characterisation   of   CaBP7   and   CaBP8.   A   number   of   distinct   conclusions   can   be  
drawn  from  this  data:  
  
? Bioinformatics   analyses   revealed   important   information   concerning   the  
evolution  of  these  proteins  and  categorised  CaBP7  and  CaBP8   into  a  group  
of  Ca2+-­‐sensors  distinct  from  CaBPs1-­‐5.    
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? Studies   examining   the   membrane   association   of   CaBP7   and   CaBP8   in  
neuronal   and  non-­‐neuronal   cell   types   revealed   that   they  belong   to   the  TA  
class   of   integral  membrane   proteins.   Localisation   of   these   proteins   to   the  
TGN  and  lysosomes  was  also  reported  ?  a  distribution  unique  to  this  group  
of  EF-­‐hand  containing  Ca2+-­‐sensors.    
? Depletion   of   CaBP7   in   HeLa   cells   confirmed   a   previously   reported   mitotic  
phenotype   for   this   protein:   upon   knockdown  of   CaBP7,   an   increase   in   the  
number   of   binucleate   cells   was   observed.   Closer   examination   of   CaBP7  
during   different   stages   of   the   cell   cycle   demonstrated   a   redistribution   of  
CaBP7-­‐positive   vesicles   to   the   vicinity   of   the   interzonal   microtubules   and  
opposite  poles  of  the  spindle  during  cytokinesis.    
? CaBP7  remained  associated  with  lysosomes  during  all  stages  of  the  cell  cycle  
and  colocalised  with  proteins  previously  implicated  in  membrane  delivery  to  
the   cell   surface   during   cytokinesis.   Lysosomes   are   emerging   as   important  
platforms  for  calcium  signalling,  and  therefore  CaBP7  may  play  a  role  in  the  
regulation   of   Ca2+   signalling   processes   at   the   lysosomal   membrane,   both  
during  interphase  and  in  dividing  cells.    
? Finally   the   use   of  NMR   spectroscopy   led   to   the   partial   backbone   and   side  
chain   assignment   of   a   100   amino   acid  N-­‐terminal   fragment   of   CaBP7.   The  
secondary  structure  of  this   fragment  was  calculated  and  closely   resembled  
that  of  Ca2+-­‐bound  CaM  and  CaBP1S  N-­‐termini.  Spectra  for  apo  CaBP7  were  
completely   distinct   from   that   of   Ca2+-­‐saturated   CaBP7   implying   that   the  
protein   undergoes   a   significant   conformational   change   upon   Ca2+-­‐binding.  
Continued   NMR   analysis   will   hopefully   lead   to   the   deduction   of   a   high-­‐
resolution  structure  for  CaBP7.    
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Table  A1.  Protein  expression  plasmids  and  descriptions.  
  
Plasmid   Antibiotic  
Resistance  
Tag     Description  
pGEX-­‐6P1   Amp   GST   PreScission  Protease  cleavage  of  GST  tag  
  
pGEX-­‐N2   Amp   GST   Tag  is  at  the  C-­‐terminus  instead  of  the  N-­‐
terminus  
  
pTrcHisA   Amp   His   High  level  regulated  expression  from  trc  
promoter.  Enhanced  translation  efficiency  
of  eukaryotic  genes.  Enterokinase  cleavage  
of  tag  
  
pTrcHisTEV   Amp   His   Same  as  pTrcHisA  except  now  encodes  a  
TEV  cleavage  site  
  
pETM11   Kan   His   TEV  cleavage  of  tag  
  
pOPIN-­‐s   Amp   His-­‐
SUMO  
SUMO  fusion  for  increased  solubility  and  
stability  of  difficult  to  express  proteins  
  
pE-­‐SUMOPRO   Kan   His-­‐
SUMO  
SUMO  fusion  for  increased  solubility  and  
stability  of  difficult  to  express  proteins.  
Powerful  T7  promoter.  
  
  240    




     
  241  
  





















     245  
  
ABELL,  B.  M.,  POOL,  M.  R.,  SCHLENKER,  O.,  SINNING,  I.  &  HIGH,  S.  2004.  Signal  
recognition  particle  mediates  post-­‐translational  targeting  in  eukaryotes.  The  
EMBO  journal,  23,  2755-­‐64.  
ALDAHMESH,  M.  A.,  AL-­‐OWAIN,  M.,  ALQAHTANI,  F.,  HAZZAA,  S.  &  ALKURAYA,  F.  S.  
2010.  A  null  mutation  in  CABP4  causes  Leber's  congenital  amaurosis-­‐like  
phenotype.  Mol  Vis,  16,  207-­‐12.  
AMES,  J.  B.,  GORDON,  J.  I.,  IKURA,  M.  &  STRYER,  L.  1997.  NMR  studies  of  calcium-­‐
bound  recoverin  containing  a  polar  mvristoyl  analog.  FASEB  Journal,  11.  
AMES,  J.  B.,  TANAKA,  T.,  STRYER,  L.  &  IKURA,  M.  1996.  Portrait  of  a  myristoyl  switch  
protein.  Current  opinion  in  structural  biology,  6,  432-­‐438.  
ARAVIND,  P.,  CHANDRA,  K.,  REDDY,  P.  P.,  JEROMIN,  A.,  CHARY,  K.  V.  &  SHARMA,  Y.  
2008.  Regulatory  and  structural  EF-­‐hand  motifs  of  neuronal  calcium  sensor-­‐1:  
Mg  2+  modulates  Ca  2+  binding,  Ca  2+  -­‐induced  conformational  changes,  and  
equilibrium  unfolding  transitions.  J  Mol  Biol,  376,  1100-­‐15.  
ASHWORTH,  R.,  DEVOGELAERE,  B.,  FABES,  J.,  TUNWELL,  R.  E.,  KOH,  K.  R.,  DE  SMEDT,  
H.  &  PATEL,  S.  2007.  Molecular  and  functional  characterization  of  inositol  
trisphosphate  receptors  during  early  zebrafish  development.  The  Journal  of  
biological  chemistry,  282,  13984-­‐13993.  
ASMARA,  H.,  MINOBE,  E.,  SAUD,  Z.  A.  &  KAMEYAMA,  M.  2010.  Interactions  of  
calmodulin  with  the  multiple  binding  sites  of  Cav1.2  Ca2+  channels.  Journal  of  
pharmacological  sciences,  112,  397-­‐404.  
ATILLA-­‐GOKCUMEN,  G.  E.,  CASTORENO,  A.  B.,  SASSE,  S.  &  EGGERT,  U.  S.  2010.  
Making  the  cut:  the  chemical  biology  of  cytokinesis.  ACS  chemical  biology,  5,  
79-­‐90.  
AUGUSTINE,  G.  J.,  SANTAMARIA,  F.  &  TANAKA,  K.  2003.  Local  calcium  signaling  in  
neurons.  Neuron,  40,  331-­‐346.  
BAHI,  N.,  FRIOCOURT,  G.,  CARRIE,  A.,  GRAHAM,  M.  E.,  WEISS,  J.  L.,  CHAFEY,  P.,  
FAUCHEREAU,  F.,  BURGOYNE,  R.  D.  &  CHELLY,  J.  2003.  IL1  receptor  accessory  
protein  like,  a  protein  involved  in  X-­‐linked  mental  retardation,  interacts  with  
Neuronal  Calcium  Sensor-­‐1  and  regulates  exocytosis.  Hum  Mol  Genet,  12,  
1415-­‐25.  
     246  
BAKER,  P.  F.  &  WARNER,  A.  E.  1972.  Intracellular  calcium  and  cell  cleavage  in  early  
embryos  of  Xenopus  laevis.  The  Journal  of  cell  biology,  53,  579-­‐81.  
BALLA,  A.  &  BALLA,  T.  2006.  Phosphatidylinositol  4-­‐kinases:  old  enzymes  with  
emerging  functions.  Trends  in  cell  biology,  16,  351-­‐61.  
BARRITT,  G.  J.  1999.  Receptor-­‐activated  Ca2+  inflow  in  animal  cells:  a  variety  of  
pathways  tailored  to  meet  different  intracellular  Ca2+  signalling  
requirements.  The  Biochemical  journal,  337,  Pt  2/.  
BATISTIC,  O.  &  KUDLA,  J.  2009.  Plant  calcineurin  B-­‐like  proteins  and  their  interacting  
protein  kinases.  Biochimica  et  biophysica  acta,  1793,  985-­‐992.  
BAYLOR,  D.  1996.  How  photons  start  vision.  Proceedings  of  the  National  Academy  of  
Sciences  of  the  United  States  of  America,  93,  560-­‐565.  
BAZHIN,  A.  V.,  SAVCHENKO,  M.  S.,  BELOUSOV,  E.  V.,  JAQUES,  G.  &  PHILIPPOV,  P.  P.  
2004.  Stimulation  of  the  aberrant  expression  of  a  paraneoplastic  antigen,  
recoverin,  in  small  cell  lung  cancer  cell  lines.  Lung  Cancer,  45,  299-­‐305.  
BEAR,  M.  F.  &  MALENKA,  R.  C.  1994.  Synaptic  plasticity:  LTP  and  LTD.  Current  opinion  
in  neurobiology,  4,  389-­‐99.  
BEECH,  D.  J.  2007.  Canonical  transient  receptor  potential  5.  Handb  Exp  Pharmacol,  
109-­‐23.  
BEILHARZ,  T.,  EGAN,  B.,  SILVER,  P.  A.,  HOFMANN,  K.  &  LITHGOW,  T.  2003.  Bipartite  
signals  mediate  subcellular  targeting  of  tail-­‐anchored  membrane  proteins  in  
Saccharomyces  cerevisiae.  The  Journal  of  biological  chemistry,  278,  8219-­‐23.  
BERGELAND,  T.,  WIDERBERG,  J.,  BAKKE,  O.  &  NORDENG,  T.  W.  2001.  Mitotic  
partitioning  of  endosomes  and  lysosomes.  Current  biology  :  CB,  11,  644-­‐51.  
BERNSTEIN,  H.  G.,  SAHIN,  J.,  SMALLA,  K.  H.,  GUNDELFINGER,  E.  D.,  BOGERTS,  B.  &  
KREUTZ,  M.  R.  2007.  A  reduced  number  of  cortical  neurons  show  increased  
Caldendrin  protein  levels  in  chronic  schizophrenia.  Schizophr  Res,  96,  246-­‐56.  
BERRIDGE,  M.  J.  1998.  Neuronal  calcium  signaling.  Neuron,  21,  13-­‐26.  
BERRIDGE,  M.  J.  2009.  Inositol  trisphosphate  and  calcium  signalling  mechanisms.  
Biochimica  et  biophysica  acta,  1793,  933-­‐40.  
BERRIDGE,  M.  J.,  LIPP,  P.  &  BOOTMAN,  M.  D.  2000.  The  versatility  and  universality  of  
calcium  signalling.  Nature  reviews.  Molecular  cell  biology,  1,  11-­‐21.  
     247  
BICHET,  D.,  CORNET,  V.,  GEIB,  S.,  CARLIER,  E.,  VOLSEN,  S.,  HOSHI,  T.,  MORI,  Y.  &  DE  
WAARD,  M.  2000.  The  I-­‐II  loop  of  the  Ca2+  channel  alpha1  subunit  contains  
an  endoplasmic  reticulum  retention  signal  antagonized  by  the  beta  subunit.  
Neuron,  25,  177-­‐90.  
BONIFACINO,  J.  S.  &  TRAUB,  L.  M.  2003.  Signals  for  sorting  of  transmembrane  
proteins  to  endosomes  and  lysosomes.  Annual  review  of  biochemistry,  72,  
395-­‐447.  
BOOTMAN,  M.  D.,  COLLINS,  T.  J.,  PEPPIATT,  C.  M.,  PROTHERO,  L.  S.,  MACKENZIE,  L.,  
DE  SMET,  P.,  TRAVERS,  M.,  TOVEY,  S.  C.,  SEO,  J.  T.,  BERRIDGE,  M.  J.,  
CICCOLINI,  F.  &  LIPP,  P.  2001.  Calcium  signalling-­‐-­‐an  overview.  Seminars  in  
cell  &  developmental  biology,  12,  3-­‐10.  
BORGESE,  N.,  BRAMBILLASCA,  S.  &  COLOMBO,  S.  2007.  How  tails  guide  tail-­‐anchored  
proteins  to  their  destinations.  Current  opinion  in  cell  biology,  19,  368-­‐75.  
BORGESE,  N.,  COLOMBO,  S.  &  PEDRAZZINI,  E.  2003.  The  tale  of  tail-­‐anchored  
proteins:  coming  from  the  cytosol  and  looking  for  a  membrane.  The  Journal  
of  cell  biology,  161,  1013-­‐9.  
BORGESE,  N.  &  FASANA,  E.  2011.  Targeting  pathways  of  C-­‐tail-­‐anchored  proteins.  
Biochimica  et  biophysica  acta,  1808,  937-­‐46.  
BORGESE,  N.,  GAZZONI,  I.,  BARBERI,  M.,  COLOMBO,  S.  &  PEDRAZZINI,  E.  2001.  
Targeting  of  a  tail-­‐anchored  protein  to  endoplasmic  reticulum  and  
mitochondrial  outer  membrane  by  independent  but  competing  pathways.  
Molecular  biology  of  the  cell,  12,  2482-­‐96.  
BORGESE,  N.  &  RIGHI,  M.  2010.  Remote  origins  of  tail-­‐anchored  proteins.  Traffic,  11,  
877-­‐85.  
BOUCROT,  E.  &  KIRCHHAUSEN,  T.  2007.  Endosomal  recycling  controls  plasma  
membrane  area  during  mitosis.  Proceedings  of  the  National  Academy  of  
Sciences  of  the  United  States  of  America,  104,  7939-­‐44.  
BOULWARE,  M.  J.  &  MARCHANT,  J.  S.  2008.  Timing  in  Cellular  Ca2+  Signaling.  Current  
Biology,  18,  R769-­‐R776.  
BRAILOIU,  E.,  RAHMAN,  T.,  CHURAMANI,  D.,  PROLE,  D.  L.,  BRAILOIU,  G.  C.,  HOOPER,  
R.,  TAYLOR,  C.  W.  &  PATEL,  S.  2010.  An  NAADP-­‐gated  two-­‐pore  channel  
     248  
targeted  to  the  plasma  membrane  uncouples  triggering  from  amplifying  Ca2+  
signals.  The  Journal  of  biological  chemistry,  285,  38511-­‐6.  
BRAMBILLASCA,  S.,  YABAL,  M.,  MAKAROW,  M.  &  BORGESE,  N.  2006.  Unassisted  
translocation  of  large  polypeptide  domains  across  phospholipid  bilayers.  The  
Journal  of  cell  biology,  175,  767-­‐77.  
BRAMBILLASCA,  S.,  YABAL,  M.,  SOFFIENTINI,  P.,  STEFANOVIC,  S.,  MAKAROW,  M.,  
HEGDE,  R.  S.  &  BORGESE,  N.  2005.  Transmembrane  topogenesis  of  a  tail-­‐
anchored  protein  is  modulated  by  membrane  lipid  composition.  The  EMBO  
journal,  24,  2533-­‐42.  
BRAUNEWELL,  K.  H.  2005.  The  darker  side  of  Ca2+  signaling  by  neuronal  Ca2+-­‐sensor  
proteins:  from  Alzheimer's  disease  to  cancer.  Trends  Pharmacol  Sci,  26,  345-­‐
51.  
BRAUNEWELL,  K.  H.  &  KLEIN-­‐SZANTO,  A.  J.  2009.  Visinin-­‐like  proteins  (VSNLs):  
interaction  partners  and  emerging  functions  in  signal  transduction  of  a  
subfamily  of  neuronal  Ca2+  -­‐sensor  proteins.  Cell  Tissue  Res,  335,  301-­‐16.  
BROWN,  J.  R.  &  AUGER,  K.  R.  2011.  Phylogenomics  of  phosphoinositide  lipid  kinases:  
perspectives  on  the  evolution  of  second  messenger  signaling  and  drug  
discovery.  BMC  evolutionary  biology,  11,  4.  
BRUNET,  F.  G.,  ROEST  CROLLIUS,  H.,  PARIS,  M.,  AURY,  J.  M.,  GIBERT,  P.,  JAILLON,  O.,  
LAUDET,  V.  &  ROBINSON-­‐RECHAVI,  M.  2006.  Gene  loss  and  evolutionary  
rates  following  whole-­‐genome  duplication  in  teleost  fishes.  Molecular  biology  
and  evolution,  23,  1808-­‐1816.  
BULBARELLI,  A.,  SPROCATI,  T.,  BARBERI,  M.,  PEDRAZZINI,  E.  &  BORGESE,  N.  2002.  
Trafficking  of  tail-­‐anchored  proteins:  transport  from  the  endoplasmic  
reticulum  to  the  plasma  membrane  and  sorting  between  surface  domains  in  
polarised  epithelial  cells.  Journal  of  cell  science,  115,  1689-­‐702.  
BURGESS,  W.  H.,  JEMIOLO,  D.  K.  &  KRETSINGER,  R.  H.  1980.  Interaction  of  calcium  
and  calmodulin  in  the  presence  of  sodium  dodecyl  sulfate.  Biochimica  et  
biophysica  acta,  623,  257-­‐70.  
BURGOYNE,  R.  2004.  The  neuronal  calcium-­‐sensor  proteins.  Biochim  Biophys  Acta,  
1742,  59-­‐68.  
     249  
BURGOYNE,  R.  D.  2007.  Neuronal  calcium  sensor  proteins:  Generating  diversity  in  
neuronal  Ca  2+  signalling.  Nature  Reviews  Neuroscience,  8,  182-­‐193.  
BURGOYNE,  R.  D.,  O'CALLAGHAN,  D.  W.,  HASDEMIR,  B.,  HAYNES,  L.  P.  &  TEPIKIN,  A.  
V.  2004.  Neuronal  Ca2+-­‐sensor  proteins:  multitalented  regulators  of  neuronal  
function.  Trends  Neurosci,  27,  203-­‐9.  
BURGOYNE,  R.  D.  &  WEISS,  J.  L.  2001.  The  neuronal  calcium  sensor  family  of  Ca2+-­‐
binding  proteins.  Biochem  J,  353,  1-­‐12.  
BUTT,  T.  R.,  EDAVETTAL,  S.  C.,  HALL,  J.  P.  &  MATTERN,  M.  R.  2005.  SUMO  fusion  
technology  for  difficult-­‐to-­‐express  proteins.  Protein  expression  and  
purification,  43,  1-­‐9.  
BUXBAUM,  J.  D.,  CHOI,  E.  K.,  LUO,  Y.,  LILLIEHOOK,  C.,  CROWLEY,  A.  C.,  MERRIAM,  D.  
E.  &  WASCO,  W.  1998.  Calsenilin:  A  calcium-­‐binding  protein  that  interacts  
with  the  presenilins  and  regulates  the  levels  of  a  presenilin  fragment.  Nature  
medicine,  4,  1177-­‐1181.  
CALCRAFT,  P.  J.,  RUAS,  M.,  PAN,  Z.,  CHENG,  X.,  ARREDOUANI,  A.,  HAO,  X.,  TANG,  J.,  
RIETDORF,  K.,  TEBOUL,  L.,  CHUANG,  K.  T.,  LIN,  P.,  XIAO,  R.,  WANG,  C.,  ZHU,  Y.,  
LIN,  Y.,  WYATT,  C.  N.,  PARRINGTON,  J.,  MA,  J.,  EVANS,  A.  M.,  GALIONE,  A.  &  
ZHU,  M.  X.  2009.  NAADP  mobilizes  calcium  from  acidic  organelles  through  
two-­‐pore  channels.  Nature,  459,  596-­‐600.  
CANDE,  W.  Z.  1980.  A  permeabilized  cell  model  for  studying  cytokinesis  using  
mammalian  tissue  culture  cells.  The  Journal  of  cell  biology,  87,  326-­‐35.  
CATTERALL,  W.  A.  2000.  Structure  and  regulation  of  voltage-­‐gated  Ca2+  channels.  
Annual  review  of  cell  and  developmental  biology,  16,  521-­‐55.  
CATTERALL,  W.  A.  &  FEW,  A.  P.  2008.  Calcium  channel  regulation  and  presynaptic  
plasticity.  Neuron,  59,  882-­‐901.  
CAVANAGH,  J.,  FAIRBROTHER,  W.  J.,  PALMER  III,  A.  G.,  RANCE,  M.  &  SKELTON,  N.  J.  
2007a.  Classical  NMR  spectroscopy.  Protein  NMR  Spectroscopy  (Second  
Edition).  Burlington:  Academic  Press.  
CAVANAGH,  J.,  FAIRBROTHER,  W.  J.,  PALMER  III,  A.  G.,  RANCE,  M.  &  SKELTON,  N.  J.  
2007b.  Multidimensional  NMR  spectroscopy.  Protein  NMR  Spectroscopy  
(Second  Edition).  Burlington:  Academic  Press.  
     250  
CAVANAGH,  J.,  FAIRBROTHER,  W.  J.,  PALMER  III,  A.  G.,  RANCE,  M.  &  SKELTON,  N.  J.  
2007c.  Relaxation  and  dynamic  processes.  Protein  NMR  Spectroscopy  (Second  
Edition).  Burlington:  Academic  Press.  
CHANDRA,  K.,  RAMAKRISHNAN,  V.,  SHARMA,  Y.  &  CHARY,  K.  V.  2011.  N-­‐terminal  
myristoylation  alters  the  calcium  binding  pathways  in  neuronal  calcium  
sensor-­‐1.  J  Biol  Inorg  Chem,  16,  81-­‐95.  
CHATTOPADHYAYA,  R.,  MEADOR,  W.  E.,  MEANS,  A.  R.  &  QUIOCHO,  F.  A.  1992.  
Calmodulin  structure  refined  at  1.7  A  resolution.  Journal  of  molecular  biology,  
228,  1177-­‐92.  
CHEN,  C.  K.,  INGLESE,  J.,  LEFKOWITZ,  R.  J.  &  HURLEY,  J.  B.  1995a.  Ca2+-­‐dependent  
interaction  of  recoverin  with  rhodopsin  kinase.  Journal  of  Biological  
Chemistry,  270,  18060-­‐18066.  
CHEN,  J.,  MAKINO,  C.  L.,  PEACHEY,  N.  S.,  BAYLOR,  D.  A.  &  SIMON,  M.  I.  1995b.  
Mechanisms  of  rhodopsin  inactivation  in  vivo  as  revealed  by  a  COOH-­‐
Terminal  truncation  mutant.  Science,  267,  374-­‐377.  
CHEUNG,  M.  S.,  MAGUIRE,  M.  L.,  STEVENS,  T.  J.  &  BROADHURST,  R.  W.  2010.  
DANGLE:  A  Bayesian  inferential  method  for  predicting  protein  backbone  
dihedral  angles  and  secondary  structure.  Journal  of  magnetic  resonance,  202,  
223-­‐33.  
CHIN,  D.  &  MEANS,  A.  R.  2000.  Calmodulin:  A  prototypical  calcium  sensor.  Trends  in  
cell  biology,  10,  322-­‐328.  
CHOI,  D.  W.  1988.  Calcium-­‐mediated  neurotoxicity:  Relationship  to  specific  channel  
types  and  role  in  ischemic  damage.  Trends  in  neurosciences,  11,  465-­‐469.  
CLAPHAM,  D.  E.  2007.  Calcium  Signaling.  Cell,  131,  1047-­‐1058.  
COOKE,  R.  M.  1997.  Protein  NMR  extends  into  new  fields  of  structural  biology.  
Current  opinion  in  chemical  biology,  1,  359-­‐64.  
COUKELL,  B.,  CAMERON,  A.,  PERUSINI,  S.  &  SHIM,  K.  2004.  Disruption  of  the  NCS-­‐
1/frequenin-­‐related  ncsA  gene  in  Dictyostelium  discoideum  accelerates  
development.  Dev  Growth  Differ,  46,  449-­‐58.  
CRANKSHAW,  M.  W.  &  GRANT,  G.  A.  2001.  Modification  of  cysteine.  Current  
protocols  in  protein  science  /  editorial  board,  John  E.  Coligan  ...  [et  al.],  
Chapter  15,  Unit15  1.  
     251  
CUI,  G.,  MEYER,  A.  C.,  CALIN-­‐JAGEMAN,  I.,  NEEF,  J.,  HAESELEER,  F.,  MOSER,  T.  &  LEE,  
A.  2007.  Ca2+-­‐binding  proteins  tune  Ca2+-­‐feedback  to  Cav1.3  channels  in  
mouse  auditory  hair  cells.  J  Physiol,  585,  791-­‐803.  
DE  BARRY,  J.,  JANOSHAZI,  A.,  DUPONT,  J.  L.,  PROCKSCH,  O.,  CHASSEROT-­‐GOLAZ,  S.,  
JEROMIN,  A.  &  VITALE,  N.  2006.  Functional  implication  of  neuronal  calcium  
sensor-­‐1  and  phosphoinositol  4-­‐kinase-­‐beta  interaction  in  regulated  
exocytosis  of  PC12  cells.  J  Biol  Chem,  281,  18098-­‐111.  
DECORDIER,  I.,  CUNDARI,  E.  &  KIRSCH-­‐VOLDERS,  M.  2008.  Mitotic  checkpoints  and  
the  maintenance  of  the  chromosome  karyotype.  Mutation  research,  651,  3-­‐
13.  
DELL'ANGELICA,  E.  C.,  SHOTELERSUK,  V.,  AGUILAR,  R.  C.,  GAHL,  W.  A.  &  BONIFACINO,  
J.  S.  1999.  Altered  trafficking  of  lysosomal  proteins  in  Hermansky-­‐Pudlak  
syndrome  due  to  mutations  in  the  beta  3A  subunit  of  the  AP-­‐3  adaptor.  
Molecular  cell,  3,  11-­‐21.  
DIETERICH,  D.  C.,  KARPOVA,  A.,  MIKHAYLOVA,  M.,  ZDOBNOVA,  I.,  KONIG,  I.,  
LANDWEHR,  M.,  KREUTZ,  M.,  SMALLA,  K.  H.,  RICHTER,  K.,  LANDGRAF,  P.,  
REISSNER,  C.,  BOECKERS,  T.  M.,  ZUSCHRATTER,  W.,  SPILKER,  C.,  
SEIDENBECHER,  C.  I.,  GARNER,  C.  C.,  GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  
2008.  Caldendrin-­‐Jacob:  a  protein  liaison  that  couples  NMDA  receptor  
signalling  to  the  nucleus.  PLoS  Biol,  6,  e34.  
DIZHOOR,  A.  M.,  RAY,  S.,  KUMAR,  S.,  NIEMI,  G.,  SPENCER,  M.,  BROLLEY,  D.,  WALSH,  
K.  A.,  PHILIPOV,  P.  P.,  HURLEY,  J.  B.  &  STRYER,  L.  1991.  Recoverin:  A  calcium  
sensitive  activator  of  retinal  rod  guanylate  cyclase.  Science,  251,  915-­‐918.  
DONATO,  R.  2001.  S100:  a  multigenic  family  of  calcium-­‐modulated  proteins  of  the  
EF-­‐hand  type  with  intracellular  and  extracellular  functional  roles.  The  
international  journal  of  biochemistry  &  cell  biology,  33,  637-­‐668.  
DUKES,  J.  D.,  RICHARDSON,  J.  D.,  SIMMONS,  R.  &  WHITLEY,  P.  2008.  A  dominant-­‐
negative  ESCRT-­‐III  protein  perturbs  cytokinesis  and  trafficking  to  lysosomes.  
The  Biochemical  journal,  411,  233-­‐9.  
DUNDR,  M.  &  MISTELI,  T.  2001.  Functional  architecture  in  the  cell  nucleus.  The  
Biochemical  journal,  356,  297-­‐310.  
     252  
EMMANOUILIDOU,  E.,  TESCHEMACHER,  A.  G.,  POULI,  A.  E.,  NICHOLLS,  L.  I.,  SEWARD,  
E.  P.  &  RUTTER,  G.  A.  1999.  Imaging  Ca2+  concentration  changes  at  the  
secretory  vesicle  surface  with  a  recombinant  targeted  cameleon.  Current  
biology  :  CB,  9,  915-­‐8.  
FADER,  C.  M.,  SANCHEZ,  D.  G.,  MESTRE,  M.  B.  &  COLOMBO,  M.  I.  2009.  TI-­‐
VAMP/VAMP7  and  VAMP3/cellubrevin:  two  v-­‐SNARE  proteins  involved  in  
specific  steps  of  the  autophagy/multivesicular  body  pathways.  Biochimica  et  
biophysica  acta,  1793,  1901-­‐16.  
FALCONE,  D.,  HENDERSON,  M.  P.,  NIEUWLAND,  H.,  COUGHLAN,  C.  M.,  BRODSKY,  J.  L.  
&  ANDREWS,  D.  W.  2011.  Stability  and  function  of  the  Sec61  translocation  
complex  depends  on  the  Sss1p  tail-­‐anchor  sequence.  The  Biochemical  
journal,  436,  291-­‐303.  
FATIMATHAS,  L.  &  MOSS,  S.  E.  2010.  Annexins  as  disease  modifiers.  Histology  and  
histopathology,  25,  527-­‐32.  
FAUROBERT,  E.,  CHEN,  C.  K.,  HURLEY,  J.  B.  &  TENG,  D.  H.  1996.  Drosophila  
neurocalcin,  a  fatty  acylated,  Ca2+-­‐binding  protein  that  associates  with  
membranes  and  inhibits  in  vitro  phosphorylation  of  bovine  rhodopsin.  The  
Journal  of  biological  chemistry,  271,  10256-­‐62.  
FAVALORO,  V.,  VILARDI,  F.,  SCHLECHT,  R.,  MAYER,  M.  P.  &  DOBBERSTEIN,  B.  2010.  
Asna1/TRC40-­‐mediated  membrane  insertion  of  tail-­‐anchored  proteins.  
Journal  of  cell  science,  123,  1522-­‐30.  
FELDMANN,  A.,  WINTERSTEIN,  C.,  WHITE,  R.,  TROTTER,  J.  &  KRAMER-­‐ALBERS,  E.  M.  
2009.  Comprehensive  analysis  of  expression,  subcellular  localization,  and  
cognate  pairing  of  SNARE  proteins  in  oligodendrocytes.  Journal  of  
neuroscience  research,  87,  1760-­‐72.  
FERIC,  M.,  ZHAO,  B.,  HOFFERT,  J.  D.,  PISITKUN,  T.  &  KNEPPER,  M.  A.  2011.  Large-­‐scale  
phosphoproteomic  analysis  of  membrane  proteins  in  renal  proximal  and  
distal  tubule.  American  journal  of  physiology.  Cell  physiology,  300,  C755-­‐70.  
FEW,  A.  P.,  LAUTERMILCH,  N.  J.,  WESTENBROEK,  R.  E.,  SCHEUER,  T.  &  CATTERALL,  W.  
A.  2005.  Differential  regulation  of  CaV2.1  channels  by  calcium-­‐binding  
protein  1  and  visinin-­‐like  protein-­‐2  requires  N-­‐terminal  myristoylation.  J  
Neurosci,  25,  7071-­‐80.  
     253  
FINDEISEN,  F.  &  MINOR,  D.  L.,  JR.  2010.  Structural  basis  for  the  differential  effects  of  
CaBP1  and  calmodulin  on  Ca(V)1.2  calcium-­‐dependent  inactivation.  Structure,  
18,  1617-­‐31.  
FINGER,  F.  P.  &  WHITE,  J.  G.  2002.  Fusion  and  fission:  membrane  trafficking  in  animal  
cytokinesis.  Cell,  108,  727-­‐30.  
FITZGERALD,  D.  J.,  BURGOYNE,  R.  D.  &  HAYNES,  L.  P.  2008.  Neuronal  calcium  sensor  
proteins  are  unable  to  modulate  NFAT  activation  in  mammalian  cells.  Biochim  
Biophys  Acta,  1780,  240-­‐8.  
FLAHERTY,  K.  M.,  ZOZULYA,  S.,  STRYER,  L.  &  MCKAY,  D.  B.  1993.  Three-­‐dimensional  
structure  of  recoverin,  a  calcium  sensor  in  vision.  Cell,  75,  709-­‐716.  
FRANKLIN,  J.  L.  &  JOHNSON  JR,  E.  M.  1992.  Suppression  of  programmed  neuronal  
death  by  sustained  elevation  of  cytoplasmic  calcium.  Trends  in  neurosciences,  
15,  501-­‐508.  
FRANSSON,  S.,  RUUSALA,  A.  &  ASPENSTROM,  P.  2006.  The  atypical  Rho  GTPases  
Miro-­‐1  and  Miro-­‐2  have  essential  roles  in  mitochondrial  trafficking.  
Biochemical  and  biophysical  research  communications,  344,  500-­‐10.  
FRIEDBERG,  F.  &  RHOADS,  A.  R.  2001.  Evolutionary  aspects  of  calmodulin.  IUBMB  
life,  51,  215-­‐221.  
FRIES,  R.,  REDDY,  P.  P.,  MIKHAYLOVA,  M.,  HAVERKAMP,  S.,  WEI,  T.,  MULLER,  M.,  
KREUTZ,  M.  R.  &  KOCH,  K.  W.  2010.  Dynamic  cellular  translocation  of  
caldendrin  is  facilitated  by  the  Ca2+-­‐myristoyl  switch  of  recoverin.  J  
Neurochem,  113,  1150-­‐62.  
GALIONE,  A.,  MORGAN,  A.  J.,  ARREDOUANI,  A.,  DAVIS,  L.  C.,  RIETDORF,  K.,  RUAS,  M.  
&  PARRINGTON,  J.  2010.  NAADP  as  an  intracellular  messenger  regulating  
lysosomal  calcium-­‐release  channels.  Biochemical  Society  transactions,  38,  
1424-­‐31.  
GERASIMENKO,  J.  V.,  GERASIMENKO,  O.  V.  &  PETERSEN,  O.  H.  2001.  Membrane  
repair:  Ca(2+)-­‐elicited  lysosomal  exocytosis.  Current  biology  :  CB,  11,  R971-­‐4.  
GERASIMENKO,  O.  &  TEPIKIN,  A.  2005.  How  to  measure  Ca2+  in  cellular  organelles?  
Cell  calcium,  38,  201-­‐11.  
GHOSH,  A.  &  GREENBERG,  M.  E.  1995.  Calcium  signalling  in  neurons:  Molecular  
mechanisms  and  cellular  consequences.  Science,  268,  239-­‐247.  
     254  
GIANSANTI,  M.  G.,  BELLONI,  G.  &  GATTI,  M.  2007.  Rab11  is  required  for  membrane  
trafficking  and  actomyosin  ring  constriction  in  meiotic  cytokinesis  of  
Drosophila  males.  Molecular  biology  of  the  cell,  18,  5034-­‐47.  
GIFFORD,  J.  L.,  ISHIDA,  H.  &  VOGEL,  H.  J.  2011.  Fast  methionine-­‐based  solution  
structure  determination  of  calcium-­‐calmodulin  complexes.  Journal  of  
biomolecular  NMR,  50,  71-­‐81.  
GIFFORD,  J.  L.,  WALSH,  M.  P.  &  VOGEL,  H.  J.  2007.  Structures  and  metal-­‐ion-­‐binding  
properties  of  the  Ca2+-­‐binding  helix-­‐loop-­‐helix  EF-­‐hand  motifs.  Biochemical  
Journal,  405,  199-­‐221.  
GOLOVANOV,  A.  P.,  HAUTBERGUE,  G.  M.,  WILSON,  S.  A.  &  LIAN,  L.  Y.  2004.  A  simple  
method  for  improving  protein  solubility  and  long-­‐term  stability.  Journal  of  the  
American  Chemical  Society,  126,  8933-­‐9.  
GOMEZ,  M.,  DE  CASTRO,  E.,  GUARIN,  E.,  SASAKURA,  H.,  KUHARA,  A.,  MORI,  I.,  
BARTFAI,  T.,  BARGMANN,  C.  I.  &  NEF,  P.  2001.  Ca2+  signaling  via  the  neuronal  
calcium  sensor-­‐1  regulates  associative  learning  and  memory  in  C.  elegans.  
Neuron,  30,  241-­‐8.  
GORDON,  D.  E.,  BOND,  L.  M.,  SAHLENDER,  D.  A.  &  PEDEN,  A.  A.  2010.  A  targeted  
siRNA  screen  to  identify  SNAREs  required  for  constitutive  secretion  in  
mammalian  cells.  Traffic,  11,  1191-­‐204.  
GOSS,  J.  W.  &  TOOMRE,  D.  K.  2008.  Both  daughter  cells  traffic  and  exocytose  
membrane  at  the  cleavage  furrow  during  mammalian  cytokinesis.  The  Journal  
of  cell  biology,  181,  1047-­‐54.  
GRABAREK,  Z.  2006.  Structural  Basis  for  Diversity  of  the  EF-­‐hand  Calcium-­‐binding  
Proteins.  Journal  of  Molecular  Biology,  359,  509-­‐525.  
GRAHAM,  T.  R.  &  BURD,  C.  G.  2011.  Coordination  of  Golgi  functions  by  
phosphatidylinositol  4-­‐kinases.  Trends  in  cell  biology,  21,  113-­‐21.  
HAESELEER,  F.  2008.  Interaction  and  colocalization  of  CaBP4  and  Unc119  (MRG4)  in  
photoreceptors.  Invest  Ophthalmol  Vis  Sci,  49,  2366-­‐75.  
HAESELEER,  F.,  IMANISHI,  Y.,  MAEDA,  T.,  POSSIN,  D.  E.,  MAEDA,  A.,  LEE,  A.,  RIEKE,  F.  
&  PALCZEWSKI,  K.  2004.  Essential  role  of  Ca2+-­‐binding  protein  4,  a  Cav1.4  
channel  regulator,  in  photoreceptor  synaptic  function.  Nat  Neurosci,  7,  1079-­‐
87.  
     255  
HAESELEER,  F.,  IMANISHI,  Y.,  SOKAL,  I.,  FILIPEK,  S.  &  PALCZEWSKI,  K.  2002.  Calcium-­‐
binding  proteins:  intracellular  sensors  from  the  calmodulin  superfamily.  
Biochemical  and  biophysical  research  communications,  290,  615-­‐623.  
HAESELEER,  F.,  SOKAL,  I.,  VERLINDE,  C.  L.,  ERDJUMENT-­‐BROMAGE,  H.,  TEMPST,  P.,  
PRONIN,  A.  N.,  BENOVIC,  J.  L.,  FARISS,  R.  N.  &  PALCZEWSKI,  K.  2000.  Five  
members  of  a  novel  Ca(2+)-­‐binding  protein  (CABP)  subfamily  with  similarity  
to  calmodulin.  J  Biol  Chem,  275,  1247-­‐60.  
HALESTRAP,  A.  P.  2009.  What  is  the  mitochondrial  permeability  transition  pore?  
Journal  of  Molecular  and  Cellular  Cardiology,  46,  821-­‐831.  
HASDEMIR,  B.,  FITZGERALD,  D.  J.,  PRIOR,  I.  A.,  TEPIKIN,  A.  V.  &  BURGOYNE,  R.  D.  
2005.  Traffic  of  Kv4  K+  channels  mediated  by  KChIP1  is  via  a  novel  post-­‐ER  
vesicular  pathway.  The  Journal  of  cell  biology,  171,  459-­‐69.  
HAYNES,  L.  P.  &  BURGOYNE,  R.  D.  2008.  Unexpected  tails  of  a  Ca2+  sensor.  Nature  
chemical  biology,  4,  90-­‐1.  
HAYNES,  L.  P.,  FITZGERALD,  D.  J.,  WAREING,  B.,  O'CALLAGHAN,  D.  W.,  MORGAN,  A.  &  
BURGOYNE,  R.  D.  2006.  Analysis  of  the  interacting  partners  of  the  neuronal  
calcium-­‐binding  proteins  L-­‐CaBP1,  hippocalcin,  NCS-­‐1  and  neurocalcin  delta.  
Proteomics,  6,  1822-­‐32.  
HAYNES,  L.  P.,  SHERWOOD,  M.  W.,  DOLMAN,  N.  J.  &  BURGOYNE,  R.  D.  2007.  
Specificity,  promiscuity  and  localization  of  ARF  protein  interactions  with  NCS-­‐
1  and  phosphatidylinositol-­‐4  kinase-­‐III  beta.  Traffic,  8,  1080-­‐92.  
HAYNES,  L.  P.,  TEPIKIN,  A.  V.  &  BURGOYNE,  R.  D.  2004.  Calcium-­‐binding  protein  1  is  
an  inhibitor  of  agonist-­‐evoked,  inositol  1,4,5-­‐trisphosphate-­‐mediated  calcium  
signaling.  J  Biol  Chem,  279,  547-­‐55.  
HAYNES,  L.  P.,  THOMAS,  G.  M.  &  BURGOYNE,  R.  D.  2005.  Interaction  of  neuronal  
calcium  sensor-­‐1  and  ADP-­‐ribosylation  factor  1  allows  bidirectional  control  of  
phosphatidylinositol  4-­‐kinase  beta  and  trans-­‐Golgi  network-­‐plasma  
membrane  traffic.  J  Biol  Chem,  280,  6047-­‐54.  
HENDRICKS,  K.  B.,  WANG,  B.  Q.,  SCHNIEDERS,  E.  A.  &  THORNER,  J.  1999.  Yeast  
homologue  of  neuronal  frequenin  is  a  regulator  of  phosphatidylinosrtol-­‐4-­‐OH  
kinase.  Nature  cell  biology,  1,  234-­‐241.  
HEPLER,  P.  K.  1994.  The  role  of  calcium  in  cell  division.  Cell  calcium,  16,  322-­‐30.  
     256  
HILFIKER,  S.  2003.  Neuronal  calcium  sensor-­‐1:  a  multifunctional  regulator  of  
secretion.  Biochem  Soc  Trans,  31,  828-­‐32.  
HILL,  J.  M.  2008.  NMR  screening  for  rapid  protein  characterization  in  structural  
proteomics.  Methods  in  molecular  biology,  426,  437-­‐46.  
HOBSON,  K.  F.,  HOUSLEY,  N.  A.  &  PEDIGO,  S.  2005.  Ligand-­‐linked  stability  of  mutants  
of  the  C-­‐domain  of  calmodulin.  Biophysical  chemistry,  114,  43-­‐52.  
HONG,  W.  2005.  SNAREs  and  traffic.  Biochimica  et  biophysica  acta,  1744,  120-­‐44.  
HONSHO,  M.,  MITOMA,  J.  Y.  &  ITO,  A.  1998.  Retention  of  cytochrome  b5  in  the  
endoplasmic  reticulum  is  transmembrane  and  luminal  domain-­‐dependent.  
The  Journal  of  biological  chemistry,  273,  20860-­‐6.  
HOOK,  S.  S.  &  MEANS,  A.  R.  2001.  Ca2+/CaM-­‐Dependent  kinases:  From  activation  to  
function.  
HOPKINS  JR,  H.  P.  &  GAYDEN,  R.  H.  1989.  Comparison  of  Ca2+  and  Mg2+  binding  to  
calmodulin.  An  enthalpy,  entropy,  and  gibbs  free  energy  analysis.  Journal  of  
Solution  Chemistry,  18,  743-­‐757.  
HORNE,  W.  A.,  ELLINOR,  P.  T.,  INMAN,  I.,  ZHOU,  M.,  TSIEN,  R.  W.  &  SCHWARZ,  T.  L.  
1993.  Molecular  diversity  of  Ca2+  channel  alpha  1  subunits  from  the  marine  
ray  Discopyge  ommata.  Proceedings  of  the  National  Academy  of  Sciences  of  
the  United  States  of  America,  90,  3787-­‐3791.  
HRADSKY,  J.,  RAGHURAM,  V.,  REDDY,  P.  P.,  NAVARRO,  G.,  HUPE,  M.,  CASADO,  V.,  
MCCORMICK,  P.  J.,  SHARMA,  Y.,  KREUTZ,  M.  R.  &  MIKHAYLOVA,  M.  2011.  
Posttranslational  membrane  insertion  of  the  tail  anchored  transmembrane  
EF-­‐hand  Ca2+-­‐sensors  Calneurons  requires  the  TRC40/Asna1  chaperone.  The  
Journal  of  biological  chemistry.  
HUBBARD,  M.  J.  &  KLEE,  C.  B.  1987.  Calmodulin  binding  by  calcineurin.  Ligand-­‐
induced  renaturation  of  protein  immobilized  on  nitrocellulose.  Journal  of  
Biological  Chemistry,  262,  15062-­‐15070.  
IKURA,  M.  &  AMES,  J.  B.  2006.  Genetic  polymorphism  and  protein  conformational  
plasticity  in  the  calmodulin  superfamily:  Two  ways  to  promote  
multifunctionality.  Proceedings  of  the  National  Academy  of  Sciences  of  the  
United  States  of  America,  103,  1159-­‐1164.  
     257  
IWASAKI,  H.,  CHIBA,  K.,  UCHIYAMA,  T.,  YOSHIKAWA,  F.,  SUZUKI,  F.,  IKEDA,  M.,  
FURUICHI,  T.  &  MIKOSHIBA,  K.  2002.  Molecular  characterization  of  the  
starfish  inositol  1,4,5-­‐trisphosphate  receptor  and  its  role  during  oocyte  
maturation  and  fertilization.  The  Journal  of  biological  chemistry,  277,  2763-­‐
2772.  
JAILLON,  O.,  AURY,  J.  M.,  BRUNET,  F.,  PETIT,  J.  L.,  STANGE-­‐THOMANN,  N.,  MAUCELI,  
E.,  BOUNEAU,  L.,  FISCHER,  C.,  OZOUF-­‐COSTAZ,  C.,  BERNOT,  A.,  NICAUD,  S.,  
JAFFE,  D.,  FISHER,  S.,  LUTFALLA,  G.,  DOSSAT,  C.,  SEGURENS,  B.,  DASILVA,  C.,  
SALANOUBAT,  M.,  LEVY,  M.,  BOUDET,  N.,  CASTELLANO,  S.,  ANTHOUARD,  V.,  
JUBIN,  C.,  CASTELLI,  V.,  KATINKA,  M.,  VACHERIE,  B.,  BIEMONT,  C.,  SKALLI,  Z.,  
CATTOLICO,  L.,  POULAIN,  J.,  DE  BERARDINIS,  V.,  CRUAUD,  C.,  DUPRAT,  S.,  
BROTTIER,  P.,  COUTANCEAU,  J.  P.,  GOUZY,  J.,  PARRA,  G.,  LARDIER,  G.,  
CHAPPLE,  C.,  MCKERNAN,  K.  J.,  MCEWAN,  P.,  BOSAK,  S.,  KELLIS,  M.,  VOLFF,  J.  
N.,  GUIGO,  R.,  ZODY,  M.  C.,  MESIROV,  J.,  LINDBLAD-­‐TOH,  K.,  BIRREN,  B.,  
NUSBAUM,  C.,  KAHN,  D.,  ROBINSON-­‐RECHAVI,  M.,  LAUDET,  V.,  SCHACHTER,  
V.,  QUETIER,  F.,  SAURIN,  W.,  SCARPELLI,  C.,  WINCKER,  P.,  LANDER,  E.  S.,  
WEISSENBACH,  J.  &  ROEST  CROLLIUS,  H.  2004.  Genome  duplication  in  the  
teleost  fish  Tetraodon  nigroviridis  reveals  the  early  vertebrate  proto-­‐
karyotype.  Nature,  431,  946-­‐957.  
JANTSCH-­‐PLUNGER,  V.  &  GLOTZER,  M.  1999.  Depletion  of  syntaxins  in  the  early  
Caenorhabditis  elegans  embryo  reveals  a  role  for  membrane  fusion  events  in  
cytokinesis.  Current  biology  :  CB,  9,  738-­‐45.  
JEZIORSKI,  M.  C.,  GREENBERG,  R.  M.  &  ANDERSON,  P.  A.  2000.  The  molecular  biology  
of  invertebrate  voltage-­‐gated  Ca(2+)  channels.  The  Journal  of  experimental  
biology,  203,  841-­‐856.  
JO,  D.  G.,  LEE,  J.  Y.,  HONG,  Y.  M.,  SONG,  S.,  INHEE,  M.  J.,  KOH,  J.  Y.  &  JUNG,  Y.  K.  
2004.  Induction  of  pro-­‐apoptotic  calsenilin/DREAM/KChIP3  in  Alzheimer's  
disease  and  cultured  neurons  after  amyloid-­‐?????????????Journal  of  
neurochemistry,  88,  604-­‐611.  
KABBANI,  N.,  NEGYESSY,  L.,  LIN,  R.,  GOLDMAN-­‐RAKIC,  P.  &  LEVENSON,  R.  2002.  
Interaction  with  neuronal  calcium  sensor  NCS-­‐1  mediates  desensitization  of  
the  D2  dopamine  receptor.  J  Neurosci,  22,  8476-­‐86.  
     258  
KABBANI,  N.,  WOLL,  M.  P.,  NORDMAN,  J.  C.  &  LEVENSON,  R.  2011.  Dopamine  
Receptor  Interacting  Proteins:  Targeting  Neuronal  Calcium  Sensor-­‐1/D2  
Dopamine  Receptor  Interaction  for  Antipsychotic  Drug  Development.  Curr  
Drug  Targets.  
KALBFLEISCH,  T.,  CAMBON,  A.  &  WATTENBERG,  B.  W.  2007.  A  bioinformatics  
approach  to  identifying  tail-­‐anchored  proteins  in  the  human  genome.  Traffic,  
8,  1687-­‐94.  
KARABINOS,  A.  &  BHATTACHARYA,  D.  2000.  Molecular  evolution  of  calmodulin  and  
calmodulin-­‐like  genes  in  the  cephalochordate  Branchiostoma.  Journal  of  
Molecular  Evolution,  51,  141-­‐148.  
KASRI,  N.  N.,  HOLMES,  A.  M.,  BULTYNCK,  G.,  PARYS,  J.  B.,  BOOTMAN,  M.  D.,  
RIETDORF,  K.,  MISSIAEN,  L.,  MCDONALD,  F.,  DE  SMEDT,  H.,  CONWAY,  S.  J.,  
HOLMES,  A.  B.,  BERRIDGE,  M.  J.  &  RODERICK,  H.  L.  2004.  Regulation  of  InsP3  
receptor  activity  by  neuronal  Ca2+-­‐binding  proteins.  EMBO  J,  23,  312-­‐21.  
KASRI,  N.  N.,  SIENAERT,  I.,  PARYS,  J.  B.,  CALLEWAERT,  G.,  MISSIAEN,  L.,  JEROMIN,  A.  
&  DE  SMEDT,  H.  2003.  A  novel  Ca2+-­‐induced  Ca2+  release  mechanism  in  A7r5  
cells  regulated  by  calmodulin-­‐like  proteins.  The  Journal  of  biological  
chemistry,  278,  27548-­‐55.  
KIM,  P.  K.,  JANIAK-­‐SPENS,  F.,  TRIMBLE,  W.  S.,  LEBER,  B.  &  ANDREWS,  D.  W.  1997.  
Evidence  for  multiple  mechanisms  for  membrane  binding  and  integration  via  
carboxyl-­‐terminal  insertion  sequences.  Biochemistry,  36,  8873-­‐82.  
KINOSHITA-­‐KAWADA,  M.,  TANG,  J.,  XIAO,  R.,  KANEKO,  S.,  FOSKETT,  J.  K.  &  ZHU,  M.  X.  
2005.  Inhibition  of  TRPC5  channels  by  Ca2+-­‐binding  protein  1  in  Xenopus  
oocytes.  Pflugers  Arch,  450,  345-­‐54.  
KLEBER-­‐JANKE,  T.  &  BECKER,  W.  M.  2000.  Use  of  modified  BL21(DE3)  Escherichia  coli  
cells  for  high-­‐level  expression  of  recombinant  peanut  allergens  affected  by  
poor  codon  usage.  Protein  expression  and  purification,  19,  419-­‐24.  
KLENCHIN,  V.  A.,  CALVERT,  P.  D.  &  BOWNDS,  M.  D.  1995.  Inhibition  of  rhodopsin  
kinase  by  recoverin.  Further  evidence  for  a  negative  feedback  system  in  
phototransduction.  Journal  of  Biological  Chemistry,  270,  16147-­‐16152.  
KOH,  P.  O.,  UNDIE,  A.  S.,  KABBANI,  N.,  LEVENSON,  R.,  GOLDMAN-­‐RAKIC,  P.  S.  &  
LIDOW,  M.  S.  2003.  Up-­‐regulation  of  neuronal  calcium  sensor-­‐1  (NCS-­‐1)  in  the  
     259  
prefrontal  cortex  of  schizophrenic  and  bipolar  patients.  Proc  Natl  Acad  Sci  U  S  
A,  100,  313-­‐7.  
KORDEL,  J.,  SKELTON,  N.  J.,  AKKE,  M.  &  CHAZIN,  W.  J.  1993.  High-­‐resolution  solution  
structure  of  calcium-­‐loaded  calbindin  D(9k).  Journal  of  Molecular  Biology,  
231,  711-­‐734.  
KOURIE,  J.  I.  &  WOOD,  H.  B.  2000.  Biophysical  and  molecular  properties  of  annexin-­‐
formed  channels.  Progress  in  biophysics  and  molecular  biology,  73,  91-­‐134.  
KUO,  H.  C.,  CHENG,  C.  F.,  CLARK,  R.  B.,  LIN,  J.  J.,  LIN,  J.  L.,  HOSHIJIMA,  M.,  NGUYEN-­‐
TRAN,  V.  T.,  GU,  Y.,  IKEDA,  Y.,  CHU,  P.  H.,  ROSS,  J.,  GILES,  W.  R.  &  CHIEN,  K.  R.  
2001.  A  defect  in  the  Kv  channel-­‐interacting  protein  2  (KChIP2)  gene  leads  to  
a  complete  loss  of  I(to)  and  confers  susceptibility  to  ventricular  tachycardia.  
Cell,  107,  801-­‐13.  
KURODA,  R.,  KINOSHITA,  J.,  HONSHO,  M.,  MITOMA,  J.  &  ITO,  A.  1996.  In  situ  
topology  of  cytochrome  b5  in  the  endoplasmic  reticulum  membrane.  Journal  
of  biochemistry,  120,  828-­‐33.  
KUTAY,  U.,  AHNERT-­‐HILGER,  G.,  HARTMANN,  E.,  WIEDENMANN,  B.  &  RAPOPORT,  T.  
A.  1995.  Transport  route  for  synaptobrevin  via  a  novel  pathway  of  insertion  
into  the  endoplasmic  reticulum  membrane.  The  EMBO  journal,  14,  217-­‐23.  
KUTAY,  U.,  HARTMANN,  E.  &  RAPOPORT,  T.  A.  1993.  A  class  of  membrane  proteins  
with  a  C-­‐terminal  anchor.  Trends  in  cell  biology,  3,  72-­‐5.  
KYTE,  J.  &  DOOLITTLE,  R.  F.  1982.  A  simple  method  for  displaying  the  hydropathic  
character  of  a  protein.  Journal  of  molecular  biology,  157,  105-­‐32.  
LAMBRECHT,  H.  G.  &  KOCH,  K.  W.  1992.  Recoverin,  a  novel  calcium-­‐binding  protein  
from  vertebrate  photoreceptors.  Biochimica  et  biophysica  acta,  1160,  63-­‐6.  
LAUBE,  G.,  SEIDENBECHER,  C.  I.,  RICHTER,  K.,  DIETERICH,  D.  C.,  HOFFMANN,  B.,  
LANDWEHR,  M.,  SMALLA,  K.  H.,  WINTER,  C.,  BOCKERS,  T.  M.,  WOLF,  G.,  
GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  2002.  The  neuron-­‐specific  Ca2+-­‐
binding  protein  caldendrin:  gene  structure,  splice  isoforms,  and  expression  in  
the  rat  central  nervous  system.  Mol  Cell  Neurosci,  19,  459-­‐75.  
LAUDE,  A.  J.  &  SIMPSON,  A.  W.  M.  2009.  Compartmentalized  signalling:  Ca2+  
compartments,  microdomains  and  the  many  facets  of  Ca2+  signalling.  FEBS  
Journal,  276,  1800-­‐1816.  
     260  
LEE,  A.,  JIMENEZ,  A.,  CUI,  G.  &  HAESELEER,  F.  2007a.  Phosphorylation  of  the  Ca2+-­‐
binding  protein  CaBP4  by  p???????????????? ?????????????????????Journal  of  
Neuroscience,  27,  12743-­‐12754.  
LEE,  A.,  JIMENEZ,  A.,  CUI,  G.  &  HAESELEER,  F.  2007b.  Phosphorylation  of  the  Ca2+-­‐
binding  protein  CaBP4  by  protein  kinase  C  zeta  in  photoreceptors.  J  Neurosci,  
27,  12743-­‐54.  
LEE,  A.,  WESTENBROEK,  R.  E.,  HAESELEER,  F.,  PALCZEWSKI,  K.,  SCHEUER,  T.  &  
CATTERALL,  W.  A.  2002.  Differential  modulation  of  Ca(v)2.1  channels  by  
calmodulin  and  Ca2+-­‐binding  protein  1.  Nat  Neurosci,  5,  210-­‐7.  
LEE,  S.,  BRIKLIN,  O.,  HIEL,  H.  &  FUCHS,  P.  2007c.  Calcium-­‐dependent  inactivation  of  
calcium  channels  in  cochlear  hair  cells  of  the  chicken.  J  Physiol,  583,  909-­‐22.  
LI,  C.,  CHAN,  J.,  HAESELEER,  F.,  MIKOSHIBA,  K.,  PALCZEWSKI,  K.,  IKURA,  M.  &  AMES,  J.  
B.  2009.  Structural  insights  into  Ca2+-­‐dependent  regulation  of  inositol  1,4,5-­‐
trisphosphate  receptors  by  CaBP1.  J  Biol  Chem,  284,  2472-­‐81.  
LI,  C.,  LU,  P.  &  ZHANG,  D.  1999.  Using  a  GFP-­‐gene  fusion  technique  to  study  the  cell  
cycle-­‐dependent  distribution  of  calmodulin  in  living  cells.  Science  in  China.  
Series  C,  Life  sciences  /  Chinese  Academy  of  Sciences,  42,  517-­‐28.  
LI,  W.  M.,  WEBB,  S.  E.,  CHAN,  C.  M.  &  MILLER,  A.  L.  2008.  Multiple  roles  of  the  furrow  
deepening  Ca2+  transient  during  cytokinesis  in  zebrafish  embryos.  
Developmental  biology,  316,  228-­‐48.  
LILLIEHOOK,  C.,  BOZDAGI,  O.,  YAO,  J.,  GOMEZ-­‐RAMIREZ,  M.,  ZAIDI,  N.  F.,  WASCO,  W.,  
GANDY,  S.,  SANTUCCI,  A.  C.,  HAROUTUNIAN,  V.,  HUNTLEY,  G.  W.  &  
BUXBAUM,  J.  D.  2003.  Altered  Abeta  formation  and  long-­‐term  potentiation  in  
a  calsenilin  knock-­‐out.  The  Journal  of  neuroscience  :  the  official  journal  of  the  
Society  for  Neuroscience,  23,  9097-­‐106.  
LITTINK,  K.  W.,  KOENEKOOP,  R.  K.,  VAN  DEN  BORN,  L.  I.,  COLLIN,  R.  W.,  MORUZ,  L.,  
VELTMAN,  J.  A.,  ROOSING,  S.,  ZONNEVELD,  M.  N.,  OMAR,  A.,  DARVISH,  M.,  
LOPEZ,  I.,  KROES,  H.  Y.,  VAN  GENDEREN,  M.  M.,  HOYNG,  C.  B.,  
ROHRSCHNEIDER,  K.,  VAN  SCHOONEVELD,  M.  J.,  CREMERS,  F.  P.  &  DEN  
HOLLANDER,  A.  I.  2010.  Homozygosity  mapping  in  patients  with  cone-­‐rod  
dystrophy:  novel  mutations  and  clinical  characterizations.  Invest  Ophthalmol  
Vis  Sci,  51,  5943-­‐51.  
     261  
LITTINK,  K.  W.,  VAN  GENDEREN,  M.  M.,  COLLIN,  R.  W.,  ROOSING,  S.,  DE  BROUWER,  
A.  P.,  RIEMSLAG,  F.  C.,  VENSELAAR,  H.,  THIADENS,  A.  A.,  HOYNG,  C.  B.,  
ROHRSCHNEIDER,  K.,  DEN  HOLLANDER,  A.  I.,  CREMERS,  F.  P.  &  VAN  DEN  
BORN,  L.  I.  2009.  A  novel  homozygous  nonsense  mutation  in  CABP4  causes  
congenital  cone-­‐rod  synaptic  disorder.  Invest  Ophthalmol  Vis  Sci,  50,  2344-­‐
50.  
LIU,  T.,  WILLIAMS,  J.  G.  &  CLARKE,  M.  1992.  Inducible  expression  of  calmodulin  
antisense  RNA  in  Dictyostelium  cells  inhibits  the  completion  of  cytokinesis.  
Molecular  biology  of  the  cell,  3,  1403-­‐13.  
LORENZ,  H.,  HAILEY,  D.  W.  &  LIPPINCOTT-­‐SCHWARTZ,  J.  2006.  Fluorescence  protease  
protection  of  GFP  chimeras  to  reveal  protein  topology  and  subcellular  
localization.  Nature  methods,  3,  205-­‐10.  
LOW,  S.  H.,  LI,  X.,  MIURA,  M.,  KUDO,  N.,  QUINONES,  B.  &  WEIMBS,  T.  2003.  Syntaxin  
2  and  endobrevin  are  required  for  the  terminal  step  of  cytokinesis  in  
mammalian  cells.  Developmental  cell,  4,  753-­‐9.  
LUKYANETZ,  E.  A.  1997.  Development  of  the  concepts  on  voltage-­‐operated  calcium  
channels.  Neurophysiology,  29,  45-­‐56.  
LUSIN,  J.  D.,  VANAROTTI,  M.,  LI,  C.,  VALIVETI,  A.  &  AMES,  J.  B.  2008.  NMR  structure  
of  DREAM:  Implications  for  Ca(2+)-­‐dependent  DNA  binding  and  protein  
dimerization.  Biochemistry,  47,  2252-­‐64.  
LUZIO,  J.  P.,  MULLOCK,  B.  M.,  PRYOR,  P.  R.,  LINDSAY,  M.  R.,  JAMES,  D.  E.  &  PIPER,  R.  
C.  2001.  Relationship  between  endosomes  and  lysosomes.  Biochemical  
Society  transactions,  29,  476-­‐80.  
LUZIO,  J.  P.,  PRYOR,  P.  R.  &  BRIGHT,  N.  A.  2007.  Lysosomes:  fusion  and  function.  
Nature  reviews.  Molecular  cell  biology,  8,  622-­‐32.  
LUZIO,  J.  P.,  ROUS,  B.  A.,  BRIGHT,  N.  A.,  PRYOR,  P.  R.,  MULLOCK,  B.  M.  &  PIPER,  R.  C.  
2000.  Lysosome-­‐endosome  fusion  and  lysosome  biogenesis.  Journal  of  cell  
science,  113  (  Pt  9),  1515-­‐24.  
MACARTHUR,  M.  W.,  DRISCOLL,  P.  C.  &  THORNTON,  J.  M.  1994.  NMR  and  
crystallography-­‐-­‐complementary  approaches  to  structure  determination.  
Trends  in  biotechnology,  12,  149-­‐53.  
     262  
MAEDA,  T.,  LEM,  J.,  PALCZEWSKI,  K.  &  HAESELEER,  F.  2005.  A  critical  role  of  CaBP4  in  
the  cone  synapse.  Invest  Ophthalmol  Vis  Sci,  46,  4320-­‐7.  
MAHLOOGI,  H.,  GONZAÃÅLEZ-­‐GUERRICO,  A.  M.,  DE  CICCO,  R.  L.,  BASSI,  D.  E.,  
GOODROW,  T.,  BRAUNEWELL,  K.  H.  &  KLEIN-­‐SZANTO,  A.  J.  P.  2003.  
Overexpression  of  the  calcium  sensor  visinin-­‐like  protein-­‐1  leads  to  a  cAMP-­‐
mediated  decrease  of  in  vivo  and  in  vitro  growth  and  invasiveness  of  
squamous  cell  carcinoma  cells.  Cancer  research,  63,  4997-­‐5004.  
MAHON,  M.  J.  2011.  pHluorin2:  an  enhanced,  ratiometric,  pH-­‐sensitive  green  
florescent  protein.  Advances  in  bioscience  and  biotechnology,  2,  132-­‐137.  
MALAKHOV,  M.  P.,  MATTERN,  M.  R.,  MALAKHOVA,  O.  A.,  DRINKER,  M.,  WEEKS,  S.  D.  
&  BUTT,  T.  R.  2004.  SUMO  fusions  and  SUMO-­‐specific  protease  for  efficient  
expression  and  purification  of  proteins.  Journal  of  structural  and  functional  
genomics,  5,  75-­‐86.  
MARTINEZ,  I.,  CHAKRABARTI,  S.,  HELLEVIK,  T.,  MOREHEAD,  J.,  FOWLER,  K.  &  
ANDREWS,  N.  W.  2000.  Synaptotagmin  VII  regulates  Ca(2+)-­‐dependent  
exocytosis  of  lysosomes  in  fibroblasts.  The  Journal  of  cell  biology,  148,  1141-­‐
49.  
MARTINEZ-­‐ARCA,  S.,  RUDGE,  R.,  VACCA,  M.,  RAPOSO,  G.,  CAMONIS,  J.,  PROUX-­‐
GILLARDEAUX,  V.,  DAVIET,  L.,  FORMSTECHER,  E.,  HAMBURGER,  A.,  FILIPPINI,  
F.,  D'ESPOSITO,  M.  &  GALLI,  T.  2003.  A  dual  mechanism  controlling  the  
localization  and  function  of  exocytic  v-­‐SNAREs.  Proceedings  of  the  National  
Academy  of  Sciences  of  the  United  States  of  America,  100,  9011-­‐6.  
MCCUE,  H.  V.,  BURGOYNE,  R.  D.  &  HAYNES,  L.  P.  2009.  Membrane  targeting  of  the  
EF-­‐hand  containing  calcium-­‐sensing  proteins  CaBP7  and  CaBP8.  Biochem  
Biophys  Res  Commun,  380,  825-­‐31.  
MCCUE,  H.  V.,  BURGOYNE,  R.  D.  &  HAYNES,  L.  P.  2011.  Determination  of  the  
membrane  topology  of  the  small  EF-­‐hand  Ca2+-­‐sensing  proteins  CaBP7  and  
CaBP8.  PLoS  One,  6,  e17853.  
MCCUE,  H.  V.,  HAYNES,  L.  P.  &  BURGOYNE,  R.  D.  2010a.  Bioinformatic  analysis  of  
CaBP/calneuron  proteins  reveals  a  family  of  highly  conserved  vertebrate  
Ca2+-­‐binding  proteins.  BMC  Res  Notes,  3,  118.  
     263  
MCCUE,  H.  V.,  HAYNES,  L.  P.  &  BURGOYNE,  R.  D.  2010b.  The  diversity  of  calcium  
sensor  proteins  in  the  regulation  of  neuronal  function.  Cold  Spring  Harb  
Perspect  Biol,  2,  a004085.  
MCFERRAN,  B.  W.,  GRAHAM,  M.  E.  &  BURGOYNE,  R.  D.  1998.  Neuronal  Ca2+  sensor  
1,  the  mammalian  homologue  of  frequenin,  is  expressed  in  chromaffin  and  
PC12  cells  and  regulates  neurosecretion  from  dense-­‐core  granules.  J  Biol  
Chem,  273,  22768-­‐72.  
MCKAY,  H.  F.  &  BURGESS,  D.  R.  2011.  'Life  is  a  highway':  membrane  trafficking  during  
cytokinesis.  Traffic,  12,  247-­‐51.  
MCNEIL,  P.  L.  &  TERASAKI,  M.  2001.  Coping  with  the  inevitable:  how  cells  repair  a  
torn  surface  membrane.  Nature  cell  biology,  3,  E124-­‐9.  
MICHALAK,  M.,  GROENENDYK,  J.,  SZABO,  E.,  GOLD,  L.  I.  &  OPAS,  M.  2009.  
Calreticulin,  a  multi-­‐process  calcium-­‐buffering  chaperone  of  the  endoplasmic  
reticulum.  Biochemical  Journal,  417,  651-­‐666.  
MIKHAYLOVA,  M.,  HRADSKY,  J.  &  KREUTZ,  M.  R.  2011.  Between  promiscuity  and  
specificity:  novel  roles  of  EF-­‐hand  calcium  sensors  in  neuronal  Ca(2+)  
signalling.  Journal  of  neurochemistry,  118,  695-­‐713.  
MIKHAYLOVA,  M.,  REDDY,  P.  P.,  MUNSCH,  T.,  LANDGRAF,  P.,  SUMAN,  S.  K.,  SMALLA,  
K.  H.,  GUNDELFINGER,  E.  D.,  SHARMA,  Y.  &  KREUTZ,  M.  R.  2009.  Calneurons  
provide  a  calcium  threshold  for  trans-­‐Golgi  network  to  plasma  membrane  
trafficking.  Proc  Natl  Acad  Sci  U  S  A,  106,  9093-­‐8.  
MIKHAYLOVA,  M.,  SHARMA,  Y.,  REISSNER,  C.,  NAGEL,  F.,  ARAVIND,  P.,  RAJINI,  B.,  
SMALLA,  K.  H.,  GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  2006.  Neuronal  Ca2+  
signaling  via  caldendrin  and  calneurons.  Biochim  Biophys  Acta,  1763,  1229-­‐
37.  
MIKOSHIBA,  K.  2007.  The  IP3  receptor/Ca2+  channel  and  its  cellular  function.  
Biochemical  Society  symposium,  9-­‐22.  
MINOR,  D.  L.,  JR.  &  FINDEISEN,  F.  2010.  Progress  in  the  structural  understanding  of  
voltage-­‐gated  calcium  channel  (CaV)  function  and  modulation.  Channels,  4,  
459-­‐74.  
MITSUYAMA,  F.,  SAWAI,  T.,  CARAFOLI,  E.,  FURUICHI,  T.  &  MIKOSHIBA,  K.  1999.  
Microinjection  of  Ca2+  store-­‐enriched  microsome  fractions  to  dividing  newt  
     264  
eggs  induces  extra-­‐cleavage  furrows  via  inositol  1,4,5-­‐trisphosphate-­‐induced  
Ca2+  release.  Developmental  biology,  214,  160-­‐7.  
MONCRIEF,  N.  D.,  KRETSINGER,  R.  H.  &  GOODMAN,  M.  1990.  Evolution  of  EF-­‐hand  
calcium-­‐modulated  proteins.  I.  Relationships  based  on  amino  acid  sequences.  
Journal  of  Molecular  Evolution,  30,  522-­‐562.  
MULLOCK,  B.  M.,  BRIGHT,  N.  A.,  FEARON,  C.  W.,  GRAY,  S.  R.  &  LUZIO,  J.  P.  1998.  
Fusion  of  lysosomes  with  late  endosomes  produces  a  hybrid  organelle  of  
intermediate  density  and  is  NSF  dependent.  The  Journal  of  cell  biology,  140,  
591-­‐601.  
MUSKETT,  F.  W.  2011.  Sample  Preparation,  Data  Collection  and  Processing.  In:  
ROBERTS,  L.-­‐Y.  L.  A.  G.  (ed.)  Protein  NMR  Spectroscopy:  Practical  Techniques  
and  Applications.  Chichester,  UK:  John  Wiley  &  Sons,  Ltd.  
MUTO,  A.,  KUME,  S.,  INOUE,  T.,  OKANO,  H.  &  MIKOSHIBA,  K.  1996.  Calcium  waves  
along  the  cleavage  furrows  in  cleavage-­‐stage  Xenopus  embryos  and  its  
inhibition  by  heparin.  The  Journal  of  cell  biology,  135,  181-­‐90.  
NAKAJIMA,  Y.  2011.  Ca(2+)-­‐dependent  binding  of  calcium-­‐binding  protein  1  to  
presynaptic  group  III  metabotropic  glutamate  receptors  and  blockage  by  
phosphorylation  of  the  receptors.  Biochemical  and  biophysical  research  
communications.  
NAKAMURA,  T.  Y.,  JEROMIN,  A.,  MIKOSHIBA,  K.  &  WAKABAYASHI,  S.  2011.  Neuronal  
calcium  sensor-­‐1  promotes  immature  heart  function  and  hypertrophy  by  
enhancing  Ca2+  signals.  Circulation  research,  109,  512-­‐23.  
NELSON,  M.  R.  &  CHAZIN,  W.  J.  1998.  Structures  of  EF-­‐hand  Ca2+-­‐binding  proteins:  
Diversity  in  the  organization,  packing  and  response  to  Ca2+  binding.  
BioMetals,  11,  297-­‐318.  
NETO,  H.,  COLLINS,  L.  L.  &  GOULD,  G.  W.  2011.  Vesicle  trafficking  and  membrane  
remodelling  in  cytokinesis.  The  Biochemical  journal,  437,  13-­‐24.  
NEUMANN,  B.,  WALTER,  T.,  HERICHE,  J.  K.,  BULKESCHER,  J.,  ERFLE,  H.,  CONRAD,  C.,  
ROGERS,  P.,  POSER,  I.,  HELD,  M.,  LIEBEL,  U.,  CETIN,  C.,  SIECKMANN,  F.,  PAU,  
G.,  KABBE,  R.,  WUNSCHE,  A.,  SATAGOPAM,  V.,  SCHMITZ,  M.  H.,  CHAPUIS,  C.,  
GERLICH,  D.  W.,  SCHNEIDER,  R.,  EILS,  R.,  HUBER,  W.,  PETERS,  J.  M.,  HYMAN,  
A.  A.,  DURBIN,  R.,  PEPPERKOK,  R.  &  ELLENBERG,  J.  2010.  Phenotypic  profiling  
     265  
of  the  human  genome  by  time-­‐lapse  microscopy  reveals  cell  division  genes.  
Nature,  464,  721-­‐7.  
NIKI,  I.,  YOKOKURA,  H.,  SUDO,  T.,  KATO,  M.  &  HIDAKA,  H.  1996.  Ca2+  signaling  and  
intracellular  Ca2+  binding  proteins.  Journal  of  Biochemistry,  120,  685-­‐698.  
NISHIMURA,  N.,  PLUTNER,  H.,  HAHN,  K.  &  BALCH,  W.  E.  2002.  The  delta  subunit  of  
AP-­‐3  is  required  for  efficient  transport  of  VSV-­‐G  from  the  trans-­‐Golgi  network  
to  the  cell  surface.  Proceedings  of  the  National  Academy  of  Sciences  of  the  
United  States  of  America,  99,  6755-­‐60.  
NOGUCHI,  T.  &  MABUCHI,  I.  2002.  Localized  calcium  signals  along  the  cleavage  
furrow  of  the  Xenopus  egg  are  not  involved  in  cytokinesis.  Molecular  biology  
of  the  cell,  13,  1263-­‐73.  
O'CALLAGHAN,  D.  W.,  HASDEMIR,  B.,  LEIGHTON,  M.  &  BURGOYNE,  R.  D.  2003.  
Residues  within  the  myristoylation  motif  determine  intracellular  targeting  of  
the  neuronal  Ca2+  sensor  protein  KChIP1  to  post-­‐ER  transport  vesicles  and  
traffic  of  Kv4  K+  channels.  J  Cell  Sci,  116,  4833-­‐45.  
OBERMULLER,  S.,  KIECKE,  C.,  VON  FIGURA,  K.  &  HONING,  S.  2002.  The  tyrosine  
motifs  of  Lamp  1  and  LAP  determine  their  direct  and  indirect  targetting  to  
lysosomes.  Journal  of  cell  science,  115,  185-­‐94.  
OHKI,  S.  Y.,  IKURA,  M.  &  ZHANG,  M.  1997.  Identification  of  Mg2+-­‐binding  sites  and  
the  role  of  Mg2+  on  target  recognition  by  calmodulin.  Biochemistry,  36,  4309-­‐
4316.  
OHYA,  S.  &  HOROWITZ,  B.  2002.  Differential  transcriptional  expression  of  Ca2+  BP  
superfamilies  in  murine  gastrointestinal  smooth  muscles.  American  journal  of  
physiology.  Gastrointestinal  and  liver  physiology,  283,  G1290-­‐7.  
OLAFSSON,  P.,  WANG,  T.  &  LU,  B.  1995.  Molecular  cloning  and  functional  
characterization  of  the  Xenopus  Ca2+-­‐  binding  protein  frequenin.  Proceedings  
of  the  National  Academy  of  Sciences  of  the  United  States  of  America,  92,  
8001-­‐8005.  
ON,  C.,  MARSHALL,  C.  R.,  CHEN,  N.,  MOYES,  C.  D.  &  TIBBITS,  G.  F.  2008.  Gene  
structure  evolution  of  the  Na+-­‐Ca2+  exchanger  (NCX)  family.  BMC  
evolutionary  biology,  8,  127.  
     266  
OSAWA,  M.,  DACE,  A.,  TONG,  K.  I.,  VALIVETI,  A.,  IKURA,  M.  &  AMES,  J.  B.  2005.  Mg2+  
and  Ca2+  differentially  regulate  DNA  binding  and  dimerization  of  DREAM.  The  
Journal  of  biological  chemistry,  280,  18008-­‐14.  
OZ,  S.,  TSEMAKHOVICH,  V.,  CHRISTEL,  C.  J.,  LEE,  A.  &  DASCAL,  N.  2011.  CaBP1  
regulates  voltage-­‐dependent  inactivation  and  activation  of  Ca(V)1.2  (L-­‐type)  
calcium  channels.  J  Biol  Chem,  286,  13945-­‐53.  
PALCZEWSKI,  K.,  SOKAL,  I.  &  BAEHR,  W.  2004.  Guanylate  cyclase-­‐activating  proteins:  
Structure,  function,  and  diversity.  Biochemical  and  biophysical  research  
communications,  322,  1123-­‐1130.  
PALMITER,  R.  D.  1974.  Magnesium  precipitation  of  ribonucleoprotein  complexes.  
Expedient  techniques  for  the  isolation  of  undergraded  polysomes  and  
messenger  ribonucleic  acid.  Biochemistry,  13,  3606-­‐15.  
PANKRATOVA,  E.  V.,  SYTINA,  E.  V.  &  STEPCHENKO,  A.  G.  1994.  Cell  differentiation  in  
vitro  and  the  expression  of  Oct-­‐2  protein  and  oct-­‐2  RNA.  FEBS  letters,  338,  
81-­‐4.  
PARK,  J.  S.,  STEINBACH,  S.  K.,  DESAUTELS,  M.  &  HEMMINGSEN,  S.  M.  2009.  Essential  
role  for  Schizosaccharomyces  pombe  pik1  in  septation.  PloS  one,  4,  e6179.  
PARK,  S.,  LI,  C.  &  AMES,  J.  B.  2011.  Nuclear  magnetic  resonance  structure  of  calcium-­‐
binding  protein  1  in  a  Ca(2+)  -­‐bound  closed  state:  Implications  for  target  
recognition.  Protein  Sci.  
PAULS,  T.  L.,  COX,  J.  A.  &  BERCHTOLD,  M.  W.  1996.  The  Ca2+-­‐binding  proteins  
parvalbumin  and  oncomodulin  and  their  genes:  New  structural  and  
functional  findings.  Biochimica  et  Biophysica  Acta  -­‐  Gene  Structure  and  
Expression,  1306,  39-­‐54.  
PECHERE,  J.  F.,  DERANCOURT,  J.  &  HAIECH,  J.  1977.  The  participation  of  
parvalbumins  in  the  activation  relaxation  cycle  of  vertebrate  fast  skeletal  
muscle.  FEBS  letters,  75,  111-­‐114.  
PEDRAZZINI,  E.,  VILLA,  A.  &  BORGESE,  N.  1996.  A  mutant  cytochrome  b5  with  a  
lengthened  membrane  anchor  escapes  from  the  endoplasmic  reticulum  and  
reaches  the  plasma  membrane.  Proceedings  of  the  National  Academy  of  
Sciences  of  the  United  States  of  America,  93,  4207-­‐12.  
     267  
PELHAM,  H.  R.  2001.  Traffic  through  the  Golgi  apparatus.  The  Journal  of  cell  biology,  
155,  1099-­‐101.  
PELISSIER,  A.,  CHAUVIN,  J.  P.  &  LECUIT,  T.  2003.  Trafficking  through  Rab11  
endosomes  is  required  for  cellularization  during  Drosophila  embryogenesis.  
Current  biology  :  CB,  13,  1848-­‐57.  
PERSECHINI,  A.  &  STEMMER,  P.  M.  2002.  Calmodulin  is  a  limiting  factor  in  the  cell.  
Trends  in  cardiovascular  medicine,  12,  32-­‐37.  
PETERSEN,  O.  H.,  MICHALAK,  M.  &  VERKHRATSKY,  A.  2005.  Calcium  signalling:  Past,  
present  and  future.  Cell  Calcium,  38,  161-­‐169.  
PETKO,  J.  A.,  KABBANI,  N.,  FREY,  C.,  WOLL,  M.,  HICKEY,  K.,  CRAIG,  M.,  CANFIELD,  V.  A.  
&  LEVENSON,  R.  2009.  Proteomic  and  functional  analysis  of  NCS-­‐1  binding  
proteins  reveals  novel  signaling  pathways  required  for  inner  ear  development  
in  zebrafish.  BMC  Neurosci,  10,  27.  
PITT,  S.  J.,  FUNNELL,  T.  M.,  SITSAPESAN,  M.,  VENTURI,  E.,  RIETDORF,  K.,  RUAS,  M.,  
GANESAN,  A.,  GOSAIN,  R.,  CHURCHILL,  G.  C.,  ZHU,  M.  X.,  PARRINGTON,  J.,  
GALIONE,  A.  &  SITSAPESAN,  R.  2010.  TPC2  is  a  novel  NAADP-­‐sensitive  Ca2+  
release  channel,  operating  as  a  dual  sensor  of  luminal  pH  and  Ca2+.  The  
Journal  of  biological  chemistry,  285,  35039-­‐46.  
POLANS,  A.,  BAEHR,  W.  &  PALCZEWSKI,  K.  1996.  Turned  on  by  Ca2+!  The  physiology  
and  pathology  of  Ca2+-­‐binding  proteins  in  the  retina.  Trends  in  
neurosciences,  19,  547-­‐554.  
POLANS,  A.  S.,  BUCZYLKO,  J.,  CRABB,  J.  &  PALCZEWSKI,  K.  1991.  A  photoreceptor  
calcium  binding  protein  is  recognized  by  autoantibodies  obtained  from  
patients  with  cancer-­‐associated  retinopathy.  Journal  of  Cell  Biology,  112,  981-­‐
989.  
POLEVOY,  G.,  WEI,  H.  C.,  WONG,  R.,  SZENTPETERY,  Z.,  KIM,  Y.  J.,  GOLDBACH,  P.,  
STEINBACH,  S.  K.,  BALLA,  T.  &  BRILL,  J.  A.  2009.  Dual  roles  for  the  Drosophila  
PI  4-­‐kinase  four  wheel  drive  in  localizing  Rab11  during  cytokinesis.  The  
Journal  of  cell  biology,  187,  847-­‐858.  
POLISHCHUK,  E.  V.,  DI  PENTIMA,  A.,  LUINI,  A.  &  POLISHCHUK,  R.  S.  2003.  Mechanism  
of  constitutive  export  from  the  golgi:  bulk  flow  via  the  formation,  protrusion,  
     268  
and  en  bloc  cleavage  of  large  trans-­‐golgi  network  tubular  domains.  Molecular  
biology  of  the  cell,  14,  4470-­‐85.  
PONGS,  O.,  LINDEMEIER,  J.,  ZHU,  X.  R.,  THEIL,  T.,  ENGELKAMP,  D.,  KRAH-­‐JENTGENS,  
I.,  LAMBRECHT,  H.  G.,  KOCH,  K.  W.,  SCHWEMER,  J.,  RIVOSECCHI,  R.,  
MALLART,  A.,  GALCERAN,  J.,  CANAL,  I.,  BARBAS,  J.  A.  &  FERRUS,  A.  1993.  
Frequenin  -­‐  A  novel  calcium-­‐binding  protein  that  modulates  synaptic  efficacy  
in  the  Drosophila  nervous  system.  Neuron,  11,  15-­‐28.  
PROUX-­‐GILLARDEAUX,  V.,  RAPOSO,  G.,  IRINOPOULOU,  T.  &  GALLI,  T.  2007.  
Expression  of  the  Longin  domain  of  TI-­‐VAMP  impairs  lysosomal  secretion  and  
epithelial  cell  migration.  Biology  of  the  cell  /  under  the  auspices  of  the  
European  Cell  Biology  Organization,  99,  261-­‐71.  
PRUUNSILD,  P.  &  TIMMUSK,  T.  2005.  Structure,  alternative  splicing,  and  expression  
of  the  human  and  mouse  KCNIP  gene  family.  Genomics,  86,  581-­‐593.  
RABU,  C.,  SCHMID,  V.,  SCHWAPPACH,  B.  &  HIGH,  S.  2009.  Biogenesis  of  tail-­‐anchored  
proteins:  the  beginning  for  the  end?  Journal  of  cell  science,  122,  3605-­‐12.  
REBELLO,  M.  R.,  AKTAS,  A.  &  MEDLER,  K.  F.  2011.  Expression  of  calcium  binding  
proteins  in  mouse  type  II  taste  cells.  J  Histochem  Cytochem,  59,  530-­‐9.  
REISCH,  N.,  AESCHLIMANN,  A.,  GAY,  S.  &  SPROTT,  H.  2006.  The  DREAM  of  pain  relief.  
Current  Rheumatology  Reviews,  2,  69-­‐82.  
RENNER,  M.,  DANIELSON,  M.  A.  &  FALKE,  J.  J.  1993.  Kinetic  control  of  Ca(II)  signaling:  
Tuning  the  ion  dissociation  rates  of  EF-­‐hand  Ca(II)  binding  sites.  Proceedings  
of  the  National  Academy  of  Sciences  of  the  United  States  of  America,  90,  
6493-­‐6497.  
RIEKE,  F.,  LEE,  A.  &  HAESELEER,  F.  2008.  Characterization  of  Ca2+-­‐binding  protein  5  
knockout  mouse  retina.  Invest  Ophthalmol  Vis  Sci,  49,  5126-­‐35.  
RIZO,  J.  &  SUDHOF,  T.  C.  1998.  C2-­‐domains,  structure  and  function  of  a  universal  
Ca2+-­‐binding  domain.  Journal  of  Biological  Chemistry,  273,  15879-­‐15882.  
ROMANI,  A.  &  SCARPA,  A.  1992.  Regulation  of  cell  magnesium.  Archives  of  
biochemistry  and  biophysics,  298,  1-­‐12.  
RUAS,  M.,  RIETDORF,  K.,  ARREDOUANI,  A.,  DAVIS,  L.  C.,  LLOYD-­‐EVANS,  E.,  KOEGEL,  
H.,  FUNNELL,  T.  M.,  MORGAN,  A.  J.,  WARD,  J.  A.,  WATANABE,  K.,  CHENG,  X.,  
CHURCHILL,  G.  C.,  ZHU,  M.  X.,  PLATT,  F.  M.,  WESSEL,  G.  M.,  PARRINGTON,  J.  &  
     269  
GALIONE,  A.  2010.  Purified  TPC  Isoforms  Form  NAADP  Receptors  with  
Distinct  Roles  for  Ca(2+)  Signaling  and  Endolysosomal  Trafficking.  Current  
biology  :  CB,  20,  703-­‐9.  
SAMPATH,  A.  P.,  STRISSEL,  K.  J.,  ELIAS,  R.,  ARSHAVSKY,  V.  Y.,  MCGINNIS,  J.  F.,  CHEN,  
J.,  KAWAMURA,  S.,  RIEKE,  F.  &  HURLEY,  J.  B.  2005.  Recoverin  improves  rod-­‐
mediated  vision  by  enhancing  signal  transmission  in  the  mouse  retina.  
Neuron,  46,  413-­‐420.  
SCHAAD,  N.  C.,  DE  CASTRO,  E.,  NEF,  S.,  HEGI,  S.,  HINRICHSEN,  R.,  MARTONE,  M.  E.,  
ELLISMAN,  M.  H.,  SIKKINK,  R.,  RUSNAK,  F.,  SYGUSH,  J.  &  NEF,  P.  1996.  Direct  
modulation  of  calmodulin  targets  by  the  neuronal  calcium  sensor  NCS-­‐1.  Proc  
Natl  Acad  Sci  U  S  A,  93,  9253-­‐8.  
SCHNURRA,  I.,  BERNSTEIN,  H.  G.,  RIEDERER,  P.  &  BRAUNEWELL,  K.  H.  2001.  The  
neuronal  calcium  sensor  protein  VILIP-­‐1  is  associated  with  amyloid  plaques  
and  extracellular  tangles  in  Alzheimer's  disease  and  promotes  cell  death  and  
tau  phosphorylation  in  vitro:  a  link  between  calcium  sensors  and  Alzheimer's  
disease?  Neurobiol  Dis,  8,  900-­‐9.  
SCHOLLMEYER,  J.  E.  1988.  Calpain  II  involvement  in  mitosis.  Science,  240,  911-­‐3.  
SCHRODER,  T.,  LILIE,  H.  &  LANGE,  C.  2011.  The  myristoylation  of  guanylate  cyclase-­‐
activating  protein-­‐2  causes  an  increase  in  thermodynamic  stability  in  the  
presence  but  not  in  the  absence  of  Ca(2+).  Protein  Sci,  20,  1155-­‐65.  
SCHROEDER,  T.  E.  &  STRICKLAND,  D.  L.  1974.  Ionophore  A23187,  calcium  and  
contractility  in  frog  eggs.  Experimental  cell  research,  83,  139-­‐42.  
SCHWALLER,  B.  2009.  The  continuing  disappearance  of  "pure"  Ca2+  buffers.  Cellular  
and  Molecular  Life  Sciences,  66,  275-­‐300.  
SCHWENK,  J.,  ZOLLES,  G.,  KANDIAS,  N.  G.,  NEUBAUER,  I.,  KALBACHER,  H.,  
COVARRUBIAS,  M.,  FAKLER,  B.  &  BENTROP,  D.  2008.  NMR  analysis  of  KChIP4a  
reveals  structural  basis  for  control  of  surface  expression  of  Kv4  channel  
complexes.  The  Journal  of  biological  chemistry,  283,  18937-­‐46.  
SEIDENBECHER,  C.  I.,  LANDWEHR,  M.,  SMALLA,  K.  H.,  KREUTZ,  M.,  DIETERICH,  D.  C.,  
ZUSCHRATTER,  W.,  REISSNER,  C.,  HAMMARBACK,  J.  A.,  BOCKERS,  T.  M.,  
GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  2004.  Caldendrin  but  not  calmodulin  
binds  to  light  chain  3  of  MAP1A/B:  an  association  with  the  microtubule  
     270  
cytoskeleton  highlighting  exclusive  binding  partners  for  neuronal  Ca(2+)-­‐
sensor  proteins.  J  Mol  Biol,  336,  957-­‐70.  
SEIDENBECHER,  C.  I.,  LANGNAESE,  K.,  SANMARTI-­‐VILA,  L.,  BOECKERS,  T.  M.,  SMALLA,  
K.  H.,  SABEL,  B.  A.,  GARNER,  C.  C.,  GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  
1998.  Caldendrin,  a  novel  neuronal  calcium-­‐binding  protein  confined  to  the  
somato-­‐dendritic  compartment.  J  Biol  Chem,  273,  21324-­‐31.  
SHIH,  P.  Y.,  LIN,  C.  L.,  CHENG,  P.  W.,  LIAO,  J.  H.  &  PAN,  C.  Y.  2009.  Calneuron  I  inhibits  
Ca(2+)  channel  activity  in  bovine  chromaffin  cells.  Biochem  Biophys  Res  
Commun,  388,  549-­‐53.  
SHU,  D.  G.,  LUO,  H.  L.,  CONWAY  MORRIS,  S.,  ZHANG,  X.  L.,  HU,  S.  X.,  CHEN,  L.,  HAN,  
J.,  ZHU,  M.,  LI,  Y.  &  CHEN,  L.  Z.  1999.  Lower  Cambrian  vertebrates  from  south  
China.  Nature,  402,  42-­‐46.  
SHUSTER,  C.  B.  &  BURGESS,  D.  R.  2002.  Targeted  new  membrane  addition  in  the  
cleavage  furrow  is  a  late,  separate  event  in  cytokinesis.  Proceedings  of  the  
National  Academy  of  Sciences  of  the  United  States  of  America,  99,  3633-­‐8.  
SKOP,  A.  R.,  LIU,  H.,  YATES,  J.,  3RD,  MEYER,  B.  J.  &  HEALD,  R.  2004.  Dissection  of  the  
mammalian  midbody  proteome  reveals  conserved  cytokinesis  mechanisms.  
Science,  305,  61-­‐6.  
SMALLA,  K.  H.,  SEIDENBECHER,  C.  I.,  TISCHMEYER,  W.,  SCHICKNICK,  H.,  WYNEKEN,  U.,  
BOCKERS,  T.  M.,  GUNDELFINGER,  E.  D.  &  KREUTZ,  M.  R.  2003.  Kainate-­‐
induced  epileptic  seizures  induce  a  recruitment  of  caldendrin  to  the  
postsynaptic  density  in  rat  brain.  Brain  Res  Mol  Brain  Res,  116,  159-­‐62.  
SMYTH,  J.  T.,  DEHAVEN,  W.  I.,  JONES,  B.  F.,  MERCER,  J.  C.,  TREBAK,  M.,  VAZQUEZ,  G.  
&  PUTNEY  JR,  J.  W.  2006.  Emerging  perspectives  in  store-­‐operated  Ca2+  
entry:  Roles  of  Orai,  Stim  and  TRP.  Biochimica  et  Biophysica  Acta  -­‐  Molecular  
Cell  Research,  1763,  1147-­‐1160.  
SNYDER,  D.  A.,  CHEN,  Y.,  DENISSOVA,  N.  G.,  ACTON,  T.,  ARAMINI,  J.  M.,  CIANO,  M.,  
KARLIN,  R.,  LIU,  J.,  MANOR,  P.,  RAJAN,  P.  A.,  ROSSI,  P.,  SWAPNA,  G.  V.,  XIAO,  
R.,  ROST,  B.,  HUNT,  J.  &  MONTELIONE,  G.  T.  2005.  Comparisons  of  NMR  
spectral  quality  and  success  in  crystallization  demonstrate  that  NMR  and  X-­‐
ray  crystallography  are  complementary  methods  for  small  protein  structure  
determination.  Journal  of  the  American  Chemical  Society,  127,  16505-­‐11.  
     271  
SONG,  M.  Y.  &  YUAN,  J.  X.  2010.  Introduction  to  TRP  channels:  structure,  function,  
and  regulation.  Advances  in  experimental  medicine  and  biology,  661,  99-­‐108.  
SONG,  S.  J.,  KIM,  S.  J.,  SONG,  M.  S.  &  LIM,  D.  S.  2009.  Aurora  B-­‐mediated  
phosphorylation  of  RASSF1A  maintains  proper  cytokinesis  by  recruiting  
Syntaxin16  to  the  midzone  and  midbody.  Cancer  research,  69,  8540-­‐4.  
STEFANOVIC,  S.  &  HEGDE,  R.  S.  2007.  Identification  of  a  targeting  factor  for  
posttranslational  membrane  protein  insertion  into  the  ER.  Cell,  128,  1147-­‐59.  
STEFER,  S.,  REITZ,  S.,  WANG,  F.,  WILD,  K.,  PANG,  Y.  Y.,  SCHWARZ,  D.,  BOMKE,  J.,  
HEIN,  C.,  LOHR,  F.,  BERNHARD,  F.,  DENIC,  V.,  DOTSCH,  V.  &  SINNING,  I.  2011.  
Structural  basis  for  tail-­‐anchored  membrane  protein  biogenesis  by  the  Get3-­‐
receptor  complex.  Science,  333,  758-­‐62.  
STEPHEN,  R.,  BERETA,  G.,  GOLCZAK,  M.,  PALCZEWSKI,  K.  &  SOUSA,  M.  C.  2007.  
Stabilizing  function  for  myristoyl  group  revealed  by  the  crystal  structure  of  a  
neuronal  calcium  sensor,  guanylate  cyclase-­‐activating  protein  1.  Structure,  
15,  1392-­‐402.  
SU,  Q.,  MOCHIDA,  S.,  TIAN,  J.  H.,  MEHTA,  R.  &  SHENG,  Z.  H.  2001.  SNAP-­‐29:  a  general  
SNARE  protein  that  inhibits  SNARE  disassembly  and  is  implicated  in  synaptic  
transmission.  Proceedings  of  the  National  Academy  of  Sciences  of  the  United  
States  of  America,  98,  14038-­‐43.  
SUBACH,  F.  V.,  SUBACH,  O.  M.,  GUNDOROV,  I.  S.,  MOROZOVA,  K.  S.,  PIATKEVICH,  K.  
D.,  CUERVO,  A.  M.  &  VERKHUSHA,  V.  V.  2009.  Monomeric  fluorescent  timers  
that  change  color  from  blue  to  red  report  on  cellular  trafficking.  Nature  
chemical  biology,  5,  118-­‐26.  
SUN,  L.,  GOROSPE,  J.  R.,  HOFFMAN,  E.  P.  &  RAO,  A.  K.  2007.  Decreased  platelet  
expression  of  myosin  regulatory  light  chain  polypeptide  (MYL9)  and  other  
genes  with  platelet  dysfunction  and  CBFA2/RUNX1  mutation:  insights  from  
platelet  expression  profiling.  J  Thromb  Haemost,  5,  146-­‐54.  
TAKEUCHI,  T.,  SARASHINA,  I.,  IIJIMA,  M.  &  ENDO,  K.  2008.  In  vitro  regulation  of  
CaCO(3)  crystal  polymorphism  by  the  highly  acidic  molluscan  shell  protein  
Aspein.  FEBS  letters,  582,  591-­‐6.  
     272  
TAKIMOTO,  K.,  YANG,  E.  K.  &  CONFORTI,  L.  2002.  Palmitoylation  of  KChIP  splicing  
variants  is  required  for  efficient  cell  surface  expression  of  Kv4.3  channels.  The  
Journal  of  biological  chemistry,  277,  26904-­‐11.  
TAKUWA,  N.,  ZHOU,  W.  &  TAKUWA,  Y.  1995.  Calcium,  calmodulin  and  cell  cycle  
progression.  Cellular  signalling,  7,  93-­‐104.  
TANG,  N.,  LIN,  T.,  YANG,  J.,  FOSKETT,  J.  K.  &  OSTAP,  E.  M.  2007.  CIB1  and  CaBP1  bind  
to  the  myo1c  regulatory  domain.  J  Muscle  Res  Cell  Motil,  28,  285-­‐91.  
TAVERNA,  E.,  FRANCOLINI,  M.,  JEROMIN,  A.,  HILFIKER,  S.,  RODER,  J.  &  ROSA,  P.  2002.  
Neuronal  calcium  sensor  1  and  phosphatidylinositol  4-­‐OH  kinase  beta  
interact  in  neuronal  cells  and  are  translocated  to  membranes  during  
nucleotide-­‐evoked  exocytosis.  J  Cell  Sci,  115,  3909-­‐22.  
TENG,  F.  Y.,  WANG,  Y.  &  TANG,  B.  L.  2001.  The  syntaxins.  Genome  biology,  2,  
REVIEWS3012.  
TERASAKI,  M.  &  JAFFE,  L.  A.  1991.  Organization  of  the  sea  urchin  egg  endoplasmic  
reticulum  and  its  reorganization  at  fertilization.  The  Journal  of  cell  biology,  
114,  929-­‐40.  
THEISGEN,  S.,  THOMAS,  L.,  SCHRODER,  T.,  LANGE,  C.,  KOVERMANN,  M.,  BALBACH,  J.  
&  HUSTER,  D.  2011.  The  presence  of  membranes  or  micelles  induces  
structural  changes  of  the  myristoylated  guanylate-­‐cyclase  activating  protein-­‐
2.  European  biophysics  journal  :  EBJ,  40,  565-­‐76.  
THOMAS,  A.  P.,  BIRD,  G.  S.,  HAJNOCZKY,  G.,  ROBB-­‐GASPERS,  L.  D.  &  PUTNEY,  J.  W.,  
JR.  1996.  Spatial  and  temporal  aspects  of  cellular  calcium  signaling.  The  
FASEB  journal  :  official  publication  of  the  Federation  of  American  Societies  for  
Experimental  Biology,  10,  1505-­‐17.  
TIPPENS,  A.  L.  &  LEE,  A.  2007.  Caldendrin,  a  neuron-­‐specific  modulator  of  Cav/1.2  (L-­‐
type)  Ca2+  channels.  J  Biol  Chem,  282,  8464-­‐73.  
TOGO,  T.  &  STEINHARDT,  R.  A.  2004.  Nonmuscle  myosin  IIA  and  IIB  have  distinct  
functions  in  the  exocytosis-­‐dependent  process  of  cell  membrane  repair.  
Molecular  biology  of  the  cell,  15,  688-­‐95.  
TOMAS,  A.,  FUTTER,  C.  &  MOSS,  S.  E.  2004.  Annexin  11  is  required  for  midbody  
formation  and  completion  of  the  terminal  phase  of  cytokinesis.  The  Journal  of  
cell  biology,  165,  813-­‐22.  
     273  
TOMBES,  R.  M.  &  BORISY,  G.  G.  1989.  Intracellular  free  calcium  and  mitosis  in  
mammalian  cells:  anaphase  onset  is  calcium  modulated,  but  is  not  triggered  
by  a  brief  transient.  The  Journal  of  cell  biology,  109,  627-­‐36.  
TOROK,  K.,  THOROGATE,  R.  &  HOWELL,  S.  2002.  Studying  the  spatial  distribution  of  
Ca(2+)-­‐binding  proteins.  How  does  it  work  for  calmodulin?  Methods  in  
molecular  biology,  173,  383-­‐407.  
TOROK,  K.,  WILDING,  M.,  GROIGNO,  L.,  PATEL,  R.  &  WHITAKER,  M.  1998.  Imaging  the  
spatial  dynamics  of  calmodulin  activation  during  mitosis.  Current  biology  :  CB,  
8,  692-­‐9.  
TOUTENHOOFD,  S.  L.  &  STREHLER,  E.  E.  2000.  The  calmodulin  multigene  family  as  a  
unique  case  of  genetic  redundancy:  Multiple  levels  of  regulation  to  provide  
spatial  and  temporal  control  of  calmodulin  pools?  Cell  Calcium,  28,  83-­‐96.  
UETAKE,  Y.  &  SLUDER,  G.  2004.  Cell  cycle  progression  after  cleavage  failure:  
mammalian  somatic  cells  do  not  possess  a  "tetraploidy  checkpoint".  The  
Journal  of  cell  biology,  165,  609-­‐15.  
VAN  DALEN,  A.  &  DE  KRUIJFF,  B.  2004.  The  role  of  lipids  in  membrane  insertion  and  
translocation  of  bacterial  proteins.  Biochimica  et  biophysica  acta,  1694,  97-­‐
109.  
VAN  DAMME,  D.,  INZE,  D.  &  RUSSINOVA,  E.  2008.  Vesicle  trafficking  during  somatic  
cytokinesis.  Plant  physiology,  147,  1544-­‐52.  
VIJAY-­‐KUMAR,  S.  &  COOK,  W.  J.  1992.  Structure  of  a  sarcoplasmic  calcium-­‐binding  
protein  from  Nereis  diversicolor  refined  at  2.0  A  resolution.  Journal  of  
molecular  biology,  224,  413-­‐26.  
VRANKEN,  W.  F.,  BOUCHER,  W.,  STEVENS,  T.  J.,  FOGH,  R.  H.,  PAJON,  A.,  LLINAS,  M.,  
ULRICH,  E.  L.,  MARKLEY,  J.  L.,  IONIDES,  J.  &  LAUE,  E.  D.  2005.  The  CCPN  data  
model  for  NMR  spectroscopy:  development  of  a  software  pipeline.  Proteins,  
59,  687-­‐96.  
WALCH-­‐SOLIMENA,  C.  &  NOVICK,  P.  1999.  The  yeast  phosphatidylinositol-­‐4-­‐OH  
kinase  pik1  regulates  secretion  at  the  Golgi.  Nature  cell  biology,  1,  523-­‐525.  
WANG,  K.  2008.  Modulation  by  clamping:  Kv4  and  KChIP  interactions.  Neurochem  
Res,  33,  1964-­‐9.  
     274  
WATSON,  R.  T.  &  PESSIN,  J.  E.  2001.  Transmembrane  domain  length  determines  
intracellular  membrane  compartment  localization  of  syntaxins  3,  4,  and  5.  
American  journal  of  physiology.  Cell  physiology,  281,  C215-­‐23.  
WAUGH,  D.  S.  2005.  Making  the  most  of  affinity  tags.  Trends  in  biotechnology,  23,  
316-­‐20.  
WEBB,  S.  E.,  LI,  W.  M.  &  MILLER,  A.  L.  2008.  Calcium  signalling  during  the  cleavage  
period  of  zebrafish  development.  Philosophical  transactions  of  the  Royal  
Society  of  London.  Series  B,  Biological  sciences,  363,  1363-­‐9.  
WEIDBERG,  H.,  SHVETS,  E.,  SHPILKA,  T.,  SHIMRON,  F.,  SHINDER,  V.  &  ELAZAR,  Z.  
2010.  LC3  and  GATE-­‐16/GABARAP  subfamilies  are  both  essential  yet  act  
differently  in  autophagosome  biogenesis.  The  EMBO  journal,  29,  1792-­‐802.  
WEINL,  S.  &  KUDLA,  J.  2009.  The  CBL-­‐CIPK  Ca(2+)-­‐decoding  signaling  network:  
function  and  perspectives.  The  New  phytologist,  184,  517-­‐528.  
WEISENBERG,  R.  C.  &  TIMASHEFF,  S.  N.  1970.  Aggregation  of  microtubule  subunit  
protein.  Effects  of  divalent  cations,  colchicine  and  vinblastine.  Biochemistry,  
9,  4110-­‐6.  
WEISS,  J.  L.,  ARCHER,  D.  A.  &  BURGOYNE,  R.  D.  2000.  Neuronal  Ca2+  sensor-­‐
1/frequenin  functions  in  an  autocrine  pathway  regulating  Ca2+  channels  in  
bovine  adrenal  chromaffin  cells.  J  Biol  Chem,  275,  40082-­‐7.  
WEISS,  J.  L.,  HUI,  H.  &  BURGOYNE,  R.  D.  2010.  Neuronal  calcium  sensor-­‐1  regulation  
of  calcium  channels,  secretion,  and  neuronal  outgrowth.  Cell  Mol  Neurobiol,  
30,  1283-­‐92.  
WHITAKER,  M.  2006.  Calcium  microdomains  and  cell  cycle  control.  Cell  calcium,  40,  
585-­‐92.  
WILDING,  M.,  WRIGHT,  E.  M.,  PATEL,  R.,  ELLIS-­‐DAVIES,  G.  &  WHITAKER,  M.  1996.  
Local  perinuclear  calcium  signals  associated  with  mitosis-­‐entry  in  early  sea  
urchin  embryos.  The  Journal  of  cell  biology,  135,  191-­‐9.  
WILSON,  G.  M.,  FIELDING,  A.  B.,  SIMON,  G.  C.,  YU,  X.,  ANDREWS,  P.  D.,  HAMES,  R.  S.,  
FREY,  A.  M.,  PEDEN,  A.  A.,  GOULD,  G.  W.  &  PREKERIS,  R.  2005.  The  FIP3-­‐
Rab11  protein  complex  regulates  recycling  endosome  targeting  to  the  
cleavage  furrow  during  late  cytokinesis.  Molecular  biology  of  the  cell,  16,  849-­‐
60.  
     275  
WINGARD,  J.  N.,  CHAN,  J.,  BOSANAC,  I.,  HAESELEER,  F.,  PALCZEWSKI,  K.,  IKURA,  M.  &  
AMES,  J.  B.  2005.  Structural  analysis  of  Mg2+  and  Ca2+  binding  to  CaBP1,  a  
neuron-­‐specific  regulator  of  calcium  channels.  J  Biol  Chem,  280,  37461-­‐70.  
WISHART,  D.  S.  &  SYKES,  B.  D.  1994.  The  13C  chemical-­‐shift  index:  a  simple  method  
for  the  identification  of  protein  secondary  structure  using  13C  chemical-­‐shift  
data.  Journal  of  biomolecular  NMR,  4,  171-­‐80.  
WONG,  R.,  FABIAN,  L.,  FORER,  A.  &  BRILL,  J.  A.  2007.  Phospholipase  C  and  myosin  
light  chain  kinase  inhibition  define  a  common  step  in  actin  regulation  during  
cytokinesis.  BMC  cell  biology,  8,  15.  
WONG,  S.  H.,  XU,  Y.,  ZHANG,  T.,  GRIFFITHS,  G.,  LOWE,  S.  L.,  SUBRAMANIAM,  V.  N.,  
SEOW,  K.  T.  &  HONG,  W.  1999.  GS32,  a  novel  Golgi  SNARE  of  32  kDa,  
interacts  preferentially  with  syntaxin  6.  Molecular  biology  of  the  cell,  10,  119-­‐
34.  
WOODS,  A.  S.,  MARCELLINO,  D.,  JACKSON,  S.  N.,  FRANCO,  R.,  FERRE,  S.,  AGNATI,  L.  F.  
&  FUXE,  K.  2008.  How  calmodulin  interacts  with  the  adenosine  A(2A)  and  the  
dopamine  D(2)  receptors.  Journal  of  proteome  research,  7,  3428-­‐34.  
WU,  Y.  Q.,  LIN,  X.,  LIU,  C.  M.,  JAMRICH,  M.  &  SHAFFER,  L.  G.  2001.  Identification  of  a  
human  brain-­‐specific  gene,  calneuron  1,  a  new  member  of  the  calmodulin  
superfamily.  Mol  Genet  Metab,  72,  343-­‐50.  
XIONG,  H.,  XIA,  K.,  LI,  B.,  ZHAO,  G.  &  ZHANG,  Z.  2009.  KChIP1:  A  potential  modulator  
to  GABAergic  system.  Acta  Biochimica  et  Biophysica  Sinica,  41,  295-­‐300.  
XU,  H.,  BRILL,  J.  A.,  HSIEN,  J.,  MCBRIDE,  R.,  BOULIANNE,  G.  L.  &  TRIMBLE,  W.  S.  2002.  
Syntaxin  5  is  required  for  cytokinesis  and  spermatid  differentiation  in  
Drosophila.  Developmental  biology,  251,  294-­‐306.  
YAKOVLEVA,  T.,  BAZOV,  I.,  CEBERS,  G.,  MARINOVA,  Z.,  HARA,  Y.,  AHMED,  A.,  
VLASKOVSKA,  M.,  JOHANSSON,  B.,  HOCHGESCHWENDER,  U.,  SINGH,  I.  N.,  
BRUCE-­‐KELLER,  A.  J.,  HURD,  Y.  L.,  KANEKO,  T.,  TERENIUS,  L.,  EKSTROM,  T.  J.,  
HAUSER,  K.  F.,  PICKEL,  V.  M.  &  BAKALKIN,  G.  2006.  Prodynorphin  storage  and  
processing  in  axon  terminals  and  dendrites.  The  FASEB  journal  :  official  
publication  of  the  Federation  of  American  Societies  for  Experimental  Biology,  
20,  2124-­‐6.  
     276  
YAMAGATA,  K.,  GOTO,  K.,  KUO,  C.  H.,  KONDO,  H.  &  MIKI,  N.  1990.  Visinin:  a  novel  
calcium  binding  protein  expressed  in  retinal  cone  cells.  Neuron,  4,  469-­‐476.  
YANG,  J.,  MCBRIDE,  S.,  MAK,  D.  O.,  VARDI,  N.,  PALCZEWSKI,  K.,  HAESELEER,  F.  &  
FOSKETT,  J.  K.  2002a.  Identification  of  a  family  of  calcium  sensors  as  protein  
ligands  of  inositol  trisphosphate  receptor  Ca(2+)  release  channels.  Proc  Natl  
Acad  Sci  U  S  A,  99,  7711-­‐6.  
YANG,  J.,  MCBRIDE,  S.,  MAK,  D.  O.  D.,  VARDI,  N.,  PALCZEWSKI,  K.,  HAESELEER,  F.  &  
FOSKETT,  J.  K.  2002b.  Identification  of  a  family  of  calcium  sensors  as  protein  
ligands  of  inositol  trisphosphate  receptor  Ca2+  release  channels.  Proceedings  
of  the  National  Academy  of  Sciences  of  the  United  States  of  America,  99,  
7711-­‐7716.  
YANG,  P.  S.,  ALSEIKHAN,  B.  A.,  HIEL,  H.,  GRANT,  L.,  MORI,  M.  X.,  YANG,  W.,  FUCHS,  P.  
A.  &  YUE,  D.  T.  2006a.  Switching  of  Ca2+-­‐dependent  inactivation  of  Ca(v)1.3  
channels  by  calcium  binding  proteins  of  auditory  hair  cells.  J  Neurosci,  26,  
10677-­‐89.  
YANG,  X.,  XU,  P.,  XIAO,  Y.,  XIONG,  X.  &  XU,  T.  2006b.  Domain  requirement  for  the  
membrane  trafficking  and  targeting  of  syntaxin  1A.  The  Journal  of  biological  
chemistry,  281,  15457-­‐63.  
YEE,  A.  A.,  SAVCHENKO,  A.,  IGNACHENKO,  A.,  LUKIN,  J.,  XU,  X.,  SKARINA,  T.,  
EVDOKIMOVA,  E.,  LIU,  C.  S.,  SEMESI,  A.,  GUIDO,  V.,  EDWARDS,  A.  M.  &  
ARROWSMITH,  C.  H.  2005.  NMR  and  X-­‐ray  crystallography,  complementary  
tools  in  structural  proteomics  of  small  proteins.  Journal  of  the  American  
Chemical  Society,  127,  16512-­‐7.  
YU,  Y.  Y.,  DAI,  G.,  PAN,  F.  Y.,  CHEN,  J.  &  LI,  C.  J.  2005.  Calmodulin  regulates  the  post-­‐
anaphase  reposition  of  centrioles  during  cytokinesis.  Cell  research,  15,  548-­‐
52.  
ZAAL,  K.  J.,  SMITH,  C.  L.,  POLISHCHUK,  R.  S.,  ALTAN,  N.,  COLE,  N.  B.,  ELLENBERG,  J.,  
HIRSCHBERG,  K.,  PRESLEY,  J.  F.,  ROBERTS,  T.  H.,  SIGGIA,  E.,  PHAIR,  R.  D.  &  
LIPPINCOTT-­‐SCHWARTZ,  J.  1999.  Golgi  membranes  are  absorbed  into  and  
reemerge  from  the  ER  during  mitosis.  Cell,  99,  589-­‐601.  
ZEITZ,  C.,  KLOECKENER-­‐GRUISSEM,  B.,  FORSTER,  U.,  KOHL,  S.,  MAGYAR,  I.,  
WISSINGER,  B.,  MATYAS,  G.,  BORRUAT,  F.  X.,  SCHORDERET,  D.  F.,  ZRENNER,  
     277  
E.,  MUNIER,  F.  L.  &  BERGER,  W.  2006.  Mutations  in  CABP4,  the  gene  encoding  
the  Ca2+-­‐binding  protein  4,  cause  autosomal  recessive  night  blindness.  Am  J  
Hum  Genet,  79,  657-­‐67.  
ZEITZ,  C.,  LABS,  S.,  LORENZ,  B.,  FORSTER,  U.,  UKSTI,  J.,  KROES,  H.  Y.,  DE  BAERE,  E.,  
LEROY,  B.  P.,  CREMERS,  F.  P.,  WITTMER,  M.,  VAN  GENDEREN,  M.  M.,  SAHEL,  J.  
A.,  AUDO,  I.,  POLOSCHEK,  C.  M.,  MOHAND-­‐SAID,  S.,  FLEISCHHAUER,  J.  C.,  
HUFFMEIER,  U.,  MOSKOVA-­‐DOUMANOVA,  V.,  LEVIN,  A.  V.,  HAMEL,  C.  P.,  
LEIFERT,  D.,  MUNIER,  F.  L.,  SCHORDERET,  D.  F.,  ZRENNER,  E.,  FRIEDBURG,  C.,  
WISSINGER,  B.,  KOHL,  S.  &  BERGER,  W.  2009.  Genotyping  microarray  for  
CSNB-­‐associated  genes.  Invest  Ophthalmol  Vis  Sci,  50,  5919-­‐26.  
ZENG,  Q.,  TRAN,  T.  T.,  TAN,  H.  X.  &  HONG,  W.  2003.  The  cytoplasmic  domain  of  
Vamp4  and  Vamp5  is  responsible  for  their  correct  subcellular  targeting:  the  
N-­‐terminal  extenSion  of  VAMP4  contains  a  dominant  autonomous  targeting  
signal  for  the  trans-­‐Golgi  network.  The  Journal  of  biological  chemistry,  278,  
23046-­‐54.  
ZHANG,  D.,  BOULWARE,  M.  J.,  PENDLETON,  M.  R.,  NOGI,  T.  &  MARCHANT,  J.  S.  2007.  
The  inositol  1,4,5-­‐trisphosphate  receptor  (Itpr)  gene  family  in  Xenopus:  
identification  of  type  2  and  type  3  inositol  1,4,5-­‐trisphosphate  receptor  
subtypes.  The  Biochemical  journal,  404,  383-­‐391.  
ZHAO,  X.,  VARNAI,  P.,  TUYMETOVA,  G.,  BALLA,  A.,  TOTH,  Z.  E.,  OKER-­‐BLOM,  C.,  
RODER,  J.,  JEROMIN,  A.  &  BALLA,  T.  2001.  Interaction  of  neuronal  calcium  
sensor-­‐1  (NCS-­‐1)  with  phosphatidylinositol  4-­‐kinase  beta  stimulates  lipid  
kinase  activity  and  affects  membrane  trafficking  in  COS-­‐7  cells.  J  Biol  Chem,  
276,  40183-­‐9.  
ZHENG,  Q.,  BOBICH,  J.  A.,  VIDUGIRIENE,  J.,  MCFADDEN,  S.  C.,  THOMAS,  F.,  RODER,  J.  
&  JEROMIN,  A.  2005.  Neuronal  calcium  sensor-­‐1  facilitates  neuronal  
exocytosis  through  phosphatidylinositol  4-­‐kinase.  J  Neurochem,  92,  442-­‐51.  
ZHOU,  H.,  KIM,  S.  A.,  KIRK,  E.  A.,  TIPPENS,  A.  L.,  SUN,  H.,  HAESELEER,  F.  &  LEE,  A.  
2004.  Ca2+-­‐binding  protein-­‐1  facilitates  and  forms  a  postsynaptic  complex  
with  Cav1.2  (L-­‐type)  Ca2+  channels.  J  Neurosci,  24,  4698-­‐708.  
     278  
ZHOU,  H.,  YU,  K.,  MCCOY,  K.  L.  &  LEE,  A.  2005.  Molecular  mechanism  for  divergent  
regulation  of  Cav1.2  Ca2+  channels  by  calmodulin  and  Ca2+-­‐binding  protein-­‐
1.  J  Biol  Chem,  280,  29612-­‐9.  
ZHU,  M.  X.,  EVANS,  A.  M.,  MA,  J.,  PARRINGTON,  J.  &  GALIONE,  A.  2010a.  Two-­‐pore  
channels  for  integrative  Ca  signaling.  Communicative  &  integrative  biology,  3,  
12-­‐7.  
ZHU,  M.  X.,  MA,  J.,  PARRINGTON,  J.,  GALIONE,  A.  &  EVANS,  A.  M.  2010b.  TPCs:  
Endolysosomal  channels  for  Ca2+  mobilization  from  acidic  organelles  
triggered  by  NAADP.  FEBS  letters,  584,  1966-­‐74.  
ZUO,  X.,  LI,  S.,  HALL,  J.,  MATTERN,  M.  R.,  TRAN,  H.,  SHOO,  J.,  TAN,  R.,  WEISS,  S.  R.  &  
BUTT,  T.  R.  2005.  Enhanced  expression  and  purification  of  membrane  
proteins  by  SUMO  fusion  in  Escherichia  coli.  Journal  of  structural  and  
functional  genomics,  6,  103-­‐11.  
  
  
